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1030 93 Amiodarone Inhibits Cardiac ATP-Sensitive K+ 
Douglas S. Holmes, Zhuo-Qian Sun, Lisa Porter, Michael Artman, 
Larry Chinitz. William A. Coetzee. The Heart Rhythm Center, New York 
University Medical Center, New York, New York, USA 
Background: The ATP-sensitive KC channel (KA~P) plays a role in patho- 
logic situations such as ischemic arrhythmogenesis. Blocking this channel in 
experimental models can reduce arrhythmias. We investigated the effects of 
amiodarone (amio) on cardiac K ATP channels and their sensitivity to ATP. 
Methods/Results: Single t<nTp channel activity was recorded using in- 
side-out patches from rat ventricular myocytes (symmetrical 140 mM K+ 
solutions and a pipette potential of +40 mV). Amio dose-dependently inhib- 
ited Kn~p channel activity (Figure). Compared to baseline current, the mean 
patch current (I/lo) was 1.0 i 0.05 (n = 4), 0.8 i 0.07 (n = 4), 0.6 f 0.07 (n 
= 5), and 0.2 + 0.05 (n = 7) after 80 s application of vehicle (DMSO) or amio 
0.1, 1 .O, IO PM respectively (ICso = 2.4 PM). The ATP sensitivity (E&) in 
the presence of 10 FM amio was 13 * 0.2 vs. 43 f 0.1 PM in controls (n = 
5; p < 0.05). Kinetic analysis showed that open and short closed intervals 
(bursting activity) were unchanged by 1 MM amio whereas interburst closed 
intervals were prolonged. Amio (10 PM) also inhibited whole cell Kb~p current 
(activated by 100 WM bimakalim). After a 10 min application of amio (10 wM), 
I/lo was 0.71 f 03 vs 0.92 i 0.09 in control (p < 0.03). 
Conclusion: Amiodarone rapidly and dose-dependently inhibited KATP 
channel activity by both increasing ATP-sensitivity and favoring channel 
closure. These actions may contribute to the antiarrhythmic properties of 
amiodarone. 
1030-94 H 34562 - A Novel Repolarization-Delaying 
Antiarrhythmic Agent With Greatly Reduced 
Proarrhythmic Potential 
Leif Carlsson, G&an Duker, Luc Hondeghem. AstraZeneca R&D Mblndal, 
Sweden, USA; HPC N. K, Oostende, Belgium 
5ackground: The usefulness of class Ill antiarrhythmic agents has been well 
demonstrated but partly limited by the potential risk of promoting torsades 
de pointes (TdP) in susceptible patients. H 345/52 was developed with the 
specific aim to delay cardiac repolarization without causing TdP. 
Methods/Results: Anesthetized rabbits were sensitized towards devel- 
oping TdP by a continues infusion of the orI-adrenoceptor agonist methox- 
amine and subsequently infused equipotent repolarization-delaying doses of 
H 345/52 (7 mg/kg, n = 8) or ibutilide (1 mg/kg, n = 8). H 345/52 prolonged 
the QT interval from 133 f 4.5 ms to 177 It 8.0 ms and ibutilide from 125 
+ 5.1 ms to 166 f 9.3 ms (mean & SEM, p < 0.001 vs baseline). However, 
whereas ibutilide induced TdP in 100% of the animals at only 0.02 + 0.345 
mg/kg, H 345/52 induced no TdP (p x 0.001 vs ibutilide) at up to 7 mg/kg. 
Conscious rabbits, a species prone to develop TdP when exposed to repolar- 
ization-delaying agents, were infused 7 mg/kg H 345/52 for 60 min. H 345/52 
significantly lengthened the QT interval (from 119 * 2.5 ms to 162 i 9.7 ms, 
p < 0.01, n = 8) and the RR interval (from 286 i 18.6 ms to 325 f 18.5 
ms, p < 0.05) but TdP was not induced in any animal. Langendorff-perfused 
rabbit hearts (basic cycle length 1000 ms) were used to assess the temporal 
variability of action potential duration (APD) and its relation to proarrhythmic 
activity. Summating the absolute difference between all action potentials in 
every minute quantified the variability of APD. Equipotent APD prolonging 
concentrations of H 345/52 (1.1 PM, n = 6) and the selective IK,-blocking 
agent almokalant (0.3 PM, n = 6) maximally prolonged APD from 264 f 23 
to 412 i 47 ms and from 251 i 17 to 436 i 72 ms, respectively. For the 30 
min perfusion period the mean deviation of APD increased from 3 f 0.4 ms 
in controls (n = 6) to 8 i 1.2 ms in H 345/52-perfused hearts and to 38 i 
7.5 ms in almokalant-perfused hearts (p < 0.001 vs H 345/52). Unequivocal 
early after-depolarizations (EADs), constituting 35.2 f 10.7% of the action 
potential amplitude, were seen in 5/6 almokalant-perfused hearts but in no 
heart perfused with H 345/52. 
Conclusion: H 345/52 delays cardiac repolarization without substantially 
increasing temporal dispersion of repolarization, without inducing EADs and 
without provoking TdP. These promising features of H 345/52 are currently 
evaluated for clinical efficacy against tachyarrhythmias. 
1030-95 The Degree of Interventricular Dispersion in 
Action Potential Duration Determines 
Susceptibility to Sudden Cardiac Death and 
Acquired Torsades de Pointes Arrhythmias 
Jurren M. van Opstal, Marc A. Vos, Jet D.M. Leunissen, Hein J.J. Wellens. 
Cardiology, CAR/M, Academic Hospital Maastricht, The Netherlands 
In our dog model of chronic complete AV-block, bradycardia-induced vol- 
ume overload leads to: 1) biventricular hypettrophy, 2) electrical remodeling 
with nonhomogeneous lengthening of action potential duration leading to 
pronounced interventricular dispersion of repolarization, defined here as LV 
minus RV monophasic action potential duration (AAPD), and 3) enhanced 
susceptibility to acquired Torsades de Pointes (TdP) and Sudden Cardiac 
Death (SCD). 
Methods: Fifty anesthetized dogs underwent an electrophysiological 
study including pacing protocols to induce TdP at 4-6 weeks of heart block. 
In all animals, AAPD at baseline and/or the ability to induce TdP by pacing 
was investigated in relation to the occurrence of SCD within weeks there- 
after. In a subset (n = 24) of the surviving dogs, the study was repeated 
after administration of the class-Ill drugs almokalant (0.12 mg/kg) or ibutilide 
(0.025 mg/kg), and the importance of AAPD at baseline for the occurrence 
of drug-induced TdP was investigated. 
Results: The incidence of SCD was 8150 dogs (16%). Six out of 8 SCD 
cases showed inducible TdP at baseline. Two of the eight dogs had telemetric 
ECG surveillance and both revealed polymorphic Vl as the cause of SCD. 
Baseline AAPD of the SCD group was much higher than of the non-SCD 
group (table, *p < 0.05). QT time, QT, and idioventricular rhythm were not 
different. 
Dogs susceptible to drug-induced TdP (12/24) already showed a signifi- 
cantly higher AAPD at baseline compared to non-susceptible dogs (table, #p 
4 0.05). This dispersion of repolarization at baseline doubled during class-Ill 
drugs, resulting in TdP in the susceptible group, being preceded by a much 
higher absolute AAPD. 
AAPD (ms) AAPD (ms) QT (ms) QT (ms) 
baseline Class Ill Baseline Class Ill 
SCD (n = 8) 
non SCD (n = 42) 
TdP during class Ill (n = 12) 
No TdP class Ill (n = 12) 
go+15 440 i 75 
55 i 35* 400 i 55 
80f15 16Oi65 405 i 65 515zt60 
40 i 25# 80 f 25# 375 f 40 460 * 60 
Conclusion: In our dog model of chronic complete AV-block the degree of 
interventricular dispersion in ventricular action potential duration at baseline 
determines susceptibility to SCD and acquired TdP. 
L--d 1030 96 Amiodarone Blocks the Late Sodium Current in Isolated Ventricular Myocytes of Explanted Failed 
Human Hearts 
Albertas I. Undrovinas, Victor A. Maltsev, Robert S.D. Higgins, 
Norman Silverman, Sidney Goldstein, Hani N. Sabbah. Henry Ford Heart 
and Vascular Institute, Detroit, Michigan, USA 
Background: Amiodarone (AMIO) exhibits mixed class I and Ill anti-arrhyth- 
mic properties. It has been studied in several randomized clinical trials and 
shown to be useful in the treatment of symptomatic ventricular arrhythmias 
in patients with chronic heart failure (HF). We recently reported the existence 
of a novel ultraslow inactivating and reactivating late sodium current (IN~L) 
in ventricular myocytes isolated from both normal (donor) and failing human 
hearts. In ventricular myocytes isolated from dogs with HF, we also showed 
that IN~L plays an important role in remodeling of the action potential in HF. 
In the present study, we tested the hypothesis that the class I anti-arrhythmic 
properties of AMIO are due, in part to blockade of IN~L. 
Methods: Studies were performed in ventricular myocytes isolated from 
explanted failed human hearts. IN=L was measured after 200 msec of the 
onset of 2 set depolarization step to -30 mV. 
Results: AMIO (5 PM) affected the steady state availability of IN~L by 
shifting the mid-point potential to -128 i 2 mV from -98 & 4 mV before 
drug (P < 0.002) and by increasing the slope to 8.6 f 0.3 mV from 7.1 i 
0.5 mV in the absence of AMIO (P 4 0.001). ICsO of the resting block was 
4.6 PM at 0.1 Hz. In contrast, AM10 (5 PM) had no effect on the peak of 
transient sodium current (IN~T). The decay time course, t, of IN~L but not IN~T, 
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was significantly accelerated by AM10 (371 f 39 vs 668 & 51 msec, P < 
0.004). 
Conclusion: AM10 preferentially blocks laa~ compared to friar. Based on 
these observation, we postulate that blockade of IN~L may be an important 
mechanism of the anti-arrhythmic potency of AMIO. 
1 1030-97 1 The Antipsychotic Agents Thioridazine, 
Chlorpromazine and Clozapine Block the 
Human-Ether-a-go-go-Related Gene (HERG) 
Potassium Channel: Cellular Mechanism for 
Proarrhythmia 
Hui Tie, Bruce D. Walker, Cameron B. Singleton, Jane A. Bursill, Ken 
R. Wyse, Stella M. Valenzuela, Min R. Qiu, Samuel N. Breit, Terry 
J. Campbell. Department of Medicine, Center for Immunology and Victor 
Chang Cardiac Research Institute, St. Vincent’s Hospital, Sydney Australia 
Background: Thioridazine and chlorpromazine are conventional phenoth- 
iazine antipsychotic agents which have been widely used for many years, 
Clozapine is the prototype of the newer atypical agents. Its use has increased 
markedly due to a superior efficacy to side effect profile. All three drugs have 
been associated with QT prolongation and sudden death. We examined the 
potential cellular electrophysiological basis underlying these observations by 
studying the effects of these agents on HERG channels. These channels are 
a primary target of drugs causing QT prolongation. 
Methods: Thioridazine, chlorpromazine, and clozapine were applied to 
HERG stably transfected into Chinese Hamster Ovary (CHOKI) cells. We 
used the whole cell configuration of the patch-clamp technique. 
Results: HERG tail currents were elicited at -60 mV after a 3.9 set 
depolarizing step from -80 mV to +30 mV. Thioridazine and chlorpromazine 
blocked these currents in a concentration-dependent manner, with an If& 
of 1.07 13 0.06 FM and 1.47 & 0.03 PM respectively. Block by thioridazine 
1 PM and chlorpromazine 3 JLM displayed no voltage-dependence between 
-30 and +30 mV, and no use-dependence at stimulation frequencies of 
0.1 and 0.5 Hz. Neither drug enhanced the rate of current decay during 
prolonged depolarizing pulses. Channel inhibition by thioridazine 1 PM and 
chlorpromazine 3 PM was independent of the depolarizing pulse duration 
using an envelope of tails protocol. Clozapine also blocked HERG tail currents 
with an ICso of 2.63 + 0.12 PM. As for the phenothiazines, clozapine block 
also displayed no voltage-dependence. 
Conclusion: Thioridazine, chlorpromazine and clozapine block the HERG 
potassium channel at clinically relevant concentrations (therapeutic con- 
centration: thioridazine 0.25-6 PM, chlorpromazine 0.6-2.5 PM, clozapine 
7.07-1.53 pm. All three drugs appear to preferentially bind to the closed 
channel state. Haloperidol and sertindole are two other antipsychotic agents 
which have been reported to block HERG channels. This blockade likely un- 
derlies the QT prolongation and proarrhythmia associated with this frequently 
prescribed group of drugs. 
I 1030 98 Antiarrhythmic Effects of a Novel Cardioprotective Drug, JTV519 on Atrial 
Fibrillation and Flutteyin the Canine Sterile 
Pericarditis Model 
Koichiro Kumagai, Hideko Nakashima, Naoki Gondo, Kikuo Arakawa. 
University Hospital of Fukuoka, Fukuoka, Japan 
Background: A new cardioprotective drug, JTV519 has blocking effects on 
inwardly rectifying K+ current as well as inhibition of Ca*+ current. However, 
its role in the atrial electrophysiology is unknown. Therefore, we investigated 
the antiarrhythmic effects of JTV519 on atrial fibrillation (AFib) and atrial 
flutter (AFI) in the canine sterile pericarditis model. 
Methods and Results: Of nine dogs with sterile pericarditis, 38 episodes 
of sustained (>30 s) AFib in 8 dogs and 24 episodes of sustained AFI in 
7 dogs were induced by the rapid atrial pacing. When AFib or AFI was 
sustained >I5 minutes, it was cardioverted and re-induced. The inducibility 
of AFib/AFI, the atrial effective refractory period (AERP) and the intra-atrial 
conduction time were compared before and after the continuous infusion of 
JTV519 (0.03 mg/kg/min). JTV519 significantly decreased the mean number 
of sustained AFib episodes (from 4.2 f 2.9 to 0 f 0, P < 0.01). In contrast, 
AFI was still inducible in 4 dogs after JTV519 (from 2.7 * 2.5 to 1.6 f 2.1, 
P= NS). JTV519 significantly prolonged AERP (from 123 f 18 to 143 f 14, 
from 127 f 18 to 151 i- 12 and from 132 f 13 to 159 i 9 ms, at basic cycle 
length of 200, 300 and 400 ms, respectively, P < O.Ol), but unchanged the 
intra-atrial conduction time (from 47 f II to 48 i 11 ms, P= NS). 
Conclusions: JTV519 produced significant antiarrhythmic effects on 
AFib, but not on AFI, in the canine sterile pericarditis model by mainly increas- 
ing AERP, suggesting that it may have potential as a novel antiarrhythmic 
agent for AFib. 
L-l...J 1030 99 Acute Effects of Dronedarone on Potassium Currents in Isolated Rabbit Ventricular Myocytes. 
Comparison With Amiodarone 
Wei Sun, Fuhua Chen, Jonnalagedda SM. Sarma, Bramah N. Singh. 
Cardiovascular Research Laboratories, Section of Cardiology, West Los 
Angeles VA Medical Center, UCLA School of Medicine, Los Angeles, CA, 
USA 
Background: Dronedarone (DR) is a new non-iodinated benzofuran deriva- 
tive structurally related to amiodarone (AM). Its electrophysiologic effects on 
the rabbit ventricular myocytes have not been reported. 
Methods: Rabbit ventricular myocytes were isolated by enzymatic disso- 
ciation. The whole-cell patch-clamp technique was used to study the delayed 
rectifier (Ix,), the inward rectifier (Ikr) and the transient outward (Ilo) potassium 
currents at 0, 1, and 10 PM concentrations of DR and AM. 
Results: DR and AM inhibited Ixr dose-dependently (Fig. A). 
Potenrml. mv PdmtM. tnv 
At +50 mV, DR and AM respectively decreased the peak tail current 
amplitude of Ikr (n = 12) by 57 & 5% (p < 0.001) and 46 f 8% (p < 0.001) 
at IO hM, and by 21 f 8% (p < 0.01) and 19 rt 8% (p c: 0.01) at 1 GM. At 
-120 mV, DR and AM respectively decreased 1x1 at a concentration of IO 
KM by 54 & 6% (p < 0.01) and 37 f 10% (p x 0.01) but not at 1 kM (Fig. 
B). Neither DR nor AM had significant effect on Ito at the tested doses. 
Conclusion: Both DR and AM inhibited cardiac Ikr and Ikr in the rabbit 
ventricular myocytes, with a tendency for DR to be more potent. These results 
are consistent with clinical data showing similar electrophysiologic properties 
of the two agents, despite the absence of iodine in DR. 
1 1030-i 00 1 Angiotensin II Antagonist Reduces 
Tachycardia-Induced Electrical Remodeling of 
the Atria 
Hideko Nakashima, Koichiro Kumagai, Hidenori Urata, Naoki Gondo, 
Munehito Ideishi. Kikuo Arakawa. Fukuoka University: Fukuoka, Japan 
Background: The blockade of the angiotensin II (Ang II) exerts a protective 
effect against myocardial injury. However, its role in atrial electrical remod- 
eling is unknown. Therefore, we investigated the effects of angiotensin-con- 
verting enzyme inhibitor, captopril, and Ang II type 1 receptor antagonist, 
candesartan, on atrial electrical remodeling. 
Methods and Results: In 19 dogs, the atrial effective refractory period 
(AERP) was measured at basic cycle length of ZOO, 300 and 400 ms before, 
during and after rapid atrial pacing. Rapid atrial pacing at 800 bpm was 
maintained for 3 hours. An infusion of saline (n = 8), captopril (n = 6), 
or candesartan (n = 5) was initiated 30 minutes before rapid pacing and 
continued until the protocol was completed. In the saline group, AERP at 
basic cycle length of 300 ms was significantly shortened during rapid atrial 
pacing (from 149 rt 11 to 132 f 16 ms, p < 0.01). In captopril or candesartan 
group, however, the AERP shortening post rapid pacing was completely 
inhibited (from 153 f 15 to 153 * 14 ms in captopril, from 142 i 9 to 147 f 
12 ms in candesadan, p = NS) and its degree (0 & 4% in captopril, 4 f 8% 
in candesartan) was significantly reduced compared to saline group (-11 i 
9%, p < 0.01 vs captopril orcandesartan). In saline group, the rate adaptation 
of AERP was lost, however, captopril or candesartan group maintained it. 
Conclusions: Inhibition of endogenous Ang II prevented tachycardia-in- 
duced AERP shortening. Ang II antagonist may provide a novel pharmaco- 
logical approach for the treatment of patients with atrial fibrillation. 
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/ 1031 59 Ability of Electrocardiography to Detect Atrial Septal Defect in Adults 
Radmira S. Greenstein, Gazala Naaz, William F. Armstrong. Division of 
Cardiology, University of Michigan, Ann Arbor, MI, USA 
Background: The ECG has been assumed to be a sensitive tool for the diag 
nosis of atrial septal defects (ASD’s). The classic descriptions of secundum 
ASD is right axis deviation (RAD) and incomplete right bundle branch block 
(IRBBB); primum ASD is left axis deviation (LAD) and IRBBB; sinus venosus 
ASD is negative P-wave in lead III. All have been described to have some 
degree of RVH and first degree AV block. The accuracy of these findings in 
the adult population has not been recently assessed. 
Methods: ECG’s of 66 patients with echo-proven ASD were reviewed. 
The rhythm, QRS and P wave axis, conduction pattern, and ventricular 
hypertrophy were recorded and analyzed by ASD type. 
Results: There were 49 secundum (74%), 5 primum (8%) and 12 sinus 
venosus ASDs (18%). 
ECGCriteria Total # f%) Secun # I%) Primum # f%) sv # m 
Sinus Rhythm 
Afibiflut 
Normal Axis 
RAD 
LAD 
FirstDegAVB 
Normal Cond 
IRBBB 
RBBB 
RVH 
Normal EGG 
51 (77) 36 (73) 
14 (21) 12 (24) 
46 (70) 36 (73) 
11 (17) 7(14) 
8 w 6 (12) 
10 (24) 6(16) 
33 (50) 26 (53) 
20 (30) 14 (29) 
4 (6) 4 (8) 
8 (12) 5 (10) 
I I I 
4 (80) 11 (92) 
1 (20) 1 (8) 
2 (40%) 0 (0) 
1 (20) 4 (33) 
2 (40) 0 (0) 
1 (25) 3 (27) 
0 (0) 7 (58) 
3 (60) 3 (25) 
0 (0) 0 (0) 
1 (20) 2 (16) 
20.(30) k(33) O’(O) 4 (33j 
Secundum ASD: Combination of RAD and IRBBB occurred in only 3 (6%). Primum ASD: 
combination of LAD and iRBBB occurred in 0 (0%). Sinus Venosus: negative P wave in 
lead III occurred in 8 (19%). 
Conclusion: The ECG is a poor predictor of ASD in the current adult 
population. The “classic” findings for each type of ASD were present in less 
than 20% of the cases. The most common ECG finding in the adult with ASD 
is a normal ECG. 
I-L-I 1031 60 Importance of Right Bundle Branch Block as an Independent Predictor of All-Cause Mortality - 
Report of 2485 Patients From a Single Center 
Barbara Hess@, Claire E. Snader, Eugene H. Blackstone, Frederic 
J. Pashkow, Michael S. Lauer. The C/eve/and Clinic Foundafion, C/eve/and, 
OH, USA 
Background: While the importance of a left bundle branch block (LBBB) as 
an important predictor of poor outcome is established, the prognostic signifi- 
cance of a right bundle branch block (REBB) as an independent predictor of 
mortality, other than in the setting of recent myocardial infarction or revascu- 
larization, is not well known. Furthermore, it is not known what impact RBBB 
has on outcome after consideration of exercise or nuclear data. 
Objective: To determine whether RBBB predicts all-cause mortality af- 
ter consideration of exercise capacity, nuclear perfusion defects, and other 
possible confounders. 
Methods: Analyses were based on 2485 consecutive adults (age 57 
It 12 years, 63% male) who were referred for symptom-limited exercise 
TI-201 SPECT testing. None had previous heart failure, valvular disease, or 
had undergone revascularization. All-cause mortality was assessed during 6 
years of follow-up. 
Results: RBBB was present in 191 patients (7.7%), LBBB in 42 (1.7%). 
There were 226 deaths (9.1%). On univariate analysis, RBBB was a strong 
predictor of death (16% vs. 9%, relative risk [RR] 1.94; 95% Cl 1.32-2.85, P = 
0.0007, see Figure) as was LBBB (26% vs 9%, RR 3.31, 95% Cl 1.81-6.07, 
P < 0.0001). After adjusting for age, gender, exercise capacity, exercise 
heart rate response, TI-201 defects and standard risk factors, RBBB not only 
remained an independent predictor (adjusted RR 1.61, 95% Cl 1.08-2.34: 
P = 0.02), but showed an even stronger association with all-cause mortality 
than LBBB (adjusted RR 1.82, 95% Cl 0.97-3.44, P = 0.06). 
Conclusions: Among patients undergoing Thallium-201 SPECT, RBBB 
was an independent predictor of death even after considering exercise capac- 
ity, nuclear perfusion defects, and other risk factors. These findings suggest 
that the clinical management of patients with RBBB needs to be reevaluated. 
1 1031-61 1 Short-Long-Short Sequences Initiating l/3 of 
Spontaneous Ventricular Arrhythmias 
Anselm Schaumann, Christian Neufert, Bernd-Dieter Gonska, 
Karl-Heinz Kuck. St Georg Hospital Hamburg and University of Goetfingen, 
Germany 
Background: In this study the importance of short-long-short sequences 
as a trigger mechanism of spontaneous ventricular tachycardias (VTs) was 
analysed. 
Methods: The short-long-short sequence was defined for RR intervals 
with changes of >30% directly preceding the arrhythmia. In 250 patients with 
survived sudden cardiac death and implantable cardioverter-defibrillators 
(ICD) spontaneous arrhythmias were analysed for the preceding rhythm 
stored in the recorded ECG strip of the implanted device. Patients with atrial 
fibrillation and pacemaker dependent rhythm were excluded. 
Results: During a follow-up of 31 f 12 months 1004 spontaneous VTs in 
102 patients were analysed. A short-long-short interval with ~30% changes 
of RR intervals was obtained in 337 (33.6%) of 1004 spontaneous VTs and 
in 66 (65%) of 102 patients with spontaneous arrhythmia recurrences. The 
prolonged (long) RR interval was terminated in 60% by a sinus beat in 41 
patients with coronary artery disease compared to 33% in 18 patients with 
cardiomyopathy. A pacer-induced ventricular complex was seen at the end 
of the prolonged RR interval in 57% of patients with cardiomyopathy but only 
in 30% of patients with coronary artery disease. 
Conclusion: Short-long-short sequences are an important trigger mech- 
anism in 33% of spontaneous VT and were seen in 65% of the patients with 
recurrent arrhythmias. 
1031-62 Clinical Significance of ST-Segment Elevation in 
Lead Vl in Acute Inferior Myocardial Infarction 
Tetsuro Sugiura, Fumiyasu Yamazaki, Yoshiaki Tsuka, Kengo Hatada, 
Nobuyuki Takahashi, Fumio Yuasa, Toshiji Iwasaka. Kochi Medical School, 
Nankoku; Kansai Medical University: Moriguchi, Japan 
Background: Precordial ST-segment depression in acute inferior myocardial 
infarction (IMI) is associated with larger infarct size, but not many studies 
have focused on STelevation (STE) in lead VI Consequently, we examined 
the clinical significance of STE in lead VI. 
Methods: One-hundred thirty six consecutive patients (pts) with Q-wave 
IMI admitted ~12 hours from the onset of chest pain were studied by means 
of electrocardiogram (ECG), echocardiogram and coronary angiogram. Pts 
were classified into 3 groups on the basis of admission ECG: G-l = 25 
pts with STE in VI, G-2 = 87 pts with ST depression in Vl and G-3 = 24 
pts with no STchange in VI. In-hospital arrhythmias (sustained ventricular 
tachycardia, atrial fibrillation and complete atrioventricular block) were also 
evaluated. 
Results: Right coronary artery (RCA) was the infarct related artery in 
all pts in G-l. Pts in G-l (68%) had significantly higher incidence of right 
ventricular Ml than the other 2 groups. Although there were no significant dif- 
ferences in the number of left ventricular asynergic segments and incidence 
of in-hospital arrhythmias between G-l (3.5 i 1.1 and 48%) and G-2 (3.2 
i 1.5 and 41%), number of asynergic segments was larger and incidence 
of in-hospital arrhythmia was higher in G-l compared to G-3 (2.3 -i- 1.5 and 
17%). When STE in V2 was also considered, pts with STE only in VI (G-la: 
12 pts) had significantly higher incidence of right ventricular Ml than those 
with STE both in VI and V2 (G-lb: 13 pts) (92% vs 46%, p = 0.02), whereas 
G-lb had significantly higher incidence of 3 vessel disease than G-l a (54% 
vs 8%, p = 0.04). 
Conclusion: STE in lead Vl in Q-wave IMI was associated with RCA 
lesion. Pts with STE only in VI was suggestive of right ventricular Ml, whereas 
STE in both VI and V2 was associated with larger ischemic burden of the 
left ventricle. 
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) 1031-67 1 Use of Body Surface Mapping in Diagnosis of 
Acute Myocardial Infarction in Patients With 
Chest Pain and Left Bundle Branch Block 
Suzanne J. Maynard, Ganesh Manoharan, Ian B.A. Menown, A.A. 
Jennifer Adgey, James Allen, John McC Anderson. Royal Victoria Hospital, 
Belfast; University of Ulster, Jordanstown, UK 
Background: The diagnosis of acute myocardial infarction (AMI) in patients 
(pts) with left bundle branch block (LBBB) is challenging. In this study, we 
compared the diagnostic accuracy of the 12-lead ECG and body surface 
maps (BSM), using creatine kinase of ztwice the upper limit of normal as the 
gold standard. 
Methods: BSMs were performed on 2691 consecutive pts presenting with 
symptoms suggestive of AMI, using 64 anterior and 16 posterior electrodes 
mounted on a flexible plastic harness. All pts had a IPlead ECG within 30 
minutes of BSM. LBBB was defined as a QRS duration of ~0.12 s in the 
presence of a supraventricular rhythm and QS or rS complex in Vi and an 
R wave peak time of at least 0.06 s in lead I, V5 or V6 associated with the 
absence of a Q wave in the same lead. Inclusion criteria were met in 57 
patients (41 male, 16 female, mean age 69 years, with a history of ischaemic 
heart disease (IHD) in 48). Of the 57 pts, 11 had AMI as defined by creatine 
kinase. Thrombolytic therapy was given to 7 pts. In addition, BSMs were 
recorded from 21 pain-free controls with LBBB (17 male, 4 female, mean age 
63 years, with a history of IHD in 12 pts). Twelve lead ECGs were scored for 
AMI using; (a) 1 mm of ST elevation concordant with the QRS complex and 
occurring in any lead (score 5) (b) 1 mm of ST depression in leads Vi-V3 
(score 3) and (c) 5 mm of ST elevation discordant with the QRS complex and 
occurring in any lead (score 2). A total score of 3 or more represented AMI. 
From BSMs, QRS and ST-T isointegral maps were plotted. In LBBB with 
AMI, there is loss of the pattern of reversal of the positions of the maximum 
and minimum potential, which typically occurs between the QRS and ST-T 
isointegral maps in cases of LBBB without AMI. BSMs lacking this reversal 
represented a map diagnosis of AMI. 
Results: Of the 11 pts with AMI, 8 met BSM criteria for AMI, compared 
with only 3 using ECG criteria (sensitivity 73% vs 27%). Of the remaining 
46, BSM correctly excluded AMI in 36 compared with 44 using ECG criteria 
(specificity 78% vs 96%) and in 20 of 21 pain-free controls compared with 
21/21 for the 12-lead ECG (specificity 95% vs 100%). 
Conclusion: BSM is more sensitive than the 12-lead ECG scoring criteria 
for diagnosing AMI in LBBB, thus improving the patients’ potential for throm- 
bolytic therapy. Although specificity for exclusion of AMI was less with BSM 
than 12-lead ECG criteria the difference was not statistically significant (p > 
0.1). The results suggest that BSM has potential to be a useful diagnostic 
tool in the diagnosis of AMI in patients with chest pain and LBBB. 
I 1031 68 Can T Wave Normalization in Infarct-Related Electrocardiographic Leads During Exercise 
Testing Predict the Viability and Extent of 
Improvement of Wall Motion of Dysfunctioning 
Myocardium After Coronary Revascularization in 
Patients With Q-Wave Infarction? 
Tatsuhiko Hata, Seiichirou Motohara, Kunihiko Kosuga, 
Akiyoshi Kawashima, Shigeo Matsui, Yung-Sheng Hsu, Hideo Tamai, 
Hiromu Uehata. Shiga Medical Center for Adult Diseases, Moriyama. Japan 
Background: In treating patients with severely depressed LV function, it is 
crucial to know in advance what extent of functional recovery is expected 
from coronary revascularization (CR). 
Methods: To elucidate whether T wave normalization (TWN) in infarct- 
related electrocardiographic leads (IRLs) during exercise testing (ET) pre- 
dicts not only myocardial viability but also the extent of improvement of wall 
motion in the infarct area, we compared the results of TWN in IRLs during ET 
with changes in regional wall motion evaluated by left ventriculography (LVG) 
in 82 patients with a recent Q-wave anterior myocardial infarction (Ml) and 
negative T waves in at least 2 IRLs. All patients underwent ET using a cycle 
ergometer (ramp provocation follows 40 w x 4 min. steady state pedaling) at 
2 weeks after successful CR. Within 1 week prior to CR, coronary angiogra- 
phy (CAG) and LVG were performed. Four months after successful CR, CAG 
and LVG were repeated. The percentage of systolic segment shortening of 
the anterior infarct area was calculated befor and after CR. 
Results: The work load of the exercise-induced TWN is in inverse corre- 
lation (P < 0.01) with the degree of the increase in the percentage of systolic 
segment shortening in the infarct area after CR. 
Conclusion: TWN in IRLs during ET can predict not only the reversibility 
of dysfunctioning myocardium after CR, but also the extent of improvement 
of regional wall motion in patients with Q-wave Ml. 
I 1031 69 The Cumulative Effects of Historical and Physical Examination Findings on the Proonostic Value of 
the Electrocardiogram 
David M. Mirvis, Marshall J. Graney. Center for Health Services and Policy 
Research and Department of Preventive Medicine, University of Tennessee, 
Memphis, Memphis, Tennessee, USA 
Background: The electrocardiogram (ECG) has been shown in epidemi- 
ologic studies to be an independent predictor of survival. These studies 
adjusted for selected comorbidity and risk factor covariates simultaneously. 
The objective of this study was to assess the value of ECG as a predictor 
of survival when adjusting for findings from the clinical history and physical 
examination, as well as for risk factors and comorbidities, in a sequence 
that mimics the progressive collection of data during the common clinical 
encounter. 
Methods: The study included data from 4518 patients, ages of 60 to 
96 years, with isolated systolic hypertension followed for up to 6 years as 
part of the Systolic Hypertension in the Elderly Project. Survival curves and 
5-year survival rates (Cox regression) of groups with normal and abnormal 
ECGs were compared. Covariates representing demographic information, 
cardiovascular disease risk factors, clinical history and physical examination 
findings for each subject were added to the survival models in blocks se- 
quentially according to the progression of the common clinical encounter, 
and the independent significance of the ECG as a predictor of survival was 
assessed at each step by log rank and difference in proportions tests. 
Results: An abnormal ECG was recorded on entry in 55.4.% of subjects. 
An abnormal ECG was associated with reduced survival when no adjustment 
for covariates was made; the difference in 5-year survival rates (A survival) 
with abnormal EGG vs normal ECG = 5.39%, p < 0.001). Survival was also 
significantly (p < 0.001) different for groups with normal and abnormal ECGs 
when demographic (A survival = 3.65%) and risk factor (A survival = 3.10%) 
variables were included in the survival models. However, after findings from 
the clinical history (A survival = 2.99%) and physical examination (A survival 
= 2.92%) were added, the survival rates of groups with normal and abnormal 
ECGs were not significantly different (p > 0.05). 
Conclusion: The prognostic value of the ECG varies with the stage in the 
clinical encounter in which it is introduced. As part of a comprehensive clinical 
evaluation, it does not add significant independent predictive information. 
1031-70 Arrhythmic Events and ST-Segment Elevation in 
Brugada Syndrome 
Hideki Itoh, Masami Shimizu, Hidekazu Ino, Masato Yamaguchi, 
Hiroshi Mabuchi. The Second Department of Internal Medicine, School of 
Medicine, Kanazawa Universitl: Japan 
Background: In many patients with the Brugada syndrome, the ECG mani- 
festations were variable. We researched the relationship between arrhythmic 
events and ST-segment elevation in patients with ST-segment elevation in 
leads Vl to V3. 
Methods: We analyzed arrhythmic events in 22 patients (19 men; mean 
age, 52 f 16 years) with the Brugada syndrome EGG pattern. 
Results: Seven patients (32%) had experienced sudden near-death. We 
obtained five ECG recordings of instances of sudden near-death. Three 
patients were in atrial fibrillation, and their ST-segment elevations were more 
pronounced than those of baseline. Among those patients, whose ECGs were 
recorded during an episode of ventricular fibrillation or syncope, ST-segment 
elevation was less pronounced following a return to sinus rhythm. Paroxysmal 
atrial fibrillation was present in 7 of the 22 patients (32%) and Arrhythmic 
events of sudden near-death or atrial fibrillation occurred in 11 patients 
(50%). Arrhythmic events, that were aborted sudden death or paroxysmal 
atrial fibrillation, occurred frequently at night and ST-segment elevated when 
arrhythmic events occurred. 
Conclusion: Of 22 patients with Brugada syndrome, 32% had atrial 
fibrillation and 50% had ventricular arrhythmia or atrial fibrillation. Brugada 
syndrome seems to be related not only to ventricular tachycardia but also to 
atrial fibrillation, and may be influenced by vagal nervous activity. 
Age (yr) 
& Sex 
ST type Arrhythmic Events Events at night ST elevation 
72 M 
77 M 
42 M 
52 M 
41 M 
40 M 
50 F 
24 M 
40 M 
51 M 
51 M 
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1031 71 Beat-to-Seat QT Variability Identifies Myocardial 
Taizo Murabayashi, Barry J. Fetics, David A. Kass, Erez Nevo, Ronald 
D. Berger. Johns Hopkins University School of Medicine, Baltimore, 
Maryland, USA 
Background: Beat-to-beat QT variability (QTV) quantifies lability in ventric- 
ular repoiarization and has been shown to serve as a marker of arrhythmia 
risk. We hypothesized that myocardial ischemia destabilizes ventricular re- 
polarization and increases QTV. 
Methods: We analyzed 74 2-hour 2-lead digitized ECG records from 68 
patients in the European ST-T Database. All patients had ischemic episodes 
during the 2-hour record, annotated by the developers of the database, based 
on ST or T-wave changes in either ECG lead. We determined the normalized 
QTV and QT variability index (QTVI) for each 5-minute non-overlapping 
epoch by automated analysis, using the ECG lead of higher signal-to-noise 
ratio. Epochs were segregated as ischemic or nonischemic, based on the 
annotations supplied with the database. For each patient parameter values 
were averaged separately among ischemic and nonischemic epochs and 
compared by paired t-test. 
Results: Normalized QTV and QTVI were greater during ischemic episodes 
than during nonischemic episodes with high significance (Table). In addition, 
QTV and QTVI had high sensitivity and specificity for detecting ischemia 
(Figure: Receiver Operating Characteristic plots). 
Nonischemia lschemia P 
QTV 0.87 + 0.12 1.39 i 0.54 <0.0001 
QlVl -0.061 i 0.10 0.16 i 0.26 <0.0001 
Conclusions: Acute ischemia is associated with labile ventricular repo- 
larization which manifests as enhanced beat-to-beat QT interval variabil- 
ity. Quantification of QTV my serve as a sensitive and specific marker of 
ischemia. The association between ischemic repolarization lability and ar- 
rhythmic risk deserves further study. 
1 1031-72 1 Reduction in QRS Voltage in Significant 
Pericardial Effusion-Reversibility After 
Pericardiocentesis and After Antiinflammatory 
Drug Treatment 
Christian Bruch, Thomas Bartel, Guido Caspari, Stephan Sack, 
Raimund Erbel. Dept. of Cardiology: University fssen, Germany 
Background: A significant pericardial effusion is often accompanied by a 
reduction in QRS voltage observed in the electrocardiogram (ECG). This 
finding is attributed to accumulation of fluid within the pericardial space. Little 
is known about the reversibilty after therapeutic procedures, 
Patients &Methods: We recorded l2-lead-ECG’s in 12 patients (pts., 48 
i 24 years) with significant pericardial effusion (mean volume 512 & 185 ml, 
diastolic compression of the right ventricle, n = 12, dyspnoea at rest, n = 8, 
neck vein distension, n = 7) before and immediately after pericardiocentesis 
(group A, n = 9) as well as before and after antiinflammatory drug treatment 
(tr), group B, n = 3). In the peripheral EGG leads the maximum R-amplitude 
was quantified before (Rbr) and after therapy (R,r). In group B, drug tr was 
performed with prednisone, starting with 500 mg (n = 1) or 250 mg (n = 2) 
respectively. In group 8, the second ECG was obtained 6 + 3 days after 
initiation of drug tr. The volume of the pericardial effusion was quantified by 
echocardiography before (Vbr) and after (V,) therapy. 
Group Rbt cmv) Rat W) 
A (n = 9) 0.36 * 0.17 0.42 + 0.21* 
B (n = 3) 0.41 ?c 0.22 0.82 i 0.37t 
p < 0.05*: A VS. !3, p < 0.05+ bt vs. at 
Vbt (ml) Vat (ml) 
545 i 255 55 * 32’. + 
463 i 230 125&78+ 
Conclusion: Reduction in QRS voltage in significant pericardial effusion 
persists after successful pericardiocentesis, but not after successful antiin- 
flammatory treatment. Our findings suggest that not only fluid accumulation 
but also inflammation contributes to the delevopement of reduced QRS volt- 
age. 
I i 031 73 The Effect of Left Ventricular Mass, Size and Wall Thickness on the Electrocardiooraphic Criteria 
Used to Diagnosis Left Ventricdar’Hypertrophy 
Navin Budhwani, Sanjeev Patel, Edward M. Dwyer. UMDNJ - New Jersey 
Medical School, Newark, New Jersey, USA 
Background: In electrocardiographic (ECG) interpretation of left ventricular 
hypertrophy (LVH), LVH has been treated as a categorical or average value 
rather than a continuous variable. However, LVH has a wide range of left 
ventricular (LV) mass(M), LV wall thickness (WT) and LV diastolic dimensions 
(DD), each of which may influence one or more ECG criteria. The purpose of 
this study was to correlate the occurrence of ECG criteria with independent 
differences in LVM, LVWT and LVDD. 
Methods: We examined for LVH the ECG and echocardiogram of 608 
patients (pts) with LVWT > 13 mm and 71 patients with LVWT < IO mm and 
LVDD > 60 mm. LVM, LVWT, LVDD were calculated from 2D Echo studies. 
Four ECG criteria used were voltage (Cornell), QRS duration (290 ms), left 
atrial enlargement (pV1) and ST-T abnormalities. 
Results: Increasing LVWT (14-19+ mm) and increasing LVDD (40-60+ 
mm) without increased LVM did not produce a significant increase in any 
ECG criteria except for an increase in the frequency (40% to 65%) of an 
abnormal QRS (p < 0.001) in LVDD > 60 mm. This however did not affect 
the overall ECG interpretation for LVH. Increasing LV mass (200-600~ gm) 
resulted in a stepwise significant increase in the frequency of each of the four 
ECG criteria, a significant decrease (13% to 0%) in the number of normal 
interpretations (p < 0.01) and a significant increase in the frequency (27% to 
76%) of probable/definite LVH (p < 0.0001). 
Conclusion: The performance of the ECG in the interpretation is signifi- 
cantly improved as LV mass increases. Little or no improvement on ECG LVH 
criteria occurs when LVDD or LVWT increases without a concurrent increase 
in LV mass. 
/ 1031-74 ] False Positive ECG Reports of Myocardial 
Infarction in Women 
Rove1 Colaco, Thomas C. Aitchison, Peter W. Macfarlane. University of 
Glasgow, Department of Medical Cardiology: Royal Infirmary, Glasgow, UK 
Introduction: Precordial electrode placement in women is still a matter 
of controversy. The vast majority of technicians place relevant precordial 
electrodes underneath as opposed to on the breast so that recommendations 
for electrode placement with respect to the 4th and 5rh intercostal spaces 
are not always met. The effect of these different approaches has not been 
systematically studied to any significant extent, particularly using automated 
ECG analysis. 
Aim: The aim of this study was to quantify the effects of electrode place- 
ment under as opposed to on the breast and to determine whether this had 
any effect on false positive computer reports of myocardial infarction (Ml) 
in women due to poor R wave progression (PRWP) based on R amplitude 
measurements in V2-V4. 
Methods: The prevalence of .PRWP was calculated by assessing all 
ECGs recorded over a 2 week period in Glasgow Royal Infirmary and inter- 
preted automatically by the Glasgow Program. In a separate study, 8 ECGs 
were recorded on each of 85 women with a variety of non acute cardiac and 
other illnesses in the following sequence: Four were recorded at one minute 
intervals, two with precordial leads V3 to V6 placed on the breast in the 
correct anatomical positions and two with electrodes V3 to V6 placed at the 
highest point under the breast. This procedure was then repeated 30 minutes 
later. Case histories of 17 females with routine automated ECG reports of 
PRWP suggestive of anterior Ml were also reviewed. 
Results: ECGs from 755 male and 560 female patients showed that 
the prevalence of PRWP was 18.6% in females and 11.1% in males. In 
the 85 women studied, a significant difference in mean RV5 was found 
between electrodes placed on as opposed to under the breast (mean paired 
difference 0.128 mV, 95% Cl 0.05 to 0.21 mV, p = 0.002). Similar results were 
found in V6. For V3 and V4, however, there was no significant difference in 
R amplitude between electrodes placed on and under the breast, e.g. for 
V3 mean paired difference was -0.04 mV, 95% Cl -0.1 to 0.03 mV, p = 
0.2. Results were independent of breast size. In 21/85, a report of PRWP 
was found -8 only with electrodes on the breast, 7 only with electrodes 
off the breast and 6 in both cases. The positive predictive value for PRWP 
suggesting anterior Ml was 64% (11117). 
Conclusions: PRWP was more common in women than men but this is 
apparently not due to placing electrodes V3, V4, underneath instead of on 
the breast. A low positive predictive value was found for PRWP suggestive 
of anterior myocardial infarction in women indicating that this criterion should 
be discarded in females. 
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/ 1051 67 A Simple Intervention to Improve Physician Practices Regarding Antithrombotic Therapy in 
Patients With Atrlal Fibrillation 
Venkata Valeti, Linda Horton, Jeffrey Schwartz, Angel Lopez-Candales. 
Buffalo General Hospital, SUNY at Buffalo, Buffalo, NL: USA 
Background: Despite compelling evidence that antithrombotic therapy in 
atrial fibrillation (AF) is highly effective in stroke prevention, many people are 
still not receiving the appropriate therapy. Therefore, we assessed the impact 
of utilizing the electrocardiography (EKG) department and pharmacy (Pha) 
intervention on improving physician practices regarding anticoagulation in 
AF. 
Methods: An initial survey was done at a large tertiary care hospital 
using a retrospective chart review to identify patients with AF eligible for an- 
tithrombotic therapy. We followed the recommendations of the fourth ACCP 
consensus conference on antithrombotic therapy to assess the effectiveness 
of our intervention. Patients admitted to the hospital, during a three-month 
period, who had an EKG diagnosis of AF were identified by the EKG depart- 
ment EKGs were color tagged and Pha attached a summary of the current 
ACCP recommendations to the front of the chart. The primary physician 
made the final decision regarding therapy. The charts were later reviewed 
and compared to the baseline figures. A similar review was done six months 
later. 
Results: At baseline, we identified 78 patients eligible for warfarin, of 
whom 19 (24%) actually received it. Of the 33 patients eligible for aspirin 
(ASA), 6 (18%) received it. After our intervention, 84 patients eligible for 
warfarin were identified, of whom 53 (63%) received it. Of the 35 patients 
eligible for ASA, 28 (80%) received it. At six months, we also demonstrated 
similar gains (59% for warfarin and 80% for ASA). The absolute increase in 
the use of ASA in eligible patients was 35-39% and that of ASA was 62% 
These results were statistically significant (p < 0.001). 
Conclusions: A simple intervention of utilizing the EKG department to 
color tag the EKGs and Pha to place the current guidelines for AF ther- 
apy on the chart and discuss with the primary physician if needed, was 
highly successful in improving the physician practices regarding the use of 
antithrombotics in patients with AF. This benefit was sustained even at 6 
months after the initial intervention. The increased use of warfarin represents 
an excellent opportunity in the prevention of stroke in the high risk population. 
1051-68 The Importance of Distinguishing Typical From 
Atypical Atrial Flutter in Assessing the Risk of 
Left Atrial Thrombus 
David M. Gilligan, lthiel A. Fuller, Andrew Prinz, Brian K. Holdaway. 
Veterans Affairs Medical Center; Richmond, VA, USA 
Background: It has been increasingly recognized that atrial flutter may be 
associated with left atrial (LA) thrombus formation and a risk of thrombo- 
embolism. However, it is unclear if this risk differs between the different 
electrocardiographic (ECG) patterns of atrial flutter. 
Methods: Over a 4 year period transesophageal echocadiography (TEE) 
was performed in 300 patients (pts) with atrial tachyarrhythmias who were 
being considered for cardioversion or ablation and who had not had prior an- 
ticoagulation >I month duration, Using 12 lead ECG criteria the arrhythmias 
were classified as atrial fibrillation (Afib), typical (Typ) or aytpical (Atyp) atrial 
flutter (Aflu). 
Results: LA thrombi, predominantly in the LA appendage, were detected 
by TEE in a total of 67 pts (22%). LA thrombi were twice as common in pts 
with atypical flutter (22/89) compared to pts with typical flutter (12/96), p = 
0.03’, Figure. The incidence of thrombus in atypical Aflu was not significantly 
different from that in AFib, (33/115). On multivariate analysis only the type of 
arrhythmia (p = 0.006) and a history of stroke (P = 0.014) were predictive of 
LA thrombus. 
Conclusions: The electrocardiographic pattern of atrial flutter is a very 
important predictor of the risk of left atrial thrombus. Clinicians should distin- 
guish typical from atypical atrial flutter in assessing thromboembolic risk. 
[IO51 -69 1 Japanese Have Low Risk of lschemic Stroke in 
Patients With Nonvalvular Atrial Fibrillation; 
Analysis of 20,000 Cases 
Fumishi Tomita, Tetsuro Kohya, Tohru Kaji, Hisashi Yokoshiki, Minoru Sato, 
Yoshinori Ito, Kohjj Sasaki, Masanori Konno, Masayuki Sakurai, 
Akira Kitabatake. Hokkaido Universi& Sapporo, Japan 
Background: Because there are ethnic differences in coagulation activity 
and Japanese have weaker coagulability as compared with Caucasian, we 
may expect lower risk of thromboembolism and preventive effects of an- 
tiplatelet drugs (aspirin, ticlopidine) in Japanese with atrial fibrillation (AF). 
However, there have been less data as to the risk of thromboembolism and 
little consensus of the role of antithrombotic therapy for the prevention of is- 
chemic stroke in nonvalvular AF (NVAF) in Japan. The purpose of the present 
study was to examine the incidence of thromboembolism and the role of an- 
tithrombotic therapy for the prevention of ischemic events in Japanese with 
NVAF. 
Methods: Nineteen thousand eight hundred and twenty-five patients who 
visited the cardiovascular clinics between March and July 1995 were enrolled. 
First, we examined the prevalence of AF and clinical characteristics of the 
patients with AF. And then, we followed the patients with AF for 2 years and 
assessed the occurrence of ischemic events (cerebral infarction, transient 
ischemic attack, and peripheral artery occlusion). 
Results: (1) There were 2667 patients with AF, and the prevalence of AF 
was 14%. Of the whole AF, 81% was NVAF. (2) Antithrombotic therapy was 
used in 53% of NVAF; 8% with warfarin and 45% with antiplatelet drugs. (3) 
The incidence of ischemic events during 1.7 year follow-up period was 3.2% 
in NVAF with neither history of cerebrovascular accidents nor antithrombotic 
therapy. Warfarin reduced the risk of ischemic events by 41% but antiplatelet 
drugs did not. 
Conclusions: The present study suggests that Japanese may have lower 
risk of thromboembolism in patients with NVAF. However, the preventive ef- 
fect of antiplatelet drugs for thromboembolism still remains to be determined. 
l.i-2-l 1051 70 Value of Transesophageal Echocardiography to Assess the Embolic Risk in Patients With Atrial 
Fibrillation Undergoing Electrical Cardioversion 
Karlheinz Seidl, Ralf Zahn, Caroline Bergmeier, Silke Breunung, 
Monika Rameken, Gregor Siemon, Jochen Senges. Heart Center 
Ludwigshafen, Germany 
Guidelines for anticoagulation (A) prior to cardiovemion (CV) of atrial fibril- 
lation (Afib) recommend, in the absence of contraindications, >3 weeks of 
warfarin A in Afib lasting longer than 48 h, and no A for Afib ~48 h before 
the CV. Aim of this prospective study was 1) to determine the incidence of 
left atrial thrombi prior to CV in patients with persistent (>48 h) Afib despite 
effective A (INR > 2) and 2) to assess the value of transesophageal echo- 
cardiography (TEE) before electrical CV in patients with persistent (>48 h) 
Afib regarding intrahospital embolic risk despite effective A (INR > 2). 
Methods: We performed 579 consecutive electrical CV in patients with 
Afib. A was effective in 538/579 CV (93%). The first 235 consecutive CV 
in patients with effective A were performed without TEE guidance, in the 
following 303 CV, TEE was performed prior to CV despite effective A. TEE 
was performed before all 41 CV with ineffective A. 
Results: TEE revealed 20 thrombi (8.6%) and in 17 patients severe or 
moderate spontaneous echocardiographic contrast were found (5.6%) before 
CV in patients with effective A. No CV was performed in these patients. TEE 
revealed thrombi and severe to moderate spontaneous echo contrast in 
8/41 patients (20%) with ineffective A. Again no CV was performed in these 
patients. 
Embolic Risk: (TIA = transient ischemic attack) 
CV, INR > 2, CV INR > 2, CV, INR c 2, 
TEE no TEE “es TEE “es 
No of pts 
Stroke 
TIA 
embolism 
all events 
235 pts 266 pts 33 pts 
1 pt (0.43%) 0 Pt 1 pt (3%) 
0 Pt 1 pt (0.4%) 2 pt (6%.) 
1 pt (0.43%) 0 Pt 0 Pt 
2 Llts (0.9%) 1 Dt (0.4%) 3 ots 19%) 
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Conclusion: 1. TEE revealed leff atria1 thrombi in about 7% of patients 
undergoing electrical CV despite effective oral A. 2. The embolic risk after 
TEE guided CV in patients with ineffective A was high (9%). 3. TEE guided 
CV in patients with effective A seems to be associated with decreased risk 
for embolic events (0.9% + 0.4%). 
/ 1051-71J Platelet Activation, Thrombus Generation and 
Fibrinolysis: A Comparison Between 
Radiofrequency Catheter Ablation of Pulmonary 
Veins for Paroxysmal Focal Atrial Fibrillation and 
Left Accessory Pathway Atrioventricular Reentry 
Tachycardia 
Ting-Yu Chiu, Ming-Ji Charng, Shih-Ann Chen, Chern-En Chiang, 
Ching-Tai Tai, Yung-Kuo Lin, Tz-Chong Chou, Philip Yu-An Ding. Veteran 
General Hospital-Taipei, and National Yang-Ming University, Taipei, Taiwan 
Background: The risk of thromboembolism during and after radiofrequency 
catheter ablation (RFCA) of pulmonary veins (PVs) for the treatment of 
paroxysmal focal atrial fibrillation (PFAF) has not been well studied. We 
checked platelet activation, thrombogenesis and fibrinolysis in RFCA of PVs 
for PFAF and RFCA for atrio-ventricular reentry tachycardia with left side 
accessory pathway (AVRT-L). 
Methods: 19 PFAF patients underwent RFCAof pulmonary veins through 
trans-atrioseptal procedure, receiving aspirin 100 mg/day plus ticlopidin 
300 mg/day before the procedure and intravenous heparin after the trans- 
atrioseptal procedure. 17 AVRT-L patients underwent RFCA with retrograde 
transaortic procedure without any antiplatelet or anticoagulant medication. 
Blood samples were taken from peripheral veins before the procedure (BL), 
after sheath insertion (Sheath in), post diagnostic EPS but before RFCA 
(Pre-Abl), post RFCA (Post-Abl) and 48 hours after the procedure (48 
hrs). P-selectin, thrombin-antithrombin complex (TAT), plasma D-dimer (DD), 
markers of platelet activation, thrombogenesis and fibrinolysis, respectively, 
were quantified by ELISA method. 
Results: Under antiplatelet and anticoagulant therapy, P-selectin was 
lower in PFAF than in AVRT-L, especially at 48 hrs (p < 0.001). TAT was 
also significantly lower in PFAF than in AVRT-L during the whole procedure 
but showed no difference at 48 hrs. However, plasma DD was still elevated 
in both groups, and there were no significant differences between PFAF and 
AVRT-L. 
Conclusion: Under both antiplatelet and anticoagulant therapy, the throm- 
bogenic potential in RFCA of PVs for PFAF might be lower in comparison 
with that in RFCA for AVRT-L. However, fibrin turnover, estimated by DD 
level, was similar between the two groups. A better antithrombotic regimen 
may still be necessary to further lower the risk of thromboembolism. 
P-selectin, TAT, DD between PFAF and AVRT-L (Median & Range) 
P-selectin (ng/mL) 
PFAF 54.5 
(18.3-98.2) 
AVRT-L 58.5 
(28.5-102.9) 
TA-r WL) 
PFAF 1.6 
(0.3-56) 
AVRT-L 
(0.4Jl1.3) 
D-Dimer (@g/L) 
PFAF 54.8 
(14.3-340.8) 
AVFIT-L 51.6 
(12.7-660.9) 
Sheath-in 
44.2 
(20.9-70)* 
55.4 
(37.7-96.9) 
19.8 
(6.9-62.7)* 
5.5 
(3.4-33) 
56.7 
(16-217.6) 
48.9 
(14.1-1051.6) 
Pre-Abl 
48.6 
(29.6-70.9) 
55.0 
(34.7-95.8) 
8.3 
(2-22.9)* 
22.1 
(16.9-107.9) 
172.9 
(62.2-l 338.2) 
78.6 
(16.7-718.7) 
Post-Abl 48 hrs 
45.9 43.2 
(27.5-72.7)* (25.6-65.8)* 
61.2 65.1 
(38.4-117.3) (26.9-124) 
6.1 7.2 
(1.3-20.5)* (1.1-122) 
33.9 1.4 
(9.8-179.1) (0.7-79) 
385.5 118.0 
(61 A-1342.2) (48.8-287) 
89.9 95.9 
(25.9-579.7) (45.9-533.9) 
* p c 0.05 between PFAF and AVRT-L at the same time point 
I 1051 72 Alterations of Release Pattern of Endothelial Dependent Hemostatic Factors and Cell Adhesion 
Molecules in Nonvalvular Atrial Fibrillation 
Ralph Winkler, Rahime Gok, Barbel Klein, Hannelore Beeck’, 
Peter Hellstern’, Gunnar Taubert, Bernhard R. Winkelmann, 
Jochen Senges. Herzzenfrum Ludwigshafen; ‘Insfitut fiir H2mostasioiogie, 
Ludwigshafen, Germany 
Background: Abnormalities of the hemostatic system are often seen in 
patients (pts) with chronic nonvalvular atriai fibrillation (AF). We investigated 
endothelial dependent hemostatic factors and endothelial markers such as 
cell adhesion molecules (VCAM-I, ICAM-I, E-selectin) in AF. 
Pts and Methods: 1340 pts scheduled for elective coronary angiography 
were investigated. Pts with acute coronary syndromes, malignancy, liver, kid- 
ney, acute or chronic inflammatory disease, coumadin or heparin treatment 
were excluded Fasting blood was obtained in the morning to minimize cir- 
cadiane change. Measurement of factors was done by commercial available 
kits. 
Results: 
SR (n = 1245) AF (n = 95) univ.p adj. p” 
Age (years) 61 i 11 64fll <O.Ol 
ACE-inhibitors/aspirin 45%/75% 52%165% both <0.05 
vWillebrand factor (%) 158&68 164f66 <0.05 0.07 
Protein S activity (%) 121 i 31 ilOi35 <0.05 <0.05 
Thrombomodulin (PgIL) 53 * 20 47f17 <0.05 0.1 
tPA antigen &g/L) 12&6 1519 <O.OOl <O.OOl 
PAI-1 antigen (&g/L) 31 i 22 42 + 34 <0.005 <O.OOl 
VCAM-1 (@g/L) 788 i 241 908 rt 331 <0.005 co.05 
ICAM- (pg/L) 245 i 77 256 + 78 0.3 0.6 
E-selectin (&g/L) 36 ct 21 38121 0.5 0.4 
(sinus rhythm = SRJ; *adjusted for age, the rate of ACE-inhibitors and gspirin 
No differences between groups were seen in gender, CAD, hypertension, 
diabetes, cholesterol, homocystein, alcohol intake, smoking, leukocyte count, 
C-reactive protein, fibrinogen, D-dimers, prothrombin time, CSE-inhibitor 
treatment. 
Summary: Significant differences between pts in AF compared to pts 
in SR showed: 1) older age, 2) increased activity of markers of endothelial 
fibrinolysis, 3) increased protein S activity, 3) elevated levels of VCAM-I, but 
no differences in the other endothelial cell/leukocytes adhesion molecules. 
Conclusion: AF is significantly associated with changes in the endothe- 
lial-dependent hemostasis and profile of endothelial leukocyte adhesions 
molecules. 
!---IL IO.51 73 Incident Thromboembolism in the Aorta, Renal, Mesenteric, Pelvic, or Extremity Arteries After 
Discharge From Hospital With a Diagnosis of 
Atrial Fibrillation 
Lars Frost, Gerda Engholm, Seren Johnsen, Henrik Msller, Steen Husted. 
Department of Cardiology; Amtssygehuset, University Hospital, Aarhus; 
Centre for Research in Healfh & Social Statistics, Copenhagen, Denmark 
Background: Atrial fibrillation (AF) is a risk factor for peripheral thromboem- 
bolic events (PTE). We estimated the risk of PTE in patients discharged with 
AF relative to the risk in the Danish population. 
Methods: A random sample of 29 802 patients aged 50-89 years with a 
diagnosis of incident AF in the Danish National Hospital Discharge Register 
during the period 1980-1993 was studied. Data on previous or concomi- 
tant cardiovascular morbidity during the period 1977-l 993 was taken from 
the register. Endpoint: First PTE recorded in the Danish National Hospital 
Discharge Register after discharge with index AF diagnosis. Risk estimates 
were calculated by Poisson regression analysis (multiplicative model) using 
the Danish population as reference population. 
Results: 
Adiusted relative risk (95% Cl1 of PTE in AF oatients 
Males Females 
Age 50-59 years 
60-69 years 
70-79 years 
80-89 years 
Hypertension 
Diabetes 
Congestive heart failure 
Isch. heart dis. with Ml 
Isch. heart dis. without Ml 
Stroke 
Perioheral arterioscl. 
6.0 (3.7-9.7) 
4.0 (2.7-6.0) 
3.7 (2.5-5.3) 
1.9 (1.2-3.0) 
0.9 (0.6-l .3) 
1.8 (1.2-2.6) 
1 .o (0.7-i .3) 
1.4 (1 .o-2.0) 
1.3(1.0-1.8) 
1.5 (1.0-2.3) 
2.6 11.6-4.1~ 
4.3 (2.0-9.4) 
6.8 (4.8-9.7) 
4.9 (3.6-6.5) 
3.2 (2.3-4.3) 
1.5 (1.2-l .9) 
1.2 (0.9-i .6) 
1.4(1.2-1.8) 
1.4 (1.0-l .9) 
1.1 (0.8-1.3) 
1.2 (0.9-I .7) 
2.8 (1.9-4.2) 
Conclusions: Patients discharged from hospital with AF have a two- to 
six-fold excess in PTE risk. PTE risk is further increased in the presence of 
diabetes and cardiovascular comorbidity. 
1051-74 Incidence of Cerebral Thromboembolic Infarction 
Associated With Paroxysmal and Persistent or 
Permanent Atrial Fibrillation 
Hikaru Muramatsu, Toshiro Shimura. Department of infernal Medicine, 
Kasugai Hospita/, Yamanashi; Department of Neurosurgery, Nippon Medical 
School, Tokyo, Japan 
Background: Chronic atrial fibrillation (AF) is associated with significant 
morbidity, increasing an increased susceptibility to embolic stroke. Recently, 
chronic AF may be divided into paroxysmal, persistent and permanent. We 
elucidated the clinical features of patients with two subtypes of chronic AF, 
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i.e. paroxysmal and persistent or permanent AF, and compared the incidence 
of cerebral thromboembolism between each group. 
Subjects: The study included 301 consecutively admitted patients with 
chronic AF (121 paroxysmal AF (group A) and 180 persistent or permanent 
AF (group B) patients), 188 men and 113 women from 34 to 97 years of age. 
Results: The mean @SD) age of patients in group B (73 rt 11 yrs) 
was significantly greater (p = 0.029) than that in group A (70 i 12 yrs). 
Echocardiographic diameter of the left atrium in group B (45 i IO mm) 
was significantly larger (p = 0.004) than that in group A (37 i 7 mm). Left 
ventricular ejection fraction in group B (61 i 14%) was significantly smaller (p 
= 0.016) than that in group A (67 f 11%). The incidence of congestive heart 
failure was significantly greater (p < 0.001) in group B (51%) than in group 
A (21%), and mortality in group B (13%) was significantly higher (p = 0.045) 
than in group A (6%). However, the risk of cerebral thromboembolism in 
group B (26% or &O%/year) was not significantly larger (p = 0.136) than that 
in group A (17% or 5.2%/year). Cerebral thromboembolism occurred in 81% 
and 94% of the patients 60 years or older in groups A and B, respectively. 
The incidence of cerebral thromboembolism in patients without underlying 
disorders in group A was only 7% (p < 0.01). 
Conclusion: The risk of cerebral thromboembolism in patients with parox- 
ysmal AF was essentially equal to that with persistent or permanent AF. An- 
tithrombotic therapy was recommended for those patients 60 years or older 
in both groups, and for those with paroxysmal AF with underlying disorders. 
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1052-93 Optimization of Atrial Defibrillation Pathways 
Without Use of Coronarv Sinus Leads in Patients 
Receiving Medtronic 7260 Dual Chamber 
Defibrillator (Jewel AF) 
G. Muqtada Chaudhry, Eduardo Warman, David Casavant, S. Dinakar Satti, 
Craig S. Vinch, Patricia Pacetti, Thomas Marchese, Charles I. Haffajee. St 
Elizabeth’s Medical Center, Tufts University School of Medicine, Boston, 
MA; Medtronic Inc., Minneapolis, MN, USA 
Right atrium (RA) to coronary sinus (CS) shock configuration yields the lowest 
defibrillation thresholds (DFTs) for atrial fibrillation (AF). The Jewel AF ICD 
uses various atrial defibrillation pathways, biphasic shocks, DDDIAAINVI 
pacing and atrial/ventricular antitachycardia pacing. We sought to determine 
which current pathway produces optimal atrial DFTs when using minimal 
obligatory VF lead systems without using a CS lead. The purpose of this 
study was to compare two of these possible pathways. 
Methods: Eighteen patients undergoing ICD implant for ventricular tach- 
yarrhythmias and concomitant AF were studied. The patients were aged 
57-86 years and had left ventricular ejection fraction of 0.28 & 0.02 (range 
0.10-0.6) and left atrial size of 4.46 f 0.16 (3.5-5.8) cm. Active fixation 
tranvenous defibrillating leads were placed at the RV apex and in RA. An 
active can Jewel AF ICD was implanted in left pectoral region and used for 
device based testing. Atrial DFTs (A-DFTs) were measured in a randomized 
fashion using a step up protocol between two configurations i.e., RV + RA(+) 
+Can(-) and RV(+) +RA + Can(-). Two AF conversions at the lowest energy 
for defibrillation were considered A-DFT. Waveform tilt was 50% if pathway 
impedance was >40 R and 65% otherwise. 
Results: 
RV + RA(+)+Can(-) RV(+)+RA + Can(-) pValW 
A-DFT (J) 9.6 5 6.9 16* 10 0.03 
Impedance (n) 43f 13 30*13 <O.Ol 
A-DFT was < 12 J for 13 pts with RV + RAGan vs 7 pts for the RV+RA + Can 
Conclusions: It is possible to achieve atrial defibrillation in ICD candi- 
dates with low EF, enlarged atria, VTNF and AF using lead systems in RA 
and RV with pectoral active can without need for a separate CS lead. Using 
this lead system the lowest DFT is obtained with the RV + RA(+)+Can(-) 
pathway. 
I i 052 94 Longest RR Interval in Atrial Fibrillation Predicts Outcome of Subsequent Cardioversion: 
A Prospective Study 
Xiao Hua Guo, Mark M. Gallagher, Jan Poloniecki, Yee Guan Yap, Gang Yi, 
Lisa Luddington, Marek Malik, A. John Camm. Sf George’s Hospital Medical 
School London, UK 
Background: We hypothesized that abnormal long RR intervals in atrial 
fibrillation (AF) reflect disturbed conduction in the AV node and its atrial 
approaches. This surface ECG index may predict the outcome of Direct 
Current Cardioversion (DCC). 
Methods: Ambulatory ECG was recorded for 24 h before and during DCC 
on 76 patients (pts) with persistent AF (57 M, 65 f 10 ys). ECG was recorded 
1 month after DCC to assess outcome. The longest RR interval over 24 h 
was obtained from each case. One-way ANOVN, x2, Fisher’s Exact Test and 
multiple regression were used. 
Results: Failed DCC (F-DC), defined as uninterrupted AF or sinus rhythm 
(SR) for ~5s occurred in 18 (23%) pts. Successful DCC (S-DC), as SR was 
restored for >5s in 58 (77%) cases. Out of 58 pts, 37 (64%) relapsed 
AF (R-AF) between 5s-30 days, 21 (36%) pts had SR restored for >30 days 
(SR-I m). F-DC and R-AFgroups had significant longer maximum RR interval 
over 24 h compared with SR-1 m group (F = DC 2553 i 670 ms; R-AF: 2483 
i 590 ms; SR-1 m: 2087 f 485 ms; p = 0,023). They were appeared 
predominantly in the day = time (6:00-21:OO p = 0.01 Fig) Multivariate 
analysis using AF duration, left atrial size and age, only dichotomy limits of 
Longest RR interval was an independent predictor for both F-DC (RR 2900 
ms p = 0.017) and AF relapsed in 1 month (RR 2600 ms p = 0.024) (Tab). 
Conclusion: Prolongation of RR interval in AF may reflect the degree of 
abnormality in intra-atrial and AV nodal conduction. The degree of longest 
RR interval in AF especially in day = time, can predict failure of DCC and 
recurrence of AF in 1 month. 
Longest R&m (Day) 
RR> 2900 me 2600 ms 
D,S v” DtS % 
S-DC: 10 (17.2) SR-1 m: 2 (9.5) 
F-DC: 8 (44.4) R-AF: 16 (43.2) 
P value 0.018 0.009 
Pos Pred % 44.4 66.9 
Neg Pred % 82.8 47.5 
Sells % 44.4 43.2 
Soec % 82.8 90.5 
[1052-95 1 Efficacy of Anti-Tachy-Pacing (ATP) Therapies 
and Low Energy Cardioversion in Terminating 
Spontaneous Atrial Tachyarrhythmias in Patients 
With Dual Implantable Defibrillator 
R. Ricci, C. Pandozi, G. Altamura, S. Toscano, F. Miraglia’ , 
A. Grammatico’ , F. deSeta’ , M. Santini. Dept of Cardiology, San Fikppo 
Neri Hospital Rome; ‘Medtronic, Italy 
Background: Atrial fibrillation (AF) is a very common arrhythmia in patients 
wearing an implantable cardioverler defibrillator (ICD), leading to palpitations, 
heart failure, angina, stroke and inappropriate discharge of the device. The 
dual implantable defibrillator (Medtronic Inc., Minneapolis, USA, model 7250) 
combines dual chamber ICD features with the capability of automatically 
detecting and treating atrial tachycardia (AT) and AF. Available atrial therapies 
include ATP (Ramp, Burst+, 50-Hz Burst) and Low-Energy Cardioversion. 
Methods: To evaluate the efficacy of the dual d&fibrillator in detecting and 
treating AT/AF, 39 patients, 32 M, F, mean age 65 & 10 years, were implanted 
and followed for 8 f 7 months (range l-24). 21 patients had ischaemic heart 
disease, 9 idiopathic dilated cardiomyopathy and 9 other heart diseases. 
Mean LVEF was 39 f 9%. 18 had AT/AF before implantation. A two lead 
configuration (.right atrium and double coil right ventricle) was utilized. 
Results: Atrial defibrillation threshold (ADFT) at implant was 5.4 * 3.3 J. 
During the follow-up 215 sustained atrial episodes were detected. 112 were 
clinically classified as AT (52%), 98 as AF (46%) and 5 (2%) as sinus rhythm. 
The detection positive predictive value was 98%. The therapy success rates 
were: 1) AT: ATP = 85% (90/106), atrial shock = 100% (6/6); 2) AF: 50-Hz 
Burst = 19% (14/72), atrial shock = 57% (15/26). The mean energy delivered 
was 17 f 7 J in effective shocks and 10 i 8 J in ineffective. ATP efficacy 
strongly correlated with the median AA interval at arrhythmia onset, showing 
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the zest results dealing with atrial cycles between 220 and 280 msec. In 9/11 
ineffective shocks delivered energy was 5 2ADFT at implant. In 2/11 high 
ADFT was observed (>27 J). 
Conclusions: Painless ATP therapies demonstrated very high efficacy 
on AT and mild, but valuable effect on AF. Atrial shock had 100% efficacy on 
AT, while efficacy on AF was strongly dependent on delivered energy level 
and relationship between implant ADFT and device programming. 
1052-96 Atrial Tachyarrhythmias in Patients With a 
Dual-Chamber Cardioverter-Defibrillator: Efficacv 
of Atrial Therapies 
M. Rameken, H. Schwacke, G. Siemon, M. Vater, S. Breunung, J. Senges, 
K. Seidl. Herzzentrum Ludwigshafen, Cardiology, Germany 
Aim of this analysis was to evaluate incidence of atrial tachyarrhythmias 
and efficacy of atrial therapies in patients (pts) with a Jewel AF 7250 dual 
chamber implantable cardiovener defibrillator (Medtronic Inc.). This device 
incorporates a dual chamber detection algorithm and provides atrial and 
ventricular antitachycardia pacing and defibrillation therapies, 
Methods: Between May 1997 and July 1999, the Jewel AF 7250 was 
implanted in 26 pts. All pts had a history of both ventricular and atrial 
tachyarrhythmias. Stored counter data were reviewed, in addition, all atrial 
episodes as well as intracardial ECGs and markers were analysed and com- 
pared to stored counter data. When more than 30 episodes were detected in 
the atrial fibrillation (AF) or atrial tachycardia (AT) detection zone, the last 30 
episodes were analysed. 
Results: During a mean follow-up of 13 f 7 months, 847 treated episodes 
of AF/AT occurred in 19 pts. First AF therapy sequence was high frequency 
burst pacing (HFBP) in 20 pts, first AT therapy sequence was a 91% Ramp 
(R) in IO pts, and a 91% Burst (B) in 6 pts. No atrial shock therapies were 
programmed. Counter data revealed success rates for first AF/AT therapy of 
36.2%. 
Review of the last 160 AF/AT episodes revealed that 73 (45.6%) episodes 
were treated effectively bythe device, whereas 87 (54.4%) episodes were not 
terminated by the administered therapy. Analysis of the median PP-Intervals 
showed no significant differences between the cycle lengths of effectively 
and non-effectively treated AF/AT episodes. 
First delivered therapy 
HFBP 
Effective 
64.6% (31/48) 
Not effective 
35.4% (15/48) 
R91% 77.5% i31/4Oj 
6 91% 15.3%iii172j 
22,5%‘(9/40~ 
84.7% (6117i) 
Conclusion: 1. Atrial therapies terminated half of spontaneous atrial 
tachyarrhythmias. 2. Comparison of counter data concerning therapy effec- 
tiveness and outcome of initiated therapies in manually analysed episodes 
revealed comparable results. 
L--LA 1052 97 Significant Morning Risk of Atrial Tachyarrhythmias in Patients With a 
Dual-Chamber Defibrillator: A Prospective Study 
of 772 Episodes in 34 Patients 
Lars Lickfett, Christian Wolpert, Werner Jung, Rainer Schimpf, 
Susanne Herwig, Bahman Esmailzadeh’ , Armin Welz’: Berndt Ltideritz. 
Depts. of Cardiology; ‘Cardiac Surgery University of Bonn, Bonn, Germany 
8ackground:A new dual-chamber implantable cardioverter-defibrillator (ICD) 
provides classification and therapy of atrial tachyarrhythmias (AT). As ICD 
shocks are tolerated best by patients (pt) during the night, information on the 
circadian variation of AT onset is necessary for therapy programming. 
Methods: A total of 34 pt with a dual-chamber Medtronic Jewel AF 7250 
ICD were included into the study. For assessing AT onset, the data logs were 
analyzed by two independent observers. 
Results: In 19/34 pt 772 episodes of AT occurred. 536 episodes were 
classified as atrial tachycardia (cycle length ~220 ms) and 236 as atrial 
fibrillation. A significant morning peak was found in both types, Only atrial 
tachycardia showed a second peak in the early evening. 
the morning. 2. Only episodes of atrial tachycardias exhibit a second peak in 
the early evening. 3. The distribution of AT is similar to the reported variation 
of ventricular tachyarrhythmias in patients with an ICD. 4. Although most AT 
occur during the day, shock therapy should be programmed during the night 
to reduce patients discomfort. 
I 1052 98 Do Internal Atrial Defibrillation Thresholds Change Over Time in Patients With Implantable 
Atrial Defibrillators Without CS Leads? 
Craig S. Vinch, G. Muqtada Chaudhry, S. Dinakar Satti, David Casavant, 
Charles I. Haffajee. St. Elizabeth’s Medical Center, Tufts University School 
of Medicine, USA 
Background: Implantable Cardiac Defibrillators (ICDs) capable of internal 
atrial fibrillation have demonstrated initial safety and efficacy in converting 
atrial fibrillation (AF). ICDs for atrial defibrillation are presently in advanced 
clinical investigation. We report our experience with internal atrial defibrillation 
thresholds (ADFTs) in patients without CS leads at implant and at one year 
follow-up. 
Methods: 22 patients received a Medtronic 7250 dual chamber ICD/pacer. 
All 22 patients had VTNF indications for ICD and had prior AF and/or atrial 
flutter. AF was induced with rapid atrial pacing or 50 Hz burst at time of 
implant and at one year. AF was allowed to persist for 5 minutes. ADFTs 
were measured using a step-up protocol (2 J + 4 J -+ 8 J + 12 J --f 18 J 
--f 27 J) using the pathway that yeilded the minimum energy for atrial defib- 
rillation at implant. The lowest energy of 2 successful attempts was defined 
as ADFT. 8 patients have completed one year follow-up and were included 
in the analysis. 5 patients were taking amiodarone at implant and 4 at one 
year. 
Results: Average ADFTs at the time of implant were 10.5 J (95% Cl: 
O-23.3 J) and 9.75 J (95% Cl: O-21.6) at one year. Average age was 66.4 
years (range 51-74). Average LA size was 4.7 (range 3.6-5.8 cm). Average 
LVEF was 27% (range IO-50%). There was no statistically significant differ- 
ence between acute and 1 year ADFTs (p = 0.84, 2 tailed t-test). Change in 
ADFTs from implant to 1 year was independent of LA size (X2 = 0.054). 
Conclusions: Internal ADFTs remained stable in the group as a whole (n 
= 8) from implant to 1 year follow-up. Acute ADFT, 1 year ADFT, and change 
in ADFTs were independent of LA size. Amiodarone use was not related to 
change in ADFT. 
1 1052-99 1 Effect of Verapamil on Burden of Atrial Fibrillation 
in Patients With Implantable Atrial Defibrillator 
Q. Wang, H.F. Tse, C.M. Yu, V. Tsang, C.P. Lau, G.M. Ayers’. Department 
of Medicine, Faculty of Medicine; The University of Hong Kong, China: 
‘InControl Inc. Redmond, Washington, USA 
Background: Prior studies suggest that changes of electrical and mechanical 
properties of the atria during atrial fibrillation (AF) may be related with cellular 
calcium overload, and can be blunted by calcium channel blockers. 
Methods: The effect of verapamil on the AF burden in patients of persis- 
tent AF treated with an implantable atrial defibrillator (IAD) was prospectively 
evaluated in 7 patients (5 M, 2 F; mean age 60 i 6 yrs) implanted with IAD. 
Their mean left atrial diameter and ejection fraction was 4.5 f 0.7 cm and 0.54 
f 0.1, respectively. Patients were randomized to receive either verapamil240 
mg/day or placebo in a crossover fashion for 8 weeks, without changing their 
antiarrhythmic drugs, The duration and numbers of AF episodes were doc- 
umented by the IAD using monitoring mode. All therapeutic shocks were 
delivered in hospital for spontaneous symptomatic AF. 
Results: Five patients (71%) received IAD therapy. 13 of 14 (94%) spon- 
taneous AF episodes were successfully cardioverted with a mean of 1.7 f 
2.1 shocks/episode. There was no significant difference in the efficacy of 
cardioversion (100% vs. 88%, p = 0.8) and the number of shocks for suc- 
cessful caridoversion (1.8 * 2.1 vs. 1.7 i 2.4, P = 0.6) in the presence or 
absence of treatment with verapamil. There was no significant changes in 
the AF burden in term of the numbers of AF episode and the total duration of 
AF in the presence or absence of treatment with verapamil. 
With verapamil Without verapamil P value 
No. of AF episode 8.0 i 8.0 9.1 f 10.8 0.83 
Total duration of AF fhrs) 418 i 511 586 + 409 0.51 
Conclusion: The results suggest that prophylactic treatment with ver- 
apamil does not significantly affect the AF burden nor the efficacy of IAD 
cardioversion in patients with recurrent AF, 
Conclusion: 1. 71% of AT episodes occur during the day with a peak in 
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1 1052-I 00 1 Reproducibility of Atrial Defibrillation Threshold 
in Patients With Induced or Chronic Atrial 
Fibrillation 
Alessandro Capucci, Giovanni Quint0 Villani, Alessandro Rosi, 
Massimo Piepoli, Guido Rusticali. Divisione di Cardiologia Ospedale Civile, 
Piacenza, Italy 
Several pharmacological or technical factors may affect atrial defibrillation 
threshold (ADFT) during an internal cardioversion (ICV) in atrial fibrillation 
(AF) patients. No controlled data are available about the reproducibility of 
ADFT in the same patient with paroxysmal AF (PAF) or chronic AF (CAF). 
We evaluated ADFT reproducibility in lone PAF (EP induced AF, IO pts, 51 
i 4 y) or chronic AF (16 pts, 64 + 7 y). In each patient the AF pattern 
(F-F interval) was characterized before each ICV attempt. Then a step up 
syncronized internal cardioversion tests (biphasic shock waveform 6 msec/6 
msec) with increasing energy levels from 0.2 to 20 joules was performed using 
a dual leads defibrillation system (Right Atrium-Coronary Sinus configuration; 
Rhythm Technologies USA) connected toan external cardioverter defibrillator 
(Ventritex HVS02). After 30 minutes of stable sinus rhythm restoration a new 
sustained AF was induced (>20 min duration) and then the ICV protocol was 
repeated (* p < 0.05 ^ NS). 
No. pts 
Antiarrhythmic drug 
F-F interval pre-ICV 1 (msec) 
F-F interval pre-ICV 2 (msec) 
ADFT 1 (Joules) 
ADFT 2 (Joules) 
ADFT SD Differences 
Coefficent of variability (CV) 
PAF 
10 
none 
175*21 
181zk20 
3.211.8 
4.9 zt 1.6 
5.1 
*27% 
CAF 
16 
diltiazem 
194*25 
202+15 
*&.5 i 3.2 
*9.2 * 4 
0.6 
7.2% 
Conclusion: 1) the ADFT is reproducible in CAF patient with similar 
EP AF pattern, while a high CV is present in PAF patient, probably related 
to different EP atrial changes than CAF population 2) patients with CAF 
presented higher ADFT compared with PAF patients. 
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1053-59 Heart Rate Variability Increases in Post-Ml 
Patients Who Begin Smoking Cessation Using 
Sustained-Release Nicotine Patches Compared 
With Patients Using Placebo Patches 
Phyllis K. Stein, Jeffrey N. Rottman, Lori Mosca. Washington University 
School of Medicine, St. Louis, MO: University of Michigan, Ann Arbor, Ml, 
USA 
Background: Decreased heart rate variability (HRV) is associated with ad- 
verse outcome in post-MI patients. Smoking cessation post-Ml improves 
survival. In normal adults, smoking cessation using the 21 mg Nicoderm 
patch is associated with increased HRV. The effects of smoking cessation on 
HRV have not been studied in post-infarct patients. 
Methods: We compared the HRV effect of smoking cessation using 
21 mg sustained-release nicotine (Nicoderm) vs. placebo patches in 18 
post-Ml patients, 9 per group. Baseline Holter recordings were obtained 
before initiation of smoking cessation and repeated 4 weeks later. Time and 
frequency domain indices of HRV were computed and changes compared 
using t-tests, 
Results: HRV did not differ between groups at baseline. Representa- 
tive changes in HRV are shown below. All values are mean It SEM and 
significantly different, p < 0.05. 
Placebo (n = 9) Nicotine (n = 9) 
Davtime Mean NN 17.6 * 
Daitime SDNN 
12.1 81.8 zk 23.9 
-9.2 f 7.5 10.7 i 5.7 
24-hr rMSSD -4.1 f 3.6 5.6 i 2.6 
Conclusions: Results warrant verification in a larger population. Smok- 
ing cessation using transdermal nicotine patches compared with quitting 
cold turkey resulted in more “favorable” changes in HRV. The mechanism 
for this effect is uncertain, but may represent a direct effect of nicotine sup- 
plementation in a population known to have a high level of tonic sympathetic 
activation. 
1053-60 Heart Rate Turbulence and Mortality in Chronic 
Heart Failure 
A. Morley-Davies, Stuart M. Cobbe, Henry J. Dargie, Raphael Schneider. 
CR/, University of Glasgow, UK; Georg Schmidt Medizinische Klinik, 
Technische Universit& Miinchen, Germany 
Background: We investigated the ability of a novel Holter derived measure, 
Heart Rate Turbulence (HRT) to predict death in chronic heart failure (CHF). 
HRT is the physiological, biphasic response of the sinus node to premature 
ventricular contractions. It consists of a short initial acceleration and an 
ensuing deceleration of the heart rate. This characteristic reaction can be 
quantified by two numerical parameters, namely the HRT Onset and the HRT 
Slope. 
Methods: 199 patients age under 75 years were studied. We determined 
simple clinical variables: age (59 f 9 years), aetiology of CHF (ischaemic 
n = 163, nonischaemic n = 36) NYHA status (2.7 I-t 0.8) ejection fraction 
(LVEF, median 22%) and presence of intraventricular conduction delay (IVCD 
+ ve 64). Investigational variables examined were: 24 hour Holter variables 
(heart rate variability- triangular index TRIIND and presence of nonsustained 
VT-NSVT), baroreflex sensitivity (BRS median 5.9 msec/mmHg), QT dis- 
persion by manual digitisation (QTd median 94 msec), and HRT. HRT was 
categorised at previously determined values and classified as both onset 
and slope normal, one abnormal or both abnormal. Events were categorised 
by established standards using information from death certificates, autopsy 
findings and hospital and GP case records. Mean duration of follow-up was 
971 f 378 days. There were 54 all cause deaths and 47 cardiac deaths. 
Results: A cox-proportional hazards analysis was performed with age, 
NYHA class, aetiology of CHF, presence/absence of bundle branch block 
and LVEF as readily obtained clinical variables. The univariate addition of 
HRV (Triangular index HR 2.04, p = 0.044) BRS (HR 2.63, p = O.Oll), NSVT 
(HR 3.3, p = 0.001) and HRT (either abnormal HR 3.01, p = 0.009; both 
abnormal HR 4.06, p = 0.001) predicted cardiac death significantly. 
Conclusion: HRT holds promise as a new prognostic marker in patients 
with chronic heart failure. 
L-l 1053 61 Is Abnormal Heart Rate Variability a Specific Feature of Congestive Heart Failure? 
Gustav0 Lopera, Heikki V. Huikuri’, Jari Tapanainen’ , Simon Chakko, 
Robert J. Myerburg, Agustin Castellanos. University of Miami School of 
Medicine, Miami, Florida, USA; ’ Oulu University: Oulu, Finland 
Background: Patients with congestive heart failure (CHF) have abnormal 
heart rate variability (HRV) characterized by reduced variability and altered 
fractal correlation properties of HR dynamics. To determine whether the ab- 
normalities in HRV are specific for CHF, or can also be caused by non-cardiac 
disorders, we studied HRV in patients with CHF and patients with various 
non-cardiac causes of altered autonomic regulation. 
Methods and Results: Standard deviation of N-N intervals (SDNN), 
along with long-term power slope (@) and the short-term fractal scaling ex- 
ponent (a) were calculated in 10 patients with various non-cardiac disorders, 
such as anemia (2) pneumonia (I), pericarditis (I), uncontrolled diabetes 
(n = 2), complicated pregnancy (I), hyperthyroidism (I), hepatic failure (1) 
sepsis (I), in 20 CHF patients, and in 20 controls matched by age. 
Conclusions: Reduced HRV and altered fractal properties of HRV are not 
specific to CHF, but can also be caused by non-cardiac disorders, suggesting 
that abnormal HR dynamics are likely to be a result of systemic neuro-humoral 
activation, rather than the result of afferent neural input from the failing heart. 
Results: 
Non-Cardiac Pts CHF Pts Controls 
SDNN (ms) 61 * 20* 74 f 32* 125 i 126 
01 0.89 i 0.22* 0.81 i 0.20* 1.18f0.12 
B -1.48 * 0.23* -1.45 f 0.35* -1.27&0.16 
*p < 0.01 compared to controls. No differences were observed in SDNN or fractal scaling 
exponents between the patients with CHF and non-cardiac patients 
Daytime SDNNIDX -1.8 i. 3.6 9.7 f 3.0 
When data were reanalyzed with only those who had complete cessation 
of smoking, (6 nicotine, 5 placebo), mean results were unchanged, and the 
difference in change in daytime mean NN remained statistically significant. 
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I 1053 62 Comparison of Post-Ectopic Turbulence Analysis, 
Fractal Analysis and Traditional Hear Rate 
Variability Analysis as Predictors of Mortality in 
Patients With a Recent and Remote Myocardial 
Infarction 
Timo H. Makikallio, Ulrik Hintze, Heikki V. Huikuri, Raul D. Mitrani, 
Agustin Castellanos, Robert J. Myerburg, Jorgen Videbek, Mogens Meller. 
The DIAMOND Study Group; Div. of Cardiology, University of Oulu, Finland; 
Div. of Cardiology: University of Miami, Miami, FL, USA; Dept. of Cardiology, 
Odense University Hospital, Denmark 
Background: Fractal analysis and post-ectopic turbulence analysis of heart 
rate variability (HRV) have recently challenged the traditional HRV analyses 
in risk stratfication. We compared the prognostic value of all these analysis 
methods in 286 patients with a remote myocardial infarction (Ml) and in 447 
patients with a recent MI. 
Methods: Traditional time and frequency domain measures, short-term 
fractal exponent (a), and turbulence onset after ventricular premature beats 
(TO) were studied in the DIAMOND-CHF and DIAMOND-MI populations. 
These populations included 286 patients with an MI, EF < 0.35, and with a 
follow-up of 647 Z!Z 377 days (OMI), and 447 patients with an acute MI, EF < 
0.35 and a follow-up of 647 & 367 (AMI). 
Results: During the follow-up, 124 (43%) deaths occurred in the OMI 
group and 114 (26%) deaths in the AMI group. ODDS-ratios and confidence 
intervals of each HRV index as a predictor of mortality were: 
AMI OMI 
‘;O 3.1 2 6 (1.7-5.5) 
(1.5-4.6) 
2.3 2 (1.2-4.4) 
(1 Z-4.2) 
SDNN 1.8 (1.0-3.1) 1.8 (0.7-4.5) 
Exponent 01 was the best HRV index as a predictor of mortality in the AMI 
group, but in the OMI group 01, TO and SDNN had the similar prognostic 
power. Ali HRV variables were better predictors of mortality in the AMI than 
OMI group. 
Conclusions: Fractal and trubulence analysis methods of HRV are more 
powerful predictors of mortality than the traditional analysis of HRV in the 
patients with a recent Ml. All HRV indices provide only limited prognostic 
information in the patients with a remote Ml. 
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1004-i 67 The Incidence and Predictors of Early Cardiac 
Arrest Following Radiofrequency Ablation of 
Atrioventricular Node for Atrial Fibrillation 
Cevher Ozcan, Arshacl Jahangir, Paul A. Friedman, Thomas M. Munger, 
Bernard J. Gersh, David L. Hayes, Stephen C. Hammill, Win K. Shen. Mayo 
Clinic, Rochester, Minnesota, USA 
Background: Cardiac arrest (CA) is a rare complication following radiofre- 
quency catheter ablation (abl) of atrioventricular node (AVN) and pacemaker 
(PM) implantation for ventricular rate control in pt with atrial fibrillation (AF). 
The true incidence of CA after AVN abl and characteristics of patients (pts) 
who have this complication are not well defined. 
Methods: We retrospectively evaluated all pts who underwent abl of AVN 
and PM implantation for drug refractory AF between 1990 and 1998. All pts 
were followed prospectively and the incidence of CA in the first 30 days 
after abl was identified. Logistic regression analysis was used to determine 
potential risk factors for CA. 
Results: Three hundred thirty-four consecutive pts with AF (175 male, 
mean age 68 ZIZ 11 yrs) underwent abl of AVN. Fifty-five percent of these 
pts were in AF at the time of abl. Six pts (1.8%; 4 female, mean age 69 
i 6 years, range 57 to 78) suffered CA in the first 30 days after the abl 
procedure (mean 6 + 6 days, range 1 to 13). Five of 6 pts who had CA had 
structural heart disease. Four pts had diabetes. None of these pts were in 
sinus rhythm at the time of abl. Complete AV block was achieved in 5 of 6 
pts without immediate complication. Mean heart rate was 112 i 17 bpm (90 
to 131) before the abl and 39 i 25 bpm (0 to 75) after abl. QTc interval 
of escape rhythm after the abl was not significantly prolong compared to 
pre-abl (mean 438 f 55 Vs 440 f 65) (p = 0.96). All except one pt (pacing 
rate 90 ppm) had ventricular pacing rate at 60 ppm. The etiology of CA 
was ventricular fibrillation (n = 3) polymorphic ventricular tachycardia (n = 
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1) and sudden death with unknown rhythm (n = 2). Two pts died at the 
time of CA, 4 were resuscitated acutely, but 2 of them died within 6 days 
after arrest. Two pts are alive 39 and 35 months after the CA. Age, gender, 
presence of cardiac disease, hypertension, antiarrhythmic drugs, duration of 
AF, diagnosis of paroxysmal or chronic AF, functional class, low LVEF, abl 
time, cycle length or duration of AF were not independent predictor for CA. 
Presence of diabetes (p = 0.01) was the only independent predictor for CA 
in this population. 
Conclusion: The incidence of early cardiac arrest after RF abl of AVN in 
pts with AF was 1.8%. Presence of diabetes was an independent predictor 
for CA. Absence of structural heart disease or pacing rate of 90 ppm does 
not exclude the risk of CA after AVN abl for AF. 
9:12 a.m. 
1004-168 Dual Site Atrial Pacing for Atrial Fibrillation 
Prevention: Triggered or Inhibited Response to 
Ectopy? 
David M. Luria, Michael R.S. Hill, Luc Mongeon, Paul A. Friedman. Mayo 
Clinic, Rochester, MN: Medtronic Inc., Minneapolis, MN, USA 
Dual site atrial pacing has recently shown promise for controlling paroxysmal 
atrial fibrillation (PAF). Different pacing modes, however, have been actively 
investigated. AF often begins with atrial premature complexes (APCs), so 
that pacemaker response (inhibition or triggering) to sensed spontaneous 
APCs could be important for arrhythmia prevention. This study sought to 
determine whether a difference exists in inhibited vs. triggered pacing for 
acute prevention of atrial fibrillation with dual site pacing. 
Methods: Dual site pacing from the high right atrium (HRA) and coronary 
sinus ostium (CS) was used during drive trains of cycle length 600 & 400 
msec during electrophysiologic study. Atrial extrastimuli were delivered only 
from the HRA (inhibited mode) or from both sites simultaneously (triggered 
mode) in a randomized progressively aggressive protocol that delivered up 
to 3 atrial extrastimuli. The protocol continued until AF was induced or the 
atrial refractory period was reached in both modes. If AF was induced in one 
mode, the same level of aggressiveness was tested in the other mode. 
Results: Seventeen patients (age 65 f 12 yrs) with ejection fraction 44 i 
18% were prospectively studied. Seven patients had a documented history 
of PAF, 8 had other forms of supraventricular arrhythmia. PAF or atypical 
flutter was induced in 13 patients. An arrhythmia was induced by extrastimuli 
delivered in both inhibited and triggered modes in all but one patient (inhibited 
mode not inducible). In 6 patients arrhythmia was induced at the same level of 
aggressiveness in both modes. Four patients developed arrhythmia with less 
aggressive stimulation during the inhibited mode, and three patients during 
the triggered mode. There was no significant difference in the prematurity of 
the extrastimuli between the two modes. 
Conclusion: Acutely, there is no difference between inhibited and trig- 
gered pacing modes for the prevention of atrial fibrillation induction during 
dual site atrial pacing. This suggests that either mode might be appropriate 
for dual site atrial pacing. 
9:24 a.m. 
1004-169 Alternate Atrial Pacing Sites Shorten Atrial 
Activation Time in Humans 
Tristram D. Bahnson, David 0. Martin, lsmael A. Vergara, Judy Battle, J. 
Marcus Wharton, Robert A. Sorrentino, Ruth A. Greenfield, Diane Lai. Duke 
University Medical Center, Durham, North Carolina, USA 
Background: Active fixation permanent pacing leads permit stable lead posi- 
tioning at right atrial (RA) sites other than the distal appendage. To determine 
whether alternate pacing sites yield decreased total atrial activation time, 
ECG P-wave duration was assessed during sinus rhythm and pacing from 
select endocardial sites. 
Methods: P-wave duration (earliest to latest activity, any lead) was mea- 
sured from high resolution IP-lead rhythm strips (100-400 mmisec, 1-5 
mV/cm) in 23 patients (49 i 14 yrs, mean i SD, 8 men). Pacing sites (see 
below) were defined relative to fixed endocardial landmarks. 
Results: P-wave duration during SR increased with age (R = 0.64, p 
= 0.001). Pacing from the CS, HS, and ApP (see key below) resulted in 
shortened mean P-wave duration compared to pacing from the distal RA 
appendage (ApD, p = 0.01, 0.004, and 0.0001, respectively). CS, HS, and 
ApP paced P-waves were of equivalent duration to those during SR (p > 
0.6). In 16/22 patients, ApP or HS paced P-waves were shortest. Pacing 
from the ApD, HL, or ML RA resulted in prolonged P-waves compared to SR 
(p < 0.008). 
Conclusions: We conclude that pacing from the ApD, HL, or ML, common 
in clinical practice, results in prolonged bi-atrial activation compared to SR 
or pacing from “non-traditional” sites near Bachmann’s bundle or the CS 
OS. Further, pacing sites yielding short total activation time can be readily 
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identified in most patients. Such sites may be of clinical value for atrial based 
pacing. Further studies are required to determine whether alternative pacing 
sites benefit patients with atrial arrhythmias. 
Atrial Activation Time with RA Pacing from Select Sites (CL = 600) 
SR APC APP HS HL ML CS 
12754 14154 126+3 129f4 143*3 155f4 129*3 
SR = sinus rhythm; ApD = distal appendage: ApP = posterior base of appendage; HS = 
high septum; HL = high lateral freewall; ML = mid lateral freewall; CS = coronary sinus 
OS. Values are mean (ms) & S.E.M. 
9:36 a.m. 
Erl 1004 170 Is Atrial Lead Implantation During Atrial Fibrillation as Efficient as After Restitution of 
Sinus Rhythm? 
Uwe K.H. Wiegand, Frank Bode, Hendrik Bonnemeier, Ralf Tiilg, 
Werner Peters, Hugo A. Katus. Medical University of Luebeck, Germany 
Background: Atrial fibrillation occurring before or during implantation of atrial 
lead is a common problem in atrial-based pacemakers. Acute cardioversion 
may protract the implantation and cause logistic problems. 
Methods: In 32 consecutive DDDR-pacemaker recipients (group A), im- 
plantation of bipolar atrial active fixation leads was performed during atrial 
fibrillation guided by intracardiac fibrillatory potential amplitude (IFPA). Atrial 
sensing and pacing properties were compared to an age- and sex-matched 
control group in whom sinus rhythm was restored prior to atrial lead place- 
ment (group B). In group A, minimal IFPA 2 1 .O mV was required for definitive 
lead position. In group B, voltage threshold < 1.5 V/O.5 ms and atrial poten- 
tial amplitude > 1.5 mV were demanded. Group A patients were converted 
to sinus rhythm until 4 weeks after implantation. Pacemaker interrogations 
were performed after 3,8 and 12 months. 
Results: In group A, implantation time was significantly shorler as com- 
pared to group B (58.7 jr 8.8 min vs. 73.0 -f; 17.3 min, p < 0.001). Mean atrial 
potential amplitude during atrial fibrillation was correlated with telemetered 
atrial potential during sinus rhythm (r = 0.49, p < O.OOi), but not with atrial 
stimulation threshold. Twelve months after implantation, stimulation (1.09 f 
0.42 V in group A vs. 1.01 f 0.31 V in group B, p = 0.88) and sensing 
thresholds (1.74 f 0.52 mV vs. 1.78 i 0.89 mV, p = 0.98) did not differ be- 
tween groups. However, in three patients of group A, a chronic atrial sensing 
threshold 5 1 mV required programming of high atrial sensitivities (0.25 mV) 
to achieve reliable atrial sensing. 
Conclusion: Atrial lead implantation during atrial fibrillation is feasible 
and reduces implantation time as compared to a intraoperative cardioversion 
strategy. However, prerequisites are required to achieve a reliable pacemaker 
function in these patients: a bipolar atrial lead should generally be used 
and the pacemaker should have the capability to program very high atrial 
sensitivities. 
9:48 a.m. 
1004-I 71 Reversion and Maintenance of Sinus Rhythm in 
Patients With Permanent Atrial Fibrillation by 
Internal Cardioversion Followed by Biatrial 
Pacing 
Nikolaos Fragakis, Julian Bostock, Carl Shakespeare, Phyllis Holt, 
Jaswinder S. Gill. Cardiofhoracic Cenfre, Guy’s & Sf Thomas’ Hospital, 
London, UK 
Background: Patients (pts) in atrial fibrillation (AF) who fail external car- 
dioversion (EXC) are regarded as in permanent AF. Internal cardioversion 
(IC) can revert many such patients into sinus rhythm (SR) but the majority 
return rapidly into AF. We examined whether pts with permanent AF could 
be maintained in SR over a long-term period by implantation of a biatrial 
pacemaker (BIP) after IC. 
Methods: 15 pts (13 M, 55 f 10 years), with AF resistant to at least 3 
attempts at EXC, had successful IC. Pts were temporarily paced biatrially 
[right atrial appendage (RAA)-distal coronary sinus (CSd)] for 48 hrs after 
the IC. Those who remained in SR received a permanent biatrial (RAA-CSd) 
pacemaker system programmed to a lower rate of 90 bpm. Recurrence of 
AF was evaluated using pacemaker diagnostics and 24 hr Holter monitoring. 
Results: Mean permanent AF duration was 9 f 42 months, underlying 
heart disease was present in 12 pts, mean left ventricular shortening fraction 
was 33 f 10% and mean left atrium diameter 48 i 4 mm. A mean of 1 .O 
4 1 .I antiarrhythmic drugs had been used before. Six pts underwent IC on 
antiarrhythmic therapy (5 on amiodarone, 1 on sotalol) which was continued 
afterwards. Permanent BIP was implanted in IO pts. At a mean follow-up of 
8 5 4 months, 5 pts (1 on amiodarone, 1 on sotalol) were still in SR, 1 pt 
relapsed to AF after 4 months while 4 pts remained in SR 5 1 month. 
Conclusion: 40% of pts with permanent AF can be maintained in SR 
over a long-term period by using BIP after IC. These results are better 
than previous published data with IC followed by antiarrhythmic therapy. IC 
with BIP is a novel modality of treatment for permanent AF directed at the 
maintenance of SR. 
IO:00 a.m. 
1004-I 72 Dual Site Right Atrial Pacing is Effective for 
Long-Term Prevention of Symptomatic Chronic 
Atrial Fibrillation 
Sanjeev Saksena, Atul Prakash, Ryszard B. Krol, Heather Sroczynski, 
Valerie Woodruff, Pamela Mackenzie. Eastern Heart Insfifufe-Atlantic 
Health System, Passaic & RWJ Medical School, New Brunswick, NJ, USA 
We examined the efficacy of dual site right atrial pacing [DAP] for prevention 
of chronic atrial fibrillation [CAF] in patients [pts] with refractory symptomatic 
AF. Fifty-three pts with paroxysmal AF [PAF] or CAF with & without organic 
heat-l disease underwent insertion & optimization of DAP systems to ensure 
continuous overdrive pacing. They were continued on previously ineffective 
drug therapy. Symptomatic AF on follow-up was confirmed by ECG, Holter 
&/or stored electrogram data in device memory. 
Results: Thirty-seven pts had PAF & 18 had CAF. Pts were on drug and 
pacing therapy & 2 pts had linear RA ablation in the CAF group. Rhythm 
control during follow-up is summarized in the figure: 
% pts 
P- NS 
100 = .. .__ I. . . . . . 1 _.._ 
80 
20 
Months 
0 
0 4 8 12 16 20 
There was no difference in rhythm control with DAP in either AF group 
based on presence or absence of heart disease. 
Conclusions: DAP is effective in long-term rhythm control in CAF. Pts 
with refractory AF derive benefit irrespective of structural heart disease. 
IO:12 a.m. 
1004-l 73 Prevention of Atrial Fibrillation by Atrial 
Overdrive Stimulation at Rest in Patients With 
Symptomatic Sinus Node Disease? 
Rainer Schrepf, Rudolf Lindlbauer. /I. Medical Clinic, Community-Hospital 
Munich-Harlaching, Teaching Hospital of the University of Munich, Munich, 
Germany 
Background: First retrospective data report a reduced incidence of atrial 
fibrillation in patients with sinus node disease and an overdrive stimulation of 
their rest rate by atrial pacemaker stimulation 
The aim of our randomized prospective cross-over trial was to determine 
the risk for atrial fibrillation (AF) in patients with pre-existing paroxysmal AF 
pacing them at a rest rate of either 40 or 85 ppm. Thus comparing inter- and 
intra individually intrinsic rhythm to atrial pacemaker stimulation. 
Methods: Ninety four patients were randomized to either 40 or 85 ppm for 
a one year follow-up with a consecutive cross-over. Every three months pa- 
tients presented in our outpatient department. Cardiac rhythm was controlled 
by a holter-ECG, the data of the inherent holter function and a questionnaire. 
Statistical analysis was performed by SAS multivariate analysis. 
Results: Episodes of paroxysmal AF were highly significant more often 
pacing at a basic rate of 40 than of 85 ppm (n = 184 vs. 49, p <: 0.005). 88 of 
the 94 patients paced at 40 ppm and 23 paced at 85 ppm had a recurrence 
of paroxysmal AF (p < 0.005). The number of episodes and of patients with 
recurrence of AF was approximately three times higher with intrinsic rhythm, 
when compared to atrial overdrive stimulation at rest. 
Conclusion: Patients with pacemaker implantation due to symptomatic 
sinus node disease with paroxysmal AF exhibited a significantly higher num- 
ber of AF episodes being in intrinsic rhythm at rest when compared to an atrial 
overdrive stimulation under the same conditions. Increased basic rate in atrial 
pacing therefore should find a wider application in this patient population. 
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1004-I 74 Multicenter Experience With Dual Site Atrial 
Pacing in Atrial Fibrillation: Importance of 
Overdrive Pacing & Device Monitoring 
Atul Prakash, Roberto Soccadamo, Natale Di Belardino, 
Agostino Mammucari, Ryszard S. Krol, Heather Sroczynski, 
Valerie Woodruff, Pamela Mackenzie, Sanjeev Saksena. Eastern Heart 
institute & RWJ Medical School, NJ, USA; Civil Hospital, Ve/etri, Rome, lraly 
Dual & single chamber pacemaker systems have been used for dual site 
RA pacing [DAP] but each has different pacing & monitoring algorithms. 
We utilized generators from different manufacturers in 64 patients [pts] with 
refractory atrial fibrillation [AF]. Generators employed had overdrive pacing 
capability & AF monitoring utilizing RR intervals alone in 24 pts (Medtronic 
Elite 2, Vitatron Topaz & Ruby, Pacesetter Trilogy), Holter monitoring in 8 
pts (ELA Chorus, Opus) & with atrial electrogram [EGM] storage in 32 pts 
(Medtronic There DR, Kappa 500). 
Results: Pacing was in the DDDR mode in 53 pts & AAIR mode in 11 pts. 
During follow-up ranging from 2-60 (mean 28 i 19) mos, rhythm control was 
achieved in 51164 pts (81%). 31 pts have had no AF recurrence, while 20 pts 
have had 1-4 symptomatic recurrences. Asymptomatic & symptomatic AF 
recurrences were usually diagnosed by high rate atrial events (>I75 bpm) 
but validation required EGM storage which was either unavailable or rapidly 
exhausted with 1 AF event. Long-term outcome for AF control is shown: 
Conclusions: 1) AF prevention with DAP can be achieved with different 
pulse generators capable of continuous overdrive pacing. 2) Monitoring in 
these devices is essential for detecting asymptomatic AF recurrences but 
currently insufficient to establish the magnitude of total AF burden. 
IO:36 a.m. 
1004-I 75 Effect of Dual Site Right Atrial Pacing on Burden 
of Atrial Fibrillation in Patients With 
Drug-Refractory Atrial Fibrillation 
C.P. Lau’, H.F.Tse’, C.M. Yu’, W.S. Teo2, R. Kamz, K.H. Ng3, 
S.K.S. Huang4, J.L. Lin”, SK. Leung’ , V. Tsang’, M. Hills, S. Fittse. ‘Queen 
Mary Hospital, China; 2Nationa/ Heart Centre; 3Singapore National 
University, Singapore; 4National Taiwan University Hospital, Taiwan; 
5Medtronic Inc., Minneapolis, MN, USA 
Background: Prior studies suggest that dual site right atrial pacing (DAP) 
may prevent atrial fibrillation (AF) in patients (pts) with drug-refractoy AF 
and bradycardia. However, the effect of DAP on AF burden in pts with AF 
who do not have an indication for concomitant bradycardia remains unclear. 
Methods: We performed a randomized, cross-over, single-blinded study 
in 22 pts (9 M, 13 F; mean age: 64 f IO yrs) with paroxysmal AF refractory 
to treatment with oral sotalol (mean dose 206 f 72 mg/day) and without 
a bradycardia indication for pacing. All pts received a DDDR peacemaker 
(Thera DR, Medtronic Inc.) with 2 atrial pacing leads positioned at the high 
right atrium and coronary sinus ostium. While keeping the dose of sotalol 
unchanged, pts were randomized in a cross-over fashion to be paced for 12 
weeks, either with high right atrial pacing at 30 bpm (control) or DAP with 
a consistent atrial overdrive pacing (CAP) algorithm that maintained atrial 
pacing at a rate slightly above the sinus rate. The number of mode switch 
episodes for AF and their duration were obtained from pacemaker memory. 
Results: DAP + CAP resulted in a higher % of atrial pacing (89 i 16 vs. 
15 i 18%, p < 0.01) and a reduced atrial ectopic frequency (9086 i 16296 
vs. 2981 &7241/day, p < 0.01) as compared to the control period. However, 
there was no significant difference in either the frequency of mode switch 
episodes (8.4 * 7.1 vs. 10.5 4 16.4/day, p = 0.6) or the % time in AF (27.1 Z!Z 
25.1 vs. 32.6 C 35.5%, p = 0.3) between the DAP + CAP and control periods. 
Conclusions: The result of the present study suggests that DAP + CAP do 
not significantly affect AF burden and frequency in patients with drug-refrac- 
tory AF who do not have a bradycardia indication for pacemaker implant, 
despite a significant reduction in atrial ectopic frequency. 
ABSTRACTS -Cardiac Arrhythmias 109A 
IO:48 a.m. 
1004-l 76 Impact of Dual Site Pacing on the Natural 
History of Symptomatic Atrial Fibrillation 
Recurrence in Patients Without Bradycardia 
H.F. Tse’, C.P. Lau’, CM. Yu’, W.S.Teos, R. Kam’, K.H. Ng3, 
S.K.S. Huang4, J.L. Lin4, S.K. Leung’, V. Tsang’, M. Hil15, S. Fit&?. ‘Queen 
Mary Hospital, China; ‘National Heart Centre; 3Singapore National 
University, Singapore; 4 National Taiwan University Hospital, Taiwan: 
5Medtronic Inc., Minneapolis, MN, USA 
Background: In patients (pts) with atrial fibrillation (AF) and bradycardia, 
dual site right atrial pacing (DAP) may prevent recurrence of symptomatic 
AF. Whether DAP is effective in preventing symptomatic AF in pts without 
bradycardia is unknown. 
Methods: In the multicenter (NIPP-AF) study, we evaluated the effect 
of DAP on symptomatic recurrence of AF in 14 pts (8 M, 6 F; mean age: 
66 f 8 yrs) with drug refractory AF. All pts underwent DDDR pacemaker 
(Thera DR, Medtronic Inc.) implantation with DAP (high right atrium + coro- 
nary sinus ostium). Pts were randomized to be paced for 12 weeks, either 
with high right atrial pacing at 30 bpm (control), or DAP with a consistent 
atrial overdrive pacing CAP) algorithm, in a cross-over fashion. The time to 
recurrence of Is’, 2”d and 3rd symptomatic AF episodes were documented 
by using trans-telephonic monitoring and symptoms were scored using an 
AF checklist. 
Results: Compared to control, DAP + CAP significantly prolonged the 
time to I*’ recurrence of AF (Figure I), without affecting the time interval to 
subsequent AF recurrence (median time to 2nd and 3rd AF episodes: 5 vs. 3 
d and 5 vs. 1 d, all p > 0.05) and AF symptom scores (Figure 2). 
Conclusions: In pts with drug-refractory AF without bradycardia, DAP 
+ CAP prolonged the time interval to Is’ symptomatic recurrence of AF. 
However, the time interval for subsequent AF recurrence and the overall 
symptoms remained unchanged. 
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1074-67 A Constant Interval From the Stimulus Artefact to 
the Local Atrial Electrogram During Coronary 
Sinus Pacing: An Electrophysiologic Tool for 
Ablation of Atrial Flutter 
Julian Villacastin, Jesus Almendral, Angel Arenal, Nicasio P. Castellano, 
Sergio Gonzalez, Mercedes Ortiz, Javier Garciia, Silvia Del Castillo, 
Juan Delcan. Hospital Marafion, Madrid, Spain 
Background: In patients with atrial flutter (AFI) previous studies have demon- 
strated a wide and homogeneous clock-wise activation wavefront, with a con- 
duction velocity ~1 m/s, through the cavotricuspid isthmus (CTI), during slow 
pacing from the ostium of the coronary sinus (CS). Thus, a constant interval 
between the stimulus artefact and the local atrial electrogram (S-A) recorded 
at the ablation catheter (Abl C), could be useful to perform radiofrequency 
(RF) ablation lines from the tricuspid annulus (TA) to the inferior vena cava 
(IVC), perpendicular to the direction of the activation wavefront. 
Patients and Methods: In 32 consecutive patients (P) with typical AFI 
who underwent successful bi-directional block of CTI, RF linear lesions were 
made during pacing at 500 ms from the CS. The Abl C (8-mm-tip) was 
positioned at the TA recording a bipolar electrogram with an AN ratio 50.1. 
After each 30 s RF application, the Abl C was withdrawn 5 mm toward the IVC. 
The ablation line was guided by the S-A in 21 P and only with conventional 
fluoroscopy in 11 P. The S-A interval was arbitrarily defined as constant, if 
variations greater than IO ms were not observed, at a paper speed of 200 
mm/s. The presence of bidirectional block across the CTI was confirmed by 
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comparing the timing and sequence of IO standard bipolar electrograms of 
a catheter positioned along the TA. 
Results: In 17 P a constant S-A interval (mean 48 f 16 ms) could be 
maintained during the RF applications. Only in 3 of these 17 P (18%) more 
than one RF line was initially required to create bi-directional CTI block. By 
contrast more than one RF line was required in all the 4 P (100%) in whom we 
were not able to maintain a constant S-A and in 7 of the 11 P (64%) in whom 
RF ablation had been only fluoroscopically guided (p < 0.005, comparing 
the 3 groups). The means of RF pulses were 9 f 6, 20 i 6 and 12 i 5 
respectively (p < 0.005). 
Conclusion: The maintenance during coronary sinus pacing of a con- 
stant interval between the stimulus artefact and the local atrial electrogram 
recorded at the ablation catheter, seems to be a useful electrophysiological 
tool to guide CTI linear RF ablation. 
1074-68 Catheter Ablation of Paroxysmal Atrial 
Fibrillation: A Novel Anatomical Approach 
Demosthenes Katritsis, Eleftherios Giazitzoglou, Socrates Korovesis, 
Pericles Kalivas, A. John Camm. Athens Euroclinic, Athens, Greece; St 
George’s Hospital Medical School, London, England 
Background: Animal studies have identified the left atrial tract &AT-ligament 
of Marshall) as a source of atrial automatic@ initiating atrial fibrillation (AF). 
Ablation of the tricuspid valve-inferior vena cava (TV-IVC) isthmus may also 
reduce the incidence of paroxysmal AF (PAF) in certain patient groups, 
whereas ablation of the LAT, coronary sinus (CS), and Bachmann’s bundle 
(Bb) has been shown to modify defibrillation thresholds or inducibility of AF. 
Methods: Nine patients (pts) with PAF, aged 60.8 f 8.1 years, with 
normal left atrial size and no structural heart disease, were subjected to 
radiofrequency ablation of the LAT, TV-IVC isthmus, Bb, and CS from the 
posterolateral area to the OS. Patients were followed-up with regular Holters 
for 6 to 18 months. 
Results: All pts displayed well organized activity with discrete signals in 
the LAT area during AF. The procedures were uneventful with mean proce- 
dure and fluoroscopy times 142.5 f 36.1 and 40.1 * 7.2 min, respectively. In 
five pts (55.5%) symptoms have disappeared and no AF was registered on 
Holter. Two pts (22.2%) still experience PAF but with decreased intensity and 
frequency than before, whereas 2 pts (22.2%) have developed permanent 
AF. 
Conclusion: Catheter ablation of the LAT, TV-IVC isthmus, Bb, and CS 
may reduce the incidence of PAF and confers considerable symptomatic 
improvement. The procedure is technically easy, relatively quick, and appar- 
ently safe. 
) 1074-69 1 Long Term Follow-Up Following Empirical 
Pulmonary Vein Isolation in Patients With 
Persistent Atrial Fibrillation and Post 
Cardioversion Immediate Recurrence of this 
Arrhythmia 
Andrea Natale, Mina Chung, Fabio Leonelli, Salwa Beheiry, 
Gey Tomassoni. The Cleveland Clinic Foundation, Cleveland, Ohio; 
University of Kentucky, Lexington, Kv; Central Baptist Hospital, Lexington, 
K’/: USA 
Background: We previously reported the acute and shot-l term success rate 
of empirical isolation of the right and left superior pulmonary vein in patient 
with persistent atrial fibrillation and immediate post cardioversion recurrence 
of this arrhythmia. 
Methods: We present the long term follow up in the same patient popu- 
lation. Patients were required to have at least 1 year post ablation follow up. 
A total of 71 patients were included. The patients undergoing the procedure 
had either normal or mildly enlarged left atrial size. Patients were selected 
because of the presence of persistent atrial fibrillation refractory to drugs with 
immediate recurrence of arrhythmia following cardioversion. 
Results: In each patient empirical isolation of the right and left superior 
pulmonary vein followed by cardioversion resulted in persistence of sinus 
rhythm with no immediate recurrence of atrial fibrillation as it was observed 
before the procedure. At follow-up, 8 patients (11%) remained in normal 
sinus rhythm without any further need of medical therapy. The remaining 
patients experienced recurrence of atrial fibrillation between 3 days and 2 
weeks from the ablation. 54 patients (76%) had spontaneous restoration 
of normal sinus rhythm upon reinstitution of the anti arrhythmic therapy 
previously ineffective. The remaining 9 patients (13%) continued to have 
atrial fibrillation. In the 54 patients successfully controlled with reinstitution 
of drugs previously ineffective, after 1 year of permanence in sinus rhythm, 
verified by multiple Holter and event recorder monitorings, antiarrhythmics 
discontinuation was attempted. Of this 54 patients, only additional 4 remained 
in sinus rhythm whereas the remaining require re-initiation of antiarrhythmics. 
Conclusion: Empirical isolation of the right and left superior pulmonary 
vein appeared to help maintenance of sinus rhythm in patients with per- 
sistent atrial fibrillation and post cardioversion immediate recurrence of this 
arrhythmia. 
1 1074-70 1 Intracardiac Echocardiography Identifies 
Pulmonary Vein Ostea More Accurately than 
Conventional Angiography 
Mauricio Arruda, Zhong G. Wang, Amit Patel, Robert A. Anders, John 
G. Kall, Douglas Kopp, Martin C. Burke, Albert C. Lin, David J. Wilber. 
University of Chicago, Chicago, IL, USA 
Circumferential ablation of pulmonary vein (PV) ostea may be useful in iso- 
lating arrhythmogenic foci. We compared angiography (ANGIO) and intrac- 
ardiac echocardiography (ICE) as methods to identify PV ostea and confirm 
optimal catheter positioning during ablation with an ultrasound catheter in- 
corporating a piezoelectric transducer mounted within an elastomeric balloon 
(Atrionix). 
Methods and Results: In 16 dogs, ANGIO was performed via transseptal 
puncture and selective contrast injection within the PV ostium (left superior 
15, left inferior 4, right superior IO). ICE images of the PV during balloon 
inflation were obtained with a 10.5 F deflectable probe positioned in the right 
atrium (Acuson). Based on ANGIO, the balloon was inflated just inside the 
ostium in 29 PV. In 8/29 (28%), balloon position by ICE was 11 cm distal to 
the ostium. ICE also identified a venous bifurcation 11 cm from the ostium 
in 17/l 9 left PV. This branching was often not visualized by ANGIO despite 
multiple injections due to subselective cannulation and dye streaming. At 
osteal sites, ICE images and doppler recordings during balloon inflation 
confirmed PV occlusion, even in the absence of visible change in balloon 
shape by fluoroscopy. In this canine model, ICE did not reliably identify the 
ostium of the right inferior PV. 
Conclusions: ICE may be superior to conventional ANGIO and fluo- 
roscopy in accurately identifying the location of most PV ostea and in guiding 
optimal balloon catheter positioning during PV ablation. These observations 
require confirmation during clinical trials in man. 
1074-71 Localization of the Orifice of the Pulmonary Veins 
bv Unioolar and Bioolar Impedance 
Mkasuiements ’ . 
D.S. He, P. Ott, F.I. Marcus, M. Bosnos. University of Arizona, Tucson, AZ, 
USA 
Ablation of the orifice of the pulmonary veins is under investigation as a means 
of preventing atrial ectopic foci from the pulmonary veins (PVs) from reaching 
the left atrium to initiate atrial fibrillation. We have explored the potential of 
measuring unipolar and bipolar impedance to localize the junction of the PVs 
and left atrium. 
Methods: A 7 Fr quadripolar catheter with a 4 mm distal electrode and 
2 mm interelectrode spacing was inserted into the lefl atrial appendage in 
two open chest dogs anesthetized with isoflurane. The catheter was guided 
into the PVs using fluoroscopy. The catheter was gradually withdrawn until 
it reached the left atrium adjacent to the PVs. Unipolar impedance at 50 
and 300 kHz was measured at 8 sites each in the PVs and atrium. Bipolar 
impedance was measured at 5 and 800 kHz at 18 PV sites and 16 atrial 
sites. At the point of increase in impedance radiofrequency (RF) energy was 
delivered to identify its location in one animal. The RF lesion was located at 
the orifice of the PV. Impedance is expressed as M f SD and the data were 
analyzed by Students t-test. 
Results: The impedance in the PVs at all frequencies is significantly 
higher than that of the atrial tissue. 
PVS Atrium D 
kHz 
50 u 
(ohms) 
656&136 
(ohms) 
277i163 <O.OOl 
3oou 573*192 235f148 <O.OOi 
5B 6181215 243h77 10.001 
600 B 384f145 2019~56 <O.OOl 
U = unipolar, B = bipolar 
Conclusion: There is a significant decrease in the impedance of the atrial 
myocardium as compared to that in the PVs, At 50 and 5 kHz this difference 
is more pronounced than at 300 and 800 kHz. In humans it is not known if 
the impedance transition will occur proximal to, or at the orifice of the PVs. 
If these results are confirmed in humans, bipolar impedance measurements 
can be used to validate catheter location at the junction of the PVs and the 
left atrium. 
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/ 1074 72 The Use of Multiple Micro Electrodes for Mapping 
and Radiofrequency Catheter Ablation of 
Pulmonary Veins 
Mauricio Arruda, Zhong Wang, Amit Patel, Robert A. Anders, John G. Kall, 
Douglas Kopp Martin Burke, Ralph J. Verdino, Albert C. Lin, David J. Wilber. 
University of Chicago, Chicago, IL, USA 
Localization of arrhythmogenic loci within the pulmonary veins (PV) may 
be difficult due to complex venous anatomy and infrequent spontaneous 
complexes. In an attempt to facilitate PV mapping, two to four multipolar 
micro-catheters (1.5-2.5 Fr) have been used for simultaneous PV mapping. 
We evaluated the feasibility and safety of creating RF lesions in the PV via 
micro-electrodes. The study catheter was a 2.5 Fr, floppy tip catheter with 4 
coil electrodes (3 mm length) with 2-6-2 mm inter-electrode spacing and a 
thermocouple proximal to each electrode (Cardima). 
Results: In 4 dogs, angiography of 8 PV were obtained pre and post 
ablation using a transeptal approach. The electrode catheters were advanced 
through the transeptal sheath into the right superior PV (4), left superior PV 
(3), and left inferior PV (1). The proximal electrode was positioned at the level 
of the PV ostium. Unipolar and bipolar recordings from the PV were of good 
quality without noise. RF current was delivered to each of the 4 electrodes 
in all 8 PV for 60 seconds or until an impedance rise. The maximum set 
temperature was either 50 or 55”C, with a mean power of 8.4 f 5.1 W, initial 
impedance of 224 i 27 Q, final impedance of 203 & 26 R, and a mean 
temperature of 52 f 3’C. An impedance rise occurred during 3 (9.4%) RF 
applications. Following ablation, PV angiography did not show any stenosis. 
The animals were sacrificed 7 days post procedure. There were no atrial 
or PV thrombus nor extracardiac injuries. At histology, PV were patent with 
healing myocardial coagulation necrosis through the thickness of PV wall 
(contiguous lesion length 6.6 I 3.4 mm, lesion depth 1.5 -+ 0.6 mm). 
Conclusions: RF current delivery via a 2.5 Fr, 3 mm multi-electrode 
catheter is feasible and safely creates full thickness myocardial necrosis of 
PV wall in this short term canine model. 
/ IO74 73 Epicardial Mapping of Focal Atrial Fibrillation in the Electrophysiology Laboratory 
Mauricio I. Scanavacca, Eduardo A. Sosa, Andre d’Avila, 
Fernando Tondato, Flavio Oliveira, Antonio Bahia, Paulo Cavalvanti. Heart 
Intitute, University of Sao Paul0 Medical School, Sao Paula, Brazil 
Background: It has been demonstrated that paroxistic atrial fibrillation (AF) 
can be treated by radiofrequency (RF) catheter ablation of the spontaneous 
atrial ectopic beat (AEB) that induces AF. The aim of this study was to 
investigate the feasibility of transthoracic epicardial mapping to identify the 
trigger of focal AF in the electrophisiology laboratory (EP lab). 
Methods: 25 pts with frequent episodes of paroxistic AF were referred 
to RF catheter ablation in our EP lab. Six of them (3 men, mean age 55 + 
10 years) presented with sporadic AEB during the 24 hs. Holter monitoring 
and were subjected to transthoracic multipolar epicardial approach mapping. 
Two decapolar catheters were inserted into the right femoral vein. One 
catheter was positioned at the lateral wall of the right atrium and the other, 
into the coronary sinus. Two decapolar catheters were inserted into the 
pericardial space using the transthoracic subxifoid approach. One catheter 
was positioned in the epicardial oblique sinus close to the right pulmonary 
veins (RPV); the other catheter was placed in the epicardial transverse sinus, 
close to the left pulmonary veins (LPV). Finally a 4-mm tip catheter was 
inserted into the left atrium through transseptal approach. An intravenous 
bolus of heparin (5000 IU) was given, followed by 1000 IU/h continuous 
infusion. The transseptal catheter was able to explore the four PV. There was 
a good anatomic relationship of the obiiquo sinus catheter with the RPV and 
of the fransversus sinus catheter with the LPV. EAB or AF were induced by 
isoproterenol, adenosine or after electrical cardioversion of paced induced 
AF. Endocardial RF pulses (60” C, 30 s) were applied at the earliest induced 
or spontaneous EAB. 
Results: The left atrium epicardial catheters identified the earliest site of 
premature beats in 5 patients. The epicardial catheter guided the successful 
RF endocardiai application in 4 pts (2 in the left superior and 2 in the left 
inferior PV). one pt presented multiple origens of AEB and in one pt the 
trigger could not be identified. No acute complications were observed and 
the echocardiogram performed 24 hs after the procedure, showed a discrete 
epicardial effusion in one patient. 
Conclusion: Multipolar transthoracic epicardial mapping is a safe, effec- 
tive and helpful method to guide RF endocardioal ablation of focal AF. 
I 1074 74 Atria1 Non-Contact Mapping and Internal Low-Energy Cardioversion - A New Concept to 
Ablate Premature Beat Associated Atrial 
Fibrillation 
Michael A.E. Schneider, Juergen Schreieck, Bernhard Zrenner, Martin 
R. Karch, Gjin Ndrepepa, Justus Schwab, Sebastian Schmieder, 
Albert Schdmig, Claus Schmitt. Deutsches Herzzenfrum and 1. Med. K/ink, 
TU Muenchen, Germany 
Background: The mapping and radiofrequency ablation of atrial fibrillation 
(AF) triggered by focal premature beats (FPB) has been reported. In the 
present study a non-contact mapping (NCM) system was used to localize 
the focal origin of recurrent AF. During the procedure AF was terminated 
reproducibly by low-energy internal cardioversion (IC) to observe and localize 
the re-induction mechanism. 
Methods: The mathematical reconstruction of 3,300 endocardial electro- 
grams is achieved via a 64 electrode wire braid around a saline filled 8 ml 
balloon. The ECG generates an isopotential map on an anatomical computer 
model of the endocardium where also a 5 kHz signal emitted from the abla- 
tion catheter’s tip is displayed. The NCM documents the earliest activation 
of AF triggering premature beats. For a left atrial mapping the NCM and the 
ablation catheter were advanced transseptally. The IC was performed using 
a single-lead system with a distal array in the left pulmonary artery and a 
proximal array in the right atrium. 
Results: NCM was used in 4 patients (pt; age 51 f 10 y., male n = 3) with 
documented AF triggered by FPB. In three pt the mapping was performed in 
the left atrium. Mildly sedated, the pt underwent 6 i 2 internal cardioversions 
(4.8 & 3.4 J; 49 i 4 Q) to reproduce the AF onset. After IC there was an 
immediate recurrence of AF in 26% (n = 5), sinus rhythm (SR) with FPB 
was observed in 63% (n = 12) and SR changing directly in AF triggered by 
FPB could be documented in 11% (n = 2). Analyzing the 14/19 episodes 
demonstrating a trigger mechanism, focal sources were localized at the left 
atrial posterior wall, at the left and right upper pulmonary vein and at the right 
atrial crista terminalis. After 14 i 6 radiofrequency applications given at the 
target sites the trigger mechanisms remained suppressed. 
Conclusion: The simultaneous NCM system in conjunction with low- 
energy IC is a promising approach to localize and ablate AF triggered by 
atrial FPB. 
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1 1075-93 1 Different Tissue Heating Effectiveness of Phased 
and Non-Phased Radiofrequency Energy During 
Linear Ablation 
Xiangsheng Zheng, Gregory P. Walcott, Dennis L. Rollins, Jeffrey A. Hall, 
William M. Smith, G. Neal Kay, Raymond E. Ideker. University ofAlabama 
at Birmingham, Birminghak, Alabama, USA 
Phased radiofrequency (RF) energy delivered on a multi-electrode catheter 
will produce currents not only between each electrode and the backplate but 
also between adjacent electrodes. This study compared the tissue heating 
effectiveness by phased RF with non-phased RF. 
Methods: Ablation was performed on the in viva thigh muscles of 5 pigs. 
The thigh muscle cradle was infused with pig blood. A 7Fr linear ablation 
catheter with six ring electrodes (3 mm long, 4 mm apart) was placed against 
the tissue with a force of 30 g with the backplate as the return electrode. 
For non-phased RF, voltage was in phase at all 6 electrodes. For phased 
RF, voltage between adjacent electrodes was 130 degree out of phase. RF 
was delivered with 4 W on every electrode for 120 sec. Two plastic plunge 
needles, each with 6 thermocouples mounted 1 mm apart, were inserted into 
the tissue with one needle beside an electrode (#I) and the other midway 
between two electrodes (#2). 
Results (see table): Peak temperatures measured by the thermocouples 
at different depths inside the tissue and the lesion depth (LD) are summarized 
Phase 
Angle 
Plunge 
Needle 
Mean peaktemperature inside tissue (“C) 
1 mm 3mm 5mm 
Lesion Depth 
(mm) 
0' #l 54.8 f 3.5 50.2 f 2.5 46.2 i 1.8 2.5 f 0.7 
#2 50.8 i 2.5 4Eh2 44.9i1.6 0.9 * 0.9 
130’ #I 56 zk 2.4 51.2 * 2.2 46.3 i 1.5 2.5 * 0.7 
#2 54.8 + 2.3* 50.3 z!z 2.3* 46.1 3~ 1.4 2.1 + 0.v 
*p < 0.05 compared to 0’ phase angle at same position. 
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below. With phased RF all IO linear lesions were continuous, while with 
non-phased RF 4 of IO were discontinuous. 
Conclusions: With the same power and same electrode tissue contact 
pressure, non-phased RF creates a discontinuous or saw-tooth shaped linear 
lesion. Phased RF creates a more uniform linear lesion. 
1 1075-94 1 Spontaneous Tachyarrhythmias and Sudden 
Death in a Conscious Ovine Model of Myocardial 
Infarction and Complete Atrioventricular Block 
Cheryl R. Killingsworth, Steven D. Girouard, Gregory P. Walcott, Tracy 
L. Gamblin, Sharon B. Melnick, William M. Smith, Raymond E. Ideker. 
University of Alabama, Birmingham, AL; Therapy Research, Guidant/CRM, 
St. Paul, MN, USA 
Background: Sudden cardiac death is often the end result of structural 
changes in the heart that create a substrate for electrophysiologic instability 
and ventricular tachyarrhythmias. We sought to develop a conscious animal 
model of sudden cardiac death that was not dependent on acute ischemia as 
the trigger for arrhythmias. We hypothesized that myocardial infarction (Ml) 
and complete atrioventricular (AV) block would create an animal model that 
would result in ventricular tachycardia (VT, r180 beats per min.), ventricular 
fibrillation (VF), and sudden cardiac death. 
Methods: Eleven sheep (42-56 kg) underwent radiofrequency ablation of 
the AV node and angioplasty balloon occlusion of the left anterior descending 
coronary artery for 150 min. A pacemaker and implantable cardioverter-defib- 
rillator were implanted for back-up pacing, arrhythmia detection and therapy, 
and for retrieval of stored electrograms. Eight animals survived the Ml and 
AV node ablation procedures. AV node ablation significantly decreased the 
intraoperataive heart rate (mean f SD, 110 & 16 vs. 50 f IO beats per min.; 
P < 0.05) ldioventricular rhythm (IVR) remained slow at one week (49 f 14 
beats per min.) and beyond. A total of 23 episodes of VT or VTNF were 
recorded during the firs 21 days of the study. Three of 7 animals surviving 
>7 days experienced 5 episodes of spontaneous ventricular tachyarrhythmia 
(see inset of electrogram). One animal developed VT (280 beats per min.) 
that required a single 31 Joule internal shock to stop the arrhythmia. Two 
other animals had a total of 4 episodes of VT (299 + 57 beats per rain.) that 
proceeded to VF and required internal defibrillation. Structural changes in 
these animals were evidenced by aneurysmal dilation of the infarction and an 
infarct size of 5.7 f 2.0% of total heart weight. Hear-l weight to body weight 
ratio was significantly greater compared to day 1 non-survivor controls, sug- 
gesting that ventricular hypertrophy was associated with chronic Ml and AV 
block (6.0 i 1.3 x 1O-3 vs. 4.6 i 0.3 x 10-3, P < 0.05). 
Conclusion: The combination of MI and AV block produced structural 
changes in the ovine heart that yielded a high incidence of spontaneous 
tachyarrhythmias. 
11075-95 1 A Randomized Study on the Effects of Pacemaker 
Programming to a Lower Output on Pulse 
Generator Longevity 
Andreas Schuchert, Thomas Meinenz. On behalf of the Low Output 
Programming lnvestiga tors; Medical Clinic, Department of Cardiology, 
University-Hospital Eppendorf, Hamburg, Germany 
Background: The programmability of cardiac pacemakers (pms) enables 
the physician at the follow-up to adjust the pacing pulse under consideration 
of the 100% safety margin with respect to the individual pacing threshold. 
The purpose of reducing the output is to prolong pm longevity. The aims of 
this prospective, randomized trial were to compare the effects of nominal 
output versus a lower output in VVI- as well as DDD-pms. The secondary 
aim was to assess how many patients (pts) can be programmed to 2.5 V/O.4 
ms instead of the nominal 3.5 V setting with >iOO% safety margin. 
Methods: The pts received the same types of VVI or DDD pros which 
were connected in the ventricle to the steroid-eluting, high-ohmic pacing lead 
CapSure Z (Medtronic). At the 3-month follow-up, pts with ventricular pacing 
thresholds ~0.15 ms at 2.5 V pulse amplitude were randomized to 3.5 V 
or 2.5 V amplitude at 0.4 ms pulse duration. Lead function and projected 
device longevity were assessed by the pm’s telemetry 6 and 12 months after 
implantation. 
Results: VVI pm: At the 3-month follow-up, 3 pts had pacing thresholds 
~0.15 ms at 2.5 V and 139 pts could be randomized. A reprogramming 
to a higher output was necessary in one patient. The mean percentage 
of ventricular pacing was of about 40% throughout the study time. The 
programming to 2.5 V output resulted in an insignificant increase of device 
longevity from 117.9 f 18.7 months in the nominal group to 123.7 & 11.9 
months at the 12-month follow-up (p = 0.16). DDD-pm: 166 pts underwent 
randomization. The mean percentage of ventricular pacing was 65% in the 
ventricle and 35% in the atrium. The 2.5 V setting significantly prolonged pm 
longevity from 98.1 f 21.3 to 112.0 & 13.6 months (p < 0.0001). In 3 pts 
(1%) we observed a late increase of the pacing threshold. 
Conclusions: Due-to the low ventricular pacing thresholds, the 2.5 V/O.4 
ms setting provided 3 months after implantation a ~100% safety margin in 
99% of the pts. The programming to a lower output slightly increased pm 
longevity compared to the nominal 3.5 V setting. The increase was only 5% 
in pts with VVI and 14% for DDD pulse generators. 
/ 107596 / Exercise Noise Seen by Pacemaker From Leads 
Johannes Sperzel, Jdrg Neuzner, Jeff Senden, Fabio Zardo, Geng Zhang’ , 
Andreas Koenig’, Roger Willems’. European Autosense Study Group; 
Kerckhoff Klinik, Bad Nauheim, Germany; Guidant Corporation, St. Paul, 
MN, USA 
Introduction: It has been reported that oversensing incidents were high 
during exercise if sensing threshold was set below 2 mV. This is especially 
true for atrial sensing. This study evaluated the relationship between ac- 
tivity-induced muscle noise and intrinsic amplitudes. The daily activity was 
simulated by asking the patients to perform different maneuvers during the 
study. Noise levels in both chambers were measured continuously along with 
intrinsic amplitudes for all cardiac cycles. 
Method: After leads implantation and routine measurements, a custom- 
made external pacing system (Guidant, St. Paul, MN) with multi-channel data 
acquisition capability was connected to the lead(s). During the study, patients 
were asked to perform deep breathing, hand gripping, elbow lifting against 
pressure and Valsalva, to elicit muscle noises. The noise levels and the 
amplitudes of P-wave and R-wave, from both the atrial and ventricular cham- 
bers were measured all the time (except for the blanking period) for every 
beat. Noise levels and intrinsic signal amplitudes were analyzed and char- 
acterized by lead types (unipolar/bipolar, acute/chronic), cardiac chambers 
(atrium/ventricle), and 4 exercise types. 
Results: 36 patients (18 males) from 3 medical centers, with average age 
of 69.8 & 11 .O yrs, participated in the acute study. They were indicated for 
pacemaker implantation or replacement. The study included 26 atrial leads 
(22 bi and 4 unipolar) from 5 manufactures and 35 ventricular leads (22 bi 
and 13 unipolar) from 8 manufactures. Among them, 4 atrial and 3 ventricular 
leads were chronic. Noise level and intrinsic amplitude ranges are given in 
the table below. 
Chamber 
Atrium 
Ventricle 
Polarity 
Bipolar 
Unipolar 
Bipolar 
Unioolar 
Noise level (mV) 
0.01-2.45 
0.02-1.24 
0.03-2.41 
0.02-1.51 
Intrinsic amplitude (mV) 
0.48-5.88 
1.10-7.62 
1.51-25.35 
1.16-22.92 
No particular kind of exercise was associated with larger muscle noise 
level. 
Conclusion: From the pacemaker’s point of view, muscle noises induced 
by various exercises in both chambers were transient in nature, and no 
specific exercise caused higher noise level. The distributions of noise and 
intrinsic amplitude overlapped, suggesting that dynamically adjusting sensing 
threshold may improve sensing performance in some patients. Muscle noise 
level measured from acute leads and chronic leads were not different on 
average. 
L-L 1075 97 Prospective Evaluation of Clinical Criteria for the 
Diagnosis of Pacemaker Lead Infection 
Didier Klug, Moustapha Jarwe, Christine Savoye, Frederique Wallet, 
Dominique Lacroix, Philippe Delfaut, Claude Kouakam, Salem Kacet. 
University of Lille, Lille, France 
Removal of infected pacemaker (PM) is recommended by several studies. 
Because lead ablation may result in severe complications and is an expensive 
procedure, reliable criteria for infection diagnosis are requested. 
Methods: We prospectively evaluated clinical, biological and transesophageal 
echographic (TEE) criteria as predictive tools to diagnose PM leads infec- 
tion by comparing with results of bacteriologic lead culture (BLC). Leads 
were extracted (surgically or percutaneously) with a great care to obtain re- 
liable BLC (3 BLC by lead, femoral extraction to avoid contamination of the 
endovascular part of the lead through an infected pocket) 
Results: 76 patients (pts) with suspected PM lead or pocket infection were 
included, 32 pts had only local symptoms, 44 pts had symptoms of systemic 
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infection. The criteria tested and their respective sensitivity (SN) specificity 
(SP), positive and negative predictive values (PPV, NPV) are summarized in 
the following table. 
35% for transthoracic cardioversion rates of 60, 80 and lOO%, respectively. 
In the absence of an anesthesiologist, routine pretreatment with ibutilide is 
associated with an increase in the mean cost of cardioversion at all success 
rates of transthoracic cardioversion. 
Criteria PPV (%) 
More than 3 procedures on PM 94 
Fever 92 
Local symptoms 89 
Biological inflamation 82 
Positive blood culture 94 
Pulmonary infarction 80 
Veaetation (TEE) 89 
NPV (%) SN (%) SP (%) 
25 29 93 
32 30 90 
24 31 66 
29 68 47 
24 27 93 
20 22 78 
14 89 50 
For each criteria the positive predictive value was high but the negative 
predictive value was low. TEE had a good sensitivity. 
Conclusion: The variables tested were very useful to diagnose PM leads 
infection. They must be considered as criteria adapted to diagnose PM leads 
infection. 
/ 1075-98 j Diagnostic Value of Thallium 201 Myocardial 
Perfusion in Permanent Paced Patients 
Alain Le Helloco, Anne Devillers, Jean-Louis Alberini, Marc Bedossa, 
Patrick Bourguet, Claude Aimange. Department of Cardiology and Nuclear 
Medecine, University Hospital, Rennes, France 
Exercise test is ininterpretable in patients (pts) with DDD pacing for the diag- 
nostis of coronary artery disease (C.A.D.). Exercise myocardial tomography 
should localize ischemia in these pts. The aim of this study is to evaluate the 
interest of myocardial tomography in pts with DDD pacemaker. 65 pts with 
mean age 67.5 i 7.3 were implanted with DDD pacemaker for high degree 
AV block (42 pts) and sick sinus syndrome (23 pts). Exercise or rest angina 
were present in 38 pts, atypical chest pain in 13 pts and myocardial infarction 
in IO pts (anterior in 5 pts, inferior in 3 pts and lateral in 2 pts). All pts un- 
derwent exercise test (E.T.) coupled with dipyridamole Thallium tomography 
(SPECT) and coronry angiogram. These pts were divided in group 1 (28 pts) 
without coronary stenosis, in group 2 (37 pts) with 20 one vessel disease 
(v.d.), 9 two vd and 8 three v.d.. 
Results: Eercise test is insufficient for diagnosis of C.A.D. 
Maximal E.T. 
Angina 
Group 1 
7 (29.2%) 
2 (8.3%) 
Group 2 
4 (16.7%) 
10 (41.7%) 
p > 0.1 
p c 0.01 
The global sensitivity (SE) of SPECT is excellent (Qi.Q%), but apical 
defect is frequent in group 1 (specificity SP = 57.1%). SPECT detects the 
defects of left anterior descending artery (L.A.D.) with SE = 72.7%, right 
coronary artery (SE for RCA = 80.9%) and left circumflex (SE for LCX = 
45.4%) but SP for LAD and RCA is respectively to 62.8% and 75%. 
Conclusion: In pts with DDD pacemaker, dipyridamole SPECT can be 
used for diagnosis of C.A.D., but infero-apical defect is possible without 
coronary stenosis. 
/ 1075-99 1 Comparison of the Cost of Transthoracic 
Cardioversion of Atrial Fibrillation With and 
Without lbutilide Pretreatment 
Hakan Oral, Bradley P. Knight, Michael H. Kim, Matthew A. Flemming, 
Frank Pelosi, Christian Sticherling, Gregory F. Michaud, S. 
Adam Strickberger, Fred Morady. University of Michigan, Ann Arbor, 
Michigan, USA 
Background: lbutilide may result in chemical cardioversion of atrial fibrilla- 
tion and facilitates transthoracic cardioversion of atrial fibrillation by lowering 
the defibrillation energy requirement. Whether routine pretreatment with ibu- 
tilide increases or decreases the cost of cardioversion of atrial fibrillation is 
unknown. 
Objective: To compare the costs of outpatient transthoracic cardioversion 
of atrial fibrillation with and without ibutilide pretreatment. 
Methods: A mathematical model was designed to compare the costs 
of the 2 cardioversion strategies in a hypothetical group of 100 patients as 
a function of the primary success of chemical cardioversion with ibutilide 
and success of transthoracic carclioversion. Models were developed for car- 
dioversion performed with and without involvement of an anesthesiologist 
for sedation. Reference cost values were obtained by review of the com- 
puterized records of 54 patients who underwent cardioversion with either 
strategy. 
Results: If an anesthesiologist is involved in the procedure, there are in- 
cremental cost-savings with routine pretreatment with ibutilide as the success 
rate of chemical cardioversion increases above critical values of 20, 27, and 
Conclusions: Whether or not routine pretreatment with ibutilide lowers 
the mean cost of cardioversion is determined by the success rates of ibutilide 
and transthoracic cardioversion and whether or not an anesthesiologist is 
involved. 
1 3 1075 100 Inter-Atria1 Conduction Delay Cannot Predict the 
Maintenance of Sinus Rhythm During Biatrial 
Pacing in Patients With Permanent Atrial 
Fibrillation 
Nikolaos Fragakis, Julian Bostock, Carl Shakespeare, Phyllis Holt, 
Jaswinder S. Gill. Cardiofhoracic Centre, Guy’s & St Thomas’ Hospital, 
London, UK 
Inter-atria1 conduction delay (IACD) is characterised by a prolonged (>120 
msec) surface P wave and extended activation time between the high right 
atrium (HRA) and the distal coronary sinus (CSd). We examined whether 
IACD could predict the long-term maintenance of sinus rhythm (SR) in pa- 
tients (pts) with permanent atrial fibrillation (AF) who underwent internal 
cardioversion (IC) followed by biatrial pacing (BIP). 
Methods: 15 (pts) (13 M, 55 i IO yrs), with AF resistant to at least 
3 attempts at external cardioversion, underwent successful IC. Pts were 
temporarily paced biatrially [right atrial appendage (RAA)-(CSd)] for 48 hrs 
after IC. The surface P wave was measured during SR (P,). RAA pacing 
(Ps) and BIP (Ps). The inter-atria1 conduction time (IACT) was also assessed 
during SR. Pts who remained in SR for 48 hrs had a permanent biatrial 
pacemaker (RAA-CSd). 
Results: Mean permanent AF duration was 09 f 42 months and 12 pts 
had underlying cardiac disease. Mean left atrium (LA) diameter was 48 f 
04 mm and mean left ventricular shortening fraction (SF) 33 f 10%. 9 pts 
relapsed to AF within 1 month (5 pts 5 48 hrs) (Group A) while 6 pts remained 
in SR after 90 & 142 days (Group B). IACT, PI, Pa and Ps did not differ in 
both groups (table). Also, age, underlying heart disease, AF duration, LA 
size, SF, energy used during IC and attempted antiarrhythmic drugs before 
or after IC did not differ. 
Group Pi 
(msee) 
P2 
(msec\ 
P3 
fmsecl 
IACT 
fmsecl 
A (n = 9) 150117 140150 13oi31 110*23 
6 (n = 6) 145133 160+30 115f30 lOOzt-26 
D 0.81 0.55 0.51 0.43 
Conclusion: P wave duration and IACD do not predict the selection of 
pts with permanent AF who can be maintained in SR with implantation of BIP 
following successful IC. 
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1076-59 T-Wave Alternans Bursting in Patients at Risk for 
Sudden Cardiac Death 
Elizabeth S. Kaufman, Birendra Julka, Carole Drabek, David 
S. Rosenbaum. MetroHealth Medical Center and Case Western Reserve 
University: Cleveland, Ohio, USA 
Background: Microvolt level T-wave alternans (TWA) detected at moderately 
increased heart rate is an established predictor of sudden cardiac death. 
Although it has been suggested that transient bursts of TWA may precipitate 
sudden cardiac death, previous studies have assumed that TWA in humans 
remains constant over time. 
Methods: To determine the short-term variability and heart rate depen- 
dence of TWA, microvolt level TWA was measured during atrial pacing at 
multiple cycle lengths in 10 patients referred for electrophysiologic testing, 
using sensitive digital signal processing techniques. 
Results: Five subjects had inducible sustained ventricular tachycardia 
(VT) and 5 did not (controls). There was a patient-specific threshold heart 
rate over which alternans appeared which was significantly lower in VT 
patients than in controls (98 f 12 vs. 120 * 25 bpm). In each of the 5 VT 
patients, although TWA amplitude remained persistently elevated (at 1 O-20 
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WV’), superimposed bursts of TWA 50-70% greater than baseline alternans 
amplitude occurred every 2-3 minutes. These bursts of TWA were seen 
despite maintaining stable heart rate. Bursts of TWA were also observed in 
controls, but occurred less frequently and only at rapid heart rates. 
Conclusions: In patients with VT, bursts of TWA that are independent 
of heart rate fluctuations occur spontaneously every 2-3 minutes. Con- 
sequently, TWA should be measured over several minutes to account for 
short-term fluctuations in alternans magnitude. Further studies are justified 
to determine if transient bursts of TWA precipitate sudden cardiac death. 
1076-60 Comparison of Repolarization Abnormality 
During Exercise in Dilated Cardiomyopathy and 
Hypefirophic Cardiomyopathy 
Nami Kuroda, Yoshio Ohnishi, Kouhei Yamashiro, Katsunori Okajima, 
Akihiko Ishida, G.E. Javier, Mitsuhiro Yokoyama. Kobe University School of 
Medicine, Japan 
Background: The aim of this study was to clarify the relationship between 
QT dispersion and T wave alternans (TWA), and to evaluate and compare the 
clinical significance of these repolarization parameters in dilated cardiomy- 
opathy (DCM) and hypertrophic cardiomyopathy (HCM). 
Methods: Eighty-six patients (pts) with cardiomyopathy (47 DCM and 
39 HCM) experienced TWA during bicycle exercise testing (EXT) using a 
CH2000 system (Cambridge Heart, Inc.). The QT interval (QT), duration 
from the Q wave to the peak of the T wave (QTp), duration from the peak to 
the end of the T wave (TpE) and the dispersion of these parameters (QTd, 
QTpd, TpEd) were measured by the 12 lead ECG at rest and a heart rate 
of 105 bpm during EXT. Four patients with a QRS duration >I20 ms were 
excluded from the analysis. 
Results: In DCM, TWA was positive (TWA+) in 19 pts, negative (TWA-) 
in 17 pts and indeterminate in 11 pts. No significant difference was observed 
in the QT, QTp, TpE and the dispersion of these parameters at rest and 
during EXT between the TWA+ and TWA- groups. On the other hand, in 
HCM, TWA was positive (TWA+) in 24 pts, negative (TWA-) in 12 pts and 
indeterminate in 3 pts. Although no difference was observed in all parameters 
at rest, max QTc and max QTp in TWA+ were significantly longer than those 
in TWA- (max QTc; 515.0 & 30.8 ms vs 486.2 f 21.6 ms; p < 0.05, max 
QTp; 285.5 & 18.6 ms vs 268.7 f 17.2 ms; p < 0.05). QTcd during EXT 
in TWA+ was longer than that in TWA- (93.4 f 26.4 ms vs 74.4 f 17.2 
ms; p = 0.07). The sensitivity of TWA and max QTc P 500 ms during EXT 
for ventricular tachycardia (VT) were lOO%, 84% in DCM and 90%, 93% in 
HCM, respectively. 
Conclusion: TWA is not related with QT dispersion at rest and during 
exercise in cardiomyopathies. TWA is an useful predictor for VT in DCM and 
HCM. Repolarization abnormality during exercise plays an important role in 
the genesis of VT especially in HCM. 
L---IA 1076 61 Comparison Between T-Wave Alternans, Late 
Potentials, QTc Dispersion and Ejection Fraction 
in Predicting Arrhythmic Events After Acute 
Myocardial Infarction: A Prospective Study 
Takanori Ikeda, Takao Sakata, Naoki Kondo, Mitsuaki Takami, 
Naoki Tezuka, Takeshi Nakae, Mahito Noro, Yoshihisa Enjoji, Kaoru Sugi, 
Tetsu Yamaguchi. Toho University Ohashi Hospital, Tokyo, Japan 
Background: Microvolt T-wave alternans (TWA), late potentials (LP) by 
signal-averaged ECG, ejection fraction (EF), and QTc dispersion (QTcd) 
have been proposed as risk markers to predict arrhythmic events. These 
marker have not been prospectively compare with each other. The purpose 
of the study was to test the hypothesis that TWA is the most significant 
predictor among these markers in the setting of acute myocardial infarction. 
Methods: We screened 142 consecutive patients with acute myocardial 
infarctions. Twenty-three patients who had wide QRS complex, atrial fibrilla- 
tion and frequent extrasystoles were excluded from the study. We sequen- 
tially assessed TWA, LP, QTcd, and EF by ventriculography in 119 patients. 
Seventeen patients with indeterminate test results of TWA and LP were 
also excluded from the study. Therefore, 102 patients were prospectively 
assessed. No antiarrhythmic drugs were used during the follow-up period. 
The study end point was the documentation of ventricular arrhythmias. 
Results: TWA was present in 50 patients (49%) LP present in 21 patients 
(21%), QTcd > 80 ms in 20 patients (20%) and an EF < 40% in 28 patients 
(27%). During a follow-up period of 13 f 6 months, ventricular arrhythmias 
defined as sustained ventricular tachycardia or ventricular fibrillation occurred 
in 15 patients (15%). Univariate Cox regression analyses revealed that all 
markers were significantly independent predictors (P = 0.006, P = 0.0008, P 
= 0.03, P = 0.003, respectively). In a multivariate Cox regression analysis, 
TWA was the most significant predictor (P = 0.02, relative hazard 10.4). The 
sensitivity and the negative predictive value of TWA in predicting arrhythmic 
events were very high (93% and 98%, respectively), whereas its positive 
predictive value (27%) was lower than those for LP, QTcd, and abnormal 
EF. 
Conclusion: Although TWA significantly predicts arrhythmic events after 
acute myocardial infarction in comparison with LP, QTcd, and EF, a more 
useful single marker may be desirable for low positive predictive value. 
l-2 1076 62 Relationship Between T Wave Alternans and Cardiac Sympathetic Nervous Dysfunction in 
Patients With Non-lschemic Heart Disease 
Masahiko Harada, Akihiko Shimizu, Kaoru Ono, Makoto Kubo, 
Masunori Matsuzaki. Yamaguchi University School of Medicine, Ube, Japan 
To clarify relationship between T wave alternans (TWA) and cardiac sym- 
pathetic denervation in patients with non-ischemic heart disease, we inves- 
tigated the presence of TWA and the cardiac sympathetic dysfunction by 
using l-123 MIBG scintigraphy. 
Methods: TWA test and l-123 MIBG scintigraphy were performed in 
28 patients (pts) who had no ischemic heart disease, proved by coro- 
nary angiography or myocardial scintigraphy on exercise. We calculated 
the heart/mediastinal count ratios in early phase (e-H/M) and delayed phase 
(d-H/M), and the washout rate after decay correction (WR) with MIBG scintig- 
raphy. The normal value was defined as 2.0 or more in both e-H/M and d-H/M, 
and 25% or more in WR. Left ventricular ejection fraction (EF) with echocar- 
diography and serum norepinephrine level (NE) at the early morning were 
also measured. 
Results: 14 pts showed a positive TWA (positive group) and 14 pts did 
a negative TWA (negative group). Comparing the various indices of scintig- 
raphy between two groups, the positive group had significantly lower values 
in e-H/M and d-H/M (p < O.OOl), but there was no significant difference on 
WR. In pts with EF 3 50% (5 pts in positive group and 14 pts in negative 
group), the above results did not change. The other hand, all 9 pts with 
EF < 50% showed positive TWA and d-H/M of less than 2.0. WR showed 
a significant positive correlation with NE that reflected the activity of the 
sympathetic nervous system (r = 0.81, p < 0.001). The positive group was 
divided into two types, the denervation type (reduction of e-H/M) and the 
high washout type (normal e-H/M and reduction of d-H/M), as shown in the 
table. 
e-H/M d-H/M WR -i”M+) WA(-) Total 
Normal + --f 1 12 13 
Denervation type 1 JZL + or t 10 1 11 
High washout type + 4. t 3 1 4 
Conclusion: It was suggested that both cardiac sympathetic denervation 
and activation of sympathetic nervous system were related to the positive 
TWA in pts with non-ischemic heart disease. 
ORAL 
Atrial Defibrillation 
Monday, March 13, 2000, 9:15 a.m.-l 0:30 a.m. 
Anaheim Convention Center, Room 304C 
9:15 a.m. 
828-l Is Overdrive Stimulation Therapy a Therapeutic 
Option in Pacemaker Patients With Paroxysmal 
Atrial Fibrillation? First Worldwide Results of a New 
Dual Chamber Stimulator 
Burkhard Hiigl’ , Katrin Ziegenbalg, Nicolas Doll, Hans Kottkamp, 
Gerhard Hindricks, Gerhard Schuler. ‘On behalf of the Multicenter Worl 
Wide AT 500~Investigators; Heart Center, University of Leipzig, Germany 
In a world wide prospective study, the feasability of the new arrhythmia 
management device (Medtronic AT 500 Model 7253) is investigated. This 
dual-chamber pacemaker uses sophisticated pattern recognition (PR-Logic) 
to classify atrial arrhythmias. It stores the intra-cardic ECG upon detection 
of an arrhythmia. In Addition, the device provides several features to treat 
atrial tachycardias using preventive pacing as well as overdrive stimulation 
therapies that should be capable to terminate atrial arrhythmias. 
Since 6/99 34 patients (pts) (age 65 f 16 y, EF 58 & 16%,) received the 
device. Underlying heart diseases are: coronary heart disease in 8 pts (13%) 
hypertension in 18 pts (30%), dilated cardiomyopathy in 4 pts (7%), other in 
15 pts (25%). All pts met the Class I indication (AHAIACC) for pacemaker 
implantation. Frequently recurrent episodes of paroxysmal atrial fibrillation 
were documented in all patients. 
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First Results: During the study period of maximally 60 days 579 episodes 
of atrial fibrillation or flutter occurred in 12 pts (35%), which were all correctly 
detected by the PR-Logic algorithm. For 213 episodes of atrial fibrillation 
with an initial cycle length of 188 rir 27 ms and a cycle length variation of 
58 + 24 ms therapy was delivered. Painless ATP burst therapy in the atrium 
successfully terminated 142 of these arrhythmias (67%). 24 episodes could 
be terminated through painless overdrive burst therapy in the atrium. No 
severe adverse events were noted. 
Conclusion: Overdrive stimulation therapy is a new save and painless 
option in pacemaker patients to terminate atrial arrhythmias including parox- 
ysmal atrial fibrillation. Continuation of this study is necessary to asses the 
efficacy of the new therapeutic options. 
9:30 a.m. 
/ 828-2 / Energy Use and Efficiency in Direct Current 
Cardioversion 
Mark M. Gallagher, Xiao-Hua Guo, A. John Camm. Department of 
Cardiological Sciences, St George’s Hospital Medical School, London, UK 
Background: Guidelines for direct current cardioversion (DCC) of atrial 
arrhythmias recommend starting with low power shocks which frequently 
fail. We have evaluated the probability of success at each energy setting to 
design a more efficient protocol. 
Methods: We recorded the sequence of shocks delivered and the effect 
on cardiac rhythm in 1838 attempts at DCC for atrial fibrillation (AF), 678 
for atrial flutter. The results of these attempts were used to calculate the 
probability of cardioversion for each shock of a standard series of incremental 
shocks, and the probability of success with a single shock at each intensity. 
Analysis was stratified for rhythm and duration of AF. In a subset of 113 
cases, the time of each shock was recorded to measure the time expended 
on unsuccessful shocks. 
Results: We analysed the effects of 5152 shocks delivered AF, 1238 in 
atrial flutter. In patients with AF for >I month, shocks of ~200 J had only a 
6.1% probability of restoring sinus rhythm. This probability fell to 2.2% with 
AF for ~6 months. The probability of success with the first shock in AF of 
>I month duration was 5.5% at ~200 J, 35% at 200J and 56% at 360J. A 
model of cumulative success constructed from these data (fig) suggests that 
a standard protocol of increasing shock intensity will require ~5 shocks to 
convert most of those with AF for 30-I 80 days, ~6 shocks for AF of longer 
duration. In practice the initial use of a more powerful shock was associated 
with the use of fewer shocks. In those with AF for >‘I80 days it also reduced 
the total energy per procedure (773 * 435J for those starting at 1 OOJ, 581 + 
314J when starting at 3OO-360J). Each extra shock added 70 f 56 seconds 
to the procedure. 
Conclusions: In persons with AF for ~30 days, shocks of ~200 J waste 
time and increase the total energy delivered. In those with AF for ,180 days, 
an initial setting of ~300 J reduces the total energy used. 
9:45 a.m. 
L--i 828 3 A Clinical Trial of a Combined Atrial and Ventricular 
Defibrillator in Patients Without Ventricular 
Arrhythmias 
Michael R. Gold, James P. Daubert, Robert W. Peters, Stephen 
Ft. Shorofsky. Universjfy of Mary/and, Baltimore, MD, USA 
Background: Both stand alone atrial and combined dual chamber shocking 
defibrillators (ICDs) are being developed to treat atrial fibrillation (AF) in 
patients (pts) with or without concomitant ventricular arrhythmias (VTNF). 
This prospective study was the first assessment of a dual chamber ICD in 
pts with atrial tachyarrhythmias, heart disease but no VTIVF. 
Methods: A Medtronic Jewel AF ICD was implanted in 83 pts with re- 
current atrial tachyarrhythmias. Adequate atrial and ventricular defibrillation 
thresholds (DFTs) were documented with standard ventricular ICD lead sys- 
tems The device was programmed with tiered therapy (antitachycardia pac- 
ing, 50 Hz burst and shocks) for atrial tachyarrhythmias and backup shocks 
for VT/I/F. 
Results: The population was 71% male with a mean age of 63 f 11 
years. Mean ejection fraction was 0.49 f 0.19 (36% ( 0.40) and 29% had 
congestive heart failure. The atrial DFT was 6.0 i 4.5 J. Pacing terminated 
57% of 261 episodes of spontaneous atrial tachycardia and 52% of 92 
episodes in the AF zone. For these arrhythmias, shocks were successful 
in 93% (52156) and 94% (242/257) of episodes, respectively. Of the AF 
episodes, 85% were treated out of hospital. No VT/VF developed with atrial 
therapies; however, 2 pts had spontaneous VF successfully treated with 
shocks. 
Conclusions: The Jewel AF ICD safely and effectively treats atrial ar- 
rhythmias in outpatients while also treating VTNF when necessary. The use 
of tiered therapy with pacing prevents a significant number of shocks. 
1O:OO a.m. 
ELI 828 4 A Novel Method in Cardioversion of Atrial 
Fibrillation Using Radiofrequency Transcutaneous 
Power Transfer and a Passive Implantable Atrial 
Defibrillator 
Ganesh Manoharan, J. Desmond Allen, Bakhtiar J. Kidwai, A.A. 
Jennifer Adgey, Noel Evans, John Anderson. Royal Vicforia Hospital, 
Belfast; University of Ulster, Jordansfown, UK 
Background: Atrial fibrillation (AF), the most common sustained arrhythmia, 
is associated with increased morbidity and mortality. AF may be intermittent. 
Current methods for defibrillation have varying success rates, risks and cost 
implications. The aims of this study were to investigate the feasibility, efficacy 
and safety of a novel passive implantable atrial defibrillator (PIAD). The 
device is powered externally by a radiofrequency (RF) energy transmitter 
and delivers a rounded monophasic DC pulse with low tilt. 
Methods: The device was assessed in 10 anaesthetized sheep (58.0 & 
2.2 kg). Two atrial defibrillation leads were placed via the internal jugular 
vein into the distal coronary sinus and right atrial appendage. These were 
connected to the PIAD which was implanted subcutaneously. The RF trans- 
mitter coil was placed on the skin overlying the defibrillator. Sustained AF 
was induced by rapid atrial pacing (Grass stimulator, 100 Hz, 5 volts) and 
defibrillation was attempted synchronised to the R wave. Three voltage levels 
(50, 75 and 100) were assessed at varying pulse widths (5, 6, 8, IO, 12, 15, 
20 and 30 ms). Attempted defibrillation was repeated 5 times at each voltage 
and pulse width setting. Successful defibrillation was defined as complete 
reversion to sustained sinus rhythm within 3 seconds of shock delivery. The 
delivered shock voltage and current were captured by a Tektronix Digital 
scopemeter and stored for analysis. 
Results: The table shows % success and mean energy delivered (ISEM 
J). No arrhythmic or other complications were observed for the total shocks 
delivered. 
PlIlS? Width rms) 5 6 8 10 12 15 20 30 
5ov %success 18 40 48 50 56 64 74 74 
J 0.16 0.23 0.37 0.43 0.53 0.66 0.87 1.28 
GEM 0 0 0.03 0.01 0.01 0.01 0.01 0.02 
75v % SUCCeSS - - 52.5 56 66 66 78 - 
J 0.65 0.89 1.11 1.38 1.87 
GEM 0.01 0.01 0.01 0.01 0.02 
1oov %s"ccess 58 72 88 100 98 98 96 98 
J 0.56 0.85 1.22 1.54 1.95 2.36 3.06 4.39 
SEM 0.01 0.01 0.01 0.02 0.02 0.03 0.04 0.06 
Conclusion: With this novel method, successful and safe defibrillation 
occurs. Good success rates achieved with a low voltage and energy may be 
due to the low tilt of the waveform produced (100% at 100 V, IO ms with 1.54 
& 0.02J). This inexpensive method is a viable alternative mode of treatment 
for patients with paroxysmal AF. 
IO:15 a.m. 
1 828-5 1 Improvement of Left and Right Ventricular Systolic 
and Diastolic Function After Cardioversion by the 
Implantable Atrial Defibrillator in Patients With Atrial 
Fibrillation 
Cheuk-Man Yu, Qiong Wang, Hung-Fat Tse, Vela Tsang, Cathy Lam, 
Sum-Kin Leung, Gregory Ayers, Chu-Pak Lau. Division of Cardiology 
Department of Medicine, Queen Mary Hospital, The University of Hong 
Kong, China 
Background: Atrial fibrillation (AF) causes atrial mechanical dysfunction, 
though whether it may cause ventricular dysfunction in short-lasting AF is 
unknown. This study investigated whether prompt cardioversion for short- 
lasting AF by an implantable atrial defibrillator (IAD) will improve left (LV) and 
right (RV) ventricular systolic and diastolic function. 
Methods: Eleven patients (mean age 59 Z!I 12 years, 9 male) with lone 
AF received an IAD (Metrix, Guidance) were studied by echocardiography 
with tissue Doppler study (TDI) for both ventricles at baseline during sinus 
rhythm, I-min, 20-min, 4-hr & I-wk after cardioversion. 
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Results: There were 44 episodes of AF, with a mean duration of 8.8 f 
9.6 days (20 min 37 days, 86% spontaneous AF). There was no change in 
M-mode measured LV fractional shortening and ejection fraction. However, 
the TDI-derived systolic velocities (TDI-S) was significantly lower immediately 
after cardioversion and only normalized at I-wk, in both LV (Baseline: 5.8 i 
1.8, I-min: 4.4 f 1.0,20-min: 4.4 f 0.9,4-hr: 5.0 f 1 .I, l-wk: 5.7 f 1.4cm/s, 
p < 0.001 when compared l- & 20-min to baseline, P < 0.05 when compared 
4-hr to baseline) and RV (Baseline: 10.4 i 2.2, 1 -min: 7.7 f 1.4, 20-min: 8.0 
i 1.3, 4-hr: 9.0 i 1.6, I-wk: 10.2 z!= 2.0 cm/s, p < 0.001 when compared 
I-min, 20-min & 4-hr to baseline). For diastolic function, transmitral Doppler 
study found a reversibly decreased early filling (E) velocity at I- (p < 0.05) & 
20-min (p < O.OOl), then back to normal at 4 hr, though there was no change 
in transtricuscid Doppler flow. However, TDI-derived E-velocity (TDI-E) was 
decreased in both LV (Baseline: 5.85 f 2.79, I-min: 5.4 f 2.3, 20-min: 5.4 
f 2.1, 4-hr: 6.1 & 2.2; I-wk: 5.8 i 1.7 cm/s, p < 0.05 when compared i- & 
20-min to baseline) and RV (Baseline: 8.7 f 3.5, I-min: 7.7 * 3.3, 20-min: 
8.1 & 3.3, 4-hr: 8.3 f 2.9: I-wk: 8.1 f 3.5 cm/s, p < 0.01 when compared 
I-min to baseline). In addition, the LV TDI-S velocity was significantly smaller 
for AF of 52 days (5.3 f 1.1 Vs 4.1 f 0.9 cm/s, p = 0.001). Shocks in sinus 
rhythm did not affect the above echocardiographic parameters. 
Conclusions: Even short lasting AF impaired systolic & diastolic function 
in both ventricles, which is reversible after cardioversion. TDI is a more 
sensitive way to assess systolic and diastolic dysfunction than conventional 
methods. 
ORAL 
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839-l Single-Center Experience With Transvenous 
Biventricular Pacing to Treat Advanced Heart 
Failure: Long-Term Clinical Results 
Christophe Leclercq, Christine Alonso, Dominique Pavin, Frbd&ic Victor, 
Pierre-O. Benoit, Philippe Mabo, J. Claude Daub&. Department of 
Cardiology, University Hospital, Rennes, France 
Permanent biventricular (Biv) pacing was recently proposed as an additive 
treatment in patients (pts) with advanced heat-l failure related to dilated 
cardiomyopathy (DCM), and intraventricular conduction delay. 
From 1994, 89 pts were consecutively implanted in the same institution 
with a permanent transvenous Biv. pacing system. 13 pts (15%) died within 
a mean delay of 8.6 f 4.4 months after the implantation time. The aim of 
the study was to assess the long-term clinical effects of Biv. pacing in the 
survivor patients who had a minimal follow-up (FU) time > 6 months. 
55 pts, mean age 69 f 7 years, were included. DCM was of idiopathic 
origin in 31, ischemic in 18 and valvular in 6. At implantation time, 65% were 
in NYHAclass Ill and 35% in class IV. 42 pts were in stable sinus rhythm with 
a mean PR interval of 260 f 55 ms and the other 13 were in chronic atrial 
fibrillation. The mean QRS duration was 190 f 27 ms. 
Results (mean FU time = 17 f 10 months) 
QRS duration fms) 
lean NYHA class 
V02 peak (ml/kg/min) 
LVEF (%) 
Before implantation End FU P 
19ozt27 160f19 <O.OOl 
3.3 f 0.5 2.3 zk 0.8 <O.Ol 
12.3 i 4 16.3i4 <O.OOl 
21 56 24 it 6 <O.Ol 
In conclusion: these results suggest that Biv. pacing may provide a sig- 
nificant and sustained improvement in symptoms and exercise tolerance 
in DCM patients with drug-refractory heart failure and major intraventricu- 
lar conduction delay. This clinical benefit is associated with a relatively low 
mortality rate. 
at the right atrial appendage (RAA) and pace both ventricles simultaneously. 
We studied the electromechanical effects of variable AV delays during atrial 
sensing and atrial pacing on left ventricular performance. 
Methods: In 7 pts with permanent BiV pacemakers (age 66 * 11 yrs, 
PR interval 243 f 56 msec, LVEF 0.27 i 0.05, V02 15 f 3 ml/kg/min), 
left and right atrial (LA, RAA) and biventricular activation was recorded 
from a transesophageal electrode (LA) and from the BiV pacemaker (RAA, 
BiV intracardiac electrograms) during VDD and DDD pacing at variable AV 
delays. Simultaneous echocardiographic measures of mitral flow and stroke 
volumes were obtained. 
Results:ln sinus rhythm with BiV pacing (VDD), atrial activation was 
simultaneous in the RAA and LA. Stroke volume and mitral flow pattern 
were optimal at AV delays between 150 and 200 msec. In DDD pacing, an 
80-100 msec delay between RAA and LA activation was observed in all 
patients, causing simultaneous LA and biventricular activation/contraction 
and significant decrease in stroke volume at AV delays < 120 msec (p < 
0.05). 
Conclusion: Placement of the atrial lead in the RAA during DDD biven- 
tricular pacing results in significant RAAILA conduction delay, most likely due 
to conduction time from the right atrial appendage to Bachmann’s bundle. 
This can limit benefit from biventricular pacing due to simultaneous LA and 
BiV activation/contraction. Consideration should be given to placement of 
the atrial lead at the right atrial insertion of Bachmann’s bundle to avoid 
conduction delay to the LA; or to AV junction ablation to allow for longer AV 
delay programming during DDD pacing. 
11:30 a.m. 
1 839-3 ) Pacing and Sensing Characteristics Within the 
Coronary Sinus and Great Cardiac Veins 
M,ichael Giudici, Stuart Winston, James Kappler, Timothy Shinn, 
lgor Singer, Helen Berrier, Mark Herner, Ross Sample, Avram Scheiner 
Genesis Medical Center, Davenport, Iowa; Dept of Therapy Research, 
Guidant Corp, St. Paul, MN, USA 
Introduction: Pacing systems are currently in use which utilize leads placed 
in the coronary sinus for pacing and sensing the atrium. In order to optimize 
electrode placement, a detailed mapping of the coronary sinus (CS) and 
great cardiac veins; (GCV) was done. 
Methods: A deflectable EP catheter was advanced to the CS and GCV 
in 25 patients. Intrinsic bipolar (5, IO and 20 mm spacing) electrograms were 
recorded twice during sinus rhythm; once while keeping the lead tip straight 
and once while deflected. Atrial and ventricular pacing voltage thresholds 
were measured between the catheter tip (-) and an indifferent electrode 
(+). For measurement purposes, the GCV and the CS were each subdivided 
into distal (D), middle (M) and proximal (P) regions, for a total of six test 
locations. 
11:15 a.m. 
839-2 Influence of Programmed AV Delay on Left 
Ventricular Performance in Biventricular Pacing 
Systems for Treatment of Heart Failure 
Leslie A. Saxon, Lisa Hourigan, Peter Guerra, Samer Dibs, Walter 
F. Kerwin, Kim Scheibly, Teresa DeMarco, Kanu Chatterjee, Elyse Foster. 
University of California, San Francisco, USA 
Background: Biventricular (BiV) pacing is under study as a therapy for 
dilated heart failure with bundle branch block. BiV systems sense and pace 
Ak,~l CS.P CS-M C9.D OC”.PGC”-*I OCY.0 -Cl,ri”n 
*PP 
El 
-,-Y*“tWl. 
EI.Cl,Od. LOC.UDR -d-P.R R*f* 
Results: Atrial pacing thresholds from within the CS/GCV were slightly 
higher than at the atrial appendage in all areas except the distal GCV. 
Ventricular thresholds were high in the CS and slowly decreased in the GCV. 
Atrial sense amplitude was 1) maximum at the proximal GCV location, 2) 
comparable to the atrial appendage and 3) was not significantly changed 
with different electrode spacings. The P/R ratio 1) was larger at smaller 
electrode spacings, 2) decreased at more distal positions in the CS/GCV 
and, 3) for the same spacing, was larger in the atrial appendage than in the 
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CSIGCV. These data suggest that the area of the distal CS may produce the 
best combination of pacing and sensing parameters. 
Conclusions: Choosing electrode placement location in the CS and GCV 
for pacing and sensing the atrium is important to achieve optimal pace/sense 
parameters. These mapping data indicate likely locations to guide similar 
lead development studies. 
11:45 a.m. 
El 839 4 Acute Effect of Multisite Pacing With Different 
Atrioventricular Delays on the Non-Invasive 
Doppler-Derived Myocardial Performance Index 
WI) 
Ote A. Breithardt, Christoph Stellbrink, Andreas Franke, Anil M. Sinha, 
Thierry Pochet’, Angelo Auricchio*, Peter Hanrath. for the PATH-CHF 
Investigators; Med. K/in/k I, RWTH Aachen; 2Dept. of Cardiology, 
Magdeburg, Germany; ’ CPI Brussels, Belgium 
Background: The myocardial performance index (MPI) is a Doppler derived 
parameter of combined left ventricular (LV) systolic and diastolic myocardial 
function, defined as the sum of isovolumetric contraction and relaxation time 
divided by ejection time (normal < 0.5). 
Methods: To assess the effect of multisite pacing on myocardiai perfor- 
mance we analyzed acute changes in MPl with pacing in 20 patients from the 
PATH-CHF study and compared the results to sinus rhythm (SR). Patients 
with heart failure, NYHA class 2 III, QRS-width > 120 ms and P&Interval > 
150 ms were included and received 2 separate pacemakers, allowing for right 
ventriclar (RV), LV and biventricular (BV) pacing at various atrioventricular 
delays (AVD). 
Results: Mean MPI at SR was 1.07. Multisite pacing with 3 individually 
different AVD (short, S; medium, M; long, L) resulted in a significant decrease 
in MPI at LV and BV with short AVD (table). 
Short AV-delay Medium AV-delay Long AV-delay 
SR RV LV BV RV I-V BV RV LV BV 
MPI 1.07 0.89 0.76 0.76 0.9 0.85 0.84 1.06 0.93 0.94 
*SD 10.5 zkO.5 10.4’5 +0.3*§ zkO.4 kO.5 zkO.5 ho.5 ho.4 ho.4 
*p < 0.001 vs. SR; §p < 0.01 vs. RV-L (ANOVA) 
Conclusion: LV and BV pacing with short AVD lead to a significant 
decrease in MPI from pathological values towards normal, indicating hemo- 
dynamic improvement in left ventricular function. MPI may be a useful non- 
invasive measure for pacing optimization in patients with congestive heart 
failure. 
Noon 
1 839-5 Non-Invasive Determination of Optimal Pacing Site 
by Doppler Echocardiography in Comparison to 
Invasive Hemodynamic Testing: Results of the 
PATH-CHF Study 
Ole A. Breithardt, Christoph Stellbrink, Andreas Franke, Osman Balta, 
Bjoern H. Diem, Thierry Pochet’ , Angelo Auricchios, Peter Hanrath. For the 
PATH-CHF Investigators; Med. Klinik I, RWTH Aachen; ‘Dept. of 
Cardiology, Magdeburg, Germany; ’ CPI Brussels, Belgium 
Background: Multisite pacing is a new treatment option for patients (pt) with 
heart failure. The PATH-CHF study included pt with heart failure, NYHA class 
> Ill, QRS-width > 120 ms and PR-Interval > 150 ms. 
Methods: 2 pacemakers were implanted for VDD pacing from right ventri- 
cle (RV), left ventricle (LV) or both ventricles (BV) at various AV-delays (AVD). 
At pre-implant maximal (max) dP/dt and pulse-pressure (PP) were measured 
invasively at sinus rhythm (SR), RV, LV and BV to determine optimal pacing 
site (OPT) and AVD. An increase of >5% from baseline in both variables 
separated responders (R) from non-responders (NR). 4 weeks post-implant 
acute changes in aortic outflow velocity time integral (VTlno) as an index for 
stroke volume were measured by CW-Doppler at SR, RV, LV and BV and 
compared to dP/dt and PP in 26 pt. 
Results: R (n = 18) and NR (n = 8) were similar in age (58 f 5 vs. 59 i 5 
yrs), EF (19 + 6 vs. 22 f 11%) and PR (201 f 33 vs. 227 f 46 ms, p = n.s.). 
Mean QRS was longer in R vs. NR (174 * 24 vs. 132 + 16 ms, p > 0.001). 
Hemodynamic response to pacing at OPT differed significantly between R 
and NR compared to SR (table). OPT in R was LV in 6 and BV in 4 pt, in 8 pt 
LV and BV were identical. Pacing sites with maximal hemodynamic response 
compared to SR were correctly identified by VTIA, in 13/18 R (72%). 
% Increase vs SR 
dP/dt (% & SD) 
PP (% i SD) 
VTI&, i% zk SD\ 
R (n = 18) 
26.7 zk 13.7 
15.4 * 9.3 
15.7 i Ii.2 
NR (n = 8) 
1.33 * 0.55 
1.4 f 0.8 
1.33 + 14.2 
p < 0.001 
p < 0.001 
D < 0.05 
Conclusion: Non-invasive Avrr increases similar to invasive parameters 
in R vs. NR at OPT. Maximal Avrr by CW-Doppler correctly identified pacing 
sites with maximum hemodynamic response in 72% of R. Doppler echocar- 
diography may be a suitable non-invasive tool for optimization in multisite 
pacing. 
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I 1097 67 Ventricular Rate Slowing by Vagus Nerve 
Stimulation Demonstrates Improved Cardiac 
Function Than Atrio-Ventricular Node Ablation 
With Pacing 
Tomotsugu Tabata, Todor N. Mazgalev, Neil L. Greenberg, Deborah 
A. Agler, Kent A. Mowrey, Don W. Wallick, Richard A. Grimm, James 
D. Thomas. C/eve/and Clinic, C/eve/and, Ohio, USA 
Background: Slowing of ventricular rate during atrial fibrillation (AF) is be- 
lieved to improve LV systolic function. 
Purpose: Using a new index based on preceding cardiac cycle length, 
we compared LV systolic function during AF with slowed ventricular rate by 
vagus nerve stimulation (VNS) and AV node ablation followed by RV pacing 
in a canine AF model. 
Methods: Doppler LV stroke volume (SV), peak +dP/dt of LV pressure 
curve and aortic peak flow (AOF) by transonic flow meter were recorded in 
8 dogs during triggered AF. The correlation between these 3 variables and 
the ratio of the preceding and pre-preceding RR intervals (RR,/RRs) were 
evaluated for 100 consecutive cardiac cycles in 3 stages. [stage 1: rapid AF; 
stage 2: AF with slowed ventricular rate by VNS; stage 3: AV node ablation 
followed by random RV pacing with the same RR intervals feedback as in 
stage 21 
Results: 1) All variables showed a significant positive correlation with 
RRr/RRs. 2) According to the value at RRt/RRs = 1 in the linear regression 
line, the impaired LV systolic function during rapid AF was significantly im- 
proved by VNS (*p < 0.0001 vs stage I), whereas it was not improved by 
RV pacing (Tp < 0.0001 vs stage 2). 
SV (ml) 
AOF (Iknin) 
+dP/dt (mmHg/s) 
Base Rapid AF 
16.0 9.7 
2.20 1.12 
2400 1401 
AF 
+ VNS 
13.4’ 
2.05* 
1766* 
Ablation 
+ RV pacing 
10.3t 
1.57’7 
1506t 
Conclusions: 1) Antegrade conduction with VNS appears important to 
preserving systolic function in rate controlled AF. 2) The values of SV, AOF 
and +dP/dt at RR,/RRs = 1 in linear regression line were useful to estimate 
LV systolic function during AF. 
/ 1097 68 Diltiazem Pretreatment on Direct-Current Cardioversion Efficacy in Persistent Atrial 
Fibrillation. Prospective Randomized Controlled 
Study 
Alessandro Capucci, Giovanni Q. Villani, Massimo F. Piepoli, Franca Groppi, 
Saverio Arruzzoli, Francesco Passerini, Alessandro Rosi, Isabella Abelli, 
Daniela Aschieri. Divisione di Cardiologia, Ospedale Chile, Piacenza, /ta/y 
Background: Direct-Current Cardioversion (DCC) of atrial fibrillation (AF) is 
the most widely used and effective treatment for sinus rhythm restoration 
but with a low success rate and high recurrence rate. Pretreatment with 
calcium-channel blocker may improve its efficacy by reversing the so-called 
“electrical remodeling” phenomenon, also related to overload in cytosolic 
calcium. 
Methods: We evaluated in a controlled, comparative, prospective study 
the effectiveness of oral diltazem pretreatment (Dl, 240 f 40 mg/die for 4-6 
weeks) compared with amiodarone (Am, 400 mgldie) or Digoxin therapy (Dg, 
0.25 mg/die) in a population of 130 patients with persistent AF undergoing to 
DCC (after effective anticoagulation therapy). 
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Results: 
DI Am W P 
Patients/sex 46/31 M 441’27 M 30122 M 
Age (years) 59 & 3 58 * 7 56f5 “S 
Left Atrium (mm) 51*5 48.5 f 5 50*5 ns 
AF duration (months) 411 311 411 ns 
HR before DCC (bpm) 81 z!z7 83zt5 88 + 3 
SR pre DCC % 6% 25% 3% o.noso5 
DCC SR 76% 91% 67% 0.05 
DCC threshold (Joules) 275 * 50 250 zk 50 275*50 ns 
ERAF (24 hours) 5% 2% 12% 0.01 
LRAF (at one month) 56% 28% 78% 0.001 
SR: sinus rhythm; ERAF. Early recurrence AF; LRAF: late recurrence AF 
Conclusions: In an out-of-hospital population with persistent AF a pre- 
treatment with diltiazem i) allows ventricular rate control and ERAF reduction, 
similarly to amiodarone therapy ii) is associated with a lower percentage of 
spontaneous sinus rhythm conversion without any significant improvement of 
electrical conversion procedure efficacy or reduction in the incidence of late 
atrial fibrillation recurrence iii) diltiazem pretreatment could be considered a 
safe therapy in those patients where amiodarone is contraindicated. 
1 1097-69 1 A Comparative Study of the Efficacy and Safety of 
Intravenous Antiarrhythmic Agents for the 
Conversion of Recent Onset Atrial Fibrillation 
George E. Kochiadakis, Nikos E. Igoumenidis, Stavros I. Chrysostomakis, 
Herakles E. Mavrakis, Maria E. Marketou, Michail D. Kaleboubas, Evagelos 
A. Zacharis, Olvia K. Phillipou, Panos E. Vardas. Cardiology Dept., 
Heraklion University Hospital, Heraldion, Crete, Greece 
Background: In a prospective, randomised, simple blind, placebo-controlled 
study, we examined the effectiveness and safety of procainamide (PC), 
propafenone (Pf) and amiodarone (A), administered intravenously, for the 
restoration of sinus rhythm in recent atrial fibrillation. 
Methods: We studied 290 patients (136 men) aged between 34 and 86 
years (average age: 65 f 11 years) with atrial fibrillation with a duration 548 
hrs. Of these, 65 were given PC (1 grin 30 min and then 2 mg/min in the next 
24 hrs) intravenously, 61 Pf (2 mg in 15 min and then 10 mg/kg for the next 
24 hrs) intravenously, 87 A (300 mg in 1 hr and then 20 mg/kg in the next 24 
hrs) intravenously and 77 placebo. Digoxin was administered to all patients 
who were not already taking it. 
Results: No statistical differences were found in the basic clinical char- 
acteristics of the 4 groups. The treatment was successful in 45 of the 65 
patients (69.2%) who received PC, in 50 of the 61 patients‘(81.9%) who re- 
ceived Pf, in 77 of the 87 patients (88.5%) who received A and in 47 of the 77 
patients (61%) who received pl (p < 0.05 for all the groups who were taking 
anti-arrhythmic medication as opposed to those who received pl, p < 0.05 
for the groups A and Pf as opposed to the groups PC and PI). The average 
restoration time was 2 f 3, 4 f 5, 9 & 8 and 12 f IO hrs, for the groups 
PC, Pf, A and PI respectively (p < 0.05 for the patient groups who received 
PC and Pf as opposed to the two other groups). It was noticed that a drop in 
arterial pressure in 10 patients in the PC group, in 7 of the Pf group and in 8 
of the A group, in which group 12 patients also showed thrombophlebitis. In 
none of the cases was it deemed necessary to discontinue the therapy. No 
other side effects were noted. 
Conclusion: All 3 medicines, when administered intravenously, are ef- 
fective in the restoration of sinus rhythm in recent onset atrial fibrillation. 
A and Pf are characterised as more effective while PC and Pf are faster. 
All 3 medicines are well tolerated by patients. The side effects noted were 
of secondary importance and were dealt with relatively easily, without the 
treatment having to be discontinued. 
1 1097-70 1 Mortality in Patients With Atrial Fibrillation - 1 
Year Follow Up of SAFIRE-D (Symptomatic Atrial 
Fibrillation Investigative Research on Dofetilide) 
Steven Singh, Martin Berk, Lawrence Yellen, Robert Zoble, 
David Abrahamson, Glare Billing, Carol Satler. Dofetilide Atria/ Fibrillation 
Investigators, Veterans Affairs Medical Center, Washington, DC, USA 
Background: Atrial fibrillation has an annual mortality of i-3% in antico- 
agulated patients (pts). Mortality may be increased in pts treated with class 
I antiarrhythmic drugs. The effect of a pure Class Ill antiarrhythmic agent, 
dofetilide (D), was evaluated in the SAFIRE-D study. 
Methods: In the SAFIRE-D Study 325 pts were randomized to D or P 
which was continued while pts remained in sinus rhythm (SR). 182 dofetilide 
treated pts [125, 250, 500 mcg, all bid] and 68 placebo treated pts with AF 
of 2 week to 7 months in duration were converted to SR pharmacologically 
or by DC conversion and entered the maintenance phase. Mean duration of 
treatment was 133 days on D and 102 days on P. All pts were followed for 
mortality to 1 year regardless of rhythm status or discontinuation of study 
treatment. Mean age was 67 years, 84% were males, 72% had NYHA class 
ll/lll, 73% had structural heart disease and 57% hypertension. 
Results: At one year, the probability of remaining in SR was 40%, 37% 
and 58% for dofetilide-treated pts [125, 250, 500 mcg,] compared with 25% 
on placebo. The 1 year all-cause mortality for placebo treated pts was 3.6% 
(3/84) and 2.5% (6/241) for dofetilide. The hazard ratio (dofetilide/placebo) 
for mortality was 0.70 (95% Cl: 0.17-2.78). 
Conclusion: The mortality risk for pts with chronic AF is low. Although 
this study was not powered to show a difference in mortality, in contrast 
to available data on Class I agents, treatment with dofetilide seems not to 
increase mortality in pts with chronic AF. 
/ 1097 71 Low-dose Amiodarone in the Treatment of Recurrent, Symptomatic Atrial Fibrillation: 
A Placebo Controlled Study 
George E. Kochiadakis, Nikos E. Igoumenidis, Maria E. Marketou, 
Emmanouel I. Skalidis, Michael D. Kaleboubas, Hercules E. Mavrakis, 
Panos E. Vardas. Cardiology Department, University Hospital of Heraklion, 
Crete, Greece 
Background: This is the first placebo controlled study that assesses the 
efficacy and safety of amiodarone in the maintenance of sinus rhythm after 
cardioversion of atrial fibrillation. 
Methods: One hundred and twenty-three consecutive patients (64 men, 
mean age 63 & IO years) with recurrent symptomatic atrial fibrillation (80 
paroxysmal, 43 chronic), were randomised into two clinically similar groups, 
after restoration of normal sinus rhythm: 63 received amiodarone and 60 
placebo. The amiodarone dosage began with 800 to 1600 mg/day for 7 to 14 
days orally and was then tapered over 7 to 12 days, generally to 200 mg/day. 
Patients randomized to placebo began with 3 tablets per day for 2 weeks, 
2 tablets per day for another 2 weeks and 1 per day thereafter. Follow up 
clinical evaluations were conducted at 2 month intervals for the first 6 months 
and at 3 month intervals thereafter. The proportion of patients remaining in 
normal sinus rhythm and/or without side effects was calculated for the two 
groups using the Kaplan-Meier method. Risk time for all patients began at 
study entry, when they were in normal sinus rhythm. 
Results: Twenty-four of the 63 patients receiving amiodarone developed 
atrial fibrillation after an average of 10 months, while 14 (10 in sinus rhythm 
and 4 in atrial fibrillation) experienced significant side effects after an average 
of 19 months. .Relapse to atrial fibrillation occurred in 53 of the 60 patients 
of the placebo group, after an average of 4 months (p < 0.0001). No patient 
in the aforementioned group showed any side effects. Sex, age, left atrial 
size and atrial fibrillation type had no significant effect on the maintenance of 
normal sinus rhythm. 
Conclusions: Amiodarone is superior to placebo and can be used for the 
maintenance of normal sinus rhythm in patients with symptomatic recurrent 
atrial fibrillation, notwithstanding the existence of a number of side effects, 
1097-72 Amiodarone in Chronic Atrial Fibrillation: 
A Controlled, Double Blind Studv for its Reversion 
and Maintenance of Normal Sinus Rhythm 
Jorge Galperin, Remberto Tortes Molina, Marcel0 Elizari, Pablo Chiale, 
Raul Ledesma, Omar Seapin, Manuel Vazquez Blanco. On behalf of the 
GEFACA Study, GEMA GROUF: Buenos Aires, Argentina 
Background: The usefulness of amiodarone (Am) for pharmacologic and/or 
electrical cardioversion (ECV) of chronic atrial fibrillation (CAF) and man- 
teinance of normal sinus rythm (NSR) has not been conclusively demon- 
strated. A multicentric, prospective, ramdomized double blind study was 
designed to test the efficacy and safety of An alone or as a coadyuvant of 
ECV for reversion and maintenance of NSR in patients (p) with CAF lasting 
from 2 months to 10 years (mean 35 months) 
Methods: Eigthy seven anticoagulated p (RIN 2-3 during 3 weeks) were 
randomized to two groups: Am 600 mg/day or placebo, during 28 days. 
ECV was performed in p that did not revert to NSR after this period of 
AM/placebo treatment. Those p who reverted to NSR received Am 200 
mg/day or placebo during the follow up. Both groups were comparable in 
terms of age, sex, cardiac compromise, CAF duration, left atrial diameter, left 
ventricle shortening fraction, and NYHA class. 
Results: 
Group 
Am (n 45) 
Placebo (n42) 
NSR to 
28 days 
33.3%(15p) 
O.O%(OP) 
p < 0.0001 
Succesful 
ECV 
69.3%(18/26) 
40.0%(14/35) 
p < 0.05 
AF recwrences 
1 month 12 months 
15.1%(05/33) 0.3%(10/33) 
71.4%(10/14) 85.7%(12/14) 
p < 0.005 p < 0.005 
JACC February 2000 ABSTRACTS - Cardiac Arrhythmias 119A 
Am was interrupted in only one p due to intolerable side effects. 
Conclusions: Am significantly reverts CAF and enhances the efficacy of 
ECV as compared with placebo with a significantly lower rate of recurrences 
during a 12-month follow up. 
1097-73 Elderly Patients do not Have an Excessive Risk 
for Complications or Recurrence Following 
Transesophageal Echocardiography-Guided 
Cardioversion of Atrial Arrhythmias: Results 
From the ACUTE Registry 
Mohammad Bashir, Richard A. Grimm, Wael A. Jaber, David L. Prior, 
Maran Thamilarasan, R. Daniel Murray, Susan E. Jasper, Todd Coffey, 
Carolyn Apperson-Hansen, Craig R. Asher, Allan L. Klein. The C/eve/and 
Clinic Foundation, C/eve/and, Ohio, USA 
Background: Concern regarding a perceived higher rate of cardioversion 
(CV) related embolic events (EMB), bleeding and recurrent atrial arrhythmias 
(AA) may deter clinicians from attempting CV of elderly pts. 
Methods: We examined the CV related complications at 4 weeks and 
recurrence of AA at 24 hrs and 1 yr along with characteristics in elderly (>75 
years) compared to young (< 75 yrs) pts undergoing TEE-guided CV of AA. 
Results: Out of 319 consecutive pts, 87 (27%) were 275 years (64 
male, 79 i 4 years) and 232 (73%) were ~75 years old (167 male, 62 
+ IO years). There was no difference in the groups with regard to the 
type and duration of arrhythmia, history of hypertension, diabetes, previous 
thromboembolic events, use of anticoagulant and antiarrhythmic medications 
and left ventricular ejection fraction. Elderly patients had a higher prevalence 
of heart failure (CHF, p = 0.006) and significantly lower left atrial appendage 
(LAA) emptying velocity (p = 0.001). Left atrial (LA), right atrial (RA) and LAA 
dimension, the prevalence of LA and RA spontaneous echo contrast and 
thrombi did not differ between groups, Embolic and bleeding (major + minor) 
complications at 4 weeks and the presence of sinus rhythm (SR) at 24 hours 
and at 1 year following CV did not differ and are reported in table. 
Age n CHF EMB (%) Bll?f?d SR-24hrs SR-1 yr 
175 yrs 67 54% 0 6.7% 95.8% 42.6% 
< 75yrs 232 37% 0 7.9% 90.9% 51.3% 
P 0.006 NS NS NS NS 
Conclusions: Despite a higher prevalence of congestive heart failure and 
low LAA flow velocities, the odds of elderly patients sustaining a complication 
or maintaining SR following TEE-guided cardioversion is not significantly dif- 
ferent from that of younger patients. Advanced age should not deter clinicians 
from offering cardioversion to their patients with atrial arrhythmias. 
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1098-93 Reversible Left Ventricular Regional Dysfunction 
Following Radiofrequency Ablation in Chronic 
Myocardial Infarction 
Jian-Fang Ren, David J. Callans, John J. Michele, Stephen M. Dillon, 
Francis E. Marchlinski. University of Pennsylvania, Philadelphia, PA, USA 
Background: Radiofrequency (RF) energy delivered to the LV infarct bor- 
der zone causes immediate wall swelling and decreased regional fractional 
shortening (FS) using intracardiac echocardiography (ICE). This study was 
designed to characterize the time course of these changes. 
Methods: ICE (9 MHz catheter within LV) imaging guided linear LV abla- 
tion at the anterior/septal infarct border zone in 6 swine (32-60 kg) 6-8 weeks 
post LAD infarct. Irrigated RF (30-40 ml/min, 3050 w, 120 set) created 49 
lesions (17 septal (Sept} and 15 anterior wall border zone {Ant), 17 echo- 
dense infarct (INF) as defined by ICE (akinesis, scar}). The wall thickness 
(THK) was measured at the RF site in end-diastole. FS was measured in the 
adjacent “normal” (NL) region (within 1 cm medial) to the RF site at Pre- and 
1, 30, 60 and 90 minutes Post-ablation, 
Results: 
Pre- 1’ Post- 30’ Post- 60’ Post- 90’ Post- 
THK-Sept 9.0 i 1 .o 11.0 kl.5” 12.3i 1.6* 13.5 * 1.2* 14.3* 1.4” 
(mm)-Ant 8.0 i 1.5 9.5 f. 1.7* 12.0 + 1.9* 12.1 i 1.9* 12.oi1.2* 
-INF 5.8 * 1.8 6.2 + 2.2* 9.1 k 1.6* 10.9 i2.2* 12.0f 1.0* 
FS-Sept 25i9 19*9* 25zt9 2816 30*4 
(%)-@t 30*11 18*12* 23514 24ztl4 34*5 
NLtolNF 26zki9 11 111- 23+15 22+16 23117 
(in Table, *p < 0.05~s. Pre-ablation) 
The LV global ejection fraction was 36 * 5% Pre- versus 32 f 10% 
Postablation (p = NS). 
Conclusions: Following imgated RF ablation, LV wall swelling increased 
continuously for 90 minutes, whereas reduced FS had recovered by 30-60 
minutes. Although impressive LV regional dysfunction follows RF delivery, 
the time course for recovery is short. 
1098-94 Is Radiofrequency Catheter Ablation of 
Symptomatic Ventricular Ectopics Justified? 
Kathy L. Lee, Katherine Fan’, Chu-Pak Lau, Hung-Fat Tse, Siu-Hong Wan, 
Cathy Lam, King-Loong Cheung’ , Elaine Chau’ Cardiology Division, 
University Department of Medicine, Queen Mary Hospital, ‘Grantham 
Hospital, Hong Kong, PR China 
Background: Frequent premature ventricular ectopics (PVC) in patients (pts) 
with no structural heart disease can be very symptomatic. 
Methods: We randomized 40 such pts with ,100 PVC/hour and moderate 
to severe symptoms to receive radiofrequency catheter ablation (RFCA) or 
conventional B-blocker (BB) therapy. The RFCA group (n = 20) and BB group 
(n = 20) had similar clinical characteristics and PVC counts at baseline. There 
were 10 pts (25%) that had more than one single morphology of PVC. Right 
ventricular outflow tract was the most common site of origin (85%). RFCA 
was guided by pace-mapping of the PVC. BB was taken regularly or when 
required in pts who received conventional treatment. 
Results: In the RFCA group, 19 (95%) pts had successful ablation. The 
mean procedure time was 123 f 40 minutes, and mean fluoroscopy time 
was 33 i 16 minutes. Symptom of palpitation was completely relieved in all 
pts after successful ablation. The mean PVC count per pt decreased from 
721ihour to 39/hour (p < 0.001). No acute complication was encountered. 
There was 1 pt (5%) with recurrence that was treated successfully by a 
second procedure. In the BB group, 4 pts (20%) had complete symptomatic 
relief, 6 pts (30%) had symptomatic improvement, 6 pts (30%) remained the 
same, and 4 pts (20%) had worsening of symptoms. The mean PVC count 
decreased from 692/hour to 532/hour in the BB group (p = NS). Side effects 
of BB were reported in 4 pts (20%). 
Conclusions: This result suggests that RFCA is associated with a high 
rate of cure and appears superior to BB in the treatment of frequent and 
symptomatic PVC. However, BB may suppress symptoms of PVC in some 
pts and should be tried if drug treatment is required. 
1098-95 Four-Dimensional Myocardial Modeling From 
Orthogonal Rotational Intracardiac Ultrasound 
Michael R. Wahl, Javier Roman-Gonzalez, Susan B. Johnson, Jon J. Camp, 
Richard A. Robb, Douglas L. Packer. Mayo Foundation, Rochester, fvtN. 
USA 
Background: Real-time, detailed anatomic imaging could benefit interven- 
tional electrophysiologic procedures. High frequency intracardiac ultrasound 
can easily show detailed endocardial surfaces needed for targeting during 
ablation. We hypothesized that orthogonal mechanical rotational ultrasound 
images could be processed into an accurate three-dimensional (3D) whole 
heart reconstruction and combined with isochoronal activation maps to pro- 
vide four-dimensional (4D) modeling of myocardial activation. 
Methods: Four scans were acquired with the 9 Fr, 9 MHz catheter, during 
catheter pull back from the LV apex to the base in dog hearts. Utilizing a 
registration (matching) technique between each sequential acquisition, these 
images were combined into 3D myocardial representations. Pre-acquired 
activation maps from a 56 bipolar electrode sock and 25 bipolar electrode 
basket were mapped onto the myocardium using customized software. 
Results: Accurate 3D myocardial representations were produced with 
interslice matching to correct the rotation about the catheter axis which varied 
12 degrees. As the fourth dimension, isochronal activation maps accurately 
depicted the ventricular excitation in ventricular pacing and its differentiation 
from activation in normal sinus rhythm. 
Conclusion: Orthogonal intraventricular ultrasound can be rendered 
into accurate 3D myocardial models, with interslice matching to provide 
an anatomic framework for viewing electrical activation. These 4D recon- 
struction techniques could remarkably enhance interventional procedures 
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for elimination of ventricular tachydardia by providing real-time, close-up 
detailed views of myocardial structures in relation to cardiac activation. 
1 1098-96 1 Normal Ventricular Electrogram Signal Amplitude 
Using Magnetic Electroanatomic Mapping: 
Influence of Recording Polarity and Mapped 
Chamber 
Francis E. Marchlinski, David J. Callans, Andrea Russo, Dusan Kocovic, 
Behzad Pavri, Erica S. Zado. University of Pennsylvania Health System, 
Philadelphia, PA, USA 
Background: Magnetic mapping (CARTO’“, Biosense) appears to be useful 
for relating electrogram (Eg) characteristics to 3-D anatomic location. To 
identify Eg amplitude (AMP) associated with endocardial disease, reference 
values are needed. 
Methods: We performed detailed sinus rhythm mapping in 10 pts (8 men, 
2 women, mean age = 36 f 18 yrs) without structural heart disease. RV was 
mapped in 8 pts and LV in 6 pts using a Navistar’” catheter. Unipolar (UNI) 
4 mm tip and bipolar (BI) tip to 2 mm ring electrode at a distance of 1 mm 
were recorded and filtered at l-180 Hz for UNI and IO-400 Hz for BI Eg. 
All aspects of RV and LV were sampled. In each pt, maps were reviewed to 
delete valvular and intracavitary, non-contract Eg before analysis. To better 
define the lower limit of normal Eg AMP for each ventricle, we documented 
the AMP cut off exceeded by 95% of Eg (Eg AMP > 95%). 
Results: (Table) Seventy-one to 168 sites were sampled per chamber for 
a total of 880 RV and 683 LV Eg recordings. 
RV BI LV 81 RV UNI LV UNI 
Mean Eg AMP (mV) 4.0 f 1.7 4.9 * 2.9’ 9.4 zt 3.9 19.6 f 6.4* 
Eg AMP > 95% (mV) 1.47 1.62 3.65 8.27 
“p < 0.01 RV versus LV 
Conclusion: Using the described recording system, reference Eg AMPS 
are RV and LV specific. These reference values are critical for defining the 
extent of abnormal endocardial substrate for ventricular arrhythmias in man 
and for distinguishing ischemia versus infarction in patients with coronary 
artery disease. 
11098-97 1 Cooled Versus Standard Radiofrequency Ablation 
for Termination of Ventricular Tachycardia 
Kyoko Soejima, William G. Stevenson, Etienne Delacretaz, Makoto Suzuki, 
Corinna B. Brunckhorst, Kristine E. Ellison, Peter L. Friedman. Brigham and 
Women’s Hospital, Boston, MA, USA 
Saline cooling of radiofrequency (RF) ablation increases lesion size in animal. 
If cooled RF increases lesion size in human infarcts it should facilitate RF 
termination of ventricular tachycardia (VT). 
Methods: Data from 85 consecutive patients who underwent endocardial 
mapping and RF ablation of VT after myocardial infarction from 6/95 to 7/99 
were reviewed. Ablation was performed using standard RF in 65 pts, and 
cooled RF ablation (Biosense Corp. and Cardiac Pathway Corp.) in 20 pts. 
Sites were included for analysis where entrainment identified the site as a 
likely Isthmus site (exit, central, or proximal) and RF was applied during VT. 
Sites were further grouped into those with and without an isolated potential 
UP). 
Results: Of 348 sites during 85 VTs from 66 pts 243 isthmus sites were 
identified. VT termination rate was higher with cooled RF at both Isthmus 
sites with IP (91% vs. 54%, p = 0.03) and without IP (36% vs. 21%, p = 0.04). 
RF termination (sites with termination/total sites) 
N Cooled Standard Fvalue 
Isthmus IP (+) 57 10111 25146 0.03 
Isthmus IP (-1 186 16l45 291141 0.04 
Conclusion: Reentry circuit paths vary in dimension, Increased VT termi- 
nation by cooled RF is consistent with production of a larger lesion in human 
infarctions. 
radiofrequency energy application (RFA) in 5 patients (pts) with inferior my- 
ocardial infarction and hemodynamically unstable ventricular tachycardia 
(VT). Mapping (1 mm distal electrode) and ablation (4 mm distal electrode) 
were performed using the CART0 system (Biosense/Cordis Webster). Bipo- 
lar voltage maps (151 i 6 points/pt) were used to define the region of scar 
(51 mv) and adjacent border zone (~2.5 mv). Sites and outcome of SR 
pacemapping were annotated. 
Results: Four pts had defibrillators and 2 were on amiodarone. The mean 
ejection fraction was 35 f 4%. At baseline, 2.4 & 1 distinct unstable VTs/pt 
were induced (cycle length 274 * 30 ms). Two pts had a single discrete 
scar abutting the mitral valve annulus (MVA). In each, a single linear series 
of RFA transected the scar from the MVA toward the apex (2.9 and 5.8 
cm respectively). Three pts had patchy scars. In these pts, 1-2 linear RFA 
(1.5-8.6 cm) were designed to connect regions of scar to each other and/or 
the MVA. In all pts, attempts were made to incorporate the best pacemap 
match sites in the linear lesion. Overall, pts received 21 f 6 RFA, and 4/5 
had no inducible VT after ablation. There were no adverse events. During 
follow-up, monthly VT episodes were reduced from 18 i 12 preablation to 
0.1 i 0.2 postablation (p = 0.03). 
Conclusions: Anatomically guided linear ablation during SR appears 
to be a feasible and potentially effective alternative for controlling frequent 
hemodynamically unstable VT following inferior infarction. 
(_I 1098 99 Relationship Between Electrode Temperature and 
Thrombus Formation Without Impedance Rise 
During Radiofrequency Ablation 
Kagari Matsudaira, Hiroshi Nakagawa, William S. Yamanashi, Fred 
H.M. Wittkampf’, Jan V. Pitha, Ralph Lazzara, Warren Jackman. University 
of Oklahoma, Oklahoma City OK, USA; ‘University of Utrecht, Utrecht, The 
Netherlands 
During RF ablation, electrode-tissue interface temperature (ETIT) may ex- 
ceed the electrode temperature (ET) due to cooling effects of blood flow. High 
ETIT may produce thrombus without impedance rise with relatively low ET. 
The purpose of this study was to determine the maximum, safe ET without 
thrombus formation using 4 mm and 8 mm electrodes with and without high 
blood flow. 
Methods: In 12 anesthetized dogs, the skin over the thigh muscle was 
incised and raised to form a cradle which was superfused with heparinized 
canine blood (ACT > 350) at 37X. A 7 Fr, 4 mm or 8 mm ablation electrode 
containing a thermocouple was held perpendicular to the thigh muscle at 
IO g contact pressure. RF lesions (n = 117) were produced with either no 
blood flow or pulsed blood flow of 150 ml/min at ET of 45”C, 55X, 65°C 
and 75’C for 60 seconds or until an impedance rise (110 n). Temperatures 
were measured at the electrode-tissue interface (ETIT) and within the tissue 
at depths of 3 mm and 7 mm. After each of application, the cradle was 
emptied of blood and the ablation electrode-tissue interface was examined 
for thrombus. 
Results: 
nP Flow ET ETIT 
Elect (momin) n (“C) (‘C) 
4mm 0 11 65 6611 
0 12 75 7ai3 
150 15 55 66+4 
150 13 65 62zk5 
8mm 0 12 55 58hl 
0 13 65 73+3 
0 12 75 91 f3 
ETIT-ET Power Thrombus Imp Lesion 
PC) (w) Form Rise Depth (mm) 
112 4i2 o/11* 001 3.4 f 0.7 
3*3 6i2 10/12* o/12 4.9 10.7 
11*4 612 o/11* OH1 4.8 5 0.7 
17*5 13f4 B/13* 0113 6.4 zt 0.4 
251 7il o/12* 0112 2.8 f 0.3 
a+4 14*5 2113* 0113 4.4 f 0.8 
16zt3 24i7 12112’ O/l2 5.7 5 0.6 
150 15 45 66zt5 2115 1613 o/15* O/15 5.1 z!= 0.6 
150 14 55 10216 47zt6 44fl3 14/14* 0114 7.4 * 0.4 
(*P < 0.05) 
Conclusions: 1) With blood flow, ETIT significantly exceeded ET and 
the difference was greater with an 8 mm electrode (due to greater electrode 
cooling); 2) Thrombus without impedance rise occurred at ETIT of ~74°C 
with ET of 65°C with 4 mm electrode and 55°C with 8 mm electrode; and 3) 
ET of 555°C (4 mm) and ~45°C (8 mm) at high blood flow may be required 
to prevent thrombus. 
1 1098-98 1 Anatomically Guided Linear Radiofrequency 
Ablation During Sinus Rhythm for 
Hemodynamically Unstable Ventricular 
Tachycardia Associated With Inferior Myocardial 
Infarction 
David J. Wilber, Mauricio Arruda, Martin C. Burke, John G. Kall, Douglas 
E. Kopp, Albert C. Lin, Peter Mazeika. Univ. of Chicago, Chicago IL, USA 
We evaluated the feasibility of sinus rhythm (SR) based mapping to guide 
1098-I 00 A New Scoring System to Assess the Degree of 
QRS Fusion During Entrainment Mapping of 
Ventricular Tachycardia as a Predictor of 
Ablation Success 
Nael Masalha, Kar-Lai Wang, Reginald T. Ho, Behzad B. Pavri, Dusan 
2. Kocovic. University of Pennsylvania Health System, Philadelphia, PA, 
USA 
Background: Concealed QRS fusion, defined as perfect matching of the 
JACC February 2000 ABSTRACTS - Cardiac Arrhythmias 121A 
paced QRS complex to the QRS of the spontaneous ventricular tachycardia 
(VT), was believed to be an important criteria in predicting the success of 
radiofrequency ablation (RFA) of VT. To better define the subtleties in QRS 
fusion, we developed a new scoring system to evaluate the influence of the 
degree of QRS fusion in predicting successful sites for VT RFA. 
Methods: 26 VT’s (mean cycle length (CL) = 387 -+ 83 ms) were induced 
in 16 patients. Entrainment mapping was performed. Criteria for RFAdelivery: 
1) Post pacing interval (PPI) minus VT cycle length ~30 ms; 2) Stimulus to 
QRS (St-QRS) ~80% VT cycle length; 3) Minimal QRS fusion. QRS fusion 
on each of the 12 leads EGG was analyzed by: 1) standard method of 
classifying QRS match as perfect or imperfect; and 2) a three point scoring 
system based upon QRS amplitude, polarity and notching. Degree of QRS 
fusion was classified as evident fusion (score 0 to 12); moderate fusion 
(score 13 to 24); mild fusion (score 25 to 35); and concealed fusion (score 
36). Successful RFA site was defined as VT termination during RF delivery, 
Results: Radiofrequency (RF) was delivered to 149 sites with successful 
VT termination in 35 sites. When PPI-VTCL < 30 ms; no significant difference 
in RF success was observed between perfect and imperfect QRS matching 
(17/55 vs 18168, p = 0.6). Using the new scoring system, 16 out of 38 sites 
of concealed fusion and 19 out of 51 sites with mild fusion were successful 
(p = 0.47). None of the 47 sites with moderate fusion was successful. In 17 
sites where PPI-VTCL > 30 ms, only 1 site was successful independent of 
the degree of QRS fusion. 
Conclusions: The criteria of PPI-VTCL < 30 ms is the most important 
predictor for success for VT RFA. Mild QRS fusion has the same success 
rate compared to concealed fusion. The new scoring method thus allowed 
better assessment of QRS fusion as predictor of success. 
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1 1099-59 / QT Dispersion: Repolarization Heterogeneity or 
Abnormality? The Strong Heart Study 
Peter M. Okin, Richard B. Devereux, Thomas K. Welty. Cornell Medical 
Center, New York, NY, USA 
Background: Previous findings have demonstrated the predictive value of 
QT dispersion (QTd) for mortality and that QTd can be explained on the basis 
of vectorcardiographic T-loop amplitude and width. These findings suggest 
that QTd may be a quantitative measure of repolarization abnormality (RA) 
as opposed to heterogeneity of R. 
Methods: QTd was measured on digitally-acquired ECGs in 1,839 Amer- 
ican Indian participants in the first Strong Heart Study examination who were 
in sinus rhythm, with no bundle branch block, and with at least 6 total leads 
and 3 precordial leads with technically adequate QT interval measurements, 
Increased QTd (~58 msec, based on the upper 98th percentile in a separate 
population of normal subjects) was present in 76 participants (4.1%). 
Results: Despite excluding patients with markedly low T-wave amplitudes 
that precluded accurate measurement of QT intervals, increased QTd was 
associated with greater degrees of repolarization abnormality with signifi- 
cantly lower T-wave amplitudes in lead I(109 f 139 vs 176 f 104 @V), lead 
II (161 * 103 vs 216 f 94 pV) and lead V5 (121 f 189 vs 262 f 147 @V), 
and greater peak ST depression (-28 f 23 vs -13 f IS @V, all p < 0.001). 
Moreover, principle component analysis of the T-wave vector loop revealed 
that increased QTd was associated with a significantly lower 1” component 
of the eigenvector (403 f 193 vs 656 + 305 WV, p x 0.001) and with higher 
ratios of the 2nd to 1” components (28 i 15 vs 17 5 IO%, p < O.OOl), indi- 
cating lower amplitude and wider T-loop widths. These differences remained 
highly significant (all p < 0.001) after controlling for baseline differences in 
age, systolic blood pressure, gender, and prevalent coronary heart disease 
between groups. 
Conclusions: Increased QTd is a reflection of quantifiable T-wave and 
ST segment abnormalities, suggesting that increased QTd is a manifestation 
of RA and not heterogeneity of R. The association of increased QTd with 
quantifiable RA may account for the predictive value of increased QTd and 
suggests that increased QTd reflects nonspecific RA. 
I 1099 60 Prognostic Significance of QTc Dispersion in 
Patients After Myocardia Infarction With and 
Without Late Potential, Ventricular Tachycardia 
and Sudden Cardiac Death 
Li-xin Zhao, Yukio Ozawa, lchiro Watanabe, Satoshi Saito, 
Katsuo Kanmatsuse. The 2nd Depart. of medicine, Nihon University School 
of Medicine, Tokyo, Japan 
Background: QTc dispersion (QTcd), late potential (LP) are used for pre- 
diction of ventricular tachycardia (VT). We examined the relationship among 
QTcd, LP and left ventricular ejection fraction (EF), and combining them 
in predicting vulnerability to VT and sudden cardiac death (SCD) in prior 
myocardial infarction (MI). 
Methods: 489 patients with MI were classified into four groups. Group A 
(16 victims of SCD with LP positive), group B (10 victims with LP negative), 
group C (87 patients with LP positive and survived over 6 years), group D 
(376 patients with LP negative and survived). All patients underwent standard 
12-lead electrocardiogram (ECG) an ambulatory and ECG. LP was analyzed 
from signal averaged ECG, Left ventricular ejection fraction (EF) was cal- 
culated from ventriculogram. QTcd was determined from onset of the QRS 
complex to the end of the T wave in 12-leads ECG by new Maquete System. 
Results: 1) QTcd in group A was significantly greater than that of group 
B, C and group D. 2) QTcd in the group of victims of SCD, and QTcd in the 
group with LP positive were significantly greater than that in survived group 
and group with LP negative, respectively. 3) EF in the group of victims and in 
group with LP positive were significantly lower than EF in group of survived 
and in group with LP negative, respectively. 4) The occurrence of VT and 
SCD in group with LP positive was significantly greater than that in group 
with LP negative, and that in group with abnormal QTcd (245 msec.) was 
significantly greater than that in group with normal QTcd (544 msec) also. 
5) By combining QTcd with LP and EF, the sensitivity to SCD detection was 
significantly increased from 53.8% to 87.5%; The sensitivity to VT detection 
was significantly increased from 86.2% to 96.3%. 
Conclusion: This study demonstrates that QTcd is a sensitive indicator 
of spontaneous VT and SCD. By combining QTcd with LP and EF, the SCD 
and VT detection were significantly improved and more sensitivi in patients 
after Ml. 
I 1099 61 QT Dynamicity, Influence of the Autonomic Nervous System and the Risk of Major Arrhythmic 
Events in Idiopathic Dilated Cardiomyopathy 
Laurent Fauchier, Dominique Babuty, Philippe Poret, Marie 
Laurence Autret, David Tena-Carbi, Pierre Cosnay, Jean Paul Fauchier. 
Cardiology 6 Department, Trousseau University Hospital, Tours, France 
Background: QT dynamicity, an evaluation of the rate dependence of QT 
interval has been proposed as a tool for assessment of the risk of cardiac 
events or ventricular arrhythmias. It has been suggested that both heart rate 
and activity of the autonomic nervous system may influence QT dynamicity. 
This study assessed the value of QT interval dynamicity normalized to the 
coefficient of variation of normal RR intervals (CVRR), a parameter taking 
into account heart rate and heart rate variability, for risk stratification of major 
arrhythmic events in patients with idiopathic dilated cardiomyopathy (IDC). 
Methods: We performed 24-h ECG recording in 140 patients with IDC in 
sinus rhythm (WHO criteria: age 5’1 f 12; 112 men; left ventricular ejection 
fraction 33 f 12%) with a history of sustained ventricular tachyarrhythmia 
(SVT) in 13/140 patients. CVRR was calculated as the standard deviation of 
all normal-to-normal RR interval divided by the mean RR. QT interval was 
measured automatically at its end with a Holter system (Elatec, Ela medical, 
France). The rate dependence of repolarization was evaluated over 24 hours 
with measurement of QTiRR slope (sQTend) and was normalized to CVRR. 
Results: With a follow-up of 48 f 39 months, 26 patients died (12 
progressive CHF, IO sudden deaths, 4 cancers) and 18 patients reached 
one of the defined study end points (sudden death, resuscitated ventricular 
fibrillation or sustained ventricular tachycardia). Univariate and multivariate 
predictors (proportional hazards model) of major arrhythmic events are in the 
following table. 
Univariate Multivariate 
LV ejection fraction NS NS 
History of sustained VT 0.0001 0.0001 
Non sustained VT 0.003 0.001 
CVRR 0.10 NS 
sQTend 0.06 NS 
sQTend/CVRR 0.005 0.004 
Conclusion: QT dynamicity normalized to CVRR may provide a signifi- 
cant improvement for risk stratification of arrhythmic events in patients with 
IDC. 
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1099-62 Determinant of QT Dispersion in Patients With 
Hypertrophic Cardiomyopathy 
Tatsuya Kawasaki, Akihiro Azuma, Hirokazu Shiraishi, Takahisa Sawada, 
Takeshi Shirayama, Masao Nakagawa, Hiroki Sugihara. Kyoto Prefectural 
Univ of Medicine, Second Deparfment of Medicine, Kyoto; Kyoto Prefectural 
Univ of Medicine, Radiology, Kyoto, Japan 
Background: QT dispersion has been used as a predictor of arrhythmoge- 
nesis because QT dispersion is thought to reflect regional heterogeneity of 
the repolarization process. However, QT interval is composed of depolariza- 
tion and repolarization processes. This study was designed to investigate 
the effect of depolarization and repolarization variation on QT dispersion in 
patients with hyperlrophic cardiomyopathy (HCM). 
Methods: Standard 12-lead ECG was recorded at rest at a paper speed 
of 50 mm/s in 36 HCM patients with anteroseptal wall hypettrophy (AS), 6 
HCM patients with lateral wall hypertrophy (L) and 17 control subjects with 
no structural heart disease. We excluded patients with non-sinus rhythm, 
atrioventricular conduction block, bundle branch block, QRS duration ,130 
ms and patients who had having amiodarone and/or beta-blocker therapy 
from this study. The end of T wave was defined as the intersection of the 
baseline and tangent line of maximal slope oft wave terminal limb. We 
measured QT interval and QRS duration in all leads with digital calipers and 
calculated, on the basis of Bazzet’s formula, QTc interval and JTc interval 
that is thought to reflect the repolarization process. We then determined the 
maximum and minimum QTc intervals, their difference yielding QTdispersion. 
Results: The maximum QTc interval was greater in AS and L than in 
control (p < 0.01); the minimum QTc interval was similar in all the 3 groups; 
consequently, QT dispersion was greater in AS and L. QTc interval was 
increased in V3 and V4 in AS and V5 and V6 in L in accordance with the 
left ventricular portion of maximum hypertrophy in each group. QRS duration 
was increased in V2 to V4 in AS and V5 and V6 in L when compared with 
control (p < 0.0001). In AS, QRS duration in V3 correlated with ventricular 
septal thickness measured with echocardiography (r = 0.573, p < 0.001). 
Accordingly, JTc interval did not differ between the 3 groups in every lead. 
Conclusion: QT dispersion depended on the heterogeneity of depolar- 
ization rather than repolarization, which fact may be related to the regionally 
different hypettrophy of the left ventricle in HCM. 
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‘1 802 1 Thickness and Extension of Myocardial Fibres 
Inside the Pulmonary Veins: Role in Radiofrequency 
Ablation of Focal Atrial Fibrillation 
Jo& A. Cabrera, DamiAn Sbnchez-Quintana, Siew Y. Ho, Jose M. Rubio, 
lmmaculada FernBndez-Rozas, Robert H. Anderson, Jerbnimo Farr& 
Fundacidn Jimenez Diaz, Madrid, Spain; National Heart and Lung Institute, 
London, UK 
Background: Complete isolation of the pulmonary veins (PV) is frequently 
required to avoid recurrences after radiofrequency catheter ablation of focal 
atrial fibrillation (AF) originating from the PV. 
Methods: We measured the extension and thickness of the myocardial 
sleeves at the venoatrial junction and within the walls of the PV in 28 normal 
human autopsied hearts from adults (52 * 18 years, 17 males). 
Results: In all hearts a sleeve of myocardium surrounded the proximal 
portion of the PV. These muscular sleeves extended into the walls of the PV 
from 4 to 19 mm. The longest sleeves were found in the right superior (8.5 
f 2 mm) (RSPV) and left superior pulmonary veins (11 f 3 mm) (LSPV). 
Table shows the thickness of the muscular sleeves (mean i SD in mm) 
and percentage of PV circumference with myocardial tissue at the PV-atrial 
junction and at 5 and IO mm from the junction into each PV. 
RSPV RIPV LSPV LIPV 
Veno-atrial 3.5 * 0.5 2.7 k 0.4 3.7 f 0.6 2.5 zt 0.3 
junction 100% 100% 100% 100% 
5 mm from 2.5 dz 0.5 2 * 0.4 2.8 zk 0.5 1.5 5 0.4 
junction 100% 71% 100% 64% 
10 mm from 2 * 0.3 1.5 * 0.2 2.3 f 0.4 1.2zkO.3 
iunction 64% 20% 7”% 5% 
Conclusions: Our findings explain that a complete electric isolation of the 
myocardium inside the PV from the left atrium is complex. These anatomic 
findings also suggest that a complete elimination of all electric myocardial 
activity from some PV, in particular the RSPV and the LSPV, can also be 
difficult. 
2:15 D.m. 
802-2 Outcome of Circumferential Radiofrequency 
Ablation of Pulmonary Vein Orifices for Suppression 
of Permanent Atrial Fibrillation 
Carlo Pappone, Filippo Gugliotta, Cosimo Di Candia, Marilu’ Loricchio, 
Gabriele Vicedomini, Salvatore Rosanio, Monica Tocchi, Patrizio Mazzone, 
Giuseppe Oreto, Simone Gulletta, Sergio Chierchia. Hospital S. Raffaele, 
.Mi/an, ltaly 
Background: Recent data suggest that intraoperative radiofrequency (RF) 
pulmonary vein (PV) isolation in mitral patients is effective for suppressing 
atrial fibrillation (AF). Whether this procedure can be applied in a broader AF 
population using a percutaneous approach is unknown. 
Methods: We selected 9 heparin-treated patients (7 men, age 29 to 
79 years) with drug-refractory permanent AF (duration 5.7 i 2.2 months), 
and no left atrial (LA) thrombi by transesophageal echocardiography (TEE). 
Six patients had left ventricular disease: 1 ischemic; 3 hypertensive; and 2 
dilated. Procedures were performed in sinus rhythm achieved by internal 
electrical cardioversion. RF lesions, deployed transseptally via a NaviStar 
catheter (CARTO, Biosense/Webster), consisted of a series of contiguous 
focal lesions (guided by CARTO) located around the anatomic orifice of 
each PV. RF power at each site was titrated by electrogram amplitude 
reduction > 75%. Pre- and post-ablation evaluation included routine 48-hour 
telemetry monitoring, TEE, monthly and symptomatic Holter monitoring, and 
daily symptom diaries. 
Results: A mean of 88 f 31 focal lesions were deployed to complete 
the PV lines requiring 276 f 81 min, with 63 & 32 min of fluoroscopy 
time. Using CARTO, the final ablation lesion was a continuous line in all 
but 2 patients, in whom satisfactory local potential breakdown could not be 
achieved around the right superior and right inferior PVs, respectively. No 
significant procedural or in-hospital complications occurred. Post-ablation 
TEE showed no significant PVflow distorsion. At discharge, all patients were 
AF-free. One patient had recurrence of AF IO days afterwards. One patient 
developed paroxysmal AF poorly controlled by drugs. Seven patients (78%) 
had negative I- and P-month Holter and remained symptom-free during a 8 
f 5 month follow-up. 
Conclusion: Our initial experience suggests that encircling the PV ostia 
by RF ablation with only electroanatomical guidance is safe and has an 
acceptable success rate in non-surgical patients with permanent AF. 
2:30 p.m. 
802-3 Catheter Ablation of Atrial Fibrillation by Linear 
Lesions: Where to Draw the Line? 
Sabine Ernst, Feifan Ouyang, Riccardo Cappato, Marius Volkmer, 
Dietmar Bbnsch, Joachim Hebe, Karl-Heinz Kuck. St. Georg Genera/ 
Hospital, Hamburg, Germany 
Background: Primary catheter ablation in the right atrium (RA) aiming at 
compartmentalization has been previously shown to be ineffective to prevent 
recurrence of atrial fibrillation. Since the majority of triggering events arise 
from within the pulmonary veins (PV), compartmentalization of the left atrium 
(LA) is mandatory. To judge the efficacy of any ablation design, validation of 
line completeness at the end of the ablation session is necessary. 
Methods: A total of 9 patients (9 m, mean age 55 f 11 yrs) with idiopathic 
atrial fibrillation underwent a left atrial compartmentalization attempt using a 
custom-made double sheath system, after a previously performed right atrial 
compartmentalization had proven to be ineffective. Using the electroanatom- 
ical mapping system CART0 two different ablation designs were attempted: 
Group I (n = 5 pfs): an encircling line around the ostia of the pulmonary 
veins (PV) to isolate triggering events arising within the PVs and a second 
line connecting the inferior lateral PV to the mitral annulus (MA) to prevent 
macro-reentry around the MA. Group 2 (n = 4): connection of the superior 
lateral to septal PVs and from the middle of this line to both the superior and 
inferior aspect of the MA, aiming at pure LA compartmentalization. 
Results: A mean number of 52 i 20 radiofrequency applications were 
applied in group 1 (group 2: 49 & 8), procedure duration amounted to 
10.3 f 0.5 hours in group 1 (group 2: 9.7 f 0.4 hrs) and 22.3 * 4.4 min 
fluoroscopy was used (group 2: 37.6 f 12.7 min). Line validation in group 2 
revealed multiple conduction gaps in all pts, resulting in recurrence of atrial 
fibrillation during the short-term follow-up (84 & 44 days). Evidence of a 
single conduction gap in one pt and complete lines in another pt of group 
1, resulted in total suppression of the arrhythmia. Attempts of re-induction 
of atrial fibrillation failed when the complete line design in group 1 was 
achieved. 
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Conclusions: Total abolition of atrial fibrillation can be achieved deploying 
left atrial linear lesions that do both isolate potential sources of triggering 
events from the PV and divide the LA in segments that are too small to sustain 
atrial fibrillation. After these lesions are achieved, atrial fibrillation is no longer 
inducible by pacing from both inside the resulting LA compartment and the 
remaining LA. The ablation concept of pure LA compartmentalization without 
concomitant trigger isolation allows still the occurrence of triggering events 
which might account for the recurrence of the arrhythmia during follow-up. 
Since in none of these pts complete linear lesions could be demonstrated, 
final judgement on the efficacy of this approach is premature. 
2:45 p.m. 
802-4 Catheter-Based Right and Left Atrial 
Compartmentalisation Procedure in Chronic Atrial 
Fibrillation Using a Novel Non-Contact Mapping 
System: Feasibility and Safety 
Karlheinz Seidl, Graydon Beatty, Axel Drbgemiiller, Silke Breunung, 
Monika flameken, Jochen Senges. Heart Center Ldwigsbafen, Germany 
Background: The percutaneous approach to catheter ablation for treatment 
of atrial fibrillation (AF) is an investigational technique. A catheter-based, 
right (RA) and left atrial (LA) compartmentalisation procedure was evaluated 
using a novel non-contact, three-dimensional mapping and contact catheter 
navigation system. 
Method and Results: Ten patients (pts, 8 male, 2 female, mean age 59 
i 7 years, heart disease 6 pts, LA-diameter 46 f 6 mm, time since first AF 6 
i 4 months, no of cardioversions before 4 f 2) who were referred for treat- 
ment of chronic AF refractory to antiarrhythmic drugs (no of failed drugs 3 * 
1) were studied. All pts had an indication for ablation of the AV junction. RA 
ablation with 3 predefined lines (from the superior to inferior vena cava in the 
posterior to posteroseptal wall, anteriorly from the superior vena cava to the 
tricuspid annulus, and across the tricuspid valve-inferior vena cava isthmus) 
was attempted in all pts (RA ablation: procedure time 374 f 81 min; pulsed 
fluoroscopy time 3.5 i 19 min). In 9 pts, LA ablation (between the mitral annu- 
Ius and the left lower pulmonary vein, to the left upper pulmonary vein, then 
to the right upper pulmonary vein, and finally to the right lower pulmonary 
vein) was performed using four different techniques for accessing the LA (LA 
ablation: procedure time 413 f 100 min; pulsed fluoroscopy time 47 i 19 
min). The deployment of the non-contact multielectrode array was performed 
under ultrasound guidance. Two complications were observed during the LA 
approach (pericardial tamponade and thrombus formation in the left atrium 
without emboiic event). No complication occurred in the RA. Non-contact 
mapping was helpful in identifying discontinuities of the linear lesion, 1 f 1 
gaps/line were found. Three pts (30%) with chronic AF are free of recurrence 
without antiarrhythmic drugs, another 3 pts (30%) are free of recurrence with 
previous ineffective drugs during a short follow-up of 3 months. 
Conclusion: 1. This study demonstrates that non-contact mapping and 
catheter ablation is feasible and relative safe in both atria. 2) Non-contact 
mapping is helpful in guiding the creation of long linear lesions, identifying 
and eliminating discontinuities in the lines. 3) However, the overall success 
rate (defined as free of recurrence without drugs) with 30% is still low in pts 
with chronic AF. 
3:00 p.m. 
802-5 Feasibility of Ablation of Focal Atrial Fibrillation 
Guided by Noncontact Left Atrial Mapping 
Paul A. Friedman, Suellen Grice, Thomas M. Munger, Win K. Shen, 
Arshad Jahangir, Robert F. Rea, Stephen C. Hammill, Douglas L. Packer. 
Mayo Clinic, Rochester, MN, USA 
In some patients with lone paroxysmal atrial fibrillation (AF), the arrhythmia is 
caused by a rapidly discharging focus, often located in or near the pulmonary 
veins (PV). Transient discharge or rapid AF initiation may limit the ability 
to localize the focus, making ablation difficult. Noncontact (NC) mapping 
penits high density mapping of transient arrhythmias, but left atrial (LA) 
use has not been described. We assessed the feasibility of noncontact LA 
mapping of focal AF. 
Methods and Results: Five patients with 8 i 4 yrs of lone PAF un- 
derwent LA noncontact mapping. The NC catheter was placed via a 10 Fr 
transseptal (TS) sheath, and the ablation catheter via an 8 Fr TS sheath, 
in a dual TS approach. A 3-dimensional LA geometry was created which 
permitted instantaneous high density mapping of a single complex within a 
realistic/surrogate anatomic context. The triggering loci originated from the 
pulmonary veins in all pts, and the culprit vein could be identified in all 5 
cases by the NC map alone (left superior PV-2, right superior PV-3). In 415 
cases, AF onset was recorded by the NC map. In 2 cases (1 left superior 
PV, 1 right superior PV) the NC map alone localized the triggering focus. 
In the remaining 3 cases, the NC map was used to identify the PV and the 
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quadrant, with multipolar catheters used adjunctively to further pinpoint the 
depth into the vein of the triggering focus. All energy deliveries were targeted 
at the focus, with output limited to 30 W; 8 i 2 lesions were delivered per 
patient. Immediate procedural success was achieved in all 5 cases. Clinical 
evaluation, including TEE and/or pulmonary venography revealed no signifi- 
cant acute complications, There was transient, mild PV spasm in one pt, not 
related to NC mapping system. 
Conclusion: 1) Noncontact mapping of the left atrium is feasible and safe 
via the dual transseptal technique. 2) Noncontact maps can be used alone to 
guide focal AF ablation in some patients. Ongoing studies will better define 
overall effectiveness and pt. selection for noncontact LA mapping of focal AF. 
ORAL 
El 848 Autonomic Nervous System 
Monday, March 13, 2000, 2:00 p.m.-3:30 p.m. 
Anaheim Convention Center, Room 304C 
2:00 p.m. 
848-i Diastolic Function is Influenced by Autonomic 
Nervous System Activity in Normal Subjects 
Maria V. Pitzalis, Massimo lacoviello, Pietro Guida, Roberta Romito, 
Cinzia Forleo, Francesco Massari, Vito Vulpis, Anna Pirrelli, Paolo Rizzon. 
Cardiology Institute, University of Bari, ltaly 
Background: We have previously suggested the existence of a relationship 
between diastolic function and autonomic nervous system activity in hyper- 
tensive patients. The aim of this study was to evaluate the role of autonomic 
nervous system and neuro-hrmonal activities in determining the diastolic 
function in normal subjects. 
Methods: Sixty-three normal subjects (26 f 5 years, 27 males) under- 
went: 2D-Echo-doppler to evaluate diastolic function (E/A), a 24-h ECG 
monitoring to evaluate time domain heart rate variabiltiy: mean RR (RR24); 
the standard deviation of RR (SDRR); the root mean square successive dif- 
ference of RR (RMSD); spectral analysis of RR and systolic pressure during 
controlled breathing to evaluate baroreflex sensitivity by using alpha index 
(cx). Mean RR was also analysed during Echo (RR-ECO). Plasma concen- 
tration of brain natriuretic peptide (BNP) was also analysed. The relation 
between E/A and age, RR-Echo, RR24, SDRR, rMSSD, and OL respectively 
were analysed by Pearson correlation; that between age and BNP by Spear- 
man correlation. A stepwise multiple regression between E/A and the other 
variables considered as independent was performed. 
Results: 
E/Am Age RR-echo RR24 SDRR RMSD (L BNP 
r -0.43 0.33 0.27 0.26 0.39 0.62 0.42 
P <0.0001 0.009 0.03 0.03 0.002 <0.0001 0.045 
E/A was significantly related with all the considered variables. Multiple 
regression showed that 01 was the first and most important variable of the 
model, followed by age and RR-Echo. This model explain 52% of total 
variance of E/A (r* = 0.52). 
Conclusion: In normal subjects the most important determinant of E/A is 
represented by baroreflex activity. 
2:15 p.m. 
848-2 Spectral Analysis of Atrioventricular Conduction 
Time Variability: A New Method for Quantitative 
Evaluation of the Effect of Autonomic Nervous 
Activity on the Atrioventricular Node 
Yu-ki Iwasaki, Yasushi Miyauchi, Motohisa Osaka, Yoshinori Kobayashi, 
Norishige Morita, Meiso Hayashi, Noriko Sasabe, Hirokazu Saitoh, 
Hirotsugu Atarashi, Takao Katoh, Teruo Takano. Nippon Medical School. 
Tokyo, Japan 
Background: The influence of autonomic nervous activity on the sinus node 
can be assessed by heart rate variability. However, the method for quantifying 
that effect on the atrioventricular (AV) node has not been established. 
Method: Intracardiac electrograms from the right atrium (A) and right 
ventricle (V) during stable sinus rhythm were obtained simultaneously in 20 
patients without sinus node or AV node dysfunction (Group I) and 5 patients 
with WPW syndrome (Group II). The A-A and AV intervals were measured au- 
tomatically using a peak detection program at a sampling interval of 0.5 msec. 
The high frequency (HF, 0.15-0.40 Hz) and low frequency (LF, 0.04-0.15 Hz) 
power of A-A (HFm and LF& and AV interval variability (HFAv and LFAv) 
were calculated using fast Fourier transform. 
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Results: In all of Group I patients, the power of the AV interval variation 
showed similar frequency peaks to that of A-A. HF*v had a significant corre- 
lation to HFAA (r = 0.61, p < 0.01) and so did LFAV to LFAA (r = 0.50, p = 0.02). 
On the other hand, in Group II, there was no power peak of the AV interval 
variation, but some frequency peaks were detectable after radiofrequency 
ablation of the accessory pathway. In 12 patients of Group I who underwent 
pharmacological autonomic blockade, both the HFA~ and LFA~/HFAv signif- 
icantly decreased after autonomic blockade (HFAv: 7.3 * 1.0m6 vs 4.7 i 
6Z6, p < 0.05, LFA~/HFAv: 1.1 f 0.7 \iS 0.6 f 0.8, p < 0.05). 
Results: 
MH+ MH- P 
RR 24-h (ms) 808 * 95 890 *79 0.002 
SDRR (ia) 
RMSSD (ms) 
Alpha (ms/mmHg) 
E/A 
BNP (pg/mL) 
157+39 196132 0.001 
47flQ 58zkl5 0.01 
14.4% 11.9 20.2 22 10.5 0.03 
1.51 zt 0.25 1.82 i 0.4 0.03 
371-1.7 1918 0.006 
Conclusion: The influence of both the sympathetic and parasympathetic 
activity on the AV node can be quantified by spectral analysis of the AV 
conduction time variability. 
2:30 p.m. 
848-3 Evidence of a Role of Endogenous Estrogen in the 
Autonomic Nervous Control of the Cardiovascular 
System 
No differences were found between FH+ and FH-. 
Conclusions: This study demonstrate for the first time that MH+ but 
not FH+ show abnormalities in autonomic nervous system activity, diastolic 
function and BNP levels. This difference could be due to hormonal profile 
and/or different heredity of hypertension predisposing factors. 
Giuseppe Mercuro, Giuseppe M.C. Rosano’, Alessandro Podda, 
Luisa Pitzalis, Sandra Zoncu. Dept ofCardio/ogx University of Cagliari; 
‘Dept, of Cardiology lstituto San Raffaele Milan0 and Roma, Italy 
3:00 p.m. 
848-5 Cardiac Autonomic Nervous Dysfunction in Diabetic 
Patients Associated With a Mitochondrial tRNA 
Mutation 
Background: Menopause is characterized by a sympathovagal alteration 
with a shift of autonomic cardiovascular control towards sympathetic hyper- 
activity. 
Methods: We studied heat-l rate variability (HRV) in IO oophorecfomized 
women (O-W, mean [&SD] age 45 & 1.5 yrs) free from specific risk factors for 
CV disease in comparison to 10 hysterectomized women with ovarian con- 
servation (Y-W), matched for age and BMI. All subjects underwent 24-hour 
ambulatory Holter ECG monitoring 1 week before and 4 weeks after surgery. 
In 80-W out of 10, Holter monitoring was repeated after 3 months of estrogen 
replacement therapy (ERT). 
Yukihiko Momiyama’, Yoshihiko Suzuki, Fumitaka Ohsuzu’ , 
Masako Ohtomo, Yoshihito Atsumi, Kempei Matsuoka, Mitsuru Kimura 
Saiseikai Central Hospital, Tokyo; ‘Natiohal Defense Medical College, 
Saitama, Japan 
Background: About 1% of diabetes mellitus (DM) is associated with a mito- 
chondrial 3243 bp tRNA mutation, which was originally found in mitochondrial 
encephalomyopathy. Cardiac autonomic nerves in patients (pts) with mito- 
chondrial DM may be affected by this mutation. 
Results: In 0-Wasignificant decrease in SDNN, SDANN, rMSSD, pNN50 
(all p i 0.05), LF (p < O.Oi), and HP power (p < 0.05) together with a higher 
LF/HF ratio (p < 0.05) were found in comparison with baseline. ERT returned 
all HRV indexes to levels comparable to those recorded prior to surgery. No 
changes in values of HRV were found in H-W. 
Methods: We investigated heart rate variability (HRV) using 24-hr Holter 
monitoring in 9 diabetic pts with the 3243 bp mutation (group A), 56 ordi- 
nary DM pts (group B) and 36 controls (group C). Mean RR, SDNN index 
(mean of all 5-min SDS of RR), rMSSD, pNN50 and AF (0.04-1.00 Hz), LF 
(0.04-0.15 Hz), HF (0.15-0.40 Hz) spectra were analyzed. All study subjects 
were negative for stress 201TI imaging or exercise testing. Pts with IDDM or 
cardioactive drugs were excluded. 
Conclusion: The present study shows that acute withdrawal of ovarian 
hormones is characterized by a decline in cardiac vagal modulation with a 
shift of autonomic cardiovascular control towards sympathetic hyperactivity. 
The lack of modification of autonomic nervous balance in Y-W excluded the 
possibility that sympathovagal alteration observed in O-W could be a conse- 
quence of surgical intervention per se. The observation that ERT returned 
values of HRV in O-W to a level comparable to baseline suggests that estro- 
gen alone is involved in the sympathovagal balance in fertile females, while 
other ovarian hormones play a marginal role. Present findings, providing an 
explanation for the mechanism involved in vasomotor disturbances observed 
in healthy postmenopausal women, could justify, at least in part, the increase 
of cardiovascular morbidity and mortality seen in these subjects. Finally, our 
data provide relevant support to the clinical utility of ERT as a beneficial 
cardioprotective agent and confirm that this type of treatment is compulsory 
in O-W. 
Results: Age and gender were similar in 3 groups. Between groups A 
and B, DM duration (14 & 8 vs 14 f 9 yr) and blood glycemic levels were 
not different. On echocardiograms, none in 3 groups had any wall motion 
abnormalities, but LV hvoertroohv was found in 22% of aroup A and 7% of 
group B. Mean RR in groups A, 6 and C were 790 i 1 IO:846 * 90 and 870 
+ 110 ms (p = NS). SDNN index, rMSSD and pNN50 in groups A and B were 
significantly smaller than those in group C. However, Group A had smaller 
SDNN index than group B (32 f 10 vs 44 f 17 ms, p < 0.05), but rMSSD (18 
f 6 vs 25 f 15 ms) and pNN50 were not different between the 2 groups. In 
frequency domain analysis, AF, LF and HF spectra were significantly smaller 
in groups A and B than in group C. However, group A had smaller AF (18 f 
6 vs 26 f 12 ms) and LF (9 + 4 vs 14 f 7 ms) than group B (p < 0.05), but 
HF (8 f 4 vs 9 f 6 ms) was not different. Notably, LF/HF ratio in group A 
was lower than those in groups B and C (1.2 f 0.4 vs 1.7 f 0.5, 1.6 & 0.4, p 
< 0.01). This ratio was not different between groups B and C. 
2:45 p.m. 
848-4 Gender-Linked Abnormalities in Autonomic Nervous 
System Activity in Normotensive Offsprings of 
Hypertensive Subjects 
Conclusion: Diabetic pts with the mutation have more severely impaired 
cardiac autonomic nervous function, especially in sympathetic nerve, than 
ordinary DM. 
3:15 nm. 
Maria V. Pitzalis, Massimo lacoviello, Pietro Guida, Roberta Romito, 
Cinzia Forleo, Francesco Massari, Vito Vulpis, Anna Pirrelli, Paolo Rizzon. 
Cardiology Institufe, University of Bari, lfaly 
848-6 Effects of Patient’s Posture on Cardiac Autonomic 
Nervous Activity in Patients With Congestive Heart 
Failure 
Background: Normotensive offsprings of essential hypertensive subjects 
(H+) have higher ambulatory blood pressure values and pathological re- 
sponces to stress tests as compared to normotensive subjects with normoten- 
sive parents (H-). These might be due to an early alteration in autonomic 
nervous system which could predispose to hypertension. We evaluated au- 
tonomic nervous system activity in 22 male H+ (MH+, 26 f 4 yrs) and 23 
age matched MH-; in 20 female. H+ (FH+, 27 f 5 yrs) and 22 age matched 
FH-. 
Shoichi Miyamoto, Masatoshi Fujita, Satoko Yamazaki, Hiroyuki Sekiguchi, 
Shigeru Eiho, Yoko Yamamoto, Shun-ichi Tamaki, Kazuaki Hiki, 
Ryuji Nohara, Yuko Nakayama, Yoshiiki Okano, Satoru Ichiyama. Takeda 
Hospital and Kyoto University Kyoto, Japan 
Methods: Family history of hypertension was defined when at least one 
of parents had essential hypertension before age of 55. Smoker and obese 
subjects were excluded. All subjects underwent a 24-hour Holter to analyse 
mean RR; the standard deviation of RR, SDRR; the root mean square 
successive difference of RR, RMSSD; furthermore, spectral analysis of RR 
and systolic pressure during controlled breathing (to evaluate baroreflex 
sensitivity, alpha index), PD-Echo-doppler (to evaluate diastolic function, 
E/A), samples for determination of brain natriuretic pepetide (BNP) were 
performed. Differences were analysed by test U di Mann. 
Background: We designed to clarify which recumbent position is preferred 
by patients with congestive heart failure (CHF) and to evaluate whether 
cardiac autonomic nervous activity (CANA) is different among 3 recumbent 
positions (S: supine, L: left lateral decubitus, R: right lateral decubitus) in 
patients with CHF. 
Methods: We studied 10 CHF patients and 10 age-matched healthy 
subjects. Each subject underwent 24-hour ambulatory ECG monitoring. A 
channel was used for recording CMs lead, and another for recording the 
signal for patient’s posture with a newly developed small sized detector 
(3.2 cm x 3.2 cm). By using spectrum analysis of heart rate variability, 
frequency-domain measures were calculated and compared among the 3 
recumbent positions. The normalized high-frequency (HF: 0.15 to 0.40 Hz) 
power was used as an index of vagal activity and the low frequency (LF: 0.04 
to 0.15 Hz)/HF power ratio as an index of sympathovagal balance. 
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Results: As shown in Table, CHF patients preferred R position, resulting 
in the normalization of CANA. 
Healthy Subjects Patients with CHF 
S L R S L R 
Time (%) 46 29 25 20 28 52 
(3to 6 Em.) zt31 533 lt17 Zt12* f19” *13 
HFiTP 0.46 0.45 0.53 0.25 0.28 0.56 
zto.15 Lko.21 10.20 ~0.20’t *o.l9”t zko.22 
LFiHF 1.21 0.94 1 .07 3.65 5.13 1.58 
lko.59 iO.36 10.71 12.69’t i5.70*t 42.30 
*p < 0.05 vs. R, tp < 0.05 vs. Healthy Subjects by ANOVA. TP = total power. 
Conclusion: R position in patients with CHF is a self-protecting mecha- 
nism of attenuating the imbalance of CANA. 
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1 1718-67 1 Figure-of-Eight Reentry involving Anatomical 
Obstacles in the Left Atrium 
Steven M. Markowitz, Kenneth M. Stein, Suneet Mittal, David J. Slotwiner, 
Marc A. Scheiner, Sei Iwai, Bruce B. Lerman. New York Hospital-Cornell 
University Medical Center, New York, N’r: USA 
Background: Although anatomical barriers to reentry in the right atrium have 
been clearly identified, reentrant circuits in the left atrium (LA) remain poorly 
defined. 
Methods and Results: IO consecutive patients (age 60 i 15; 4 F) with 
left atrial (LA) tachycardia underwent electoanatomical mapping with the 
CART0 Biosense system. In four patients, reentrant circuits were defined, 
and the remaining six had focal activation patterns. Two patients demon- 
strated reentry around pulmonary veins. The other two demonstrated similar 
macroreentrant circuits characterized by a figure-of-eight involving the pul- 
monary veins and the mitral annulus. In these figure-of-eight tachycardias, 
the wavefront activated the posterior LA in an inferior direction between the 
left and right pulmonary veins (LPV, RPV). At the mitral annulus, the wave- 
front divided and activated the lateral and septal walls in a superior direction, 
uniting at the roof of the LA. A multipolar catheter recorded “early” activation 
in the mid-coronary sinus (CS). thus identifying the site of wavefront engage- 
ment of the mitral annulus, with centrifugal spread to the proximal and distal 
CS. Both patients with figure-of-eight reentry had mitral valve disease, one 
with a remote mitral valve repair and one with a bioprosthetic mitral valve. 
In one patient with a figure-of-eight circuit, the tachycardia was successfully 
ablated in a region of slow conduction between the mitral annulus and the 
ostium of the right superior pulmonary vein. 
Conclusions: The pulmonary veins and mitral annulus may constitute 
anatomical barriers that support figure-of-eight reentry. 
1 i 18-68 Right Atrial Postero-Septal Double Potentials as 
an Indicator of Left Atrial Origin of Ectopic 
Tachycardia 
Kyoko Soejima, William G. Stevenson, Etienne Delacretaz, Corinna 
B. Brunckhorst, William H. Maisel, Peter L. Friedman, Brigham and 
Women’s Hospital, Bosfon, MA, USA 
The high postero-septal (PS) right atrium is adjacent to the left atrium near 
the right superior pulmonary vein (RSPV). We hypothesized that analysis of 
activation at this site could distinguish left atrium (LA) from right atrial (RA) 
tachycardias (AT). 
Methods: LA mapping was performed in 12 pts with LA AT (8 from RSPV, 
4 from other LA sites). 
Results: In LA AT the earliest RA sites were high PS in 1 i/l 2 pts. At these 
sites, double potentials (DP) were recorded. At 11 of the 12 sites of earliest 
activation, components of DPs reversed during sinus rhythm as compared to 
AT, indicating the 1 st component of DP was due to the far-field LA activation. 
RF application at these sites decreased the 2nd component (0.47 f 0.23 + 
0.29 f 0.18 mV, p = O.OOOl), but not the far-field Is’ component (0.27 & 0.23 
+ 0.23 f 0.17 mV, ns). In 8 RSPV AT, the 1” component was earlier than the 
P waveonset (-29 f 18 ms); incontrast toother LAAT(12 f24 ms, p=O.O2). 
ECG 
sinus 
v__ 
PAC 
Abl l-2 pmUon ,C-+ 
Conclusions: A DP in the high PS RA which reverses the timing of its 
components during sinus rhythm indicates LA origin of AT. Early activation of 
the first component in LA AT suggests origin from the RSPV. 
1118-69 Catheter Ablation of Atrial Tachycardia Using a 
Novel Non-Contact Mapping System. Success 
Rate is Influenced by the Characteristics of 
lsopotential Maps and Unipolar Electrogram 
Morphologies 
Karlheinz Seidl, Graydon Beatty, Silke Breunung, Monika Rameken, 
Jochen Senges. Heart Center Ludwigshafen, Germany 
The objective of the study was to determine the usefulness of a novel 
non-contact mapping and catheter navigation system for catheter ablation of 
focal atrial tachycardias (AT). 
Methods: In 18 patients (pts) with AT, ablation was performed. Three 
classifications of isopotential maps (IPM) and unipolar electrograms (UECG) 
morphologies were observed. 
Results: Group 1: In 4 AT’s, IPM displayed a narrow, sharp ring of colors 
around a discrete white center spot. The earliest activation was simultaneous 
with the rapid spread of activation and the virtual UECG displayed a QS 
morphology with a rapid dV/dt in the range of 37-470 mV/ms. The induction 
mode for these AT’s was burst stimulation in 2 and spontaneous occurrence 
during isoproterenol infusion in 2 pts. Ablation was successful in all 4 AT. 
Group 2: In 11 AT’s, IPM displayed a more broad ring of colors. In this case 
the ring of colors was 2 to 3 cm wide, with little or no white color in the 
center which then flowed through a narrow zone of preferential conduction to 
the rapid spread of activation. The UECG displayed a low amplitude, broad 
and smooth QS morphology with dV/dt in the range of 5-98 mV/ms in front 
of the second component at exit with a rapid dV/dt in the range of 34-870 
mV/ms, which shows a small, sharp R-wave morphology. All 11 AT were 
induced by programmed electrical stimulation. Ablation was successful in 
all 11 AT. Group 3: In 3 AT’s, IPM displayed a very broad ring of only 2 
or 3 shades of colors, which rapidly expanded into a nearly simultaneously 
activated region of breakthrough. The UECG displayed a low amplitude, 
broad and fractionated waveform with a dV/dt in the range of 6-28 mV/ms 
followed by a second component during endocardial breakthrough with a 
gradual dV/dt in the range of 3-55 mV/ms, both with R-wave morphologies. 
The induction mode was programmed stimulation in 1 and burst stimulation 
with isoproterenol infusion in 2 pts. Catheter ablation failed in all 3 pts. 
Conclusion: 1. Three classifications of IPM and waveform morphologies 
were observed. 2. The success rate was influenced by IPM and waveform 
morphology characteristics. 3. Success rate was lOO%, in group 1 and 2 
suggesting an endocardial or midwall (subendocardial) origin. Ablation failed 
in all pts in group 3 suggesting an deeper origin. 
1118-70 Single-Procedure Double-Chamber 
Three-Dimensional Electroanatomic Mapping for 
Ablation of Septal Tachycardia 
Dietrich Pfeiffer, Annerose Neugebauer, Maika Mende, Norberl Klein, 
Andreas Hagendorff. Department of Cardiology University of Leipzig, 
Leipzig, Germany 
Background: Atrial septal tachyardia (AST) may be ablated from the right or 
the left atrium. This decision can be extremely difficult. We describe 11 pts 
with AST with radiofrequency catheter ablation using the CARTO@ system 
for dual-chamber atrial mapping in a single ablation procedure. 
Patients and Methods: Eleven pts (9 women, age 36-21 y) with AST (4 
incessant, 7 paroxysmal) were referred for catheter ablation after l-2 con- 
ventionally unsuccessful ablation procedures. No arrhythmia was inducible 
using extrastimuli. lsoprenaline was infused during mapping and ablation 
procedures in 7 pts. We performed biatrial electroanatomic mapping in both 
atria during AST with 24-66 points and delivered energy in both atria in 2 
and in a single atrium in 9 pts. 
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Results: The focus was detected in the right atrium close to sinus node 
in 3, in the left atrium near the ostium of the right upper pulmonary vein in 5 
and in the lower left atrial septum in 2 pts. The earliest onset of right and left 
atrial activations differed 1534 ms. Propagation maps demonstrated better 
than isopotential maps the breakthrough. The foci could be ablated with 2 
to 8 radiofrequency pulses. Procedure duration ranged between 180 and 
300 min, radiation exposure was 9-21 min. One relapse was seen during 
follow-up of 9 f 3 months after 3 months. 
Conclusions: (1.) AST is difficult to localize and needs careful right and 
left atrial mapping. (2.) The CARTOm system is able to detect a focus in 
or close to the interatrial septum using biatrial mapping. (3.) The system 
increases the success-rate of conventional ablation procedures in AST, de- 
creases radiation exposure, but does not shorten the procedure-time. 
1 1118-71 1 Utility of Noncontact Mapping in Guiding 
Successful Ablation in Patients With Previouslv 
Failed Ablation Procedures 
Paul A. Friedman, Suellen K. Grice, Thomas M. Munger, Win K. Shen, 
Arshad Jahangir, Robert F. Rea, Doug Beinborn, Stephen C. Hammill, 
Douglas L. Packer. Mayo Clinic, Rochester, MN, USA 
Noncontact (NC) mapping permits high density endocardial mapping of sus- 
tained or transient arrhythmias. The ability of this approach to reconstruct 
electrograms and to localize potentials has been shown, but its clinical utility 
remains unproven. We sought to assess the utility of NC mapping to guide 
complex ablation procedures in patients with previously failed ablations. 
Methods and Results: Eleven consecutive pts with previously failed 
ablation underwent repeat study guided by NC mapping. Patients had the 
following arrhythmias at the repeat study: ectopic atrial tachycardia - 2, typical 
atrial flutter (AFL) - 1, scar AFL-2, focal atrial fibrillation (AF)-1, idiopathic left 
ventricular tachycardia (VT) - 1, coronary VT- 1, right ventricular outflow tract 
(RVOT) VT- 3. Successful ablation occurred in IO/Ii NC map guided studies 
using 4 mm tip standard ablation catheters. In 2 pts (one with RVOT VT, one 
with focal AF), the ablated arrhythmia would only sustain transiently-both 
were successful. In 2 pts, an arrhythmia was found (and ablated) which was 
not treated at the first study (l-Focal AF, 1 -scar AFL). One pt with RVOT had 
no inducible arrhythmia or ambient ectopy to map after NC mapping system 
insertion. No energy was delivered, but this procedure was counted as a 
failure. There were no complications. The NC mapping system was rated as 
important for redo procedure success in 9/l 0 successful cases in an operator 
questionnaire. 
Conclusion: 1) Noncontact mapping can successfully guide ablation in 
complex cases in which previous efforts have failed; 2) Success is likely due 
to improved localization of arrhythmogenic substrate and the ability to map 
transient arrhythmias. 
1 1118-72 ) Feasibility of Combined Non-Contact and 
Electroanatomical Mapping for Guiding Ablation 
of Complex Arrhythmias 
Thomas M. Munger, Paul A. Friedman, Suellen K. Grice, Stephen 
C. Hammill, Douglas L. Packer. Mayo Foundation, Rochester, MN, USA 
Background: Electroanatomical (EA) and Non-contact (NC) mapping are 
emerging as useful stand alone adjuncts to traditional arrhythmia mapping 
techniques for identifying the origins of supraventricular and ventricular ar- 
rhythmias. 
Methods: To examine the utility of simultaneous EA and NC mapping for 
characterizing arrhythmias, 8 patients (4 with atrial tachycardias (ATs) and 4 
with ventricular tachycardias (VTs)) underwent EP evaluation. Of these, 4 had 
significant heart disease, with VT in three. Specific arrhythmia mechanisms 
included point source AT in 2, isthmus-dependent and incisional-scar related 
atrial flutter in 1 each, RV outflow tract VT in 1, nonsustained VT related to 
dilated cardiomyopathy in 1, and infarct related reentrant VT in 2. Mean age 
was 49 i 17 years (20-64), and LV EF was 49 i 20% (20-65). 
Results: After baseline testing, both EA and NC mapping catheters were 
deployed in the RA in 3, across the TV in 1, in the RVOFT in 1, and in the LV 
in 3. NC system geometry rendering the underlying chamber was undertaken 
during the 40 i 16 min total EA map generation time. No significant interaction 
“noise” was noted. Activation maps disclosed focal arrhythmic sites in 2 
patients with AT and 2 with VT, while scar related AT and isthmus-dependent 
atrial flutter were seen in 2, and reentrant VT in 2 patients. Earliest indicators 
of arrhythmia origin with EA and NC mapping were 17 i 9 mm apart. Ablation 
directed at the earliest site successfully eliminated all 4 ATs and 2 of the VTs. 
The other 2 VTs were substantially modified but not eliminated. NC provided 
“real” time activation and global arrhythmia depolarization characterization, 
while EA provided specific localization of activation in SD-space. 
Conclusion: The use of both systems simultaneously is feasible and 
provides mutually distinct information regarding arrhythmia origin and endo- 
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cardial surface activation. The combination of these techniques may be very 
useful for targeting complex clinical arrhythmias. 
I 1118 73 Single Puncture, Repeated and Multicatheter Transseptal Electrophysiological Access to the 
Left Atrium 
Dipen C. Shah, Pierre Ja’is, Meleze Hocini, Fiorenzo Gaita’, 
Riccardo Riccardi’, Michel Ha’issaguerre, Jacques Clementy. /#pita/ 
Haut-Lb&que, CHU de Bordeaux, Pessac, France; ‘Ospedale Civile, Asti, 
lialy 
Introduction: Retrograde transaortic and transmitral access to the left atrium 
(LA) is difficult and does not allow free manipulation and stable positioning. 
With the increasing need for extensive mapping and ablation procedures in 
the LA, the limitations of single catheter transseptal access have become 
evident; emphasizing the requirement for multicatheter and repeated access. 
Methods: Between June 1998 and July 1999, 224 ablation and map- 
ping procedures requiring left atrial access were performed transseptally, 
34 through a patent foramen ovale. Transseptal puncture was performed 
under flouroscopic guidance and with continuous pressure monitoring. Mul- 
tiple catheters were introduced into the LA through multiple sheaths placed 
over multiple guidewires introduced through a single transseptal puncture - 
sheath or more commonly passed alongside transseptally placed guidewire 
in the LA through one puncture or through a patent foramen ovale: the 
guidewire trajectory could be followed across the septum and into the LA 
under flouroscopic guidance by the second catheter. 
Results: One to three catheters including duodecapolar Halo catheters (n 
= 6) were placed in the LA. Two or more 7 F catheters were routinely placed 
in 37 procedures and in all but 5 cases with a single long sheath. There were 
no complications related to puncture, catheter placement or manipulation 
except for self limited coronary air embolism during catheter exchange. The 
transseptal access was recrossed without requiring repuncture usually within 
4 weeks after the initial puncture in 120 procedures; while repeat puncture 
was required in 41 procedures There were no longterm complications related 
to left atrial access. 
Conclusions: Multicatheter transseptal access to the LA is safe and rou- 
tinely possible without requiring multiple punctures or sophisticated imaging 
systems; an early repeat procedure does not require a repeat septal punc- 
ture. The transseptal route provides the best means for mapping and ablating 
in the LA. 
I 1118 74 Linear Cryo Ablation of the Cavo Tricuspid Isthmus Under Guidance by Phased Array 
Intracardiac Echocardiography 
David Keane, Chris Houghtaling, Huang Qin, Thomas Aretz, Jeremy 
N. Ruskin. Massachusetts General Hospital, Boston, MA, USA 
Background: Creation of a continuous trans-isthmus linear lesion with a 
conventional radiofrequency tip catheter under fluroscopic guidance, can re- 
quire a large number of applications before conduction blockis achieved. We 
evaluated the feasibility of transvenous linear cryoablation under guidance 
by phased array intracardiac echocardiography in six goats (60 kg). 
Methods: At baseline, trans-isthmus bidirectional conduction was mea- 
sured with a multielectrode halo catheter. A 10 F deflectable phased array 
intracardiac echo catheter (AcuNav) was advanced from the left femoral vein 
to the right atrium to image the isthmus at 8.5 Hz using a conventional echo 
platform (Sequoia, Acuson). An 8.5 F deflectable linear cryoablating catheter 
with a distal 2.5 cm linear freezing section (CryoCath) was introduced via the 
right femoral vein. The cryo catheter was advanced into the right ventricle 
and then withdrawn and deflected onto the isthmus under echo guidance to 
maximize tissue contact. Cryoablation was performed for two cycles of five 
minutes duration each at -55°C in four locations as the catheter was progres- 
sively withdrawn across the isthmus from the tricuspid annulus to the inferior 
vena cava. Following ablation, trans-isthmus conduction was again studied. 
Histology sections were obtained after 48 hours survival post ablation. 
Results: Optimal in-plane imaging of the isthmus and the linear cryo 
section of the ablating catheter was achieved in all cases. Adherence of the 
ctyo section of the ablating catheter to the endocardium could be appreciated 
at the onset of each cryo application. Bidirectional conduction block was 
achieved after the above ablation protocol in four of six cases. On histology, 
continuous transmural isthmus lesions were found in four of six cases. 
Conclusion: Deflectable phased array intracardiac echo can be effec- 
tively used to image linear catheter ablation. Trans-isthmus conduction block 
can be achieved in this experimental model with a transvenous linear cryoab- 
lation system. 
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1 1119-93 / How to Program Detection Algorithms for 
Discrrmination of Ventricular From 
Supraventricular Tachycardias in a Single Lead 
Cardioverter-Defibrillator? 
Anselm Schaumann, Ole Fabian, Bernd-Dieter Gonska, 
Claus Schmitz-Elsen, Marius Volkmer, Karl-Heinz Kuck. St. Georg Hospital 
Hamburg and University of Goettingen, Germany 
Background: Supraventricular tachycardias (SVT) initiating inappropriate 
therapy in implantable Cardioverter-Defibrillators (ICD) used to be a problem 
in up to 25% of patients. Enhanced detection criteria of ventricular tachycar- 
dias (VT) should improve the specifity of VT detection. 
Methods: We evaluated to what extent the use of “enhanced detection” 
criteria, stability (S), programmed 16-30 ms, and an onset (0) of 9%, could 
discriminate VT from SVT using a single lead in 150 patients (mean age 63 
years, 69% coronary artery disease) during a follow-up of up to three years. 
Results: Of 150 patients 79 had 641 spontaneous VTs, with complete 
ECG storage of 10 set preceding the VT. For 93% of VTs measured S was 
~22 msec. In 23 VTs (15 patients) the detection criteria were not fulfilled, 
automatically initiating the programmed “sustained rate duration”. In only 4 
VT the therapy was delayed more than 6 seconds. The 0 for most VTs (97%) 
was measured ?9%. No serious complications occurred due to detection 
delay. Using our programmed values for S (mean of 23 msec (16-30) and 
onset (9%) inappropriate shock delivery, due to fast SVT, was noted in only 
4.6% of patients during the first year, 3.4% at the second and 1.8% at the 
third year of follow up, 
Conclusion: Programmed S (16-30 ms) and 0 (9%) criteria are sufficient 
for reliable detection of spontaneous VT and therefore should be programmed 
on to minimize inappropriate therapy delivery to 2-5% per year. 
11 i 9-94 First Results With a New Morpholgy Criterion for 
Discrimination of Suoraventricular and Ventricular 
Tachycardias ’ 
Susanne Herwig, Werner Jung, Christian Wolpett, Susanne Spehl, 
Lam Lickfett, Rainer Schimpf, Christian Schneider’, 
Bahmann Esmailzadeh’ , Armin Welz’, Berndt Liideritz. Depfs. of 
Cardiology; ‘Cardiac Surgery, University of Bonn, Bonn, Germany 
Although various enhanced detection criteria such as the sudden onset and 
the rate stability criterion have been introduced to clinical practice for better 
discrimination of supraventricular (SVT) and ventricular tachyarrhythmias 
(VT), there is still a significant amount of inappropriate defibrillator therapies. 
Therefore, a new morphology based criterion, which differentiates the origin 
of rhythm by the amplitude, the sequencing of peaks and the surface between 
the peaks and the baseline, has been developed to further increase specificity 
in the treatment with the implantable defibrillator. The aim of the present study 
was to evaluate the clinical performance of this new detection algorithm. 
Patients and Methods: A total of 15 patients (pts) received an ICD 
(Angstrom; Ventritex Inc., St Jude Medical). The morphology criterion was 
programmed to the active or passive mode. The algorithm works as follows: 
QRS-morphology is measured during baseline sinus rhythm and a template 
is programmed. If 5/8 cycles during tachycardia resemble by more than 60% 
to the sinus template, the rhythm is classified as SVT. If the accordance is 
below 60% the arrhythmia is classified as VT. 
Results: A total of 216 spontaneous tachyarrhythmias were recorded in 
10115 pts. Among these 1761180 episodes were appropriately detected as 
VT. This results in a sensitivity of (98%). 4 VTs in 1 patient were discriminated 
as SVT. In this patient there was a preexisting right bundle branch block, so 
that the criterion was programmed to the passive mode. 8/30 supraventricular 
rhythms including atrial fibrillation and sinus tachycardia were determined to 
be SVT and resulted in inappropriate therapies. These detection failures 
occurred only in patients, who were programmed to the passive mode 
Conclusions: 1. The new morphology criterion significantly reduces in- 
appropriate detection of supraventricular tachyarrhythmias while maintaining 
a sensitivity of 98%. 2. The measurement of QRS-morphology is subject to 
a change over time and should therefore be repeated at each follow-up. 3. 
Together with rate stability and sudden onset the new criterion represents a 
further improvement in arrhythmia detection. 
L-l 1119 95 Should All Patients Receive a Dual Chamber Device? Unanticipated Use of the Implantable 
Defibrillator as a Pacemaker 
Anton0 Sutandar, Solimon Solimon, Raja’a Kaddaha, Margo E. Vloka, 
Jonathan S. Steinberg. Sf Luke&Roosevelt Hospital Cenfer and Columbia 
Universifl: New York, N): USA 
Background: Most patients receiving an implantable cardiovener defibrillator 
(ICD) do not require pacemaker therapy. Routine selection of a dual chamber 
ICD may be an appropiate contingency for enhanced pacing and sensing 
features, but is more expensive. 
Methods and Results: To examine one component of this issue, we 
reviewed the records of 83 consecutive patients, who had no pacing indication 
at implant and in whom unanticipated pacing could be quantified. All ICDs 
were programmed to VVI 40 ppm at implant. Overall, 28 patients (34%) 
developed a significant need for pacing during follow-up of 20 & 10 mos: (1) 
510% pacing use in 3 mo period at any interrogation, (n = 15), (2) intentional 
increase in pacemaker lower rate for chronotropic incompetence (n = 6), (3) 
hospitalization with heart failure requiring transient or permanent increase in 
lower pacing rate (n = 4), and (4) inpatient or outpatient ECG documentation 
of paced rhythm at lower rate (n = 3). Patients developing a significant need 
for pacing differed from those not requiring pacing with regard to age (71 i IO 
y vs 64 f 12 y, p < 0.05) and history of paroxysmal atrial fibrillation (AF) (46% 
vs 22%, p < 0.05). Both groups were similar in other clinical characteristics 
prior to implant (presence of CAD, EF, presence of IVCD/bundle branch 
block, and arrhythmic presentation) and in electrophysiologic characteristics 
(sinus node, AV node, and His Purkinje function, and inducibility of VT). The 
positive predictive accuracy of significant variables were age > 75 y, 13125 
(52%) and paroxysmal AF, 13125 (52%). 
Conclusions: These results suggest that ICD patients commonly require 
unanticipated bradycardic pacing support, particularly those who are older 
or who have paroxysmal AF. Dual chamber ICDs should be considered for 
patients in whom significant pacing use is likely to develop. 
[_I 1119 96 Dual-Chamber Implantable Cardioverter Defibrillator vs Single-Chamber Implantable 
Cardioverter Defibrillator: High Incidence of 
Device and Lead Related Complications in 
Dual-Chamber Implantable Cardioverter 
Defibrillator 
Tamana Takahashi, David S. Cannom, Edward Abdullah, Robert D. Lerman, 
Young Park, MO Bishara, Marc Girsky, Anil K. Bhandari. Good Samaritan 
Hospital, Los Angeles, California, USA 
Background: Recently, some have advocated the routine use of Dual-Cham- 
ber Implantable Cardiovener Defibrillator (DC-ICDs) over Single-Chamber 
Implantable Cardiovetter Defibrillator (SC-ICDs) but the available data is 
scanty regarding the frequency of complications between the two types of 
ICDs. 
Methods: Between July, 1997 and April 1999, 178 consecutive patients 
had implantation of transvenous SC-ICDs (104 pts) and DC-ICDs (74 pts). 
The major complication rate (defined as those that required surgical correc- 
tion) was determined by a retrospective review of the medical records and 
follow-up data of IO f 6 months, 
Results: Twelve (16%) of the 74 pts with DC-ICDs had a total of 16 major 
complications as compared to 6 (6%) of 104 pts with SC ICDs (p < 0.01). 
Sixteen complications in DC-ICDs included: atria1 lead dislodgment (4) atrial 
lead fracture (I), ventricular lead fracture/sensing malfunction (4) RV per- 
foration (I), pocket infection/hematoma (4), and ICD generator malfunction 
(2), Six complications in SC-ICDs included: ventricular lead dislodgment (Z), 
pocket lead hematoma (3) and pneumothorax (1). As compared to SC-ICD 
recipients, patients with DC-ICDs had lower LVEF (29% f 12% vs 35% i 
16% p < 0.035) and a higher prevalence of non-ischemic cardiomyopathies 
(48% vs 28%, p < 0.0076). 
Conclusions: As compared to SC-ICDS, DC-ICDs may be associated 
with a high frequency of device and lead related major complications and this 
needs to be taken into consideration in deciding when to implant a DC-ICD. 
I 1119 97 Experiences With a New Fractally Coated Single Pass Single Lead Electrode for Dual Chamber ICD 
Systems in 30 Patients 
Michael Niehaus, Thomas Kotte, Andreas Schuchett’ , Stefan Thamasett, 
Dietrich Pfeiffer, Roberto Belke, Juergen Tebbenjohanns. Depts. of 
Cardio/og)s Medical School Hannover; ’ University-Hospital Eppendorf 
Hamburg, Germany 
Background: Common available dual chamber ICD systems use two sepa- 
rate leads for sensing and pacing in atrium and ventricle. Complications due 
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to the atrial (A) lead have been reported. We designed and evaluated a new 
single lead dual chamber VDD-lead for dual chamber ICDs. 
Methods: In a German multicenter study we tested a prototype VDD-lead 
(a single-coil defibrillation electrode with 2 additional fractally coated rings 
for bipolar sensing in the atrium) in 30 pts. A. arrhythmias were induced 
using a bipolar stimulation catheter or an A. screw tip electrode. A. and 
ventricular (V.) signals were recorded during sinus rhythm (SR), A. flutter 
(AFLU), A fibrillation (AF) and V tachycardia (VT) or ventricular fibrillation 
(VF). Terminations of V. arrhythmias were performed by internal DC-shock. 
The position of the A. sensing rings was in close contact to the lateral A. wall. 
Results: In 27 of 30 pts. (90%) implantation of the electrode was success- 
ful. Mean A. pacing threshold was 2.5 f 0.9 V/O.5 ms, mean A. impedance 
was 213 f 31 Q. For A. sensing see Table. The mean V. sensing was 13.3 i 
7.9 mV, mean V. impedance was 577 f 64 a. Defibrillation was successful 
with 20 J in all patients. 
Atr. VDD 
Atr. Detection 
SR [mV]/SD AFlu [mV]/SD AF [mV]/SD VF [mV]/SD 
2.75 1.6 1.46 * 0.3 0.93 4 0.37 1.4 i 0.52 
99.6% 87% 56% 90.1% 
Conclusions: The new designed VDD dual chamber electrode with frac- 
tally coated atrial sensing rings provides stable detection of atrial and ventric- 
ular signals during SR, AFlu and VF and offers an option to optimize single 
lead ICD therapy especially in those patients without a history of AF. 
1 1119-98 1 Can Correlation Waveform Analysis of ICD Shock 
Electrograms be Used to Discriminate Ventricular 
From Supraventricular Rhythms? 
Amy Chang, Amin Al-Ahmad, Steve Nunley, Mark S. Link, Munther 
K. Homoud, Caroline B. Foote, Craig Swygman, Deborah Confalone, N.A. 
Mark Estes Ill, Paul J. Wang. New England Medical Cenfer, Boston, MA; 
CPI Guidanf, St. Paul, MN, USA 
Background: Algorithms using template-matching and electrogram width 
have been used for the analysis of the rate-sensing electrograms from im- 
plantable defibrillators (ICD). Very little work has been conducted to examine 
the suitability of the shock electrogram for distinguishing supraventricular 
rhythms from ventricular tachycardia. 
Methods: Stored ICD electrograms of ventricular tachycardia (VT) were 
retrieved and underwent signal processing using MATLAB’“. A sinus or VT 
beat was selected as a template for comparison with other identified beats. 
We used an automated correlation waveform analysis to compare the stored 
ICD ventricular shock electrogram during sinus rhythm and monomorphic VT 
in 15 patients. 
Results: The average correlation coefficient for sinus beats compared 
to a sinus template was 0.992 i 0.008. The average correlation coefficient 
between the sinus template beat and 10 VT beats was 0.786 f 0.011. For 
each patient the correlation coefficients for sinus vs. sinus beats and sinus 
vs. VT beats were statistically different (p < 0.0001). In addition, for each 
patient, the average correlation coefficient for sinus vs. VT beats was less 
than the lower confidence limit for the correlation coefficients of sinus vs. 
sinus beats. Thus, in all 15 patients, VT was correctly distinguished from 
sinus rhythm using correlation waveform analysis. 
Conclusions: Using correlation waveform analysis, the shock electro- 
gram may be able to discriminate supraventricular rhythms from VT. The 
shock electrogram may be particularly suited for this analysis because of its 
larger “field of view” compared to the rate electrogram. 
u 1119 99 Longevity of Newer Generation Implantable 
Cardioverter Defibrillators 
Antonis S. Manolis, Themos N. Maounis, Vassilis Vassilikos, 
John Chiladakis, Dennis V. Cokkinos. Onassis Cardiac Surgery Center, 
Athens; Patras University Patras, Greece 
Bckground: Manufacturers of newer generation implantable cardioverter 
defibrillator (ICD) devices promise a 4-7-year projected longevity. The aim 
of the present study was to assess the pulse generator longevity among 92 
consecutive patients (pts) who received an ICD over the last 4 years. 
Methods: The study included 85 men and.7 women, aged 58 i 15 years, 
who received a newer generation transvenous ICD under general (n = 40) 
or local (n = 52) anesthesia. The underlying disease was coronary artery 
disease (n = 58) valvular heart disease (n = 4), cardiomyopathy (n = 26) 
or electrical disease (n = 4). The mean left ventricular ejection fraction was 
35%, and pts presented with ventricular tachycardia (n = 72) or ventricular 
fibrillation (n = 17) or syncope (n = 3). 
Results: One (n = 76) or two (n = 10). ICD leads were implanted: 6 
pts received a dual-chamber ICD. The ICD devices were implanted in the 
abdomen (n = 17) or in the chest (n = 75). The defibrillation threshold was 
9.9 i 3.6 joules. Pacing and sensing thresholds averaged 0.7 f 0.8 V/14 + 
5 mV respectively. All ICDs were biphasic devices. Active or hot can devices 
were used in 69 pts. Over 4 years, ICD pulse generator replacement was 
performed in 14 patients (15%). These pts were 13 men and 1 woman, aged 
62 & 13 years, with a mean ejection fraction of 40 f 13%. The indication for 
ICD implantation was ventricular tachycardia (n = 9) ventricular fibrillation 
(n = 4), or syncope with inducible ventricular tachycardia (n = 1). The mean 
ICD device longevity in these 14 pts was 40 & 10 months. In 5 pts the ICD 
devices exhibited premature battery depletion within 19-36 months. All 14 
pts had minor or modest use of the ICD devise electrical therapy with shocks 
or antitachycardia pacing. 
Conclusion: Newer generation transvenous ICDs continue to have rela- 
tively limited longevity of 3.3 f 0.8 years. A considerable percentage (36%) 
of these newer generation ICD devices demonstrate premature, battery de- 
pletion by 3 years, thus falling short of the 3-year manufacturer’s warranty. 
These findings have important implications particularly in view of the high 
expense involved with this electrical therapy. 
I 1119 100 Optimization of kelationship Between Auxiliary 
and Primary Shock Waveforms in Dual Shock 
Defibrillation 
Robert G. Walker, Bruce H. KenKnight’, Raymond E. Ideker. University of 
Alabama at Birmingham, Birmingham, AL; ‘Guidant CRM, St. Paul, MN, 
USA 
Background: Recent work on dual shock defibrillation has shown that deliv- 
ery of a biphasic (61) auxiliary (AUX) shock to the weak-field area of the heart, 
just after a conventional endocardial shock (PRIM), can lower defibrillation 
thresholds (DFTs) as effectively as a monophasic (M) AUX delivered just 
before PRIM. Earlier studies have also suggested there may be a different 
mechanism of DFT reduction for BI AUX delivered after PRIM. Our objectives 
in this study were to investigate whether a BI AUX delivered after PRIM al- 
lows additional optimization of the AUX-PRIM relationship, and to determine 
whether delivery of both shocks from a single capacitor is as effective as a 
two capacitor configuration. 
Methods: In 6 pigs, DFTs were determined for PRIM shocks delivered 
through leads placed in the RV apex and SVC, followed by 4/3 ms BI AUX 
shocks delivered from a lateral LV epicardial line electrode to a catheter 
electrode in the left jugular vein. Three PRIM waveforms were tested: 4/3 ms 
BI, 4 ms M, and 7 ms M. AUX leading edge amplitude was adjusted to either 
the trailing edge amplitude of PRIM (to simulate a single capacitor) or 0.5 
times the trailing edge of PRIM. These configurations were compared to a 5 
ms M AUX followed by a 4/3 ms BI PRIM, tested at six AUX amplitudes (50, 
100, 150, 200, 250, and 300 Volts). The AUX-PRIM coupling interval was 
always 5 ms. 
Results: The mean control DFT (PRIM with no AUX) was 11.6 f 7.5 J. 
DFTs (total delivered energy AUX + PRIM) for the 12 configurations tested 
are shown in the table. AUWPRIM ratio = AUX leading edge/PRIM trailing 
edge voltage. 
PRIM followed by4/3 ms 81 AUX 
PRIM waveform 413 ms 61 4msM 7msM 
AUX/PRIM ratio 1 0.5 1 0.5 1 0.5 
DFT (J) 6.5i2.2 9.4zk3.7 5.71k22.4 9.244.0 7.9zk4.6 11.2h6.3 
5 ms M AUX followed by 4/3 ms BI PRIM 
AUX amplitude 5ov ioov 150v 2oov 250 V 3oov 
DFT (J) 11.7zk7.6 8.4f4.0 7.3i4.0 6.02~3.1 5.4i2.4 6.Oz!z22.5 
Conclusions: Dual shock defibrillation with M PRIM followed by BI AUX 
can be as effective as the optimum M AUX followed by BI PRIM, reducing 
delivered energy DFTs by approximately 50%. The ability to deliver PRIM 
and AUX from a single capacitor may enhance the clinical viability of dual 
shock defibrillation. 
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/ 1120-59 / Lateralization of Cortical Activity in Patients With 
Neurocardiogenic Syncope: Possible Etiology of 
Syncope 
Marco A. Mercader, Samuel J. Potolicchio, P. Jacob Varghese, 
Guha Venkatraman, Sung W. Lee. George Washington Universifx 
Washington, DC, USA 
Background: The mechanism of neurocardiogenic syncope (NCS) is thought 
to be the result of excitation of mechanoreceptors in the heart, stimulation 
of C fibers, and activation of autonomic nervous system. Previous studies 
have shown that ictal epileptiform activity in the left temporal lobe may result 
in bradycarclia and asystole. Therefore, we studied the cortical activity by 
computerized EEG during up-right tilt table tests. 
Methods: 12 patients underwent upright tilt table test for evaluation of 
syncope or near-syncope. Standard 70 degree tilt table test was done with 
ECG and EEG monitoring. EEG waveforms were analyzed using both visual 
inspection and spectral analysis. 
Results: The study population included six males and six females ranging 
in age from 17 to 66. 6112 patients (50%) had a positive tilt table test. Five 
of the six tilt positive patients (83%) had slow wave activity that lateralized 
to the left side of the brain, while none of the tilt negative patients exhibited 
iateralization. Spectral analysis revealed that the lateralization occurred in the 
delta frequency range. The lateralization preceded syncope or pre-syncope 
by I-1 9 seconds (7.0 i 5.7 set). Increase in left cortical activity coincided 
with the onset of bradycardia. The patient who did not show lateralization of 
cortical activity developed junctional rhythm at 40 minutes of tilt table test 
and slight decrease in blood pressure associated with pre-syncope. 
Conclusion: 1. Lateralization of cortical activity to the lefi side of the brain 
occurs before syncope. 2. Cortical activity may play a role in neurocardiogenic 
syncope. 3. EEG findings may help in diagnosis of neurocardiogenic syncope. 
I 1120 60 Randomized, Placebo-Controlled Trial of Fludrocortisone to Treat Neurally Mediated 
Hypotension in Chronic Fatigue Syndrome 
Peter C. Rowe, Hugh Calkins, Karen DeBusk, Sally Snader, Katherine 
E. Lucas, Ravinder Anand, Robin McKenzie, Geetika Sharma, Brenda 
A. Cuccherini, Norberto Soto, Patricia Hohman, Mark Wolff: Stephen 
E. Straus. Johns Hopkins Medical Institutions, Baltimore, MD; Laboratory of 
Clinical Investigation, N/A/D, N/H, Bethesda, MD, USA 
Background: Patients with chronic fatigue syndrome (CFS) are more likely 
than controls to develop neurally mediated hypotension (NMH) during tilttable 
testing. This trial examined the efficacy of fludrocortisone as monotherapy 
for adults with both CFS and NMH. 
Methods: Individuals aged 18 to 50 years who satisfied the 1994 CDC 
criteria for CFS and had NMH provoked during a Z-stage tilt test were 
randomly assigned to receive fludrocortisone 0.1 mg/day or placebo for 9 
weeks. The primary outcome was the proportion with a 15 point improvement 
on a 100 point global Wellness score. 
Results: Of 171 potentially eligible subjects, 106 (62%) had hypotension 
provoked during the tilt test, 6 of whom were excluded before randomization 
into two groups of 50 patients each. Baseline demographic and illness char- 
acteristics between the groups were similar; CFS had been present for at 
least 3 years in 71%. The treatment was well tolerated. Of those treated with 
fludrocortisone, 7150 (14%) experienced at least a 15 point improvement in 
their Wellness scores, compared to 5/50 (10%) in the placebo arm. There 
were no differences in several other symptom scores or in the proportion 
who remained normotensive during the follow-up tilt test at the end of the 
treatment period. 
Conclusions: As monotherapy for NMH, in adults with CFS, fludrocorti- 
sone was no more efficacious than placebo for the amelioration of symptoms. 
Further studies will be needed to determine if other medications or combi- 
nation therapy will be effective in treating the orihostatic intolerance in this 
population. 
ELI II 20 61 Use of an Implantable Loop Recorder in Patients With Recurrent Syncope of Unknown Origin is a 
Cost Effective Diagnostic Strategy 
Hugh Calkins, Andrew Krahn, Brian Olshansky, Peter Zimetbaum, 
Win Shen, Paige Bingham, Greg Bell. The Johns Hopkins Medical 
Institution, Baltimore, MD, USA 
Background: Implantable loop recorders (ILR, Medtronic, Reveal) have 
recently become available for use in the evaluation of patients with recurrent 
syncope of unknown origin. The purpose of this study was to t evaluate 
the cost-effectiveness of the Reveal monitor by comparing the cost and 
diagnostic yield of a conventional diagnostic evaluation practice with those 
of the Reveal ILR. 
Methods: The type and frequency of tests used in the current diagnostic 
approach were obtained from the HCIA claims data base. All the costs were 
obtained from the Medicare Fee Schedule. 
Results: Over the 14 month period, the cost of Reveal approach was 
significantly greater than that of a conventional evaluation whether a cardiac 
cause was suspected ($3,844 versus $1,097) or not ($3,733 versus $144). 
In order to evaluate cost effectiveness, differences in the diagnostic yields 
of the two strategies were also considered. Based on the frequency of 
use of diagnostic tests in the HCIA data base and the published yield of 
these diagnostic tests, the yield of a conventional diagnostic evaluation was 
calculated to be 4.3% and 2.8% per event (excluding the first event) for 
those with and without a suspected cardiac cause. The yield of Reveal was 
calculated to be 86% per event. For Reveal, the costs per diagnosis over 
a 14-month period were $6,138 and ‘$10,650 for those with and without 
suspected cardiac cause. For the standard practice, the costs per diagnosis 
over a 1Cmonth period were $23,195 and $10,529 respectively. 
Conclusion: Placement of an implantable Holter monitor in a patients 
with recurrent syncope of known origin appears to a cost effective diagnostic 
strategy. 
/ 1120-62 1 Transcranial Doppler, Near-Infrared Spectroscopy 
are Useful Techniques for Diagnosis of 
Cardiogenic Syncope 
lgor Singer, Harvey L. Edmonds Jr., Aida Sehic, Lisa Hatter. Universify of 
Louisville, Louisville, Kentuc& USA 
Background: Physiology of syncope is poorly understood despite the routine 
use of tilt table testing (T). To better understand the underlying mechanisms 
of syncope, we utilized simultaneous measurements of extracranial Doppler 
ultrasound of carotid artery, transcranial near-infrared spectroscopy, and the 
EEG bispectral index (BIS) during the standard upright T. 
Methods: Ten patients, age 15-59, 3 females and 7 males, underwent 
tilt table testing to 70” for 30 min because of symptoms of near syncope or 
syncope. Middle cerebral artery blood flow was measured with transcranial 
Doppler ultrasound and Pourcelet’s vascular resistance index or RI (systolic 
- diastolic/systolic velocity) was calculated. Transcranial near-infrared spec- 
troscopy (NIS) determined change in the cerebral hemoglobin as an indicator 
of blood volume. BIS objectively documented the time course of episodes of 
unconsciousness (BIS < 85). 
Results: 
(All results are expressed as % of supine baseline measurement) 
SBP DBP HR SV DV NIS Head Hab RI BIS 
Syncope (n = 3) 
Mean 53 71 22 56 28 64 113 217 Pm 
SD 2 11 38 49 28 9 3 95 
No Syncope (n = 7) 
Mean 95 110 123 93 109 95 a3 89 Neg 
SD 2 17 20 29 49 7 67 20 
P= 0.0001 0.006 0.0001 0.16 0.03 0.0001 0.48 0.007 
SBP = systolic blood pressure, DBP = diastolic blood pressure, HR = heart rate, SV = 
systolic velocity, DV = diastolic velocity 
Conclusions: Patients with true cardiogenic syncope are characterized 
by a significant fall in SBP and DBP, HR deceleration, accompanied by 
corresponding SV and DV decrease and a significant fall in NIS with an 
increase in RI. These results suggest a significant decrease in cerebral blood 
flow and cerebral oxygen saturation during cardiogenic syncope preceding 
objective documentation of neuronal dysfunction. 
130A ABSTRACTS -Cardiac Arrhythmias JACC February 2000 
ORAL 
(8571 Atrial Fibrillation/Flutter: Noninvasive Risk 
Assessment 
Monday, March 13, 2000, 4:00 p.m.-.930 p.m. 
Anaheim Convention Center, Room 304C 
4:00 p.m. 
El 857 1 Progressive Deterioration of Atrial Electrical Function Prior to Flutter in Grown Up Congenital 
Heart Patients 
Wei Li, Michael Y. Henein, Han B. Xiao, Jane Somerville, Derek Gibson. 
Royal Brompton Hospital, London, UK 
Atrial flutter (AFL) is the commonest arrhythmia in grown up congenital heart 
patients and often results in significant deterioration of symptoms. To assess 
ECG changes that may indicate progressive atrial or ventricular dysfunction 
and hence result in atrial AFL we studied 39 patients with AFL, age 36 
+ 11 years, 25 males, and compared them with 23 age and diagnosis 
matched controls without AFL. 3 consecutive annual 12 lead ECGs were 
retrospectively analysed in each group, the last was 0.8 + 0.6 year before 
development of AFL. 
Results: 
Variables 
P duration (ms) 
3 year prior to AFL 
2 year 
1 year 
P voltage (mv) 
3 year prior to AFL 
2 year 
1 year 
AFL (N = 39). No AFL (N = 23) 
103zt24 ’ 101 * 17 
115*24 102117 
126 * 24 105114 
1.9Ito.9 1.5zkOo.6 
i.a* 1.0 1.4 * 0.6 
1.5 i 0.9 1.4 z!z 0.7 
P value 
NS 
<O.Ol 
<O.OOl 
<0.05 
NS 
NS 
Only in patients with flutter P wave duration increased by 11 ms and its 
voltage fell by 0.16 mv each year. QRS duration did not change over the 
course of the 3 years in both groups. 
Conclusion: These findings demonstrate persistent intra-atrial conduc- 
tion delay and impairment of atrial activity shown by progressive broadening 
of P wave duration and fall of amplitude in patients developing flutter. This 
marker may help in identifying patients at high risk of atrial flutter who might 
benefit from early prophylactic antiarrhythniic therapy. 
4:15 p.m. 
Erl 8.57 2 Electrocardiographic Events Preceding the Onset of Atrial Fibrillation: Insights Gained Using an 
Implantable Loop Recorder 
David S. Schwartzman’, Mark L. Browns, Stephanie M. Fittsz. ‘Universify of 
Pittsburgh Medical Center, Pittsburgh, PA; “Medtronic Inc., USA 
Background: It has been hypothesized that optimal therapy for atrial fibrilla- 
tion (AF) patients may be stratified based on the cardiac rhythm immediately 
preceding the onset of AF. 
Objective: To estimate the relative frequency of different kinds of car- 
diac rhythm immediately preceding AF, and to estimate the prevalence of a 
dominant cardiac rhythm preceding AF. 
Methods: A subcutaneously implanted loop recorder (RevealTM) was 
used to capture the electrocardiographic (ECG) events preceding the onset 
of AF paroxysms in 27 pts (22 men; age 36-75 years; structural heart disease 
in 9 pts; sinus node dysfunction in 12 pts). Eighteen pts were taking a type 
I or Ill antiarrhythmic drug; 9 pts a beta blocker. Each patient was followed 
for at least one mo (range 1-11 mo; mean 4.7 f 2.5 mo). Patients activated 
the device when they felt the onset of AF. The device was programmed to 
retain the entire ECG for 6 minutes prior to activation. For inclusion in this 
study, a stored ECG had to have: 1, AF onset included; 2. >8 consecutive 
measurable RR intervals immediately preceding AF onset; and 3. freedom 
from noise. A Holter monitor was performed and the mean sinus rate was 
defined as the basal heart rate (BHR), against which the hear-l rates on the 
ECGs were interpreted: tachycardia was defined as rate > 1 OO/min, relative 
tachycardia was defined at >120% of BHR, and bradycardia was defined as 
<50/min. 
Results: 26 patients have activated the device thus far. In 20 of these 
patients, some or all of the ECG acquisitions included the onset of AF. A 
total of 281 AF onset ECGs were available for analysis; of these, 94 onset 
ECGs met inclusion criteria. Atrial premature beats were demonstrated to be 
associated with AF onset in all ECGs. A short-long-short initiating sequence 
was observed in 17 ECGs (8 pts). Sinus tachycardia was observed in 7 ECGs 
(3 pts); relative sinus tachycardia in 6 ECGs (2 pts), and sinus bradycardia 
in 6 ECGs (2 pts). Of the 18 pts with 12 onset ECGs, a consistent AF onset 
sequence was observed in only 4 pts. 
Conclusions: Knowledge of ECG events preceding AF onset may have 
utility in helping to tailor AF treatment. 
4:30 p.m. 
El 857 3 Natural Course or Technical Error? Assessment of Day-to-Day Variability of Atrial Signal Averaged 
Electrocardiogram in Healthy Subjects 
lrina Savelieva, Kudret Aytemir, Qiuzhen Xue’, A. John Camm, 
Marek Malik. St. George’s Hospital Medical School, London, UK; 
‘Marquette Medical Systems, Milwaukee, WI, USA 
Background: Although atrial signal averaged electrocardiogram (SAECG) 
allows to identify patients prone to atrial tachyanthythmias, its relevance for 
monitoring purposes has not yet been established. The aim of the study was 
to assess day-to-day variability of atrial SAECG in 51 healthy subjects (30 
men; age 32 + 8 years). 
Methods: In each subject, atrial SAECGs were recorded and processed 
by PHiRES (Marquette Medical Systems) at 5 min, the following day, 1 week 
and 1 month. Automatically detected onset and offset of the filtered P wave 
were reanalyzed by 2 independent observers, and the averaged values of 
the 6 SAECG parameters were calculated: total filtered P wave duration 
(Pr,,), root mean square (RMS) voltage of the terminal 20, 30, 40 ms and of 
the entire Pr,, (RMS-Ps,-,, RMS-Pss, RMS-P4s, RMS-P), and P wave integral 
(P-lnt). Relative errors (RE) of different pairs of measures were used to 
assess the intrasubject variability. 
Results: The immediate and day-to-day variability of Pr,r was very low, 
with RE 1.3%, 2.7%, 2.9%, 4.2% at 5 min, 1 day, 1 week, 1 month, respectively 
(p < 0.0001 between RE at 5 min and delayed recordings; p i 0.05 between 
delayed recordings). The voltage parameters of atrial SAECG and P-int were 
highly variable, with RE exceeding 10% in the immediate and l&20% in 
delayed recordings (Figure; asterisks = RE at 5 min; open circles = RE at 1 
day; closed circles = RE at 1 week; cross-lines = RE at 1 month). 
PCO, RMS-PI0 RMS-Pm RMS-PZO RMS-P P ,nt 
Conclusion: (1) The filtered P wave duration is the only reliable param- 
eter of atrial SAECG with low variability as assessed in the immediate and 
long-term recordings in healthy subjects; (2) an extremely high variability 
of the voltage parameters in both the immediate and delayed recordings is 
likely caused by poor signal-to-noise ratio of P wave; (3) P wave duration but 
not the voltage parameters of atrial SAECG can be used for diagnostic and 
monitoring purposes in cardiac patients. 
4:45 txm. 
El 857 4 Atrial Signal Averaged Electrocardiogram Does Not 
Depend on Age, Gender and Heart Rate 
Kudret Aytemir, lrina Savelieva, Marek Malik. St. George’s Hospital Medical 
School, London, UK 
Background: Age- and gender-specific differences have been recognized 
for ventricular signal averaged electrocardiogram (SAECG). Little data are 
available on this issue with regard to atrial SAECG. 
Methods: The effects of age, gender, heart rate, and standard electrocar- 
diographic measures on atrial SAECG were assessed in 51 healthy subjects 
(32 & 8, range 19-55; 31 men). Six atrial SAECG parameters were obtained 
using PHiRES software (Marquette Medical Systems): total filtered P wave 
duration (Pr,r), root mean square (RMS) voltages of the terminal 20, 30, 40 
ms and of the entire Pr,r (RMS-Pzs, RMS-Pss, RMS-P40, RMS-P), and P 
wave integral (P-lnt). 
Results: (1) Although unfiltered P wave duration and PR interval differed 
significantly in men and women (116 i 13 ms vs 109 f 15 ms, 152 f 19 vs 
Men Women D 
hot I+ 123.7 ~6 7.2 121.5 zk 10.8 0.42 
RMS-PdO [uV] 6.1 zk 2.3 6.2 + 1.9 ho.80 
RMS-Pso [uv] 5.0 ?c 1.7 4.9i 1.9 0.93 
RMS-Pzo [uV] 4.9i 1.7 4.6 * 1.9 0.89 
RMS-P [uV] 8.2 i 2.1 6.4zk 1.6 0.66 
P-Id [UVS] 768 5 181 770 * 166 0.94 
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145 f 16 ms, p < 0.004), no gender-related difference was observed for Pr,: 
or the voltage SAECG parameters (table, mean i SD). (2) Atrial SAECG did 
not depend on age or heart rate (r = 0.095-0.14, p = ns). (3) No systematic 
relation was found between Ptot and RMS voltages. (4) Pr,, correlated with 
unfiltered P wave duration and PR interval in women (r = 0.65 and 0.54, p < 
0.0001) but not in men (I = 0.34 and 0.12, p = ns). 
Conclusion: In subjects under 55 years, atrial SAECG does not depend 
on age. Despite the absence of gender-specific difference for the mean 
absolute values of atrial SAECG, women have a significantly stronger relation 
between SAECG and standard ECG measures. 
500 p.m. 
/ 857 5 P Wave Signal Averaged ECG Criteria in Predicting 
Early Recurrence of Atrial Fibrillation: A Prospective 
Study 
Xiao Hua Guo, Yee Guan Yap, Mark M. Gallagher, Lisa Luddington, A. 
John Camm, Marek Malik. St George’s Hospital Medical School London, UK 
Background: P wave signal-averaged ECG (P-SAECG) has been used to 
predict early recurrence of atrial fibrillation (AF) after Direct Current Car- 
dioversion (DCC) but the optimum criteria have not been determined. We 
investigated these using a new filter technique. 
Methods: P-SAECG were recorded 1 hr after DCC in 62 patients (pts) 
suffered persistent AF (30 M, 66 f 10 ys) using a P wave-triggered Fast 
Fourier Transformation (FFT) filter technique (40-250 Hz) (Marquette P Hi- 
Res). Noise level was 0.4 i 0.1 PV. The filtered P wave duration (PD) and 
RiMS voltage of the last 20 ms (RMS20) of P wave were evaluated. Four 
criteria were proposed for classifying a P-SAECG as positive: 1. Prolonged 
PD greater than the gender specific median value only (M p 153 ms: F 2 
151 ms). 2. Reduced RMSZO only (M 2 4 mV; F 2 3 mV). 3, Either 1 or 2 
positive. 4. Both 1 and 2 positive. All Patients were assessed 7 days after 
DCC and divided into 2 groups: Sinus Rhythm (SR) (n = 45, 73%) and Earn 
recurrent AF (R-AF) (n = 17, 27%). ,$ and multivariate analysis were used. 
Results: There was no significant difference in Age, LA size, duration of 
AF between SR and R-AF groups. Among above 3 clinic variables, criterion 
4 was the only independent predictor of AF recurrence by 1 week (P = 0.042) 
and was significantly more common in R-AF group than in SR group (table). 
Follow UD 1. Prolonaed PD 2. Reduced RMS20 3. Either 1 or 2 4. Both l&2 
SR pts (%) 20 (44) 25 (56) 31 (69) 12 (27) 
R-AF Pts (%) 12 (71) 11 (65) 13 (77) 10 (59) 
P value 0.066 0.515 0.557 0.018 
Conclusion: The combination of prolonged PD and reduced RMS20, 
using FFT filter in P-SAECG, was predictive of early recurrence of AF after 
DCC. 
5:15 D.m. 
857-6 The Frequency Analysis of the Signal-Averaged ECG 
of the P Wave is a Good Predictor of the Efficacv of 
Class ill Antiarrhythmic Drugs to Maintain the Skws 
Rhythm in Patients With Recurrent Idiopathic Atrial 
Fibrillation 
Eduardo C. Barbosa, Pat.110 Roberto B. Barbosa, Paula Ginefra, Francisco 
M. Albanesi F.. Univ. do Esfado do Rio de Janeiro, Rio de Janeiro, Brazil 
Background: The ACUTE registry demonstrated that the use of class Ill 
antiarrhythmic drags (ADIII) was a good predictor of sinus rhythm in patients 
(pts) post-cardioversion from atrial fibrillation in previous study we demon- 
strated that fragmented atrial potentials (FAP) detected by the frequency 
domain analysis of the signal-averaged ECG (FDSAECG) of the P wave 
were able to identify pts at risk for lone atrial fibrillation. The aim of this study 
was to assess the FDSAECG in predicting recurrence of idiopathic persistent 
atrial fibrillation (IPAF) in pts under ADIII therapy. 
Methods: In 33 pts with 2 or more previous symptomatic episodes of 
IPAF, despite of antiarrhythmic class I or II therapy, the FDSAECG of the P 
wave was performed after conversion to sinus rhythm and free-drug state. 
The following parameters were analyzed: The mean (MET) and the standard 
deviation (SEC) of the frequency intersegmentar spectral correlation and the 
standard deviation (SET) of signal energy frequency edge track. During a 
follow-up of 38 + 8 months, all pts received ADIII (amiodarone, 200 mg to 
400 mg qd - 22 cases, and sotalol, 80 to 160 mg bid - 11 cases). 
Results: During the follow-up, the pts were divided into two groups: Group 
I comprised of those with frequent recurrence of AF, defined as 3 or more 
events per year (16 pts, mean f SD 4.6 & 1.2 events/year), and Group II 
composed by those with frequent recurrence of AF, with less than 3 events 
per year (17 pts. mean -+ SD 1.5 i 0.6 events/year). MEC, SEC and SET for 
groups and II were as follows: 
MET 
SEC 
SET 
Group 1 
73.4 i 8.9 
38.4 z!z 11.8 
72.6 zt 14.6 
Group 2 
84.3 + 3.8 
26.8 i 8.3 
66.7 i 20.3 
P 
0.04 
0.002 
NS 
With cutoff point of MEC < 78. SEC > 32 and SET > 75. FAP defined 
by the presence of at least two abnormal criteria was observed in 12116 
pts group I and in 3/17 pts group II (p = 0.0009). Sensitivity, specificity and 
positive and negative predictive values of FAP for frequent recurrence of 
IPAF were 75%, 82%, 80% and 78% respectively. 
Conclusions: The results suggested that FD analysis of SAECG P wave 
accurately predicted pts whose ADIll therapy will be effective in maintaining 
the sinus rhythm without frequent recurrence of IPAF. (State Government 
financial support). 
ORAL 
El 866 Atrial Fibrillation: Pathophysiology 
Tuesday, March 14, 2000, 8:30 a.m.-l 0:OO a.m. 
Anaheim Convention Center, Room 304C 
8:30 a.m. 
El 866 1 Characterization of Pulmonary Vein Anatomy and 
Physiology in Patients With and Without Atrial 
Fibrillation 
Douglas L. Packer, Carolyn L. Stevens, Thomas M. Munger, Dale Bergman. 
Mayo Foundation, Rochester, MN, USA 
Background: Understanding the characteristic architecture, location and 
dimensions of the pulmonary veins (PV) is of critical importance for char- 
acterizing the mechanisms underlying atrial fibrillation (AF) and developing 
treatment strategies for its elimination. 
Methods: Therefore, PV anatomy was examined by longitudinal, 5.5-l 0.0 
MHz phased-array, intracardiac ultrasound in 21 pts undergoing EP studies. 
8 had underlying heart disease, 7 had atrial enlargement, and 8 had prior AF. 
PVs were characterized with the imaging catheter positioned in the RA. 
Results: The orifices of the left superior and inferior PVs were separated 
by 4-7 mm in 19, were contiguous in 2 pts, and emptied into a common 
antrum in 3. The right superior (S) and inferior (I) PVs were separated by 
3.8-7.7 mm in 20 pts, contiguous in I, and entered into a common antrum 
in 3. The RSPV diameter was 16 f 2 mm, RIPV 15 + 2 mm, LSPV 13 i 
3 mm, and LIPV was 14 i 2 mm. Peak velocities of all normal PVs ranged 
between 0.19 and 0.99 misec with no significant difference between veins. 
The left PVs in 4 pts with chronic AF were significantly larger than those 
without AF: LSPV = 15.3 f 1.7 mm vs 12.4 * 2.8 mm (p = 0.03) and LIPV 
= 16.1 Z!Z 0.9 mm vs 13.0 i 1.9 (p < 0.001). The RSPV diameter of 17.5 
ZIZ 1.5 mm was also larger than the 15.4 f 1.7 mm diameter in pts without 
AF (p = 0.06). The LSPV velocity was also significantly less in pts with than 
without chronic AF (0.33 i 0.06 vs 0.48 f 0.12) (p = 0.02). There was no 
difference in other vein diameters, velocities, vessel separation or left atrial 
size. PV size in 3 pts with paroxysmal AF was not different than those without 
arrhythmias. 
Conclusions: This information provides a characterization of PV posi- 
tioning, relationships, and size in pts undergoing EP evaluatron. The larger 
PV size in pts with chronic AF in the absence of differences in left atrial 
size suggests a contributing role in this arrhythmia. This information may be 
useful in conceptualizing PV anatomy, understanding the mechanism of AF 
and developing ablation strategies. 
8:45 a.m. 
866-2 Is Atrial Fibrillation a Heritable Disorder? Insights 
From the Framingham Study 
Emelia J. Benjamin, Martin G. Larson, Philip A. Wolf, Jane C. Evans, 
William B. Kannel, Ralph B. D’Agostino, Daniel Levy. The National Heart 
Lung and Blood Institute’s Framingham Study, MA, USA 
Background: Sporadic reports have identified families wherein multiple 
members have developed atrial fibrillation (AF); one study reported genetic 
linkage of AF to the q22-q24 region on chromosome IO. The extent of ge- 
netic predisposition to AF remains unknown, We examined the heritability of 
AF in participants in the Framingham Heart Study. 
Methods: Among 1028 AF cases, 880 occurred within nuclear families. 
To assess familial correlations (parent-offspring, sibling, and spousal corre- 
lations) we used generalized estimating equations in the setting of logistic 
regression. We modeled the probability of AF according to sex, age, cohort, 
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as well as hypertension, diabetes, valvular heart disease, heart failure and 
myocardial infarction. Subsequently, we estimated the heritability of AF. 
Results: The familial correlations are displayed below. We estimated 
the heritability of AF as (0.0688 + 0.0605)*(1 + 0.0184)/(1 + 0.0184 + 
2*0.0184*0.0605) = 0.13. 
# Pairs # AF* correlation 
Parent-Offspring 6122 599 0.0605 
Sibling-Sibling 4501 317 0.0688 
Spouse-spouse 3373 669 0.0164 
*AF cases within type of relative pair add to more than 680 because some subjects 
contributed to more than one type of pair. 
Conclusion: While familial AF is well described, our data suggest that in 
the community AF has demonstrable but minor heritability after adjusting for 
age, sex and clinical risk factors. 
9:00 a.m. 
866-3 New Onset Atrial Fibrillation: Gender Differences in 
Presentation, Outcome, and Treatment 
K.H. Humphries, CR. Kerr, S.J. Connolly, G. Klein, J. Boone, M. Green, 
Ft. Sheldon, M. Talajic, P. Dorian, J.J. Spinelli. University of British 
Columbia, Vancouver, EC, Canada 
Background: The Canadian Registry of Atrial Fibrillation (CARAF) enrolled 
a representative cohort of patients at time of first ECG diagnosis of atrial 
fibrillation (AF). Presentation, outcome, and anti-thrombotic (AT) use were 
evaluated for gender differences. 
Methods: Patients were followed annually without intervention by CARAF 
investigators. 899 patients (62% male), with mean follow-up of 4.2 years, 
were available for evaluation. Cox proportional hazards analysis was used 
to assess risk of bleeding. 
Results: Significant differences between women and men were noted for 
several baseline characteristics: 
Variable 
age at presentation (mean (SE)) 
asvmptomatic AF f%) 
Women Me” ‘P’ 
65.4 (0.66) 60.5 (0.61) <O.OOi 
14.8 26.2 <O.OOi 
Hi&bypass surge; (%) 3.0 7.7 0.004 
Hx of MI (%) 10.4 21.7 <O.OOl 
Hvpertension (%) 49.1 33.5 <O.OOl 
Hyof hyperth$kfism (%) 4.4 2.0 0.033 
At 3 months, women had more frequent recurrent paroxysmal AF than 
men (37.3% vs 24.2% p < O.OOl), but progression to permanent AF was 
identical (21 .l%) and mean time to progression was similar (1090 days 0, 
1136 days d, p = 0.35). Prevalence of AT use (63.7%) was the same, but 
the choice of AT therapy varied significantly by gender and age (p(lnteraction) 
= 0.04). Older women (275 years) were 54% less likely to receive warfarin, 
but twice as likely to receive ASA than older men. Risk of major bleed varied 
by gender and warfarin use (p(rnteracrion) = 0.02). Women on warfarin had 
144% greater risk of major bleed than men did (Q-7.5%, g-2.3%). Mean 
INRs at time of bleed were high, but the difference (P -3.94, d-3.16) was not 
significant. 
Conclusion: Women z 75 years are less likely to receive warfarin than 
men of similar age, but regardless of age, women receiving watfarin are more 
likely to have a significant bleed. 
9:15 a.m. 
1866-4 1 Myocardial Connections Between the Left Atrium 
and the Coronary Sinus Musculature in Man 
Atsunobu Kasa’i, Frederic Anselme, Alain Cribier, Nadir Saoudi. /Spita/ 
Charles Nicolle, Rouen, France 
Anatomic studies have shown that muscle morphologically identical to that 
of the atrial myocardium consistently surrounds the coronary sinus (CS) 
and that the CS musculature (M) is connected to that of the left atrial (LA) 
myocardium in the proximal portion of the CS and inconstantly in its distal 
portion. We attempted to document the electrophysiological findings of distal 
connection between LA and CSM in man. 
Methods: Seventeen patients (pts, 11 males) mean aged 50.4 years 
underwent an electrophysiological study during which a decapolar catheter 
with 2 mm interelectrode spacing every 7 mm was inserted to coronary 
sinus (CS) with proximal electrode pair positioned at the ostium Associated 
A arrhythmias were paroxysmal A fibrillation (AF; n = 5), A flutter (FI; n = 6)) 
and other (n = 6). Baseline Si and one extrastimulus (ES) were delivered 
during distal CS pacing while recordings were obtained from the 4 remaining 
bipoles. 
Results: 1) Double potentials (DP) with progressive interpotential sep- 
aration from PCS to DCS as a function of the DCS AES prematurity were 
detected in 4 pts (23%) suggesting block in a direct local pathway distally 
connecting the CS to the LA and leading to reversion of lower LA activation. 
Local delay in this pathway without complete CS-LA block with resulting LA 
activation fusion was observed in 4 other cases. Separated DP were more 
often found in pts with AF/AFI (7/8 vs. l/Q, p < 0.01). Increased age was not 
associated with presence of DP. 
Conclusion: The ability to dissociate LA from CS suggests the presence 
of discrete connections between these structures in man. Their presence 
was frequently associated with the clinical occurrence of AF or AFI. 
9:30 a.m. 
El 866 5 Time Course of Atrial Electrical Remodeling After Conversion of Chronic Atrial Fibrillation: Is It 
Related With Recurrence? 
Emmanuel G. Manios, Emmanuel M. Kanoupakis, Michail D. Kaleboubas, 
Magdalini K. Zeaki, Hercules E. Mavrakis, Panagiotis E. Vardas. Cardiology 
Dept., Heralclion University Hospital, Heraklion, Crete, Greece 
Background: The time course of atrial electrical remodeling and its relation 
to recurrence in postconversion chronic atrial fibrillation (CAF) patients have 
not been adequately studied. 
Methods: In 22 drug free, CAF patients electrically converted to sinus 
rhythm, effective refractory period (ERP) at 500 ms, monophasic action 
potential at 90% of repolarization (MAPdQO) at five cycle lengths (CL, 350, 
400, 450, 500, 600 ms), and P wave duration were measured three times: 
within 20 min post-conversion, 24 hours and one month later. Ten subjects 
with no history of AF and normal atrial structure served as a control group. 
Patients were followed up for recurrence for one month; ten relapsed. 
Results: ERP increased from 202 & 22 to 245 i 32 to 246 f 27 ms (p 
< O.OOi), attaining a level comparable to controls (239 & 23 ms) within 24 
h. MAPdQO significantly (p < 0.001) increased (from 182 + 17 to 197 * 21 
to190f12msatCL350msand208rt22to234~22to233~21msat 
CL 600 ms) also reaching control levels within 24 h. MAPdQO exhibited an 
abnormal adaptation to rate only in the first evaluation. P wave duration was 
prolonged (144 & 40 ms) and exhibited a slower course of shortening (128 i. 
34 to 122 f 27 ms, p < 0.001). Patients with higher value of MAPdQO in the 
immediate post conversion period were more likely to relapse (p = 0.0002). 
Conclusions: ERP and repolarization shortening as a result of CAF are 
reversed within 24 h after conversion, while P wave duration reduces more 
slowly. Post-conversion MAPdQO values contain prognostic information for 
recurrence. 
9:45 a.m. 
866-6 Electrophysiological Mapping and Histological 
Examinations of the Swine Atrium With Sustained 
Atrial Fibrillation - A Suitable Animal Model for 
Studying Human Atrial Fibrillation 
Jiunn-Lee Lin, Shoei K. Stephen Huang, Ling-Ping Lai, Jyh-Shen Lin, 
Shih-Ping Chen. National Taiwan University Hospital, Taipei, Taiwan 
Background: An animal model of sustained atrial fibrillation (AF) closely 
mimic human AF is needed for studying the electrophysiologic mechanisms 
and for developing the therapeutic technique. 
Methods: Sixteen adult Yorshire-Landrace pigs weighing 74 f 14 kg 
were studied. Each pig received a high-rate atrial pacing (600 ppm) from the 
high RA via an implanted pacemaker (ltrel-II) for 6 weeks. 
Results: Within the 6-week pacing period, 14 pigs developed sustained 
AF (23 days) after discontinuing atrial pacing and prior to sacrifice. The 
remaining 2 pigs died of congestive heart failure and acute volvulus respec- 
tively. Compared to the baseline, there were significant increases in the 
echocardiographic dimensions of the LA, the LV end-systole and end-dias- 
tole prior to killing (26 i 4 mm, 28 f 5 mm, and 45 * 6 mm vs. 36 f 5 mm, 
34 i 4 mm, and 54 i 6 mm, all p < 0.01). The LV fractional shortening didn’t 
change (37 i 5% vs. 35 f 4%, p > 0.05). The heat-l weighed 460 f 12 gm. 
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Epicardial 224-bipole plaque mapping (3.5 mm inter electrode distance) in 
8 pigs revealed simultaneous presence of 4 + 1 reentrant wavelets at the 
right atrial free wall (RAFW) and 6 & 2 wavelets at the LA free wall (LAFW). 
The mean fibrillatory A-A interval was 180 i 11 ms in the RAFW, and 172 
f 6 ms in the LAFW. DL-sotalol (1.5 mg/kg, iv) couldn’t terminate AF in any 
of the 6 tested pigs. Electron microscopic examination of the LA tissue in 
4 pigs revealed disruption of myofibrils and Z-band crowding in a scattering 
pattern, and prominent mitochondrial compensatory overproliferation with 
mixed emptying or lysis. 
Conclusions: This study has demonstrated a suitable animal model of 
sustained AF in adult pigs for studying human AF. The electrophysiological 
and pathological findings of the atrium showed the characteristics resembling 
those in humans. 
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L--L 1140 6/ New Electrophysiological Finding Favouring the 
Existence of a Distal Common Pathway in 
Atrioventricular Nodal Reentrant Tachycardias 
Jesus D. Martinez-Alday, Jose M. Ormaetxe, Maria F. Arkotxa. i-lospital de 
Basurto, Bilbao, Spain 
Background and Hypothesis: The presence of a proximal common path- 
way (CP) in AVNRT is controversial; however the existence of distal CP 
(DCP) is more accepted. We proposed a new electrophysiological finding to 
study the DCP based in the two following assumptions: 1) If there is not a 
DCP interpose between the tachycardia circuit and the His bundle, during 
ventricular entrainment (VE) of the tachycardia the first beat that capture the 
His bundle necessarily must be the first beat in advance the atrium; On the 
contrary, if there is a DCP the first beat that captures the His will not advances 
the atrium due to collision in DCP and 2) Because of, during VE is almost 
impossible to discern the His electrogram it was assumed that the His bundle 
is captured when the QRS paced morphology during VE is identical to the 
QRS paced morphology during sinus rhythm. In other words, we compared 
during VE the beat number in which the morphology of QRS is totally paced 
with the beat number that advance the atrium. 
Material and Methods: We studied 18 p (14 F/4 M) with AVNRT and 
tachycardia cycle length (TCL) of 370 * 52 ms. The AVNRT was entrained 
with a paced train of 10 to 40 ms under TCL. A train in sinus rhythm was 
delivered at TCL to compared QRS morphology. Faster trains were delivered 
to study the influence of pacing CL. 
f&A 
Results: In all patients but one the reset of the atrial electrogram (at mean 
beat of 5.6 f 1.5) was always preceded by the capture of the His bundle (at 
mean beat of 3.6 i 1.2). This result was critically dependent of the pacing 
rate during VE, (i.e. faster trains could jump the supposed DCP in only one 
beat) 
In conclusion: This study adds a new electrophysiological finding sup- 
porting the idea of the presence of a DCP in AVNRT. 
/ 1140-68 / Initial Experience With Subthreshold Stimulation 
at Target Sites for Slow Pathway Ablation in 
Uncommon Atrioventricular Nodal Reentrant 
Tachycardia 
Stephan Willems, Christian Weiss, Matthias Hoffmann, Rudolf Riippel, 
Rudolf0 Ventura, Thomas Meinertz. University Hospital fppendorf 
Hamburg, Germany 
Background: Subthreshold stimulation (STS) applied during atrioventricular 
nodal reentrant tachycardia (AVNRT) of the common (“slow-fast”) type has 
been shown to effectively characterize target sites suitable for slow pathway 
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(SP) ablation. The present study sought to investigate the impact of STS in 
the uncommon variants of AVNRT. 
Methods and Results: 11 consecutive pts. with sustained uncommon 
type AVNRT (“fast-slow”: n = 8, “slow-slow”: n = 3) were prospectively 
investigated. Uncommon AVNRT with a mean cycle length of 357 f 51 
msec was reproducibly induced without spontaneous termination in all pts. 
Mapping of the SP during sinus rhythm was started posteroseptally close 
to the coronary sinus OS and continued to more midseptal sites, if required. 
Criteria for selection of target sites for STS and radiofrequency current (RF) 
ablation included recording of fractionated atrial activation with a possible 
SP potential. Long duration (5 set) constant current STS during uncommon 
AVNRT was performed in a stepwise manner (max. 5 mA) at each site eligible 
for SP ablation until termination of AVNRT or capture occurred. Irrespective 
of the STS effect RF was delivered subsequently at each site (65”C, 60 set) 
after exclusion of catheter dislocation. Termination of uncommon AVNRT 
due to STS-induced block of the retrograde SP occurred without capture in 
9/11 patients. This was exclusively observed at successful RF sites. STS 
was ineffective at any unsuccessful RF target site. Uncommon AVNRT was 
rendered noninducible in all pts. after a median of 2 (I-14) RF pulses. 
Conclusions: Uncommon AVNRT can be interrupted by STS delivered 
at successful target sites for SP ablation in most pts. (82%). The high positive 
and negative concordance between the effects of STS and subsequent RF 
application indicates that STS-mapping of the SP may be also useful in rare 
forms of AVNRT. 
1140-69 Origin of Junctional Tachycardia During 
Radiofrequency Ablation of Atrioventricular Nodal 
Reentrant Tachycardia in Man 
J. Vijay Jayachandran, John M. Miller, Douglas P. Zipes. Krannerf Institute, 
Indianapolis, Indiana, USA 
Background: During slow pathway (SP) ablation (AVMOD) for atrioventric- 
ular (AV) nodal reentrant tachycardia (AVNRT), ventriculo-atrial (VA) block 
during junctional tachycardia (JT) often heralds damage to the anterograde 
fast pathway (FP) despite delivery of energy at a site remote from the 
anatomic FP. The mechanism by which this occurs is unknown. We tested 
the hypothesis that VA conduction during JT occurs via an upper common 
pathway (UCP) or “upper turnaround” in patients undergoing AVMOD. 
Methods: 13 consecutive patients in whom 3 or more beats of JT with 
constant cycle length (CL) during AVMOD were studied. Relative activation 
times in milliseconds (ms) of the His bundle (H) and the earliest rapid de- 
flection recorded in the high right atrium (HRA), were defined as: HAsvr = 
onset of H to HRA during slow-fast AVNRT, HAvp = end of H to HRA during 
right ventricular apex pacing at cycle length (CL) of AVNRT immediately after 
termination of AVNRT, HAJT = onset of H to HRA during JT. 
Results: Atrial activation sequence during JT was similar to that during 
AVNRT. Mean AVNRT CL was 369 f 63 ms, mean time to onset of JT from 
onset of RF energy delivery was 5.8 f 4.8 set and mean JT CL was 472 f 
127 ms. HAvp (150 * 34 ms) was longer (p < 0.0001) than HAsvr (118 & 
26 ms), consistent with the presence of a lower common pathway (LCP). In 
each patient, HAJT mean (90 f 26 ms) was significantly shorter than HAsvr 
(p = 0.003) as well as HAvp (p < 0.0001). 
Conclusions: 1) Since HAJT is always <HAsvr, JT does not originate 
in either the LCP or His bundle. 2) Atrial activation during JT and SVT 
(retrograde FP) occur via similar pathway/tissue. Although our findings are 
also consistent with excitation of the FP during JT, this is unlikely due to 
the anatomical distance from the usual site of AVMOD to the FP as well as 
the early onset of JT during energy applications. Thus VA conduction during 
JT may be due to retrograde conduction via an UCP or a connection from 
the SP to the FP (upper turnaround). 3) VA block during JT at the time of 
AVMOD may be due to damage to the UCP or upper turnaround and may be 
a harbinger of heart block or prolonged AV interval following AVMOD without 
signifying actual damage to the FP. 
1140-70 Morpholological Features of the Right A-V 
Junction in Ebstein’s Malformation: Implication 
for Radiofrequency Ablation 
Jose A. Cabrera, Damian Sanchez-Quintana, Siew Y. Ho, Jeronimo Farm, 
Jose M. Rubio, lnmaculada Fernandez-Rozas, Pedro Marcos-Alberta, 
Robert H. Anderson. Fundacidn Jimenez Diaz, Madrid, Spain; National 
Heart and Lung Institute, London, UK 
Background: Understanding the anatomy of the A-V junctional area in Eb- 
stein’s anomaly of the tricuspid valve (TV) may facilitate radiofrequency 
catheter ablation (RFCA) procedures. 
Methods: We examined 8 autopsied hearts (age: II-56 years) with 
isolated Ebstein’s malformation to elucidate the gross morphological features 
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of the right A-V junction. As controls we also examined 16 normal heart 
specimens. 
Results: In hearts with Ebstein’s anomaly the septal and mural leaflets of 
the TV were hinged at various points within the inlet of the right ventricle. The 
plane of the effective TV orifice was displaced anterosuperiorly to varying 
degrees. (range 10%35”). The extent of the atrialized component of the fight 
atrium was 40 f 13 mm (range: 19-52). 
T. Todam TK-base Isthmus TVA diameter 
Ebstein 19.617 6.6 i- 1.7 29.4 zt 6.1 161 zt 35 
Normal 18.7 & 4 12.3 i 2.6 30*4 104f07 
The inferior isthmus was similar in both groups, but the triangle of Koch 
(TK) was significantly (p < 0.001) smaller in hearts with Ebstein’s anomaly. 
The latter differences were determined by the presence of a muscular crest 
within the TK at the level of the TV annulus (TVA) whose mean width was 
2 i 0.8 mm. Table shows the dimensions (in mm) of the tendon of Todaro, 
base of the TK (TK-Base), inferior isthmus and TVA diameter in hearts with 
Ebstein’s and controls. 
Conclusions: Ebstein’s malformation is more than a simple, downward 
displacement of the TV. The presence of a muscular crest at the theoretical 
level of the TV annulus, and the small triangle of Koch are anatomic features 
that may be releveant for RFCA. 
L-2 1140 71 Differential Effects of Anesthesia on Atrioventricular Nodal Fast and Slow Pathways 
Dirar S. Khoury, Huabin Sun, Peggy L. Jackson, Lloyd H. Michael, William 
H. Spencer Ill. Baylor College of Medicine, Houston, Texas, USA 
Background: Intact and isolated animal hearts have been increasingly used 
to study atrioventricular nodal (AVN) electrophysiology. The site of earliest 
right atrial (RA) activation was previously identified in anterior septum above 
the His region during retrograde ventriculoatrial conduction over the fast 
pathway, and in posterior septum between the coronary sinus ostium and 
tricuspid annulus during retrograde conduction over the slow pathway. How- 
ever, effects of anesthesia on the AVN and on the fast and slow pathways 
are not clear. 
Methods: A basket-catheter carrying 64 electrodes (EPT) was used to 
map the RA of 8 dogs. Electrical-anatomical features of the RA were verified 
at baseline (sinus node, His region, tricuspid annulus, and coronary sinus 
ostium). In group I, 4 dogs were anesthetized by isoflurane inhalation (2%). 
In group II, 4 dogs were anesthetized with intravenous sodium pentobarbital 
(30 mg/kg). 
Results: During ventricular pacing (cycle length 20 ms < sinus), the 
shortest VA interval in group I was 111 f 17 ms. The site of earliest RA 
activation was above the His region (above tendon of Todaro), suggesting 
conduction over the fast pathway. In group II, the shortest VA interval was 158 
& 14 ms (p = 0.005 compared to group I). The site of earliest RA activation 
was below tendon of Todaro and anterior to the coronary sinus ostium, 
suggesting conduction over the slow pathway. In group I dogs, anesthesia 
was switched over to intravenous sodium pentobarbital during the course 
Of the experiment. Subsequently, the short&t VA interval was prolonged to 
220 + 43 ms (p = 0.009 compared to isoflurane) and the site of earliest RA 
activation shifted from anteridr to posterior septim, suggesting a respective 
change in retrograde conduction from the fast to the slow pathway. 
Conclusion: In canine, retrograde conduction over the AVN fast and 
slow pathways can be altered by anesthesia. Therefore, role of anesthesia 
or sedation should be considered during AVN electrophysiological testing 
and induction of reentrant tachycardia. 
1140-72 Selectivity and Negative Dromotropic Effect of an 
Ai Adenosine Receptor Partial Agonist 
Lin Wu, Huixiu Liang, John C. Shtyock, Jeffrey A. Zablocki, Venkata Palle, 
Luiz Belardinelli. Universiry of Florida, Gainesville, Florida; CV 
Therapeutics, Pa/o Alto, California, USA 
Background: The clinical use of full agonists of the Al adenosine receptor 
is limited by their actions to cause AV block and bradycardia. By use of 
partial agonists, it may be possible to moderately slow AV nodal conduction 
without the risk of causing second-degree AV block. To test this hypothesis, 
we determined the effects of CVT-2759, a derivative of the full agonist 
CVT-510 (N6-[S-R-tetrahydrofuranylaminolpurine riboside), on guinea pig 
isolated hearts. 
Methods: Guinea pig hearts (n = 48) were isolated and perfused with 
K-H solution with or without drugs. Hearts were instrumented for recording 
of atrial rate, stimulus-to His bundle (S-H) conduction time (Al AdoR medi- 
ated), coronary conductance (Aa AdoR mediated), and monophasic action 
potential. 
Results: CVT-2758 significantly increased the S-H interval by 11 msec 
from 46 f 2 to 57 f 3 msec (n = 5, p < 0.05) with a half-maximal effect 
at 2.8 f 1.3 uM. CVT-2759 did not cause second-dearee AV block at anv 
concentration. The selective Al AdoR antagonist CPX-(50 nM) significant& 
attenuated the effect of 10 PM CVT-2759 (n = 7, p < 0.05). In comparison, 
the full A, AdoR agonist N6-cyclopentyladenosine (CPA) caused an increase 
of the S-H interval from 44 f 1 to 81 i 5 msec at a concentration of 15 
nM, and second-degree AV block in all hearts at concentrations higher than 
20 nM. CVT-2759 caused no slowing of atrial rate in either the absence or 
presence of IO nM isoproterenol (n = 4). In contrast, CPA (1 /IM) decreased 
atrial rate from 206 f 18 to 2 f 1 bpm (n = 4) in the absence of isoproterenol 
and from 301 f 12 to 69 i 18 born (n = 4) in the presence of isooroterenol. 
Prolongation of the S-H interval aid AV’block caused by 15 and 20 nM 
CPA were significantly and partially reversed by IO WM CVT-2759. Coronaty 
conductance was increase; by &T-2759 with a half-maximal effect of 31 
f 5.1 PM (n = 5). CVT-2759 did not shorten the atrial monophasic action 
potential. 
Conclusion: Cm-2759 is a partial agonist of the A1 adenosine receptor 
and may be used to cause moderate slowing of AV nodal conduction without 
causing AV block, bradycardia, or shortening of the duration of the atrial 
monophasic action potential. 
[ 1140-73 ( Determinants of Heart Rate Dynamics After Slow 
Pathway Ablation 
Steven M. Markowitz, David J. Christini, David J. Slotwiner, Kenneth 
M. Stein, Suneet Mittal, Bruce B. Lerman. New York Hospital-Cornell 
University Medical Center, New York, NY USA 
Background: Changes in heart rate dynamics after slow pathway ablation 
have been attributed to interruption of vagal efferents in the posterior AV 
groove. To test this hypothesis, we studied the time course and determinants 
of autonomic changes after slow pathway ablation. 
Methods and Results: In 26 patients (age 46 f 14; 19 F) who underwent 
slow pathway ablation, time and frequency domain parameters of heart rate 
variability (HRV) were calculated before, 30 min after, and 1 day after RF 
ablation. 18 of these pts received isoproterenol (iso) during the procedure 
for arrhythmia induction, with the infusion terminating 230 min prior to HRV 
analysis. Immediately after ablation, there were significant decreases in 
mean RR interval, RMSSD, pNN50, and high frequency power, but these 
parameters returned to baseline 1 day later. By multivariate analysis, the 
only significant predictor of the immediate decrease in mean RR interval 
was the dose of iso during ablation (Rz = 0.32, p = 0.006). To test the 
hypothesis that exogenous catecholamines cause changes in HRV 30 min 
after ablation, measurements were made in 8 patients before and 30 min 
after iso exposure during an EP study. These data demonstrated a significant 
decrease in mean RR interval and trend toward a decrease in high frequency 
power, similar to the acute changes noted above. Muscle sympathetic nerve 
activity, measured by peroneal microneurography in IO healthy volunteers, 
demonstrated a prolonged and significant increase in sympathetic nerve 
traffic after stopping iso, in conjunction with a decrease in high frequency 
HRV. 
Conclusions: Changes in autonomic tone after slow pathway ablation 
are transitory and are largely determined by administration of exogenous cat- 
echolamines during EP study. These data suggest that autonomic changes 
after slow pathway ablation are not related to denetvation of cardiac vagal 
efferents. 
1140-74 Intravenous CVT-510, a Selective Al-Adenosine 
Agonist, Prolonas Atrio-Ventricular Nodal 
C&duciion in P>tients at Electrophysiologic 
Study 
Bruce B. Lerman, Kenneth M. Stein, Steven M. Markowitz, Suneet Mittal, 
David J. Slotwiner, Luiz Belardinelli, Revati Shreeniwas, Andrew A. Wolff. 
Cornell University Medical College, New York, New York; CV Therapeutics, 
Palo Alo, California, USA 
Background: CVT-510 (6-(N-3’-(R) tetrahydrofuranyl)-amino-purine ribo- 
side), is a selective A, -adenosine receptor agonist with anti-arrhythmic po- 
tential. This study, the first in humans, was designed to test the effects of 
CVT-510 on atrio-ventricular (AV) nodal conduction. 
Methods: Patients with n&ma1 AV nodal function at electrophysiologic 
study (N = 17) received a single intravenous bolus of CVT-510. Vital signs, 
AH i&vals (AH) and HV intervals (HV) were measured during sinus rhythm 
and during atrial pacing (600 msec cycle length) at 1, 5, IO, 15, 20, 30, 45 
and 60 minutes (min) after dosing. 
Results: CVT-510 prolonged AH during pacing more than during sinus 
rhythm. AH during pacing was longest at 1 min after dosing, returning to near 
baseline by 20 min. 
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Dose Level (mcg/kg) 0.3 1.0 3.0 10 30 
” 5* 4”* 3 3 2 
Sinus AH, baseline (msec) 85.2 98.0 74.3 92.0 77.0 
Sinus AH, increase at 1 min (msec) 1 .o 4.3 9.0 9.0 AV block 
Paced AH, baseline (msec) 96.5 107.0 88.0 128.0 92.0 
Paced AH, increase at 1 min (msec) 7.0 10.3 22.0 47.0 AV block 
*t- = 4 and *“n = 3 during pacing due to sinus cycle lengths ~600 msec. 
CVT-510 at 0.3 to 10 mcg/kg caused no effects on sinus rate, HV or 
systemic blood pressure; there were no serious adverse events at these 
dose levels. At 30 mcg/kg, CVT-510 produced transient complete heart block 
in both patients. P waves and ventricular escape were present and systolic 
blood pressure was unaffected. 
Conclusions: CVT-510 promptly prolongs AV nodal conduction at doses 
that do not effect sinus rate or blood pressure. Selective stimulation of the 
At -adenosine receptor by CVT-510 may be useful for immediate control of 
heart rate in atrial fibrillation or flutter and to convert paroxysmal supraventric- 
ular tachycardia to sinus rhythm, while avoiding vasodilatation mediated by 
the Aa-adenosine receptor and the depressor and negative inotropic effects 
of beta-blockers and calcium channel blockers. 
Results: Patients were predominantly male (154, 89.5%) and Caucasian 
(145, 84.3%). Seventy-two (41.9%) patients were NYHA functional class 
11-111, Although randomization was stratified, the majority of patients (106, 
785%) in the AZ groups had LVEF < 35% whereas PL patients (37) were 
equally distributed between the two strata. More AZ treated patients withdrew 
due to AEs compared to PL (33,24.4% Vs 7, 18.9%). The overall incidence of 
arrhythmic events in AZ treated patients was comparable to placebo. Three 
episodes of Torsade de Pointe (TdP) were reported in 2 patients treated with 
125 mg AZ.. Two of the episodes were considered to be possibly related 
to drug. The patients recovered in all 3 instances. Five patients died (3 PL, 
2 AZ) of non-arrhythmic and non-drug related causes. A modest degree 
of QTc prolongation was observed in AZ treated patients compared to PL 
(mean change from baseline: 35 mg 4.2%, 75 mg 3.5%, 125 mg 3.4%, PL - 
0.9%). 
Summary of Adverse Events-All Patients 
35mgAZ 75mgAZ 125mgAZ All AZ PL 
N = 44 N=45 N=46 N=135 N = 37 
# (%) pts withdrawn 
due to AEs 
# (%) arrhythmic AEs 
Worsening VT/TdP 
SWlCODt2 
10 (22.7%) 9 (20.0%) 14 (30.4%) 33 (24.4%) 7 (18.9%) 
10 (22.7%) 13 (28.9%) 15 (33%) 38 (28%) 10 (27%) 
7 (15.9%) 9 (20%) 6 (19.6%) 25 (18.5%) 7 (18.9%) 
3 (6.6%) 4 (8.9%) 6 113.0%) 13 (9,6%1 3 (8.1%) 
POSTER 
pi-q Implantable Cardioverter-Defibrillators 
Tuesday, March 14,2000,9:00 a.m.-11:OO a.m. 
Anaheim Convention Center, Hall A 
Presentation Hour: 1O:OO a.m.--11 :00 a.m. 
#;%) deaths i i2.3%j .I {2.2%j ’ 0 ’ 2 (i.5sj 3 i8.204 
Motialitv rate/l00 &wars 3.23 2.86 - 2.06 10.63 
LVEF was unchanged by treatment with AZ (35 mg +I .9%, 75 mg +7.4%, 
125 mg +5.9% Vs PL - 1.5%) as were defibrillation threshold (DFT) and 
anti-tachycardia pacing voltage. 
1141-93 The Effect of Chronic Oral Amioclarone Therapy 
on Defibrillation Energy Requirement in Patients 
With Implantable Defibrillators Having Biphasic 
Waveforms 
Conclusion: 1 year treatment with AZ in patients with an ICD appears 
to be safe and well tolerated. Treatment did not result in any change in 
hemodynamic status (LVEF) or affect device performance as determined by 
DFT. 
Frank Pelosi, Jr., Hakan Oral, Michael H. Kim, Christian Sticherling, Steven 
P. Chough, Robert Baker, Bradley P. Knight, Gregory F. Michaud, 
Fred Morady, S. Adam Strickberger. University of Michigan, Ann Arbor, 
Michigan, USA 
1141-95 The Effect of ICD Shock on Electrogram Width 
Jeffrey Wang, Craig Swygman, Howard Kim, Paul J. Wang, Mark S. Link, 
Munther K. Homoud, Caroline B. Foote, N.A. Mark Estes Ill, New England 
Medical Center, Boston, MA, USA 
Background: The effect of chronic amiodarone therapy on defibrillation 
energy requirements (DER) in humans with implantable defibrillators (ICD) 
having biphasic waveforms has not been evaluated. The purpose of this study 
is to establish the effect of chronic oral amiodarone therapy on the DER. 
Background: Using stored ICD electrograms, interpretation of the rhythm 
following an ICD shock is particularly important. Widening of the ventricular 
electrogram following an ICD shock has been observed but has been poorly 
quantitated. 
Methods: Twenty-one patients with an ICD having a biphasic waveform 
(mean age 63 i 16 years, ejection fraction 0.31 f 0.12) underwent a step 
down DER determination (21, 17, 14, 11, etc. to 1 Joule) 73 + 21 days after 
initiation of oral amiodarone therapy (289 i 99 mg/d). Serum amiodarone 
and desethylamiodarone (DEA) concentrations were measured at this time. 
This DER was compared to the baseline step down DER determined 212 i 
235 days prior to the initiation of amiodarone therapy. 
Methods: The stored ICD electrograms from 174 shock episodes in 68 
patients were retrieved and reviewed. The ventricular electrogram width in 
sinus rhythm was measured and compared to the electrogram width in sinus 
rhythm following each ICD shock. The episodes were divided based on the 
type of electrogram (rate-sensing or shock). 
Results: The baseline DER was 10.2 f 4.1 Joules and increased sig- 
nificantly after amiodarone therapy to 13.4 f 5.2 Joules (p = 0.01). The 
DER increased 4.1 + 5.4 Joules (62 rt 75%). A linear relationship between 
amiodarone (r = 0.6, p = 0.02) and DEA concentrations (r = 0.6, p = 0.02), 
with the DER during chronic amiodarone therapy was observed. Similarly, 
the degree of elevation of the DER during amiodarone therapy was directly 
related to the amiodarone (r = 0.8, p = 0.001) and DEA (r = 0.8, p = 0.001) 
concentrations. 
Results: In all 174 episodes, the ventricular electrogram width increased 
significantly. An increase in electrogram width was observed after both single 
and multiple shocks. These changes in electrogram width are seen with both 
rate-sensing and shock electroExams (EGM). 
Pre-Shock Post-Shock P value 
Width Width 
All episodes 132.5 i- 45.8 145.2 i 50.3 <0.0001 
Rate-sensing EGM 107.1 i 21.2 116.9 ?C 20.7 <0.0001 
Shock EGM 167.7 f 52.3 189.0 & 57.2 <0.0001 
Sinale Shock 130.1 f 46.9 143.3 * 51.7 <0.0001 
Muiiiple Shocks 142.4 zk 40.2 153.2 i 43.8 <O.OOl 
Conclusions: Chronic oral amiodarone therapy increases DER by 62% 
in patients with ICDs having biphasic waveforms. Serum concentrations of 
amiodarone and its metabolite DEA appear to be directly related to the DER. 
1141-94 Safety Aspects of Azimilide in Patients With an 
Implantable Carclioverter Defibrillator: 1 Year 
Follow-up 
Conclusions: Ventricular electrogram width increases after single and 
multiple ICD shocks, affecting both rate-sensing and shock electrogram. 
Caution should be taken in interpreting the widened post-shock electrogram 
to avoid misclassification of the rhythm as ventricular in origin. 
Colin M. Hislop, Jose G. Brum, Hussein Al-Khalidi, Laurie P. Gunderson, 
lmran Niazi, Tony Simmons, Patrick Chou, lgor Singer, Richard Henthorn. 
frocfer & Gamble F’harmaceuficals, Cincinnati OH: Linder Center for 
Cardiovascular Research, The Christ Hospital, Cincinnati OH, USA 
!-.--i 1141 96 Detection of Regional Myocardial lschemia Using an ICD Lead Set 
Michael E. Benser, Gregory P. Walcott, Cheryl R. Killingsworth, Steven 
D. Girouard, Raymond E. Ideker. GuidantKRM, St. Paul, MN; University of 
Alabama at Birmingham, Birmingham, AL, USA 
Background: The safety and efficacy of the anti-arrhythmic agent Azimilide 
(AZ, Vaughan Williams class Ill) was investigated in a double-blind ran- 
domized placebo controlled study of patients with Implantable Cardiovener 
Defibrillators (ICD) over a period of 12 months. 
Objective: We hypothesized that transient episodes of regional myocardial 
ischemia, as realized by two-minute occlusions at six sites within the coronary 
arteries (CA), could be detected by ST-level changes from a far-field ICD 
lead-set signal (RV- + SVC+ + Can+). 
Methods: 172 patients were randomized to treatment with either placebo 
(PL) 35 mg, 75 mg, or 125 mg daily. AZ. Randomization was stratified 
according to Left Ventricular Ejection Fraction (LVEF < 35% or ? 35%). 
Methods: In eleven swine (41 I 4 kg), a two-electrode (RV, SVC) defib- 
rillation catheter and left pectoral can electrode were situated. Under fluoro- 
scopic guidance, a balloon catheter was sequentially directed to between two 
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and six (4 A 2) of the following CA positions: proximal (p) and distal (d) left 
anterior descending (LAD), p and d left circumflex (LCX), and p and d right 
main (RM). From four. minutes before through 18 min after each two-min, 
occlusion, the RV- + SVC+ + Can+ signal was continuously recorded. Off 
line, an algorithm was developed to detect the ST level of each beat, and, 
based on the smoothed time derivative of this trend, predict the presence or 
absence of an occlusion. 
Results: Prior to occlusions, ST levels were stable; upon occlusion, 
ST levels were altered monotonically. 6/B pLAD, 7/B dLAD, 6/7 pLCX, 3/B 
dLCX, 4/4 pRM, and 4/5 dRM occlusions were appropriately detected by the 
ST-based algorithm. Additionally, before the occlusions and after 6 minutes 
of arrhythmia-free reperfusion, the algorithm correctly detected the absence 
of occlusion in 23/26 cases. 
Conclusions: 30/40 CA occlusions were appropriately detected from the 
ST-level changes in the far-field ICD signal. Among the six occlusion sites 
tested, only dLCX occlusions were undetected more than half the time; 84% 
of all other occlusions were appropriately detected. Thus, detection by ICDs 
of transient myocardial ischemic events, even those of relatively small spatial 
extent, may be feasible. 
) 1141-97 ] Mortality in Octogenarians After Implantable 
Cardioverter-Defibrillators: When is Too Old? 
Nour M. Juratli, Mark J. Niebauer, Ayman S. Al-Khadra, Bruce L. Wilkoff, 
Mina K. Chung. Cleveland Clinic Foundation, Cleveland, Ohio, USA 
Background: Although implantable defibrillators (ICDs) improve mortality in 
selected patients, benefit in the very elderly is unproven. To determine if high 
mortality in octogenarians should limit ICD implantation in this group, survival 
was studied after first ICD implants. 
Methods: After initial ICD implantation in 404 patients, survival status 
was assessed by recent ICD clinic visits, telephone contact, and a national 
death registry. Univariate, multivariate, and Cox regression analyses were 
performed. 
Results: Over a follow-up period of 425 i 269 days, 621404 (15.3%) 
patients died. This group had lower LVEF (21.4 f 7.9% vs. 29.9 f 12.3%, p 
< 0.001) and tended to be older at implant (66.4 + 9.8 vs. 63.4 f 11.2 years, 
p = 0.055). Although mortality was similar in pts 60-84 yrs by decade, pts 
1 85 yrs had significantly higher mortality than younger pts (57.1 vs. 14.6%, 
p = 0.002). Independent predictors of death included age (hazard ratio (HR) 
1.039, Cl 1.013, 1.066, p = 0.003) and LVEF (HR 0.922, Cl 0.894, 0.951, p 
< 0.001). 
tipla*Ma,er Survival curves by Age 
Days after Implant 
Conclusions: Advanced age and poorer LVEF predict worse survival 
after ICD implantation. High early mortality in patients 285 years old warrants 
careful consideration for ICD implantation in this age group. 
11141-98 1 Lead Failures in Implantable Defibrillator 
T$e~;“opd Efficacy and Safety of Current Follow Up 
B. Schulte, H.F. Pitschner, J. Sperzel, H. Rbderich, Jcrg Carlsson, 
C. Hamm, J. Neuzner. Kerckhoff-K/ink, Bad Nauheim, Germany 
Background: There is a substantial incidence in cardiovetter-defibrillator 
(ICD) lead failures (ICD-LF). Early detection of ICD-LF is mandatory for 
therapy safety. We thus examined the efficacy of standard follow up (FU) 
methods to detect andfor predict ICD-LF. 
Methods: Patients with transvenous ICD-leads, implanted after octo- 
ber 1990 performed FU every 3 months. FU consisted of complete de- 
vice interrogation, analysis of stored and real-time electrograms, lead mea- 
surements (pace-threshold, pace-impedance, signal amplitude if available). 
Chest X-rays, defibrillation threshold testing and determination of defibrilla- 
tion impedance were not performed routinely. 
Results: ICD-LF occurred in 301428 (7%) patients, 6-84 months after 
device implantation. At the time of diagnosis lead measurements were diag- 
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nostic in 15/30 patients (50%). Pathological X-ray findings were not observed 
in any patient. Only in 4130 patients (13%) routine FU predicted subsequent 
ICD-LF (decrease in pacing impedance). ICD-LF with a definite risk for sud- 
den cardiac death (potential shock or sensing failure) were classified as 
severe, ICD-LF was classified as minor, if only insulation defects causing 
inappropriate therapy (IT) were observed. 
Severe Minor 
Shock Sensing OVC?rSellSe OVC?KX?liS3 
Failure Failure with IT without IT 
n=l3 .=Q n=19 “E? 
Conclusions: Thus at the time of first diagnosis of ICD-LF, in 50% of the 
patients the implanted device was non-functional. This observation demon- 
strates the significant limitations of current ICD-FU. The wider use of device 
implemented “automatic alert functions” may contribute to an increase in 
safety in ICD-therapy. 
1 1141-99 ( Spontaneous Ventricular Tachycardias During 
Follow Up of 160 Patients With a Primary History 
of Ventricular Fibrillation Alone 
Anselm Schaumann, Ole Fabian, Bernd-Dieter Gonska, 
Claus Schmitz-Elsen, Dietmar BBansch, Marius Volkmer, Karl-Heinz Kuck. 
St. Georg Hospital Hamburg and University of Goettingen, Germany 
Background: The risk of ventricular tachycardias (VT’s) in patients with a 
history of ventricular fibrillation (VF) alone is yet not known, but might have 
therapeutic consequences. 
Methods: The occurrence of VT’s was evaluated in 160 patients after 
survived sudden cardiac death due to VF and implanted cardiovetter defib- 
rillators (ICD’s). In all patients with a history of VF and no known VT’s new 
tiered therapy ICD’s were implanted and antitachycardia pacing (ATP) was 
programmed on. Most of the patients had coronary artery disease (n = 90) or 
idiopathic cardiomyopathy (n = 48). The left ventricular function was reduced 
(EF = 38%). In only 37 of the 160 patients a VT was inducible at the baseline 
ventricular stimulation. Spontaneous ventricular arrhythmias were analyzed 
with the stored ECG and therapy history recorded by the ICD. 
Results: During the follow-up of 31 (3-80) months 1857 spontaneous 
ventricular arrhythmias occurred in 97 (61%) patients. VF was the only 
recurrent arrhythmia in 36 patients. Spontaneous VT’s were seen in 27 
patients and 34 patients had both, VT and VF recurrences. VF was seen 185 
times and treated with primary shock delivery. ATP attempts were successful 
in terminating 1496 (90%) of 1672 spontaneous VT’s In 35 of 97 patients 
ATP was able to terminate 90-I 00% of all spontaneous VT’s 
Conclusion: Patients with a history of VF alone have in 63% recurrences 
of spontaneous VT’s during follow up. Only 10% of all spontaneous arrhyth- 
mias are VF in these patients. Therapeutic considerations should include VT 
management and ATP programming. 
POSTER 
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1142-59 Clinical Aspects of LQTS in Probands of 
Parents With and Without Clinical Manifestations 
of LQTS 
Wojciech Zareba, Arthur J. Moss, Jennifer L. Robinson, Mark L. Andrews. 
The International LQTS Registry Research Group, University of Rochester, 
Rochester, NY USA 
Whenever a new long QT syndrome (LOTS) proband is identified, his/her 
parents are evaluated regarding the possibility of carrying the disorder. In 
the majority of cases, one of the proband’s parents is affected, but, in some 
families there is no clear evidence for LQTS inheritance from evaluated 
parents. The aim of this study was to evaluate differences in clinical aspects 
of probands with versus without at least one affected parent. We identified 
177 probands in whom parents were evaluated by ECGs and clinical history. 
In 47 probands, both parents were unaffected by ECG criteria (QTc < 0.42s) 
and had no history of cardiac events (CEs). In 130 probands, at least one 
parent was considered affected having QT p 0.42s or a history of cardiac 
events. Table below shows the clinical and ECG characteristics of probands 
with affected and unaffected parents. 
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Probands with Probands with 
Affected Parents Unaffected Parents 
(n = 130) (n = 47) 
Females 91 (70%) 30 (64%) 
QTc (ms) 511 zt 55 507 * 58 
HR @pm) 7ozt17 73122 
CEs 111 (85%) 40 (85%) 
ACAILD 35 (27%) 13 (28%) 
Age QIS’ CE (yrs) 1318 8 i 6* 
AM/l-D = aborted cardiac arrest/LQTS death *p c 0.001 
Conclusions: The LOTS probands with and without affected parents 
have similar demographic and ECG characteristics and similar probability of 
cardiac events, although probands of unaffected parents experience cardiac 
events at an earlier age. The findings suggest that the severity of LQTS in 
probands bears only a weak relationship to the clinical expression of LQTS 
in parents. 
1 1142-601 Heart Rate Variability Measures are Equivalent in 
Genetically Affected and Unaffected Members of a 
Family With the Long QT Syndrome due to a 
HERG Mutation 
Elizabeth S. Kaufman, Guhan Rammohan, Eiran 2. Gorodeski, Niuton 
S. Koide, Linda M. Verrilli, Sudha lyengar, Carlo Napolitano, Silvia G. Priori. 
MefroHealfh Medical Center, C/eve/and, Ohio; Fondazione S. Maugeri, 
Pavia, ltaly 
Background: In congenital Long QT Syndrome (LQTS), torsade de pointes 
can be provoked by autonomic triggers: however, baseline autonomic func- 
tion has not been evaluated in this population. 
Methods: To evaluate baseline autonomic function in patients with LQTS 
vs. control subjects, heart rate variability on 24-hour Holter ECG recordings 
was measured in 36 related members of a family with LQTS. Testing was per- 
formed off beta blockers. Subjects also underwent genetic typing. Unpaired 
t-tests were used to compare heart rate variability measures in genetically 
affected and unaffected individuals. 
Results: Fourteen subjects were found to have a mutation in the HERG 
gene (abnormal). When compared to subjects without this mutation (normal), 
no significant differences were found for mean RR (msec), standard deviation 
of RR (SDRR), or for log transformed high frequency (0.15-0.40 Hz) and low 
frequency (0.04-0.15 Hz) power (LnHFP and LnLFP). 
Conclusion: No significant difference was found in any measure of heart 
rate variability between genetically normal and abnormal individuals in this 
family with LQTS. 
Normal 
Abnormal 
Age 
(YW 
38i13 
34* 13 
Mean RR 
(msec) 
795 + 89 
840 i 94 
SDRR 
78.9 i 32.6 
76.4 i 25.3 
Ln HFP 
11.0 * 2.0 
11.2 + 2.7 
Ln LFP 
12.7 i 2.0 
12.9 i 2.7 
!--.-A 1142 61 Microvolt Level T-Wave Alternans is Prevalent in a Family With Congenital Long QT Syndrome Due 
to a HERG Mutation 
Elizabeth S. Kaufman, Eiran 2. Gorodeski, Niuton S. Koide, Linda M. Verrilli, 
Guhan Rammohan, Nael 0. Bahhur, Sudha lyengar, Carlo Napolitano, 
Silvia G. Priori. MetroHealth Medical Center, C/eve/and, Ohio, USA; 
Fondazior;e S. Maugeri, Pavia, lfaly 
Background: Grossly visibly T-wave alternans (TWA) is an important prog- 
nostic sign in congenital Long QT Syndrome (LQTS). 
Methods: Using sensitive signal processing techniques, we investigated 
the prevalence of microvolt level TWA in a large family with LQTS due to a 
HERG mutation. Forty-eight related family members (26 M, 22 F, age 34 rt 
14, range II-71 years) underwent TWA measurement during exercise on a 
stationary bicycle, as well as genetic typing. We compared the prevalence 
of TWA in subjects with and without a HERG mutation. The TWA test was 
considered interpretable if HR > 105 was achieved, with noise < 1.8 iV 
and ectopics ~10%. TWA was considered abnormal if amplitude ~1.9 WV at 
a threshold HR q 11 O/min, lasting at least 1 min and persisting above the 
threshold HR. 
Results: Seventeen of 20 mutation positive and 24 of 28 mutation neg- 
ative family members had interpretable TWA tests and were included in this 
HERG Mutation No HERG Mutation 
TWA+ 3 0 
TWA- 14 24 
analysis. Among genetically affected family members, 18% had abnormal 
TWA. None of the genetically unaffected family members had abnormal 
TWA. 
Conclusions: Microvolt level TWA is present in a subset of individuals 
with LQTS due to a HERG mutation. Further studies and more extended 
follow-up are needed to determine if abnormal TWA in this population can 
identify the phenotype at risk for sudden death. 
/ 1142 62 Index of Morphological Dissimilarity: A Novel 
Approach to Quantify Spatial Heteroseneitv of 
Vkkricular Repolariiatibn Morphology - 
Jean-Philippe Couderc, Wojciech Zareba, Atsunobu Nomura, Arthur 
J. Moss. University of Rochester, Rochester, NY USA 
Background: Recent cellular experiments have shown that heterogeneity of 
repolarization influences the overall T-wave shape. Our study investigates 
inter-lead heterogeneity of T-wave morphology using a new computerized 
approach for quantifying spatial heterogeneity of repolarization in the X, Y 
and 2 leads. 
Methods: An Index of Morphological Dissimilarity (IMD) compares energy 
distribution of T-waves between leads. Our approach is independent from 
T-wave offset localization, the analyzed segment begins 80 ms after the R 
peak with a duration equal to 4/7 of the RR duration, distribution of energy 
in this segment is based on an orthogonal time-scale transformation. The 
discriminant power of IMD was compared to that of the principal components 
analysis parameter (based on the ratio of the two first eigen values measuring 
T-loop roundness), in healthy subjects (n = 126), and LQTS patients with 
sodium channel mutation (10 carriers and 13 non-carriers). Normal values 
for PCA and IMD were based on their upper 95% limit obtain from the healthy 
group. 
Results: In comparison to non-carriers and healthy subjects, LOTS car- 
riers show higher heterogeneity of repolarization as demonstrated by all 
parameters (see table). IMD showed high correlation with PCA (r = 0.78, p = 
0.0001). PCA and IMD values were not correlated with heart rate (HR). 
Healthy Non-carrier Carrier 
(n = 126) (tl= 13) (n = 10) 
HR km) 68.8 110.7 68.8 * 15.0 56.3 i 14.2* 
PCA 0.1010.10 (10) 0.14 zk 0.06 (0) 0.30 i 0.12t (4) 
IMD (mV2) 7.7 i 3.0 (5) 6.6 i 2.8 (0) 16.0 * 4.1* (10) 
* p = 0.003; t p = 0.0003; * p < 0.00001; (pts above the normal 95% limit) 
Conclusion: 1) Morphological heterogeneity of repolarization is identified 
in LQTS carriers by both IMD and PCA parameters. 2) IMD provides better 
discrimination of carrier LQT3 patients than PCA and could have useful 
clinical applications for diagnosing T-wave abnormalities. 
ORAL 
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Tuesday, March 14,2000, IO:30 a.m.-Noon 
Anaheim Convention Center, Room 304C 
lo:30 a.m. 
tzl 875 1 The Impact of Anatomical Variations in the lshmus 
Area on Atrial Flutter Ablation 
Jan van Asseldonk, Martin Gardien, Albert Meijer. Cafharina Hospital, 
Eindhoven, The Netherlands 
Background: Creation of bidirectional conduction block in the isthmus area 
(IA) is the requisite in successful treatment of atrial flutter (AFI) by radiofre- 
quency catheterablation (RF). The first target of RF is a line between tricuspid 
valve (TV) and inferior caval vein (VCI). The second target of RF is a line 
from the TV to the coronary sinus OS (SCO) and from the SC0 to the VCI. 
Anatomical variations may influence success rates of RF for AFI. 
Methods: We studied anatomical variations in the IA in 52 autopsy hearts 
(34 male, median age 71 years) and its effect on catheter manipulation. We 
measured the TV-VCI distance in the lateral, the mid and the medial pari 
of the IA. Both parts of the alternative ablation line were measured. We 
scored characteristics of the eustachian valve (EV), eustachian ridge (ER) 
and pectinate muscles (PM). If the ER reached the SCO, whith a fibrous 
appearance of the VCI-SC0 area, the heart was classified as type A. In the 
type B hearts the ER did not reach the SCO, with a musculous appearance of 
the VCI-SC0 area. A RF catheter was inserted and influence of anatomical 
variations on manipulation was examined 
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Results: The width of the first target (TV-IVC) varied from 12 to 50 mm 
(mean 28.7 f 9.4), from 12 to 35 mm (mean 22.5 + 5.5) and from 17 to 42 
mm (mean 25.6 f 5.0) in the lateral, the mid and the medial part respectively. 
The second target varied in width from 3 to 17 mm (mean 8.2 f 3.5) and 
from 3 to 20 mm (mean 10.3 & 3.8) in the VCI-SC0 and in the SCO-TV area 
respectively. An EV was present in 34 patients (65%), varying in height up to 
19 mm (mean 5.5 f 5.5), and an ER in 36 patients (69%), varying in height 
up to 13 mm (mean 2.3 & 2.6). PM, varying in thickness, extended into the 
IA in 40 patients (77%), reaching the SC0 in 13 of them. The width of the 
PM free pat-l of the IA in between PM and SC0 anged up to 25 mm (mean 
7.3 f 6.8). A high EV or ER or outspoken PM or a, broader IA complicated 
tissue contact of the cathetertip (ct) causing non-continuous lines. Bending 
the ct, use of a long introducer sheath or a superior caval vein approach 
may facilitate the moves of the ct, preventing gaps in the ablation lines. In 21 
patients (40%) the ER reached the SC0 (type A hearts). 
Conclusions: The IA varies considerably in anatomy. This influences 
contact of the ct with underlying tissue. To improve the success rate of 
RF of AFI different approaches reckoning with anatomical variations should 
be considered. In 40% of the hearts the ER-SC0 area might as well not 
conduct. 
lo:45 a.m. 
875-2 Concordant Bipolar Atrial Electrogram Polarity 
Predicts Isthmus Block During Ablation of Type I 
Atrial Flutter 
John M. Fontaine, Maged Nageh, Joseph Pennington, Bharat Kantharia, 
Farooq Padder, Sabrina Wilbur, Steven Kutalek. MCP and Hahnemann 
University, Philadelphia, Pennsylvania, USA 
Background: CAVA-Tricuspid Isthmus (CTI) block after radiofrequency en- 
ergy ablation (RFA) of type I atrial flutter (AFL) is suggested when pacing 
from the coronary sinus (CS) shows sequential atrial activation along the 
Halo’” (H) catheter positioned in the CTI. CS pacing during block produces 
counterclockwise activation of the atrial septum with late activation of the 
lateral right atrium and sites immediately lateral to the line of block. We pos- 
tulate that during CS pacing the activation wavefront is expected to be linear 
along the most distal bipolar recording sites lateral to the ablation line, hence 
the initial polarity of the local electrogram (EGMs) would be similar. 
Methods: We evaluated 25 patients (P) with type I AFL undergoing RFA. 
The H catheter was positioned in the CTI. We recorded the initial polarity in 
the HI and H2 distal bipoles during CS pacing and AFL, and measured the 
stimulus (S) to EGM duration in Hi and H2 before and after CTI block. 
Results: Fourteen P had AFL during the study. Bipolar atrial EGMs 
during spontaneous or induced AFL demonstrated the same initial polarity 
and morphology in Hi and H2 (concordant) in all P. Before RFA the S to 
Hi and H2 duration was 92 f 24 and 109 f 29 ms, respectively (p = ns). 
There was no significant difference between the S to Hl and H2 duration 
after CTI block (159 f 35 and 153 f 37 ms, respectively p = ns); whereas 
the difference between these values before and after RFA were significant (p 
< 0.001). Concordant HI and H2 EGMs were present in 20 of 25 P. Four of 
5 P with discordant EGMs had recurrent AFL over a mean follow-up period 
of 6 months; whereas none with concordant EGMs had recurrent AFL (p c: 
0.0001). The difference in S to Hi or H2 duration after RFA did not predict 
recurrence of AFL. 
Conclusion: Concordant bipolar atrial EGMs in Hi and H2 may be used 
to confirm CTI block and predict successful AFL ablation. 
11:OO a.m. 
III 875 3 Local Double Potential Versus Right Atrial Activation Mapping Analysis as Criteria for Achievement of 
Complete Bidirectional Isthmus Block During 
Typical Atrial Flutter Ablation: A Randomized Study 
Frederic Anselme, Atsunobu Kasa’i, Alain Cribier, Nadir Saoudi. Rouen 
University Hospita/, Rouen, France 
Low lateral (LL) right atrial (RA) activation mapping (AM) at the tricuspid 
ring-inferior vena cava isthmus (I) is the method of reference to assess 
achievement of complete bidirectional block (CBIB) during radiofrequency 
(Rf) ablation of atrial flutter (AFI) ablation. It has recently been suggested 
that recording of widely separated double potentials (WSDP) during abla- 
tion line mapping (ALM) could be a sufficient marker of the presence of 
CBIB. We therefore prospectively compared RAAM and ALM in assessing 
CBIB. 
Methods: Forty consecutive patients (pts, 35 males) with a mean age of 
63 & 10 years (35-80) were randomized in either Group (Gr) 1 (RAAM) or Gr2 
(ALM). In all pts, a decapolar catheter was inserted into the coronary sinus 
(CS), and a decapolar “Halo” shaped catheter was positioned at the LLRA 
with the distal bipole located as close as possible to the AL. Electrograms 
were displayed from CS, Halo and distal ablation bipoles in Grl, and from 
CS and AL bipoles in Gr2, while all of them were recorded and stored for 
retrospective analysis. 
Results: Expressed as mean f SD. P = ns between groups. 
N Age SUCCf?SS RF duration Flue. T Proc.T 
(year) (se@ (min) (min) 
Grl 17 64zt6 100% 545*371 24*17 94146 
Gr2 23 63zt12 91% 118211188 24Al6 115*47 
Fluo. T: fluoroscopy time; Proc. T procedure time. 
In 8 pts (21%) ALM and RAAM were not concordant in assessing CBIB: 
WSDP+ without CBIB using RAAM (n = 3); WSDP- or ambiguous with CBIB 
using AM (n = 5) leading to unnecessary Rf pulses in 3 pts. 
Conclusions: WSDP recording alone is not sufficient in assessing CBIB 
in 21% of pts. Discordant results support simultaneous RAAM in AFI ablation. 
11:15 a.m. 
875-4 Short-Term Follow-Up of Patients Post-Ablation of 
Atrial Flutter: Implications for Long-Term Success 
Suneet Mittal, Mithilesh K. Das, Kenneth M. Stein, Steven M. Markowitz, 
David J. Slotwiner, Marc A. Scheiner, Sei Iwai, Bruce B. Lerman. New York 
Hospital-Cornell University, New York, New York, USA 
Background: Bidirectional right atrial isthmus block (BDB) is the best marker 
of long-term success after radiofrequency ablation (RFA) for atrial flutter 
(AFL). However, despite achievement of BDB, there remains a 10% recur- 
rence rate, mostly within the first 6 months of RFA. We sought to determine 
whether recurrence of AFL is related to the resumption of right atrial isthmus 
conduction within the first 24 hours following RFA. 
Methods: We evaluated 50 consecutive pts (40 M/IO F, 61 & 14 years) 
who underwent RFA of isthmus-dependent AFL. 30 min following successful 
ablation, BDB was demonstrated in the basal state and during infusion 
of isoproterenol in all patients. A follow-up study was performed the day 
following ablation; if BDB was no longer present, reablation was performed 
until BDB was achieved. 
Results: BDB was demonstrated in all pts following the initial RFA. 39/50 
(78%) pts underwent a follow-up study. At follow-up, resumption of isthmus 
conduction was present in 7/39 (18%) pts. All were successfully reablated 
during that session. During a follow-up of 192 i 128 days (range 23-573 
days) months, only 2/39 (5%) pts who underwent a follow-up study have 
had a recurrence of AFL. In contrast, 2/11 (18%) pts who did not undergo a 
follow-up study have had a recurrence of AFL. 
Conclusions: (1) Following RFA for AFL, there is resumption of isthmus 
conduction within the first 24 hours in approximately 20% of patients. (2) 
These data suggest that recurrence of AFL following RFA does not result 
from slowly evolving conduction changes in the ablated area but rather 
is related to a resumption of isthmus conduction within the first day of the 
procedure. Therefore, a follow-up study may be warranted in pts who undergo 
RFA for AFL. 
11:30 a.m. 
875-5 Is Catheter Ablation of Atrial Flutter Guided by 
Electroanatomical Mapping (CARTO) More Effective 
Than the Conventional Approach? 
Stephan Willems, Christian Weiss, Matthias Hoffmann, Rudolf Rtippel, 
Rudolf0 Ventura, Thomas Meinertz. University Hospital Eppendorf. 
Hamburg, Germany 
Background: The present randomized prospective study sought to inves- 
tigate the efficacy of the conventional technique for radiofrequency current 
(RFC) ablation of atrial flutter (Aflut.) compared to a strategy based on elec- 
troanatomical mapping (CARTO). 
Methods and Results: 36 consecutive patients referred for catheter ab- 
lation of common type Aflut. were randomly assigned to either conventional 
(group I) or CARTO-guided technique (group II). In +I pts. similar multipolar 
catheters were inserted into coronary sinus and placed at the tricuspid annu- 
Ius, respectively. lntraatrial conduction patterns were assessed before and 
after ablation with both techniques. The ablation procedure was performed 
under fluoroscopic guidance in group land was mainly oriented on navigation 
and three-dimensional electroanatomical mapping within the magnetic field 
in group II. The induction of a complete bi-directional block within the poste- 
Group I Group II 
(n= 18) (n =18) 
RFC-pulses 15.2 zt 6.3 12.4 15.3 
Overall fluoro-time (min) 29.4 * 7.3 8.6 & 3.1 (p < 0.05) 
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rior cavotricuspid isthmus (PI) was the attempted endpoint in both groups. In 
all pts. RFC ablation was started with a 4-mm electrode and continued with 
a large &mm tip electrode when 21 applications failed. lntraatrial conduction 
via PI was completely interrupted in all patients (see table). 
In goup II a flouroscopy time of 3.8 * 1 .I min was required for the ablation 
procedure following catheter positioning. 
Conclusions: Atrial flutter can be effectively abolished using the conven- 
tional technique as well as guided by electroanatomical mapping. However, 
the overall fluoroscopy time can be significantly reduced despite the adjunc- 
tive use of conventional multipolar mapping catheters, whereas the number 
of required RFC-pulses is not substantially decreased. 
11:45 a.m. 
CII 875 6 Catheter Ablation of Atrial Flutter Using a Novel 
Non-Contact Mapping System: Observation of 
Different Mechanisms 
Karlheinz Seidl, Silke Breunung, Monika Rameken, Axe1 Drogemiiller, 
Jochen Senges. Heart Cenfer Ludwigshafer?, Germany 
Catheter ablation of atriai flutter (AF) was performed in 27 patients (pts) using 
a non contact endocardial mapping system (NCM, EnSite, Saint Paul, MN) 
in which an anatomical model of the right atrium was obtained to identify the 
pattern of activation, to plan and navigate lines of ablation, and to confirm 
conduction block with pacing. 
Aim of the study was to report the initial experience with the NCM for 
mapping and catheter ablation of AF. 
Results: Establishment of right atrial geometry and logging of defined 
atrial landmarks on the constructed endocardium was accomplished in 19 f 
10 min. Total procedure time was 162 * 48 min. total fluoroscopy time was 
21 & 14 min. Different mechanism of atypical AF were observed in 9127 pts 
(33%). 
Mechanism No of pts (27 pts) Total success rate (85%) 
Tvcical (counterclockwise) 14LXs 14LIts (100%) 
Typical (clockwise) 
Atypical 
Left atrium 
Crista terminalis AT 
4 pts 
9 pts 
4 pts 
3 ms 
3 pts i75%) 
6 pts (66%) 
2 pts 
2 Dts 
Posteroseptal AT 2’pt z’pt 
AT = atrial tachycardia 
Pulse propagation at the ablation line was determined during pacing by 
the NCM. NCM instantaneously identified the area where a discontinuity in 
the line of block was present; 1 & 1 gaps in the ablation lines were identified 
after pacing from each side of the line. Subsequently repeat energy deliveries 
to close each gap were guided by non contact mapping. 
Conclusion: 1. NCM is helpful to identify different forms of AF. About 
i/3 of AF are atypical forms. 2. By providing an instantaneous high density 
propagation vector at all sites along the ablation line, NCM is helpful in 
localizing discontinuities of linear lesions, and thus facilitates the creation of 
complete conduction block by navigating the ablation catheter to the gap. 
3. The success rate of typical (counterclockwise and clockwise) AF is 94% 
using the NCM. However, in atypical forms of AF success rate is only 66%. 
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1 1164-67 1 Short-Term Electrophysiological Changes of the 
Atria After Internal Cardioversion: Cause of 
Immediate Reinitiation of Atrial Fibrillation? 
Thomas Korte, Michael Niehaus, Gabriele Borchert, Jtirgen Tebbenjohanns. 
Dept. of Cardiology, Medical School Hannover, Germany 
Short-term electrophysiological changes of the atria (WRA) have been 
proposed as cause of immediate reinitiation of atrial fibrillation (IRAF) after 
internal cardioversion (IC), but have not been studied in humans after IC 
of chronic (cAF) and intermittent AF (IAF) (AF-duration < 24 h). After IC of 
cAF in 31 patients (pts) (AF duration: 26 i 45 months, LA: 45 i 6 mm) 
and iAF (LA: 40 f 7 mm) in 15 pts sinus rate (SR), P wave duration (PW), 
action potentials duration at 90% repolarisation (APDas) at 2 sides of the RA 
in sinus rhythm and conduction times (CT) between high RA and coronary 
sinus (CS) at 500 ms were measured during a time period of 20 min. 
Results: 
O.min l.min 3.min lO.min 20.min 
SR (ms) 929i246 834+208 865+216 889i155 8585136 
PW(ms) 117i26 115ztt26 116525 117124 119*23 
APDgo (ms) 167*30 200+39* 207i46** 224i-37 214129 
LZIRA->CS/500(ms) 129f37 122&26 126131 130+28 
Lz/CS->RN500lms~ 142&26 128*30 132i32 141*22 
SR, PW and interatrial CT did not significantly change. There was a 
significant 52 i 30 ms APDsa prolongation, 82% of which occurred in min 
O-1 (p i 0.0001”) and min l-3 (p < 0.001”) after IC. APDaa prolongation 
and its time dependence were not significantly different in pts with cAF, IRAF 
(n = 17 pts), LA > 45 mm and class Ic/lll antiarrhmic drugs (p > 0.05). 
Conclusions: (1) There is a significant APDas prolongation in minute 
O-3 after internal cardioversion of atrial fibrillation. Sinus rate and interatrial 
conduction times remain constant. (2) The prolongation of atrial APD9c does 
not significantly differ in pts with chronic AF, IRAF, enlarged LA and class 
Ic/lll antiarrhythmic drug treatment, 
1164-68 Action Potential Remodeling in the Human Right 
Atrium With Chronic Lone Atrial Fibrillation 
Toshiyuki Osaka, Atsushi Itoh, ltsuo Kodama. Shizuoka Saiseikai Genera/ 
Hospital, Shizuoka; Nagoya University Nagoya, Japan 
Background: It has been shown in animal experiments that recurrent induc- 
tion of atrial fibrillation (AF) or long-lasting atrial pacing causes a shortening 
of the atrial effective refractory period (ERP) and action potential duration 
(APD) as well as a loss of their physiological adaptation to rate. Much re- 
mains to be clarified as to the electrical remodeling in human patients with 
chronic AF. 
Methods: Monophasic action potentials (MAPS) were recorded from the 
right atrial free wall at pacing cycle lengths (CLs) of 300, 333, 400, 500, 
600 and 750 ms after external cardioversion in 13 patients with chronic lone 
AF and compared their configuration with those obtained from 11 control 
patients. 
Results: APDs at 50% and 90% repolarization (APDsc, APDsc) at the 
shortest CL (300 ms) in control and AF patients were 131 * 14, 213 f 19 
ms and 134 i 10, 210 -+ IO ms, respectively (mean i SD). APDs in control 
patients increased linearly with increases in CL, reaching maximal values 
of 175 f 32 ms (APDsc) and 275 + 41 ms (APDac) at a CL of 750 ms. in 
AF patients, the steady-state CL-APD relation was shifted downward and 
flattened at CLs longer than 500 ms; APDsa and APDas at a CL of 750 ms 
were 156 f 18 ms, 232 f 28 ms, respectively. APDsas at CLs of 600 and 
750 ms were significantly shorter in AF than in control patients. No significant 
difference was obtained in APDso between the two groups at any CL tested. 
MAP configuration in AF patients was characterized by an acceleration of the 
late repolarization. The difference between APDas and APDss (APDsssO) in 
control patients was increased with increases in CL, reaching a plateau at a 
CL of 500 ms. This CL-dependent slowing of the late repoiarization of MAPS 
was abolished in AF patients. The atrial ERP, measured at CLs of 400 and 
600 ms, showed changes parallel to those of APD,e. ERP at a CL of 600 
ms in AF patients (224 * 13 ms) was significantly shorter than that in control 
patients (247 i 25 ms). 
Conclusion: Chronic lone AF leads to electrical remodeling in human 
atrium, which causes a loss of rate-response of the late repolarization of 
action potential, leading to a shortening of APD and ERP at slower heart 
rates. 
1164-69 Organized and Reproducible Atrial Activation is 
Present Globally and Regionally During Phases of 
Human Atrial Fibrillation 
Sanjeev Saksena, Atul Prakash, Ryszard B. Krol, George Philip. Eastern 
Heart Institute-Atlantic Healfh System, Passaic, NJ, USA 
We performed simultaneous regional right & left atrial mapping of sponta- 
neous atrial fibrillation /AF] in IO patients [pts] with refractory AF to determine 
if organized & reproducible atrial activation sequences could be identified at 
onset & termination of sustained AF. Ten pts with spontaneous AF were 
mapped in 4 atrial regions with 3-5 close bipolar catheter electrodes for 
discrete repetitive electrogram sequences. Activation sequences were clas- 
sified as showing global biatrial or regional organization or disorganization at 
AF onset in 31 episodes & at termination in 15 episodes. 
Results: At onset of AF, global organization was seen in 29131 episodes 
(94%) of pts whereas at AF termination it was seen in 4115 episodes (29%, 
p c 0.01). Regional organization at onset & termination is shown: 
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Period Women Men 
Age 65-84 y Agez85y Age65-84~ Agez85y 
" % n % d % n % 
1960-69 o/175 0 0149 0 41177 2.0 0120 0 
1970-79 51235 2.0 2161 3.0 71175 4.0 2125 8.0 
1980-89 81285 3.0* 10/191 5.0# 14/241 6.0* 3136 8.0 
Conclusions: AF onset is characterized by a single dominant biatrial 
activation wavefront in most pts. Reproducible regional activation wavefronts 
are common after initiation & at termination of AF. These may represent 
organized regional/global tachyarrhythmias amenable to regional ablation or 
pace termination strategies. 
/ 1164 70 Effects of Adrenergic Stimulation on Atrial Electrical Activity During Atrial Fibrillation 
Maria V. Pitzalis, Massimo Grimaldi, Giovanni Luzzi, Matte0 Anaclerio, 
Cinzia Forleo, Paolo Rizzon. Cardiology Institute, Universify of Bari, 
lfaly 
Background: During atrial fibrillation (AF) the possibility of increasing con- 
duction velocity could be able to organize atrial electrical activity by increasing 
the AF circuit dimension. We evaluated whether handgrip (105 seconds at 
40% of maximum effort, H), an adrenergic stimulus, modifies left and right 
atrial electric activity in pts with persistent AF, before and after lbutilide (1 mg 
i.v., Ibu) infusion. 
Methods: After informed consent, 8 pts underwent the following evalua- 
tions: baseline; H; saline infusion; handgrip; Ibu; H; a second dose of Ibu; H. 
Saline and Ibu were given in IO min. The number of atrial deflections > 0.1 
mV/min at the level of right (by a catheter in free wall) and left (by a catheter 
in the coronary sinus) atria were recorded and the number of cycles/min 
calculated. 
Results: Ibu significantly reduced cycles/min in both atria (p < 0.05). H 
significantly reduced them in comparison with baseline, saline and Ibu (see 
figure; l = p < 0.05). Four pts showed cardioversion during Ibu, 2 during H. 
CyCidIlli” fgg Intervention 
I aanclgrip 
mase,inc Saline Ibutilidc 1 lbutilide 2 
Conclusion: During AF, the adrenergic stimulus caused by H is able to 
organize atrial activity as the result of an increased conduction velocity that 
causes a reduction in the number of AF circuit. The effect of a combined 
use of drug increasing atrial refractory period and intervention increasing 
conduction velocity opens new possibilities in the treatment of AF. 
1164-71 Age-Related Increase in Atrial Flutter and Secular 
Trends Over 3 Decades in Older Men and Women 
of Rochester, Minnesota 
Teresa SM. Tsang, George W. Petty, Marion E. Barnes, JoRean D. Sicks, 
Michael W. O’Fallon, Paul A. Friedman, Jack P. Whisnant, James 
B. Seward, Bernard J. Gersh. Mayo C/inic, Rochester, MN, USA 
Objective: There is evidence that the thromboembolic risk associated with 
atrial flutter is significantly increased over that of the general population. 
Little epidemiologic data exists with respect to incidence of atrial flutter, and 
whether this atrial arrhythmia may assume an important role in the aging 
population of the U.S. is unknown. 
Methods: The study population included 2052 persons (45% male) aged 
~45 years who comprised the matched control group for a stroke case-control 
study. The diagnosis of atrial flutter was confirmed by ECG for all subjects. 
Results: Atrial flutter increased with age in both genders, and reached 
approximately 5% in women, and 8% in men ? 85 years (Table). Atrial flutter 
occurred more frequently in men than in women within the same age stratum. 
For both genders, a secular trend of increasing atrial flutter over the 3 time 
periods was observed. 
*p = 0.02, #p = o.o5,*p = 0.04testforcalendaryeartrend within age-sexgroup 
Conclusion: Secular trends over 3 decades indicate an increase in atrial 
flutter among older adults. Reasons for this age-related increase and the 
observed trends require further investigation. 
I 1164 72 Two Point (1986 and 1996) Prevalence of Atrial Fibrillation in Adult Residents of Rochester, 
Minnesota: A Population-Based Study 
Teresa SM. Tsang, Irene Meissner, JoRean D. Sicks, Marion E. Barnes, 
George W. Petty, Michael W. C’Fallon, Bijoy K. Khandheria, Jack 
P. Whisnant, James B. Seward, Bernard J. Gersh. Mayo C/ink, Rochester, 
MN, USA 
Background: A significant increase in atrial fibrillation (AF) prevalence from 
1968 to 1989 was found for men but not women in the Framingham Hear-i 
Study. Reasons for this trend remain poorly understood. We determined 
two-point AF prevalence in population samples from a community to assess 
for a secular trend. 
Methods: The 1986 and 1996 study populations included randomly se- 
lected residents aged >45 years from Rochester (n = 1684) and Olmsted 
County (n = 598) equally distributed over 1 O-year intervals. Presence or 
absence of AF was determined by medical record review with ECG confir- 
mation. 
Results: AF prevalence increased with age, exceeding 12% at age 2 75 
y. Prevalence was higher in men than in women in the older (~65 y) age 
groups (Table). 
Conclusion: Based on cross-sectional data, AF prevalence appears to 
have increased from 1986 to 1996, with the greatest rise in the ?5 y age 
group. Increasing AF prevalence in the progressively aging U.S. population is 
predicted to have significant implications for healthcare and socioeconomic 
planning. 
Age45-54y Age55-64~ Age6C74y Agee75y 
n % n % n % n % 
Women 
1986 l/212 0.5 31206 1.5 81202 3.0 36R36 12.2s 
1996 o/70 0 o/77 0 3/63 4.8 15190 17.0* 
Men 
1986 11203 0.5 z/209 1 .o 131215 6.0 26/174 16.15 
1996 Ii71 1.4 l/80 1.3 4155 7.3 19192 21.0* 
“p < 0.05 for year 1996 compared to 1986 within age strata; §p < 0.05 test for age trend 
within calendar year-gender group 
1164-73 Changes in P-Wave Dispersion and P-Wave 
Duration Following Open Heart Surgery Correlate 
With the Peak Incidence of Atrial Fibrillation 
James P. Tsikouris’,“, C. Michael White’.“, Alisha Dunn’~‘, Satyendra Giri’ , 
Jeffrey Kluger’,s ‘Hartford Hospital, Hartford, Connecficuf; ‘University of 
Connecticut Schools of Pharmacy and Medicine, Sforrs, Connecficuf, USA 
Background: Increased P-wave dispersion (P-disp) and maximum P-wave 
duration (P-max) predict development of atrial fibrillation (AF) in the general 
population. Since AF after open-hear-l surgery (OHS) follows a unique pattern 
with a significant peak on days 2-3, the present study evaluated whether a 
time-dependent relationship of P-disp and P-max existed after OHS. 
Methods: A 12-lead ECG was obtained in 13 patients on the day of 
surgery (DOS) 5 6 hours after OHS, and on post-OHS days 1-4. The 
P-wave duration was measured manually in all 12 leads in a blinded fashion. 
Measurements were performed using a precision rule and a magnifying lens. 
The P-max and the minimum P-wave duration (P-min) from each of the 12 
leads were calculated. P-disp was defined as the difference between the 
P-max and P-min. Data were analyzed using repeated measures ANOVA 
with Bonferroni corrected t-test. 
Results: Comparisons between all groups revealed a significant increase 
in P-disp between post-OHS day 1 and 2 (35.0 + 4.91 vs 42.61 f 4.59 ms, 
p < 0.05), and post-OHS day 1 and 3 (35.0 i 4.91 vs 44.61 f 5.94 ms, p 
< 0.05). There was also an increase in the P-max between post-OHS day 
1 and 3 (101.4 & 7.7 vs 111.4 f 5.89 ms, p i 0.001). On post-OHS day 4, 
both P-disp and P-max, after increasing on post-OHS day 2 and 3, returned 
to similar values as the DOS. 
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Conclusions: This study shows that nonuniform atrial conduction (P-disp) 
is greatest on post-OHS day 2 and 3, and prolonged atrial conduction time 
(P-max) is greatest on post-OHS day 3. These findings coincide with the time 
period of greatest risk of AF after OHS. 
Variable DOS Day 1 Day 2 Day 3 Day 4 
P-disp (ms) 40.1 f 7.0 35 lk 4.9 42.6 zk 4.6 44.6 zt 5.9 40 i 4.8 
P-max (ms) 107 i a.9 101 zt 7.7 108f5.5 111 * 5.9 10716.1 
1164-74 Quantitative Characterization of P Wave From 
Limb Leads of Surface Electrocardiogram to 
Identify Left Versus Right Pulmonary Vein Origin 
Manisha Ashar, David J. Callans, Dusan Kocovic, Behzad Pavri, Francis 
E. Marchlinski. University of Pennsylvania Health System, Philadelphia, PA, 
USA 
Background: Patients with paroxysmal atrial fibrillation may have focal atrial 
premature beats (APBs) originating from the pulmonary veins (PVs). Intrac- 
ardiac mapping of these foci is often difficult due to infrequent APBs. We 
sought to evaluate and quantify P wave (Pw) characteristics on limb leads of 
surface electrocardiogram (EKG) using PV pacing to distinguish left vs. right 
PV origin. 
Methods: PV pacing was performed from the proximal 1 cm of each of 
the 20 PVs at pacing cycle length of 600 ms in IO patients. Surface EKG 
was recorded and filtered at 30-500 Hz (Prucka Engineering). Pw amplitude 
(Amp) and duration (Dur) was measured in 3 consecutive Pws in 12 leads 
during stable capture. Pw were defined as isoelectric when Amp was x0.03 
mV. 
Results: 
Table 1. *p < 0.05 
Amplitude mV Dur ms 
I II III 11/111 aVL PW 
LVP 0.01 zkO.03 0.15z!z0.07 0.13i.O.06 1.1 ho.16 -0.07iO.03 161 A36 
Range -0.03-0.06 0.03-0.28 0.03-0.22 0.8-l .36 -0.12-0.01 108-223 
RPV 0.09iO.03” 0.14iO.06 0.07f0.04* 2.3zkl.l” 0.00+0.05 112+14’ 
Ranoe 0.06-0.18 0.05-0.28 0.02-0.17 1.25-6 -0.09-0.09 W-137 
Table 2. Pw characteristics which distinguished L from R PV origin were: 
Criteria 
a. Pw Amu lead I < 0.05 mV 
Sensitivity (%) 
95 
Specificity (%) 
100 -
b. Pw Amp 11/111 < 1.5 100 90 
c. Isoelectric/negative Pw lead aVL 100 40 
d. PwDur ? 120 ms 100 65 
a+b+c+d 98 75 
Conclusions: 1 Pacing right and left PV demonstrates unique Pw char- 
acteristics. 2. Quantitative assessment of these EKG features may help 
regionalize focal triggers of atrial fibrillation from PVs. 
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[II 65-93 1 Long-Term Survival Following Permanent 
Pacemaker Implantation in Patients With Dilated 
Cardiomyopathy 
Peter A. Brady, Win K. Shen, Mehdi Razavi, Linda K. Hyberger, David 
0. Hodge, David L. Hayes. Mayo Clinic, Rochester, Minnesota, USA 
Background: Short-term studies in selected patients (Pts) with dilated car- 
diomyopathy (DCM) suggest that standard dual chamber pacing (SDCP) 
improves hemodynamics and reduces symptoms. However, whether short- 
-term responses to SDCP predict improved long-term survival in Pts with 
DCM and congestive heart failure (CHF) symptoms remains unknown. 
Methods: To determine this we compared survival of all Pts with DCM 
and CHF who underwent SDCP at Mayo Clinic between 1992 and 1999 
(Group 1) to Pts with DCM and CHF who did not undergo SDCP (Group 2). 
Age and sex-specific population mortality rates were used to estimate the 
expected mortality for this group. 
Results: CHF was the primary indication for SDCP in group 1 Pts although 
3 (6%) also had symptomatic bradycardia. All CHF Pts (Groups 1 and 2) 
were on maximal tolerated CHF medication at the time of the study. Mean 
follow-up was 1.3 & 1.3 years (Group 1) versus 3 f 2 years (Group 2). Patient 
characteristics and survival (Kaplan-Meier estimates) is shown below. 
Group Age yrs 
&SD 
EF < 50%; 
n w 
P value 
1 53 (74) 70*11 50 (96) 64 56 0.22 
2 216 (42) 77+ 12 78 (57) 76 61 
Even after adjusting for age, sex and baseline EF, SDCP was not asso- 
ciated with a survival benefit in Pts in group 1 versus groups 2. Expected 
survival of group 1 Pts was 96% and 92% at 1 and 2 years respectively (p < 
0.0001 versus observed survival). 
Conclusions: Despite short-term hemodynamic benefit, in the absence of 
conventional indications, SDCP in Pts with DCM and CHF is not associated 
with improved long-term survival. Whether alternative pacing modalities, 
such as biventricular pacing, which improves hemodynamics and exercise 
capacity in Pts with CHF and LBBB is associated with improved long-term 
survival in Pts with CHF needs further evaluation. 
11165-94 ( Transcranial Doppler Detection of Microemboli 
During Endocardial Biventricular Pacing in 
End-Stage Heart Failure 
Florence Leclercq, Saad Kassnasrallah, Jean-Christophe Macia, 
Jean-Marie Blard, Jean-Luc Pasquie, R. Grolleau. Arnaud de Weneuve 
Hospital, Department of Cardiology, Universify of Monfpellier, France 
Background: Left ventricular (LV) endocardial pacing through trans-septal 
catheterization was recently reported as an alternative to epicardial or en- 
dovenous LV pacing in patients with end-stage heart failure and widened 
QRS. However, the thromboembolic risk associated with deliberate or inad- 
vertent LV endocardial pacing remains unclear. 
Methods: Transcranial Doppler (TCD) monitoring of microemboli signals 
(MESS) was performed in eight patients with end-stage cardiomyopathy and 
widened QRS (QRS duration P 180 ms), before (3 f 2 days) and after (10 
I+= 5 days) placement of a endocardial lead in the LV via jugular transseptal 
catheterization. Right atrial (RA) and right ventricular (RV) leads were placed 
via the subclavian vein in order to obtain a biventricular (LV and RV; n 
= 3) or a triple chamber (RA, RV and LV, n = 5) configuration of pacing. 
Four patients were previously treated with anticoagulant therapy related to 
paroxysmal (n = 1) or permanent (n = 3) atrial fibrillation. After LV lead 
placement, all patients were treated with oral anticoagulant therapy with a 
target international normalized ratio of 3. 
Results: No neurologic event occurred with a mean follow-up of 10 i 
5 months, MET’s (mean 30 h 6 per patient during one hour monitoring) 
were detected before LV lead placement in 2 patients with chronic atrial 
fibrillation. Mean count of MET’s was unchanged in these 2 patients after LV 
lead placement (mean 25 f 5 per patient; p = 0.5). Endocardial LV pacing 
was not associated with occurrence of MET’s in the 6 other patients. 
Conclusion: LV endocardial pacing performed in patients with end-stage 
cardiomyopathy and treated with oral anticoagulant therapy, did not appear 
to be associated with occurrence or enhancement of microemboli signals 
detected with TCD. 
!-.--,A 1165 95 Variations in Selection of Dual Chamber and Rate 
Responsive Pacemakers: Influence of Geographic 
Region and Physician Gender 
Dhiraj D. Narula, Wael A. Jaber, Margot E. Vloka, John S. Kim’, Michael 
D. Larsen’, Raja’a M. Kaddaha, Frederick A. Ehlert, Jonathan S. Steinberg. 
St. Luke’s=Roosevelt Hospital Center, New York, NY; ‘Medtronic Inc., 
Minneapolis, MN, USA 
Age and gender have been reported to affect utilization of dual chamber (D) 
and rate responsive (E) pacemakers. Whether regional variations in practice 
or physician (MD) gender impact on this is not known. 
Methods: 293,518 (48% female (F)) consecutive US pts with new PPM 
over 5 y were identified from an industrial database. Utilization of D-PPM 
vs. single chamber & of R-PPM vs. non R-PPM was analyzed. Implanting 
MD gender was identified in 161,029 pts using software to match common 
gender-specific names. A logistic regression was performed to assess the 
effects of pt age, pt gender & region of implant, and, in a second analysis, 
MD gender, on selection of PPM type. 
Results: F gender was associated with lower use of D-PPM (OR 0.92) 
& R-PPM (OR 0.78, p < O.OOOl), as was older age (p < 0.0001). The 
region of implant affected use of both D-PPM and R-PPM (see table), with 
the Mid-Atlantic region having the lowest utilization of R-PPM and D-PPM. 
Gender differences were accentuated in some regions (p = 0.002). Female 
MDs were more likely to use D-PPM (OR 1.08, 95% Cl 1.04-1.11) and 
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R-PPM (OR 1.47, 95% Cl 1.32-1.64) similarily in both M and F pts (p = 
NS). 
Region Paci MOUtl W.N. E.N. W.S. E.S. Mid New S. 
fit tain cent Cent Cent. Cent Atl. ElXl. Atl. 
OR for 0.96 1.06 1.28 1.0 0.81 0.99 0.8 1.14 1.05 
D-PPM * ’ * * * * * 
OR for 0.89 1.14 1.13 1.25 0.95 1.57 0.67 0.59 1.16 
n.ppN * * * * * * * * * 
W = West, E = East, N = North, S = South, Cent. = Central, Alt. = Atlantic, Eng. = England, 
* = p < 0.05, OR = odds ratio 
Conclusions: The geographic region and the gender of the implanting 
MD impact on the selection of pacing system. Bias against F pts is not 
affected by the gender of the implanting MD but is affected by region. 
1165-96 Doppler Index and Plasma Level of Atrial 
Natriuretic Hormone are Improved by Optimizing 
Atrioventricular Delay in Atrioventricular Block - 
Patients With Implanted DDD Pacemakers 
Noritaka Toda, Toshiyuki Ishikawa’ , Takashi Tsunematsu, Naoki Nozawa, 
lzumi Kobayashi’ , Kazuyuki Miyamoto, Hisaichirou Tsukiyama, 
Shinichi Sumita’ , Kazuo Kimura’, Satoshi Umemura’ Ashigarakami 
Hospifal, Kanagawa; ’ Yokohama City Universit): Yokohama, Japan 
Background: Doppler index (DI) is a sum of isovolumetric contraction time 
and isovolumetric relaxation time divided by ejection time and has a clinical 
value of combined systolic and diastolic myocardial performance. Elevated 
DI means cardiac dysfunction. Elevated plasma level of ANP is associated 
with decreased left ventricular function, We performed a cross over study 
to compare DI and ANP between optimal atrioventricular delay (oAVD) and 
long atrioventricular delay (IAVD) in patients with DDD pacemakers. 
Subjects and Methods: Subjects were 13 patients (5 males, 78.5 f 9.7 
(SD) years old) with AV block and with implanted DDD pacemakers. Ejection 
fraction was 63.4 f 15.1%. We alternated AV delays (125, 150, 175, 200, 
225, 250 msec) and measured LV outflow time-velocity integrals by means 
of pulse Doppler echocardiography and obtained cardiac output (CO). The 
oAVD was defined in individual patient as that which was associated with the 
greatest CO. IAVD was defined 250 msec. oAVD and IAVD were randomly 
programmed. Pacing rate was set at 70/min. Plasma level of ANP, renin, 
adrenaline, noradrenaline, dopamine, cardiothoracic ratio (CTR) in chest 
roentgenogram and echocardiography (DI, LVDd, LVDs, LVEF, A/E) were 
measured one week after programming. AVD was switched to another AVD 
and measurements were repeated after one week. 
Result: oAVD was 158 f 19 msec. DI was significantly lower in oAVD 
than in IAVD (0.701 f 0.258 vs 0.947 f 0.291, p < 0.05). Plasma level of 
ANP was significantly lower in oAVD than in IAVD (22.0 f 16.7 vs 47.7 * 
42.6, p < 0.05). There were no significant differences in plasma level of renin, 
adrenaline, noradrenaline, dopamine and LVDd, LVDs, LVEF, AJE. 
Conclusion: Elevated DI means decreased total cardiac function. Ele- 
vated plasma level of ANP is attributed to an increase in atrial pressure or 
atrial distention. DI and plasma level of ANP was significantly lower in oAVD 
than in IAVD. Our study shows importance of the oAVD setting in patients 
with implanted in DDD pacemakers and DI and plasma level of ANP are 
good indicator for optimizing AV delay. 
I 1165 97 Adjusted Pacemaker Implant Rates are Lower in 
Women Than Men at All Ages-Is Gender Bias at 
Work? 
Dhiraj D. Narula, Wael A. Jaber, Margot E. Vloka, John S. Kim’, Michael 
D. Larsen’, Anton0 Sutander, Frederick A. Ehlert, Jonathan S. Steinberg. 
St. Luke’sRoosevelt Hospital Center; New York, NY; ‘Medtronic Inc., 
Minneapolis, MN, USA 
Among elderly pts receiving permanent pacemakers (PPM), women (W) 
outnumber men (M); this may reflect true differences in disease rates, the 
larger nos. of elderly W, or gender bias. 
Methods: From an industrial database, 296,219 (48% W) consecutive US 
pts with new PPM over 5 y were identified &stratified by quintiles of age. The 
proportions of M and W in each quintile were identified, &the Mantel-Haenzel 
test used to compare these to the proportions of M & W from US census data, 
& to the proportions of M & W with cardiovascular disease (CVD) identified 
in the National Health and Nutrition Examination Survey Ill. The odds ratio 
(OR) was calculated as the ratio of the observed to the expected frequency 
for M to that of W. 
Results: When adjusted for US census data, M were much more likely 
to receive PPM than W in all age groups (see figure, OR 1.45 to 1.78, p < 
0.0001). When adjusted for CVD, M were still more likely to receive PPM 
(OR 1.11-1.88, p < 0.0001). 
Conclusions: M received a greater no. of PPM than expected for their 
numbers in the general population and the prevalence of CVD. This may 
reflect a greater incidence or severity of conduction system disease in M than 
W, or a gender bias in access to PPM therapy. Further study is warranted. 
1165-98 Cardiac Pacing Reduces Falls in Carotid Sinus 
Hypersensitivity: The SAFE-PACE Trial 
Rose Anne Kenny, Rodney S. Bexton, Nick I. Steen, John Bond, D. 
Andrew Richardson. Cardiovascular investigation Unit and MRC Centre for 
Brain Aging, University of Newcastle, UK 
Background: Because retrospective and circumstantial evidence support a 
causal association between carotid sinus hypersensitivity (CSH) and non- 
accidental falls (NAF), our study objective was to determine whether cardiac 
pacing reduced the frequency of falls in a prospective study of patients with 
cardioinhibitory CSH (CICSH). 
Methods: Prospective RCT of cardiac pacing in a consecutive series 
of adults over 50 years attending the ER during a one year period (the 
SAFE-PACE jSyncope And Ealls in the Elderly-Pacing And Carotid sinus 
Evaluation] trial). Patients who had fallen, were cognitively normal, with no 
apparent extrinsic or medical explanation for falls, had carotid sinus mas- 
sage (CSM) supine and upright, with phasic heart rate and blood pressure 
monitoring. Patients were randomised to pacing (RDR, Medtronic) or no pac- 
ing intervention during one year follow up. Primary outcome was frequency 
of falls, secondary outcome frequency of syncope, recorded by daily diary 
cards. CICSH was defined as 3 seconds of asystole during 5 seconds of 
CSM. 
Results: Of 24,264 attendees with falls (35% of all attendees over 50) 
39% were accidental, 26% had a medical explanation, 16% were cognitively 
impaired and 14% were NAFs. Of 1,521 who agreed to CSM, 23% had 
CSH and 16% had CICSH. 175 patients were randomised (73 * IO years; 
60% female; median 3 (I->lOO) falls, over median 1 (O-16) years pre-ran- 
domisation) 70% had sustained injury and 32% fracture during episodes. 
Control and paced patients were matched for baseline clinical characteris- 
tics. Controls were more likely to fall (OR 4.1 (2.4-11.4)) than paced patients. 
Recurrent fallers (2 or more falls in 1 year, including index fall) were more 
likely to fall than other patients (OR 2.5 (1 .I-5.3)). Subjects randomised to 
pacing were more likely to fall in the weeks before they were paced (OR 
2.7 (2.1-3.5)). Recurrent fakers who were paced were less likely to fall than 
recurrent fallers who were not paced (OR 0.35 (0.16-0.57)). Patients who 
had two or more unexplained falls pre-pacing were less likely to have falls 
or syncopal episodes after pacing (n = 64; falls 3 (1.9-4.4); syncope 0.2 
(0.2-0.5); controls 50; falls 12 (6-17.7); syncope 0.9 (O-l .4); p < 0.01; p < 
0.003). 
Conclusion: Cardiac pacing significantly reduces falls and syncope in 
older adults with carotid sinus hypersensitivity. This has major implications 
for health service provision and implications for ACC Pacing Guidelines. 
1165-99 Cardiac Sympathetic Innervation Abnormalities in 
Patients Paced Chronically From the Right 
Ventricular Apex: An l123 
Metaiodobenzylquanidine (MIBG) Cardiac 
Scintigraphic Study 
Emmanuel N. Simantirakis, Vassilis K. Prassopoulos, Stavros 
I. Chrysostomakis, George I. Kochiadakis, Sophia I. Koukouraki, Marina 
K. Kanakaraki, Nikolaos S. Karkavitsas, Panagiotis E. Vardas. Cardiology 
Dept., Heraklion University Hospital, Heraklion, Crete, Greece 
Background: The aim of this study was to investigate whether there are 
MIBG scintigraphic abnormalities in paced patients where the ventricular 
stimulus originates from the apex of the right ventricle and is fully paced. 
Methods: We studied 42 patients, mean age 65 ZIZ 9, -who had been 
paced for a mean period of 32.45 & 18.16 months in DDD mode because of 
complete atrioventricular block. Twenty three healthy individuals aged 64 f 9 
years served as a control group. None of the patients had any condition that 
might affect myocardial adrenergic innervation. All patients underwent planar 
and SPECT myocardial imaging 4 hours after intravenous infusion of 5mCi 
Ii23-MIBG. The heart to mediastinum (H/M) ratio was calculated in order to 
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quantify cardiac MIBG accumulation, while the SPECT study was performed 
in order to investigate the regional distribution of adrenergic innervation. All 
patients undenvent a SPECT TIzo’ myocardial study during the same week 
as the ltZ3-MIBG study. 
Results: The H/M ratio was smaller in paced patients than in the controls 
(p < 0.001). 92.9% of paced patients had regional adrenergic innervation 
abnormalities, mainly in the inferior (100%) and apical (42.6%) wall. 52.4% 
of paced patients had regional perfusion defects in the inferior (100%) and 
apical (27.3%) wall, as well. Although there was a tendency for patients with 
larger duration of pacing to have perfusion defects (p = 0.07), there was no 
correlation between the duration of pacing and MIBG abnormalities, 
Conclusions: Stimulation from the apex of the right ventricle appears to 
lead to disturbances of adrenergic innervation of the ventricular myocardium. 
This provides another reason to seek alternative pacing sites which could 
ensure a more normal activation sequence. 
1165-I 00 Treatment of Paced Patients With Acute 
Myocardial infarction 
Saif S. Rathore, Kevin P. Weinfurt, Bernard J. Gersh, William J. Oetgen, 
Kevin A. Schulman, Allen J. Solomon. Georgetown University Medical 
Center, Washington, DC; Mayo Foundation, Rochester, MN; Delmarva 
Foundation for Medical Care, faston, MD, USA 
Background: Paced rhythms mask the electrocardiographic presentation of 
acute myocardial infarction (Ml) and may result in the inadequate treatment 
of paced patients. 
Methods: Using data from the Cooperative Cardiovascular Project, we 
evaluated Medicare beneficiaries age 65 years and older treated for a con- 
firmed Ml between 1994 and 1996 (n = 102,249) for a paced rhythm. Paced 
and non-paced patients’ clinical characteristics were compared by chi-square 
and t-test analysis. To determine the influence of pacing on treatment, pa- 
tients were evaluated for the provision of two ACCiAHA acute Ml recom- 
mended therapies (ASAon arrival, beta blockers on discharge) in multivariate 
logistic regression models adjusting for demographics, illness severity, treat- 
ment contraindications and hospital characteristics. The influence of pacing 
on short-term mortality was evaluated by unadjusted and adjusted 30.day 
mortality logistic regression models; long-term mortality was evaluated by a 
Cox proportional hazards model (mean follow-up: 582 days). 
Results: 1,954 (1.8%) of patients presented with a pacemaker rhythm. 
Paced patients were less likely to receive ASA (OR: 0.69, 95% Cl: 0.59, 0.76) 
and beta blockers (OR: 0.79, 95% Cl: 0.56, 1.11) compared to non-paced 
patients. Mortality rates were higher for paced patients at 30-days (20.9% 
vs. 18.1%, p = 0.001) and one year (47.1% vs. 36.1%, p = 0.001). When 
adjustments were made for illness severity and diminished use of ASA and 
beta blockers, there was no increased mortality risk at 30 days (OR: 1.03,95% 
Cl: 0.90, 1.16), but paced patients remained at increased risk of long-term 
mortality (HR: 1.12, 95% Cl: 1.06, 1.18). 
Conclusions: Paced patients were less likely to receive indicated acute 
MI treatment and were at greater risk for mortality than non-paced patients. 
However, this mortality risk diminished when adjusted for Ml treatment, sug- 
gesting improved MI recognition and treatment may improve outcomes, par- 
ticularly in the short-term. 
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1166-59 Lipophilic Betablockers Exert Greater Effect on 
Dynamic Ventricular Repolarization Than 
Hydropilic Ones 
Maria V. Pitzalis, Massimo lacoviello, Francesco Massari, Cinzia Forleo, 
Filippo Mastropasqua, Paolo Rizzon. Cardiology Institute, University of Sari, 
/tab 
Background: It has been suggested that lipophilic betablockers have greater 
antiarrhythmic effects than hydrophilic betablockers in post-myocardial infarc- 
tion patients and animal models which is not due to a different modulation 
of the autonomic nervous system. The aim of this study was to evaluate 
the effect of lipophilic betablocker on ventricular repolarization in normal 
subjects. 
Methods: Seventeen normal subjects entered in this randomized, sin- 
gle-blind cross-over study designed to compare the effects of nadolol (80 
mgiday) and slow-release metoprolol (200 mg/day) on 24-hours ventricu- 
lar repolarization using the ELATEC system (ELA Medical). The parameters 
considered were: the mean value and the standard deviation of QT evaluated 
at the apex and at the end (QTe) of the T wave, the values corrected for heart 
rate and the slope of QT/RR linear relationship. The effects of the two agents 
were evaluated only on those parameters reproducible at short-term (15 * 2 
days). 
Results: The most reproducible parameters were: the mean values of QT 
apex corrected for heart rate (QTac) and the slope of QTe/RR (QTe slope). 
Nadolol was associated with a greater adrenergic blockade than metoprolol 
(lengthening of mean RR interval: +25 j, 7 and +I7 f 8%, respectively: p 
< 0.001) and a lower effect on ventricular repolarization (reduction of QTac: 
-0.6 f 3 and -2.5 f 2.1% respectively, p < 0.01; reduction of QTe slope: 
-5 zk 16~s -15 + 15%, p < 0.05). 
Conclusion: At the dosages used in the study, metoprolol showed lower 
adrenergic blockade but greater effect on ventricular repolarization than 
nadolol. This is the first evidence that the lipophilicity of betablockers plays 
an important role on ventricular repolarization dynamicity. 
/ 1166-60 1 Does Dispersion of Repolarization Depend on 
Cardiac Cycle Length and Should it be 
Rate-Corrected? Observations in 1096 Healthy 
Subjects 
lrina Savelieva, Shankara B. Reddy’ , A. John Camm, Marek Malik. St 
George’s Hospital Medical School, London, UK; ‘Marquette Medical 
Systems, Milwaukee, WI, USA 
Background: (1) Recognzing the importance of rate-correction for QT inter- 
val, it has been assumed that a similar approach is need for QT dispersion. 
(2) Recently, it has been suggestecl that the relation between QT and RR 
intervals may be different from that described by existing formulae for rate- 
correction, and (3) a late phase of ventricular repolarization (Tpeak-Tend 
interval (TpTe) in the surface ECG) is rate-independent. 
Methods: The relation between dispersion of QT, QTpeak (QTp), TpTe 
intervals and RR interval were evaluated in 1096 healthy volunteers (age 33 
f 12; 910 men). Measurements were processed using QT Guard software 
(Marquette Medical Systems) in a simultaneously recorded 12-lead ECG. 
Dispersion was determined (1) by subtracting the minimum from the maxi- 
mum values of the QT, QTp, TpTe intervals, and (2) by computing interlead 
standard deviations (SD) of the corresponding intervals. 
Results: Although QT and QTp intervals closely correlated with RR in- 
terval (r = 0.81 and 0.79, p < O.OOOl), this correlation was weak for QT and 
QTp dispersions (r = 0.16 and 0.12; p < 0.01) and QT and QTp SD (r = 0.16 
and 0.09; p < 0.02). TpTe interval showed a poor relation to RR interval (r = 
0.33, p < 0.02), and none of the TpTe dispersion parameters depended on 
cardiac cycle length (r = -0.02-0.04; p = 0.56). 
Conclusion: (1) Dispersion of total ventricular repolarization and of its 
early phase are weakly related to RR interval; (2) dispersion of the late 
phase of repolarization does not depend on heart rate; (3) rate-correction of 
dispersion of repolarization using routine formulae designed for QT interval 
may be inappropriate. 
/ 1166-61 / QT Dispersion Should Not be Corrected for Heart 
Rate in Normal Subjects and Patients With 
Ventricular Tachycardia 
Vassilis Vassilikos, Apostolos Psichogios, John lakovou, Themos Maounis, 
Antonis Manolis, Dennis V. Cokkinos. Is’ Cardiology Department Onassis 
Cardiac Surgery Center, Athens, Greece 
Background: There is no consensus of opinion whether QT dispersion 
(QTD) should be corrected for heart rate (HR). We investigated whether 
programmed HR changes affect QTD and its rate-corrected values in normal 
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subjects and patients (pts) with a history of sustained ventricular tachycardia 
@VT). 
Methods: We prospectively studied 32 healthy individuals (age 38.7 + 
13.5, 21 male, Group A), who underwent electrophysiology study for eval- 
uation of supraventricular tachycardias or syncope and 16 pts (age 56 f 
14.6, 14 male, Group 6) evaluated for UT. QTD and corrected for HR QTD 
(QTDc) were calculated at rest, and during continuous right atrial pacing for 
one minute at 100, 120 and 150 beatdmin. The QTD was defined as the 
difference between the maximum and minimum QT interval on the simulta- 
neously recorded 12-lead ECG (Bard EP Labsystem). The QT intervals were 
measured with a custom-made computer software. The QTDc was corrected 
for HR using Batett’s formula [QTDc = QTD/d(R-R)]. 
Results: QTD did not change significantly from baseline at any HR in 
both groups. However, QTDc increased significantly with atrial pacing in a 
similar manner both in normal individuals and in pts with sVT (table). 
SR 
OTD (Gr A) 37116 
QTD (Gr 6) 36f16 
QTDc (Gr A) 38ilP 
QTDc (Gr 8) 39119 
*p = 0.02, **p = 0.003 
100 beatshin 120 beatslmin 150 beatslmin 
36zk15 38k 16 35* 15 
36zk 10 34* 13 43* 12 
45&16* 50 f 18* 54 * 22* 
47 * 14** 46 * 19x* 68 i 20** 
Conclusions: QTD does not change over a wide range of heart rates in 
normal individuals and in pts with sVT, and should be used in its uncorrected 
form. Correction by Bazett’s formula results in significant QTDc prolongation, 
yielding values which by many investigators are considered abnormal. 
) 1166-62 1 Changes in the ST-lsointegral Maps in Brugada 
Syndrome Family Members 
Raul Weiss, Vladimir Shusterman, Anna Beigel, Benhur Aysin, 
Doris Cavlovich, Barry London, Dennis M. McNamara, Susan Brode, 
Venkateshwar Gottipaty, Kelley P. Anderson. Cardiovascular 
Institute/UPHS, Pittsburgh, PA, USA 
introduction: Right bundle branch block and ST segment elevation in leads 
VI to V3 is the hallmark of Brugada Syndrome. ECG at times is non-diagnos- 
tic because the ECG criteria is only partially met. Detailed characterization of 
the body surface distribution of ST-E may improve identification of affected 
persons. 
Methods: We examined QRST and ST-isointegral maps of 6 affected 
members of a Brugada syndrome family (Grl) and 5 unrelated controls 
(GR). Signals from 32 pre-assigned thoracic leads were reconstructed into 
19Ppoint maps. QRST and ST integrals were calculated on the average 
QRST complex in each lead after application of a special baseline correction 
algorithm. Results are in mV*ms. 
Results: Mean QRST-integrals were not significantly different between 
the groups (5.45 f 24.2 and 11.4 f 6.54, p = 0.72). Means of the absolute 
values of ST-integrals were significantly higher in Grl (25.5 f 3.19) than in 
Gr2 (12.5 f 5.30, p = 0.006). Spatial dispersion of ST-integrals measured 
as standard deviation (SD) and range (RN) were also significantly higher in 
Grl than in Gr2 (SD: 29.2 f 4.69 and 16.6 i 7.56, p = 0.018, RN: 160 f 
43.8 and 86.8 + 40.4, p = 0.006). In Grl, amplitude of the maximum positive 
ST-integral (positive pole) declined after infusion of epinephrine (122 f 50.5 
and 101 f 48.6, p = 0.046) but did not change significantly after intravenous 
propranolol. 
Conclusions: Mean absolute ST-integral and dispersion of ST-integrals 
were greater in affected family members than unrelated controls. ST-isointe- 
gral maps might provide markers of Brugada Syndrome unobtainable from 
standard 12 lead ECG. 
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880-l Heart Rate Turbulence in Post-Ml Patients With and 
Without Diabetes 
dictor in post-MI patients. HRT is believed to reflect a baroreflex triggered 
by ventricular premature complexes (VPCs). According to this hypothesis, in 
patients with autonomic dysfunction HRT method should not provide signifi- 
cant results. This study investigated the performance of HRT in patients with 
and without diabetes. 
Methods: The study was performed in patients of the placebo arm of the 
EMIAT trial. Out of a total of 586 patients, 95 suffered from diabetes and 
491 did not. Primary endpoint was total mortality, median follow up was 22 
months. HRT was determined in a 24-hour Holter ECG performed 2 weeks 
after the index infarction according to the recently published methodology. 
A Cox-proportional hazards analysis was performed with respect to age, 
mean heart rate in Halter, HRV index, Ml history, LVEF and HRT, all with 
prospectively set dichotomy limits. 
Results: 2-year mortality in patients with diabetes mellitus was 26.3% and 
11.6% in patients without diabetes. HRT was the strongest multivariate risk 
stratifier in patients without diabetes, while in patients with diabetes, the only 
independent predictor was mean heart rate. The results of the multivariate 
Cox regression analysis are listed in the Table (only significant factors are 
shown). 
Variable 
Mean RRI 
Previous MI 
LVEF 
Diabetes No diabetes 
Relative hazard P Relative hazard P 
3.3 0.01 
- 2.0 0.01 
1.9 0.03 
HRT 4.3 <O.OOOi 
Conclusion: In patients without diabetes, HRT is a very potent risk 
stratifier. In contrast, there is no association with mortality in patients with 
diabetes. Our findings support the hypothesis that HRT is mediated by a 
autonomic reflex. 
2:15 D.m. 
880-2 Altered Fractal Properties of Heart Rate Dynamics as 
a Predictor of Sudden Cardiac Death in the Elderly 
Timo H. Makikallio, Raul D. Mitrani, Agustin Castellanos, Robert 
J. Myerburg, Leif B. Sourander, lsmo Rbiha, Heikki V. Huikuri. Die: of Card., 
Univ. of 00/u, Finland; Div. of Card, Univ. of Miami, FL, USA 
Background: A specific abnormality in the short-term fractal properties of 
heart rate (HR) dynamics predicts mortality in the patients with heart failure 
and has also been observed in the patients with life-threatening arrhythmias. 
We tested the hypothesis that abnormal fractal characteristics of HR dy 
namics predict sudden cardiac death also in a random population of elderly 
subjects. 
Methods: A random sample of 347 subjects of age > 65 years, who 
had a comprehensive clinical evaluation, laboratory tests and 24-hour ECG 
recordings were subsequently followed up for 10 years. HR dynamics, in- 
cluding traditional R-R interval variability measures along with long (j3) and 
short-term (a) fractal scaling exponents, were analyzed from the baseline 
24-hour ECG recordings. 
Results: By the end of the IO-year follow-up, 184 had died and 163 
were still alive. Seventy-four subjects had died of cardiac cause, and 28 
deaths were defined as sudden cardiac deaths occurring within one hour 
after the onset of the symptoms and without a non-cardiac cause of sudden 
death at autopsy. In univariate analysis, reduced 01 (~1.0) was the best 
HR variability index as a predictor of cardiac mortality (relative risk 2.4, 
95% Cl, 1.8-3.1, p < 0.0001). Abnormal a-value was a particularly strong 
predictor of the occurrence of sudden cardiac death (relative risk 4.0, 95% 
Cl, 2.5-6.5, p < O.OOOl), but it did not predict the non-cardiac causes of 
death. After adjusting for demographic variables, functional class, history 
of heart disease or congestive heart failure, cardiac medication, as well as 
lipid and glucose values in the multivariate proportional hazards analysis, 
reduced a-value remained as an independent predictor of sudden cardiac 
death (relative risk 3.6, 95% Cl, 2.0-6.7, p < 0.0001). 
Conclusions: Altered short-term fractal properties of HR dynamics an- 
alyzed from 24-hour ECG recordings indicate an increased risk for cardiac 
mortality, particularly sudden cardiac death, in the random population of 
elderly subjects. 
Petra Batthel, Georg Schmidt, Marek Malik’, Raphael Schneider, 
Alexander Hierl, A. John Camm’, Albert Schbmig. Deutsches Herzzenfrum 
& 1. Medizinische Klinik, Jechnische LJniversit#f Miinchen, Munich, 
Germany; ‘St George’s Hospifal Medical School, London, UK 
Background: Heart Rate Turbulence (HRT) is a newly established risk pre- 
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El 880 3 Baroreflexsensitivity and Heart Rate Variability are independent Risk Indicators for l-Year-Mortality in 
Patients After Acute Transmural Myocardial 
Infarction and Individually Optimized Therapy: 
Results of the Post-Infarct Risk Stratification Study 
(PIRS) 
Karlheinz Seidl, Monika Rameken, Karl GohI, Frank Gietzen, 
Christine Huber, Christine Strunk-Mueller, Jochen Senges. PlRS Study 
Group, Germany 
PIRS is a prospective multicenter study for risk stratification in patients (pts) 
with acute myocardial infarction (AMI) after individually optimized acute and 
long term therapy. 
Aim of the study was to evaluate which independent RI identifies high 
risk pts for mortality following optimal treatment in the 1990ies? All pts 
underwent risk stratification at day 7-14. The following risk indicators (RI) 
were predefined: 1) EF 5 40%, 2) Holter ECG positive, if one of the following 
parameters was positive: a) 110 VPBlh, b) 34 couplets/24 h, c) ~1 salves/24 
h, 3) late potential (LP), 4) heart rate variability 5 75 ms (HRV) and 5) 
baroreflex sensitivity 5 3 ms/mmHg (BRS). 
Results: In PIRS, 1029 pts (mean age 59 f 11 yrs, 77% male) with AMI 
(an?erior AMI 46%) were enrolled after individually optimized acute therapy 
(acute revascularisation: 75% [thrombolysis 36%, primary angioplasty 50% 
and both 14%], aspirin in 96% and B-blockers 77% of pts in the first 24 
h, ACE-inhibitors in 63% of pts in the first 48 h) plus optimized long-term 
treatment (aspirin 90%, p-blockers 79%, ACE-inhibitors 71%, statins 38%). 
One year follow up was complete in 97% of pts. During a median follow up 
of 24 months (quartiles 15-32 months) mortality was 6.4%. 
Using Cox regression analysis independent risk factors for mortality were: 
Atria! fibrillaticrl 
Age z 70 yrs 
EF 5 40% 
BRS 5 3 ms/mmHg 
HRV (SDNN 5 75 ms) 
“adjusted 
Risk ratio* Confidence interval $3 value 
3.34 1.1-10.19 0.034 
2.62 1.49-4.58 <O.OOl 
2.36 1.34-4.17 0.003 
2.20 1.214.01 0.01 
2.01 1.15-3.52 0.015 
Conclusion: 1) Total mortality is 6.4% during a median 2 year follow up 
in pts with AMI and individually optimized acute and long-term treatment. 2) 
BRS and HRV, both markers of autonomic dysbalance, are independent RI 
for mortality in pts with AMI, discharged from the hospital. 
2:45 p.m. 
l_I 880 4 The Effect of Infarct Location on Magnetocardiographic QRS Complex Late Fields in 
Post-Infarction Patients With Sustained Ventricular 
Tachycardia 
Petri Korhonen, Markku Makijarvi, Lauri Toivonen, Juha Montonen. Division 
of Cardiology, Helsinki University Central Hospifal, Helsinki; Laboratory of 
Biomedical Engineering, Helsinki University of Technology Espoo, Fin/and 
Background: Time-domain analysis (TDA) of magnetocardiographic (MCG) 
late fields of the QRS complex is sensitive in identification of patients with 
ventricular tachycardia (VT) after myocardial infarction (Ml). Fragmentation 
analysis (FRA) examines the number of polarity changes within the QRS 
complex which is increased in VT patients. The aim was to compare TDA 
and FRA in identification of VT patients in a case-control study and to examine 
if Ml location affects the results. 
Methods: Altogether 136 patients with remote Ml were included, 53 with 
and 83 without history of sustained VT. Ml was anterior in 63 and inferior in 52 
patients. High-resolution MCG was recorded. Three TDA parameters (QRS 
duration, low-amplitude signal duration and root-mean-square amplitude of 
the low amplitude signal) were calculated analogous to signal-averaged 
ECG. Abnormal values in two of the parameters were required for a positive 
late field. For FRA two parameters describing the number of polarity changes 
in QRS were calculated; at least one had to be abnormal to classify FRA 
analysis positive. Cut-point values were selected by optimizing the sum of 
sensitivity and specificity of each parameter. 
Results: Both methods performed well in classifying patients into VT and 
no VT groups. The classification was slightly better in anterior than in inferior 
MI, and TDA performed slightly better than FRA (Table). 
Table. The sensitivity and specificity of TDA and FRA in VT identification 
TDA sensit. TDA specif. FRA sensit. FFiA saecif. 
All Patients 
Anterior MI 
Inferior MI 
81% 72% 87% 61% 
88% 75% 89% 61% 
81% 64% 75% 61% 
Conclusion: Magnetocardiographic late fields and QRS fragmentation 
can identify post-Ml patients prone to sustained VT. The accuracy seems 
especially good in anterior MI. 
3:00 p.m. 
880-5 Value of Classic and New Risk Indicators for 
ldentifvina Patients at Hiah Mortalitv Risk: Results 
of the PO&Infarct Risk &atification Study (PIRS) 
Karlheinz Seidl, Monika Rameken, Karl GohI, Frank Gietzen, 
Christine Huber, Christine Strunk-Mueller, Jochen Senges. PlRS Study 
Group, Germany 
PIRS is a prospective multicenter study for risk stratification in patients (pts) 
with acute myocardial infarction (AMI) after individually optimized acute and 
long term therapy. 
Aim of the study was: which independent RI identifies high risk pts for 
mortality best following optimal treatment in the 1990ies? All pts underwent 
risk stratification at day 7-14. The following risk indicators (RI) were prede- 
fined: 1) EF 5 40%, 2) Holter ECG positive, if one of the following parameters 
was positive: a) >I0 VPBA, b) ~4 couplets/24 h, c) ~1 salves/24 h, 3) late 
potential (LP), 4) heart rate variability (HRV) 5 75 ms and 5) baroreflex 
sensitivity 5 3 ms/mmHg (BRS). 
Results: In PIRS, 1029 pts (59 f 11 yrs, 77% male) with AMI (anterior 
AMI 46%) were enrolled after individually optimized acute therapy (acute 
revascularisation: 75% [thrombolysis 36%, primary angioplasty 50% and 
both 14%], aspirin in 96% and /?-blockers 77% of pts in the first 24 h, early 
ACE-inhibitors in 63% of pts) plus optimized chronic therapy (aspirin 90%, 
B-blockers 79%, ACE-inhibitors 71%, statins 38%). One year follow up was 
complete in 97% of pts. During a median follow up of 24 months mortality 
was 6.4%. 
RI % of uts RR Cl PPV Sensitivitv Saecificitv _, 
EF ( 40% 18% 2.4 1.3-4.3 16% 46% 84% 
EF + BRS 6% 3.8 1.6-8.9 29% 31% 96% 
EF + HRV 6% 2.4 1.1-5.2 21% 20% 95% 
EF + >I0 VPBih 5% 2.3 1.1-5.0 26% 20% 96% 
EF + Afib 0.7% 8.1 2.3-29.0 43% 5% 99% 
EF+HR>lOObom 2% 4.0 1.3-13.0 27% 7% 99% 
[RR = multivariate risk ratlo adjusted to 10 variables, including age, sex, prior AMI, dia- 
betes mellitus (Cox regression analysis), Cl = confidence interval, PPV = positive predic- 
tive value.] 
Conclusion: 1) For riskconsiderations EF must always be included. Only 
in combination with EF the PPV reaches acceptable values. 2) The highest 
mortality risk have pts after AMI with the combination EF 5 40% and atrial 
fibrillation (Afib) with a PPV of 43%. This combination has a high specificity, 
however at the cost of sensitivity. 3) The best combination for risk stratification 
is EF + BRS with a PPV of 29% with reasonable sensitivity and specificity. 
3:15 p.m. 
880-6 T-Wave Alternans During Ventricular Pacing 
Mathew C. Fedor, Jason S. Chinitz, Douglas S. Holmes, Neil E. Bernstein, 
Scott Ruffo, Anastasios Manaris, Laurie J. Balch, William Slater, 
Mariano Rey, Larry A. Chinitz. The Heart Rhyfhm Center, New York 
University Medical Center, New York, NY USA 
Background: T-Wave alternans (TWA) has been shown to be useful in 
predicting sudden cardiac death. However, the presence of atrial arrhythmias 
or the inability of patients to exercise to an appropriate heart rate limits the 
applicability of this test. We investigated the correlation of TWA measured 
during submaximal bicycle exercise (CH 2000, Cambridge Heart Inc.) with 
ventricular pacing, as well as the efficacy of TWA in predicting arrhythmic 
events. 
Methods: Thirty-five patients with implantable cardiovetter defibrillators 
(ICD) underwent TWA analysis during both exercise and ventricular pacing 
through their ICD. Of these patients, 13 had adequate results with exercise 
(regular heart rate above 110 bpm and acceptable noise levels) and 26 
with ventricular pacing. The results of these tests were then evaluated for 
concordance and correlated with a history of appropriate ICD therapies. 
Results: Ten patients had adequate data during both pacing and exercise 
with a 90% (g/IO) concordance (p < 0.05; Fisher Exact Test). In 22 of the 26 
patients with adequate pacing data, TWA accurately identified appropriate 
ICD therapies (p = 0.001; sensitivity = 92%; specificty = 76%). Ventricular 
stimulation did not predict clinical events or the results of pacing TWA. 
Conclusion: TWA during ventricular pacing accurately identified clinical 
events in patients at risk for ventricular arrhythmias and correlated with 
exercise data. The limitations of exercise induced TWA may be overcome by 
ventricular pacing, thus increasing the utility of this powerful tool. 
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883 1 The Role of Genetic Reprogramming in a Canine 
Model of Chronic Atrial Fibrillation -Alterations in 
Gene Expression of Markers of Hypertrophy and 
Calcium Homeostasis Proteins 
Sonja Weyerbrock, Eugen C. Palma, Franz X. Roithinger, 
Koichiro Kinugawa, Yoshinari Goseki, Paul B. Sparks, Michael D. Lesh, 
Edmund C. Keung, Paul C. Simpson, Randall J. Lee. University of 
California, San Francisco, CA, USA 
Background: It is well established that genetic reprogramming occurs in 
ventricular hypettrophy and heart failure. Molecular characterization of cel- 
lular hypertrophy in ventricular myocytes shows characteristic succession of 
changes in gene expression of the so called ‘markers of hypettrophy’. These 
changes consist of reexpression of the fetal gene program with upregulation 
of beta-myosin heavy chain (j%MHC) and downregulation of alpa myosin 
heavy chain (a-MHC). Concomitant there are also changes in the calcium 
homeostasis genes consisting of upregulation of the sodium/calcium-exchanger 
(NCX) and a downregulation of sarcoplasmic calcium ATPase (SERCA). 
Therefore, the present study was designed to determine whether atrial fibril- 
lation (AF) causes genetic reprogramming in the atria similar to what is seen 
with ventricular hypettrophy. 
Methods: Right (RAA) and left (LAA) atrial appendages were obtained 
from 7 dogs with chronic AF following rapid pacing (800 bpm) with a mean 
pacing interval of 122 f 37 days and a mean duration of 21 + 37 days and 
were compared with 7 control dogs. Changes in the protein content of NCX 
and SERCA were determined by Western blot analysis. To assess alterations 
in the protein and mRNA content of the markers of hypertrophy in RAA a 
silver stain after electrophoretic separation of the cardiac MHC isoforms and 
a RNase protection assey were performed (n = 4). 
Results: The protein content of NCX was significantly increased ,in RAA 
(p = 0.008) and LAA (p = 0.04) in chronic AF, whereas the protein expression 
of SERCA in both atrial appendages (p = 0.025) were significantly decreased 
during chronic AF. In RAA, AF was associated with a significant increase in 
the mRNA and protein expression of ,&MHC (p = 0.03), but not a-MHC. 
Conclusion: 1) AF is associated with genetic reprogramming similar to 
that is seen with ventricular hypettrophy. 2) It can be speculated that that 
genetic reprogramming of the atrium may play a role in the transition between 
paroxysmal and chronic AF. 
2:15 p.m. 
1 883-2 1 Verapamil Reverses Atrial Electrical Remodeling 
Due to Dilatation in Langendorff-Perfused Rabbit 
Hearts 
Markus Zarse, Evangelia Athanatou, Jens Robert, Christoph Stellbrink, 
Peter Hanrath. University of Technology Aachen, Germany 
Background: Both, rapid pacing (RP) and atrial dilatation (AD) cause short 
term electrical remodeling (ER) by reducing atrial effective refractory periods 
(AERPs). However, only the pharmacological effects on ER due to RP but 
not due to AD have been investigated. 
Methods: In 24 hearts basal (b) AERPs were measured under stepwise 
increase in intra-atrial pressure (IAP) [cm HnO] up to 20 cm Hz0 or the 
induction of sustained atrial fibrillation (SAF, > IO min). After deflation AERPs 
were measured every 2 minutes for 10 minutes of RP [20 Hz]. After adding 
Verapamil[O.5 mg/l] (Ve, n = 9), a blocker of the L-type Cap+-channel (LTCC), 
Cariporide [0.3 mg/l] (Car, n = 8), a Na+/H+-channel blocker or Glibenclamide 
[0.05 mgil] (Gli, n = 7)), a K& -channel blocker to the perfusate (0.5 mg/l), 
the protocol was repeated. 
Results: 
cm HpO 0 6 10 Pre RP RP4 mln RPIO min 
AERP b 83f3 72 * 49 61 zk 3.5* 8413 f35*3* 54 * 2.5 
AERP Gli 89f3 77f2 66 f 3.7 82 z!z 3.3 64 f 3.5 60 zt 3.7 
AERP Car 88 * 2.1 7752 62zt8 8814 69 f 3.8 59 -t 4.8 
AERP Ve 69 zt 4.9’ 73f5 81 i 6.5' 76 i2.8' 67f3.5 72i4.2# 
*p < 0.05 ANOVA, ‘p -c 0.05 compared to b 
Gli and Car did not prevent the induction of SAF. Ve prevented the 
induction of SAF in all hearts. 
Conclusion: ER occurs to a similar extent after RP and AD, suggesting 
a common pathophysiological mechanism of both forms of ER. Gli and Car 
do not influence ER suggesting that ischemia or acidosis do not play a 
substantial role in either form of ER. Ve significantly shortens AERP at 0 cm 
H20, diminishes ER due to RP and reverses ER due to AD, suggesting a 
crucial role of the LTCC for both farms of ER 
2:30 p.m. 
I 883 3 Effect of Digoxin on Atrial Fibrillation-Induced Atrial Remodeling 
Christian Sticherling, Hakan Oral, Michael H. Kim, Steven P. Chough, 
Robert Baker, Kristina Wasmer, Frank Pelosi, Gregory F. Michaud, Bradley 
P. Knight, S. Adam Strickberger, Fred Morady. University of Michigan, Ann 
Arbor, Michigan, USA 
Background: Verapamil has been demonstrated to markedly attenuate the 
shortening in atrial effective refractory period (AERP) that occurs after a 
brief episode of atrial fibrillation (AF), suggesting that calcium-loading may 
be responsible for the shortening in AERP (atrial remodeling). The purpose 
of this study was to determine the effect of digoxin (Dig), which increases 
intracellular calcium (iCa), on AF-induced changes in AERP. 
Methods: Twenty-nine pts (age 43 + 16 yrs) without structural heart 
disease undergoing catheter ablation of PSVT were randomly assigned to 
receive either Dig, 0.25 mgiday, for 2 wks before the procedure (n = 15), 
or no therapy (n = 14). After successful ablation, autonomic blockade was 
achieved with atropine and propanolol and the AERP was measured at basic 
drive cycle lengths (BDCL) of 350 ms and 500 ms. AF was induced by rapid 
pacing, and upon cardioversion to sinus rhythm after 7.5 + 2.4 min (range 
5-12.2 min), the AERPs were remeasured. The mean Dig level was 1 .O f 
0.4 rig/ml in the Dig group and 0 f 0 in the controls. 
Results: The baseline AERPs did not differ in the Dig and Control groups. 
Post-AF the AERPs at BDCL of 350 ms (p = 0.001) and 500 ms (p = 0.01) 
were significantly shorter in the Dig group. AAERP (Pre-AF minus Post-AF 
AERP) was significantly greater in the Dig group at both cycle lengths (table). 
BDCL 350 ms BDCL500ms 
Pre-AF Post-AF AAERP Pre-AF Post-AF AAERP 
Dig 193f 14 157*14* 37zk16 206~t24 175+17* 35% 18 
Control 200fiO 1t3oi20* 2Oi13 216+12 196i22* 2oz!z15 
P 0.13 0.001 0.004 0.18 0.01 0.03 
“p < 0.003 vs Pre-AF 
Conclusions: Dig significantly accentuates the acute reduction in AERP 
that results from a brief episode of AF. This may be attributable to a greater 
increase in iCa in patients treated with Dig, which may predispose them to a 
greater risk for recurrence of AF. 
2:45 p.m. 
El 883 4 Extracellular K+ Accumulation in Canine Right Atria During Rapid Rates and Atrial Fibrillation In Wivo 
Akira Miyata, Joshua D. Dowell, Douglas P. Zipes, Michael Rubart. Krannert 
Institute of Cardiology, Indianapolis, Indiana, USA 
Based on in vitro studies, rate-related accumulation of extracellular K+ is 
thought to critically influence atrial refractoriness, automaticity, and excitabil- 
iv, by altering K+ equilibrium potential and K+ conductance. Despite their 
importance, changes in extracellular K+ concentration ([K+],) in response to 
sudden increases in rate have not been described previously in mammalian 
atria in viva. Specifically, the response of [K+10 to acute atrial fibrillation (AF) 
is unknown. We therefore measured [K+], in right atria of pentobarbital anes- 
thetized dogs (n = IO) during incremental right atrial pacing and acute AF 
using K+-sensitive electrodes Shortening of atrial pacing cycle length (CL) 
from a baseline of 380 ms resulted in sustained elevations of [K+], (Fig A). 
Peak increase averaged 0.18 + 0.04 mM (mean f SEM) above baseline 
(3.50 * 0.08 mM) at CLs of 350 ms, 0.23 f 0.03 mM at 330 ms, 0.32 I!= 0.04 
mM at 300 ms, 0.50 f 0.06 mM at 280 ms, and 0.80 f 0.09 mM at 250 ms. 
AF was induced by rapid right atrial pacing at a CL of 100 ms from a baseline 
of 380 ms. An example, of the response of extracellular K+ levels to acute 
AF is shown in Fig B. Maximal increase in [K+10 during AF averaged 0.80 f 
0.07 mM, which occurred within 90 seconds after onset of fibrillation. This 
value was not significantly different from that during pacing at the shortest 
CL (250 ms; P > 0.05). The increase was not sustained but declined towards 
baseline values by 0.54 * 0.06 mM after 5 minutes of continuous fibrillation 
(P < 0.05), and returned to pre-fibrillation levels within 90 seconds after 
conversion to sinus rhythm. 
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Conclusion: Accumulation of extracellular K’ implies an imbalance of 
cellular K+ &flux and influx, resulting in net intracellular K+ loss. Our data 
therefore suggest that sudden rate changes cause redistribution of the trans- 
membrane K+ gradient. These ionic changes in K+ may contribute to the 
pattern of electrical activation and recovery, as well as drug actions, during 
atrial tachyarrhythmias. 
3:00 p.m. 
/ What? 
883 5 A-A lntervals During Atrial Fibrillation: A Marker for 
Jayakumar Sahadevan, Raja N. Ghanem, Kunihiro Matsuo, Yasushi Tomita, 
Ceieen M. Khrestian, Bruce S. Stambler, Albert L. Waldo. Case Western 
Reserve Universifi: Cleveland, OH, USA 
Eackground: The mean intetval between local activation (A-A interval) dur- 
ing atrial fibrillation (AF) has been suggested as an index of local refrac- 
toriness. The underlying concept is that during AF due to multiple wavelet 
reentry, atrial tissue is reexcited as soon as it has regained excitability. How- 
ever, AF may be due to several mechanisms (multiple reentrant wavelets, 
unstable reentrant circuits: a single stable reentrant circuit and a single focus 
firing rapidly). We hypothesized that in AF due to a single stable reentrant 
circuit, minimal (min) and mean A-A intervals would be similar at sites in 
the reentrant circuit, but would vary widely at sites activated by fibrillatory 
conduction. 
Methods: During 5 induced AF episodes in 5 dogs with sterile peri- 
carditis, 372-400 unipolar electrograms were recorded simultaneously using 
standard multiplexing techniques from both right and left atria. Activation 
maps consisting of 1 O-l 2 consecutive windows (I .2 second duration) were 
analyzed from each episode of sustained atrial fibrillation (2 5 minute dura- 
tion), and A-A intervals were measured by standard computer techniques. 
In all 5 episodes, AF was due to a single stable reentrant circuit in the left 
atrium. 
Results: 
m? Sites in Reentry Circuit Sites !n Fibrillatory Conduction 
# Min A-A (ms) Mean A-A (ms) Min A-A (ms) Mean A-A (ms) 
1 96-l 02 101-102 66-l 98 102-202 
2 94-96 98-106 76-138 99-182 
3 110-114 116-117 78-136 115-163 
4 108-110 113-114 68-168 110-195 
5 112-116 117-118 76-122 114-228 
At 88% of sites demonstrating fibrillatoty conduction, the difference be- 
tween the minimal and mean A-A intervals was 520 ms. 
Conclusions: Based on this model of AF: 1) a similarity (55 ms) of 
minimal and mean A-A intervals suggests the mechanism is due to a stable 
reentry circuit or a single focus firing rapidly; 2) a large difference (?20 
ms) between minimal and .mean A-A is consistent with the presence of 
fibrillatory conduction; 3) because of wide temporal and spatial variability of 
A-A intervals, data from randomly selected recording sites may be difficult to 
interpret, and is unlikely to reflect refractoriness predictably. 
3:15 p.m. 
883-6 Reduced PAdrenergic Responsiveness of Calcium 
Inward Currents in Human Atrial Myocytes of 
Patients With Heart Failure 
Juergen Schreieck, Mathias Busch, Bjarne Krebs, Rtidiger Lange, 
Bernhard Kemkes’ , Albert Schiimig, Claus Schmitt. 1. Med. Klinik and Dt 
Herzzentrum, JU; ‘KH Bogenhausen, Munich, Germany 
Background: Downregulation of ventricular ,+adrenergic pathways in heart 
failure is well established. If the same holds true for the human atrium 
has not been adequately addressed. In consideration of recent advances in 
the understanding of atrial remodeling and its relation to atrial dilation and 
fibrillation, a?riai electrophysiology of patients with heart failure should be 
reevaluated in the presence of sinus rhythm. 
Methods: Specimens of human atrial appendages were obtained from 
patients undergoing open heart surgery with and without heart failure. Pa- 
tients were divided in two groups, one group with reduced left ventricular 
ejection fraction (LVEF < 45%), the other group with normal LVEF (>60%). 
All patients had stable sinus rhythm. Enzymatically isolated myocytes were 
studied by whole cell patch clamp techniques. Calcium inward current was 
measured by depolarizing currents at room temperature. 
Results: Baseline calcium inward current densities were simiiar for both 
groups of patients, 1.23 f 0.13 pA/pF (n = 20 cells; LVEF > 60%) vs. 1.44 
+ 0.18 pA/pF (n = 14 cells; LVEF < 45%; mean ZII SEM). However, after 
stepwise exposure of the atrial myocytes to isoproterenol in concentrations of 
1, 10, 100 nM and 1 w.M, maximal increment of calcium currents were signifi- 
cantly attenuated in myocytes of the low LVEF compared to the normal LVEF 
group. Increment factors were 4.0 i 0.7 vs. 8.4 i 1.8, respectively. Con- 
centration dependence was not shifted to the right. Calculated half-maximal 
effect of isoproterenol on calcium currents were around 5 nM for both groups. 
Conclusion: In the atrial myocytes of patients with reduced LVEF the 
p-adrenergic responsiveness of calcium inward currents is markedly re- 
duced. Possible implications would be a reduced action potential duration 
and force development in the atria of heart failure patients after ,5’-adrenergic 
stimulation which may increase the susceptibility for atrial fibrillation and 
thromboembolic events. 
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I 1186 67 Transcription Factors in Purkinje Fibers 
Linda B. Pauliks, Kimiko Takebayashi-Suzuki, Takashi Mikawa. Weill 
Medical College of Come// University New York, New York, USA 
Background: Our previous studies have shown recruitment of the Purkinje 
fibers (PFs) from beating cardiomyocytes in the periarterial and subendo- 
cardial regions of the chicken heart. In culture, this transformation can be 
induced with endothelin-I (ET). PFs express a unique set of genes, including 
neuronal and skeletal muscle proteins. In this study, we have identified the 
first time muscle specific transcription factors, including basic helix-loop-helix 
proteins, expressed in PFs. 
Methods: lmmunostaining of transcription factor epitopes was performed 
on embryonic and adult hearts and counterstained with ALD 58, a monoclonal 
antibody that recognizes a specific marker in chicken PFs. In addition, tran- 
scription factors expressed in the ET-induced PFs in culture were examined 
by both immunostaining and reverse transcriptase polymerase chain reac- 
tion (FIT-PCR). The RT-PCR products were analyzed by DNA-electrophoresis 
and sequencing. 
Results: Differentiating PFs were positive for ALD 58 from embryonic 
day 15 onward in viva. A subpopulation of PFs became positive for anti- 
bodies specific for skeletal muscle transcription factors, such as myo D and 
myogenin, from embryonic day 18. In contrast, beating cardiomyocytes were 
negative for these transcription factors. In the cell culture system, ET induced 
PFs also stained positive for myogenin and myo D. The expression of these 
transcription factors was further confirmed by RT-PCR. 
Conclusion: The skeletal muscle specific transcription factors, myo D 
and myogenin, are expressed during the transformation of beating cardiomy- 
ocytes into PFs in the chicken, both in vitro and in viva. 
Supported by the NIH (HL56128, HL.56987, HL62175). 
I 1186 68 Pure Iridium Metal Microelectrode for 
Transmembrane Potential Recording in Isolated 
Swine Right Ventricle 
Chikaya Omichi, Moon-Hyoung Lee, Toshihiko Ohara, Hrayr 
S. Karagueuzian, Peng-Sheng Chen. Cedars-Sinai Medical Center, Division 
of Cardiology and UCLA School of Medicine, Los Angeles, CA, USA 
Background: Machine-pulled high-impedance glass microelectrode (GM) is 
a standard instrument for single cell transmembrane potential (TMP) record- 
ing. However, GM is fragile and difficult to impale, especially in beating 
ventricular tissues. The purpose of this study was to test the hypothesis that 
a high-impedance metal electrode (ME) can be used as an alternative to GM 
for TMP recording. 
Methods: Pure iridium ME (World Precision Instruments) with 3 pm thick 
parylene-C insulation was used. The MEs have a nominal impedance of 
3.5-4.0 MQ. The exposed tips are sharpend to 1 pm. ME and GM filled with 
3 mol/L KCL were used to record endocardial TMP in 5 isolated, purfused 
swine right ventricles. The TMPs were simultaneously recorded with both 
microelectrodes (~2.0 mm apart) during pacing (PCL 500 ms and dynamic 
pacing: 8 stimuli were delivered from 400 to 150 ms at progressively shorter 
coupling intervals). The action potential duration (APD) to 50% (APDso) and 
90% (APDgo) repolarization time were measured. A dynamic APD restitution 
curve was constructed by plotting APDSO versus preceding diastolic interval. 
Slowmax of the restitution curves were calculated by computer analysis. 
Results: The basic morphology of TMP recorded with ME and GM were 
comparable. At least 120 (range, 20-38) GMs were used to complete a 
sinqle study (3 to 6 hours). In contrast, ME recording quality was stable 
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throughout the study and no replacement was necessary. The APDsc and 
APDso recorded by ME and GM showed significant correlations (APDso; ME: 
206 * 34 ms vs GM: 209 4 41 ms, r = 0.97, p < 0.005, APDee; ME: 241 
f 29 ms vs GM: 236 + 31 ms, r = 0.98, p < 0.005). Slopemax of the APD 
restitution curves during pacing also revealed a significant correlation (ME: 
1.65 =k 0.54 vs GM: 1.80 i 0.98, r = 0.87, p < 0.05). 
Conclusion: These results show that the APD and APD restitution curves 
recorded by the MEs and GMs were comparable. However ME is stable 
throughout the study. Therefore ME may have advantage over GM in TMP 
recordings in the beating cardiac tissue. 
Source of Trigger Ca*+ for CICR is Switched From 
Ca*+ Channels to Na+-Ca*+ Exchangers During 
Heart Failure Transition in Hypertrophic Rat 
Ventricular Myocytes 
Toshiaki Izumi, Yasuki Kihara, Shigetake Sasayama. Kyoto University 
Graduate School of Medicine, Kyoto, Japan 
Background: Uncoupling between the transsarcolemmal Caa+ influx and 
the SR Caa+ release has been reported in diseased ventricular myocytes, 
but its precise feature remains unclear. Dahl salt-sensitive (DS) rats with 
hypertension demonstrated a stage of compensated LV hypertrophy (LVH) 
at 11 wk, followed by LV dysfunction and pulmonary congestion (CHF) at 17 
wk. Using this model, we investigated relationships between L-type calcium 
current (Ica), cytosolic calcium transient (CAT), Na+-Gas+ exchanger current 
(Ina& and SR calcium contents and their stage-specific changes during the 
transition from LVH to CHF. 
Methods: The LV myocytes were enzymatically isolated from DS rats 
at each stage. The age-matched Dahl salt-resistant (DR) rats were used as 
control. In thefura2-loaded cells, Ica and CaT were simultaneously measured 
by the conventional patch clamp technique with a pulse protocol of 200 
msec from -40 mV to -30 -+70 mV. lnaca was measured as a Nia+ (5 
mM)-sensitive component with a ramp pulse protocol of 1 set from +60 
mV to -120 mV. The SR calcium content was measured as the peak Ca’+ 
concentration during a rapid caffeine (10 mM) application. 
Results: The Ica density and its voltage-dependence showed no signif- 
icant changes in either stages. The SR calcium contents were also equal 
among the groups. The peak value of CaT (F340/380) at +I0 mV was not 
changed in LVH; however, it was decreased by 10% (p < 0.05) in CHF. Fur- 
thermore, CaT showed tonic (sustained) pattern at more positive potentials 
than +40 mV in CHF, while it showed the normal phasic (transient) pattern 
at any voltage in LVH. The lnaca current showed significant increase both in 
LVH and CHF to the same extent by 2.30- and 2.26-fold, respectively. 
Conclusion: The data indicate that Ca*+ influx through the increased 
lnaca may be supplemental to Ic,-mediated CICR in LVH. Instead, it plays a 
dominant role as the trigger of CICR in CHF, when uncoupling between Ica 
and SR Caa+ release is manifest. 
1186-70 Impact of Auxiliary Shock Waveform and 
Amplitude on Dual Shock Defibrillation 
Robert G. Walker, Bruce H. KenKnight’, Raymond E. Ideker. University of 
Alabama at Birmingham, Birmingham, AL; ‘Guidant CRM, St. Paul, MN, 
USA 
Background: Previously reported data have demonstrated that delivery of 
a sub-threshold auxiliary shock (AUX) to the weak-field area of the heart, 
in conjunction with a conventional endocardial defibrillation shock (PRIM), 
can lower delivered energy defibrillation thresholds (DFTs) by 50%. Earlie’r 
studies have shown that for dual shock defibrillation with AUX delivered 
before PRIM, there is no difference in the degree of DFT reduction between 
a monophasic (M) and a biphasic (BI) AUX waveform. However, earlier 
studies have also suggested there is a substantial waveform effect when 
AUX is delivered after PRIM. Our objective in this study was to determine the 
optimum AUX waveform and amplitude when AUX is delivered after PRIM. 
Methods: In six pigs, dual shock DFTs were determined for 4/3 ms BI 
PRIM shocks delivered through endocardial leads placed in the RV apex and 
SVC, followed by M or El AUX shocks delivered from a lateral LV epicardial 
line electrode to a catheter electrode in the left jugular vein. AUX pulsewidths 
of 4 ms (M) and 4/3 ms (BI) were tested at shock strengths of 50, 100, 150, 
200, 250, and 300 Volts. The PRIM-AUX coupling interval was 5 ms. PRIM 
and AUX were delivered from separate 150 pf capacitor banks. 
AUX amplitude 
AUX 50 v 1oov 15ov 2oov 250v ROO v 
M 14.4i4.9 18.Oi5.0 27.O~k14.3 21.0f4.8 24.3i12.7 26.5f8.5* 
BI 11.6It6.3 12.9zk5.9 10.5zk5.0* 8.0&3.3* 6.8 zt 3.2* 7.7 5 2.4* 
Results: The mean control DFT (PRIM with no AUX) was 14.4 i 
5.0 J. DFTs (total delivered energy PRIM + AUX) for the 12 AUX wave- 
form/amplitude combinations tested are shown in the table. 
DFTs for BI AUX were lower than M AUX at every AUX amplitude. 
Increasing the amplitude of BI AUX reduced the DFT to a minimum at 250 V, 
a 53% DFT reduction vs. control. Conversely, DFTsfor M AUX trended higher 
with increased amplitudes, and no M AUX performed better than control. 
Conclusions: In conjunction with previous work, these results suggest 
that the mechanism of dual shock DFT reduction may be different for AUX 
before PRIM and AUX after PRIM. The significant interaction between AUX 
parameters must be considered in any dual shock defibrillation scheme. 
I 1186 71 Myocardial Contractility Modulation Using a Non-Excitatory Electrical Signal 
ltzhak Shemer’ , Bella Felzen, Yuval Mika, Yaakov Haham, Yoav Kimchy, 
Shlomo Ben-Haim’ , Nissim Darvish. impulse Dynamics, Tirat-Hacarme/; 
’ The Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel 
Background: Contractility of cardiac muscle can be modulated by pharma- 
cological agents or via delivery of excitatory electrical signals such as paired 
pacing. This study shows that cardiac contractility modulation (CCM), can 
be modified markedly by a non-excitatory electrical signal synchronized to a 
pacing signal and delivered during the absolute refractory period (ARP). 
Methods: CCM signal effect was studied on isolated myocytes and papil- 
lary muscle.(PM). Myocytes obtained from healthy guinea pigs were isolated 
using standard techniques. Myocyte shortening and intracellular calcium 
changes (using Fura- AM) were recorded. Rabbit right PM, placed in an 
organ bath was stretched to L,,, and the ARP was measured using a 2-ms 
current signal with amplitude 10 times the threshold. Muscle tension (T) and 
action potential (AP) were recorded using force transducer and intracellular 
micropipette, respectively. 
Results: CCM signal elevated peak [Ca*+]i in isolated myocytes 18.7 f 
4.1 (mean f SE; n = 3) and increased myocytes shortening by 19.3 i 6.3 
(n = 4). CCM signal applied to paced PM increased peak isometric tension 
by 134.4 f 9.2% (n = 20) with negligible change in diastolic tone. Moreover, 
the relaxation rate, namely peak -dT/dt, was improved by 76.7 f 4.6% (n = 
17). Action potential duration at 80% repolarization (APDsc) increased by 10 
& 2% (n = 6) on the very first beat. APDso prolongation remained constant 
throughout CCM signal application, while contractility increased gradually 
until reaching a steady-state level within 3-6 beats. Upon signal removal 
contractility returned to baseline within 3-6 beats. Unlike post-extra systolic 
potentiation (PESP), CCM signal effect exhibited dose-response behavior 
to signal amplitude. Moreover, changing CCM signal parameters decreased 
contractility and shortened APDsO. 
Conclusion: We suggest that CCM signal is a novel potent method for 
contractility modulation. The rapid contractility response to the signal exhibits 
a pronounced advantage over any known inotropic agents, 
1186-72 Dispersion of Repolarization During Life is 
Closely Related to Collagen Volume Fraction at 
Autopsy 
Clare E. Bonnar, Vicki E. Save, Gordon A. Milne, Alistair J. Robertson, 
Stuart D. Pringle, Allan D. Struthers. University of Dundee, Ninewells 
Hospital & Medical School, Dundee, UK 
Background: QT-dispersion is a marker of sudden cardiac death (SCD) in 
cardiovascular disease. Myocardial fibrosis is thought to also cause SCD. 
We have examined whether QT-dispersion on the surface EKG is related to 
myocardial fibrosis at autopsy. 
Methods: 43 hearts were examined by morphometric analysis of the col- 
lagen volume fraction (CVF), using a digital image analysis system. 1,130 
myocardial tissue blocks were processed and 25,824 digital images of my- 
ocardium examined in detail, to calculate the mean-CVF of all 43 hearts. 
QT-dispersion was measured manually using a digitizer. 
Results: The mean age of patients at death was (72.5 f 1.7) yrs. 20 
patients were male. EKG’s were obtained 44.0 (510.5) days before death, 
range (0 to 364). Mean QT-dispersion was 48.2 (f3.4) msec and mean-CVF 
was 2.9 (f0.5)%. Results required logarithmic transformation before analy- 
sis. Stepwise multiple linear regression analysis, showed that mean-CVF was 
the only factor related to QT-dispersion. The results were highly statistically 
significant (@ = 0.50, p < 0.001). 
Conclusion: Our study establishes definitively for the first time, that 
patchy myocardial fibrosis can be detected during life by QT-dispersion 
on the surface EKG. It also adds enormous credence to the hypothesis 
that sudden cardiac death is commonly due to myocardial fibrosis causing 
electrical inhomogeneity. 
*denotes p < 0.05 compared to control 
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/ 1186-73 1 Development of Impressive Neovascularization in 
Chronic Radiofrequency Energy Lesions 
Susan B. Johnson, Douglas L. Packer, Sam Asirvatham. Mayo Foundation, 
Rochester, MN, USA 
The characteristics of chronic radiofrequency (RF) lesions have not been 
extensively studied. In order to determine the late histologic outcome of RF 
energy delivery, tissue from 7 dogs undergoing irrigation tip RF ablation was 
examined at 6 months. Lesions were created with 66 + 4 watts of power 
accompanied by impedance pop development in 18/33 (55%). 16 lesions 
were examined histologically with H&E, Masson trichrome, and Lawson’s 
elastic Van Gieson stains to assess the relative constituents of the tissue. 
There was no significant difference between lesion size in those accompanied 
with vs without impedance pops. Of the lesions examined at 6 months, those 
occurring with an impedance pop (n = 9) measured 5.6 f 1.9 mm in width, 6.7 
-i 2.4 mm in depth and 187 f 112 mm3 in volume, which were not significantly 
different than the 5.9 * 1.5 mm, 6.4 f 1.3 mm and 165 f 97 mm3 dimensions 
seen in lesions without impedance pops (n = 7), respectively. These 6 month 
lesions were significantly smaller than comparable lesions (n = 16) seen at 5 
days post ablation (p < 0.001). Importantly, detailed histologic examination 
of late lesions demonstrated impressive intralesion neovascularization with 
multiple endothelialized vessels with smooth muscle borders. There were 
49 f 21 vessels per high power field with the 6 month lesions, significantly 
greater than the 4 f 2 vessels seen on histology 5 days after ablation (p 
< 0.001). There was a tendency for greater neovascularization (56 f 26 
versus 40 f 8 vessels) in those lesions produced during impedance pop 
deliveries. Cartilage was also present in the 6 month lesions. We conclude 
that lesions contract over time and extensive neovascularization develops 
over the course of lesion maturation. The occurrence of an impedance pop 
with greater crater formation may facilitate this neovascularity. This marked 
change in tissue perfusion may be of importance in the long-term outcome 
of ablation in ischemic heart disease and might suggest RF energy delivery 
as an alternative method of percutaneous myocardial revascularization. 
/ 1186-74 / Loss of the Relationship Between Refractory 
Pariod and Reentry Period in the Epicardial 
Border Zone of Hearts With Healed Infarcts. The 
Role of Gap Junctional Connexins 
Toshihiko Ohara, Ji-Min Cao, Keiko Ohara, Babak Armin, Ajay Naik, William 
J. Mandel, Michael C. Fishbein, Peng-Sheng Chen, Hrayr S. Karagueuzian. 
Cedars-Sinai Medical Center and UCLA School of Medicine, Los Angeles, 
CA, USA 
Background: Experimental and simulation studies have shown that an in- 
crease in the effective refractory period (ERP) increases the core size and the 
period of functional reentry. while ERP shortening has the opposite effects. 
We hypothesized that the predictive ability of ERP-reentry period relation- 
ship that exists in normal hearts is lost in the remodeled hearts with disrupted 
cellular couplings. 
Methods and Results: The epicardial border zone (EBZ) of 5 open-chest 
anesthetized dogs was mapped during ventricular fibrillation (VF) 6-8 weeks 
after LAD occlusion. The left anterior epicardium (same site as the EBZ) 
of 3 dogs with no LAD occlusion (N) was also mapped. Three seconds of 
VF data (3 s after VF onset) were analyzed with 477 bipolar electrodes 1.6 
mm apart. Activation during VF was visualized dynamically. The ERP was 
significantly (P < 0.05) longer in the EBZ than in N (183 + 12.9 ms ~~0.176 
h 14.5 ms). Conduction velocity (CV) along and across the fiber during VF 
was significantly slower in the EBZ than in N (38.2 f 9.5 vs. 55.9 & 13.7 cm/s 
and 19.5 & 5.1 vs. 37.9 i 7.8 cm/s respectively). We captured and analyzed 
12 episodes of reentry in the EBZ and 5 in N with each having clockwise 
and counterclockwise rotations. Core perimeter of reentry in the EBZ was 
significantly (P < 0.001) smaller than in N (1.92 f 0.26 cm vs. 3.12 i 0.38 
cm). The period of reentry however, was not significantly different in the EBZ 
and N (98.4 f 10.9 ms vs. 108 i 7.9 ms). CV around the core of reentry 
was slower in the EBZ compared to N (19 & 23 cm/s vs. 30 f 3.7 cm/s, 
P < 0.01). The EBZ had reduced and disrupted immunostaining of Cx43 
and Cx45 distribution compared to N both in the end-to-end and side-to side 
locations. 
Conclusions: An increase in the ERP of the EBZ unlike in normal hearts 
does not increase the period of reentry. The loss of ERP-period relationship 
in the EBZ may be caused by partial cellular uncoupling that simultaneously 
slows the CV and decreases the core size resulting in no change in reentry 
period. 
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1~ - 1 - 1187 93 ST Segment- and Bradycardia-Based Prediction of 
Imminent Cardiac Death in a Conscious Canine 
Model With Healing Infarction and Acute lschemia 
Michael E. Benser, Cheryl R. Killingsworth, Gregory P. Walcott, William 
M. Smith, Raymond E. Ideker. Guidant CRM, St. Paul, MfV; University of 
Alabama at Birmingham, Birmingham, AL, USA 
Objective: We hypothesized that bradycardia or significant acute ST devia- 
tion (STD) would predict imminent sudden cardiac death (SCD) in a conscious 
canine model with healing infarction and potentially acute ischemia. 
Methods/Results: Twelve dogs (19 f 2 kg) survived an initial procedure 
comprising left anterior descending artery (LAD) infarction and the situation 
of five epicardial electrodes distributed over the LV, a pace/sense and de- 
fibrillation catheter in the RV, a subcutaneous ICD Can in the left pectoral 
thorax, and a small hypodermic needle in the leff circumflex artery (LCX). 
The 2 RV and 5 LV egrams were filtered (0.5-500 Hz) and telemetered 
continuously as the animals recovered. 7/12 dogs died suddenly between 
12 and 72 hrs. post-op (group A). The remaining 5/12 dogs survived to a 
procedure at 96 hrs post-op in which a thrombus was induced via DC current 
through the LCX needle (group B). A test algorithm, based on the detection 
of bradycardia and the time-derivative of beat-to-beat changes in the ST 
segment, was optimized to predict, retrospectively, SCD imminent within 15 
min. over 19 f 6 pre-SCD hrs of the group A dogs to 100% (717) sensitivity 
and 95% (4821508) specificity. This algorithm was then applied prospectively 
to 20 & 6 hrs of the group B dogs and exhibited 100% (l/l) sensitivity and 
95% (448/473) specificity. Further analysis revealed that 5/7 group A dogs 
died due to ventricular tachyarrhythmias preceded by significant acute STD; 
the other 2 died of pronounced bradycardia. 
Conclusion: An algorithm based solely on the detection of bradycardia 
and acute ST deviation was able to predict imminent SCD in this animal 
model with 100% sensitivity and 95% specificity. 
L--l-I 1187 94 Transmural Dispersion of Repolarization Recorded During Acute Myocardial lschemia in In 
Situ Canine Hearts 
Xiaohong Zhou, Raymond E. Ideker. The University of Alabama at 
Birmingham, Birmingham, AL, USA 
Background: Repolarization of an action potential (AP) is an important index 
to evaluate the cardiac electrophysiological properties. While repolarization 
over the ventricular surface has been observed via techniques of optical 
recording, MAP contact or suction electrodes and floating microelectrodes 
in in situ hearts, its transmural change is not known in either normal or is- 
chemic hearts. Thus, transmural monophasic action potentials (MAPS) which 
represent repolarization were recorded in normal and ischemic myocardium. 
Methods: A needle containing three bipolar MAP electrodes with 5.5 mm 
between adjacent electrodes was inserted into the anterior free wall of the left 
ventricle in each of 5 open-chest dogs. MAPS were simultaneously recorded 
from sub-epicardial (epi.), mid-myocardial (mid.) and sub-endocardial (endo.) 
tissue. APDSO of MAPS from these three layers were determined. Dispersion 
of repolarization was determined by subtracting the shortest APDgo from 
the longest APDSO from these three layers. Acute myocardial ischemia was 
produced by 15 min occlusion of left descending coronary artery. 
Results: The figure shows an example of the simultaneous MAP record- 
ings before and during acute myocardial ischemia. The mean & SD of APDsQ 
was 184 f 19 ms, 194 f 21 ms and 198 I!= 21 msfor the three layers from 
epi. to endo. before ischemia, and 102 * 13 ms, 131 i 36 ms and 150 f 33 
Before ischemia 
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ms forthese three layers during 15 min ischemia (p < 0.05 vs. corresponding 
values before ischemia). The transmural dispersion of APDgo was 15 f 7 ms 
before ischemia and 54 f 26 ms during ischemia (p < 0.05). 
Conclusion: These results raise the possibility that repolarization can be 
observed transmurally in the ventricles. A significant transmural dispersion of 
repolarization was observed during acute myocardial ischemia with epicardial 
action potential duration shortened the most. 
u Model 
1187 95 Evolution of Ventricular Fibrillation in a Canine 
Jian Huang, Jack M. Rogers, Ramon W. Pedoto, Fenlong Lin, William 
M. Smith, Raymond E. Ideker. Universify of Alabama at Birmingham, 
Birmingham, AL, USA 
Background: Recent electrical and optical mapping studies have examined 
only the first few tens of seconds of ventricular fibrillation (VF). We used new 
pattern analysis algorithms to characterize the evolution of the first 5 min of 
VF. 
Methods: VF episodes were mapped from 6 dogs using 504 electrodes 
(21 x 24 plaques) with 2-mm inter-electrode spacing from the right ventricular 
epicardium for 5 minutes. We computed the following descriptors as functions 
of time (mean over 6 animals): number of wavefronts (WFs) during 1 set of 
VF, percent of WFs that arose within the mapped region by breakthrough or 
focal activity, and percent of WFs that completed at least one cycle of reentry. 
Results: The number of WFs increases early and then decreases markedly 
over the next 5 min of VF. The incidence of reentry on the epicardium in- 
creases to a maximum by 2 min of VF and then decreases almost to zero. 
The incidence of epicardial breakthrough or focal activity increases markedly 
between 2 and 5 min of VF. 
Time (EC) 
Conclusion: VF changes dramatically during the first 5 min with epicardial 
reentry being common during the first 2.5 min and a breakthrough pattern 
compatible with intramural reentry becoming dominant over the next 2.5 min. 
I Ii 87 97 Pause-Dependent Torsades de Pointes in Acquired Long QT Interval: Long Term Clinical 
O&come - 
Antoine Da Costa, Thierty Chalvidan’, Ali Belounas, Marc Messier, 
Michel Viallet, Jean ClaudeDeharo’ , Hassan Mansour’, 
Dominique Lamaisot?, Alexis Cerisier, Pierre Djiane’ , Karl Isaaz. 
’ Universi(v of Saint-Etienne, Marseille; ‘Clermont-Ferrancl, France 
Long term prognostic of pause-dependent torsades de pointes (PD TDP) 
due to acquired long QT syndrome, a disorder that may lead to sudden death 
(SD), have not been fully investigated. 
Methods: 105 pts (age 74.5 f 9.9, 81 females) were included based on 
the association of 4 criteria: (1) ECG documented PD TDP; (2) prolonged QT 
interval and corrected QT using Bazett’s formula (QTc); (3) long-short initi- 
ation sequence; (4) baseline bradycardia or drug or metabolite disturbance 
known to induce PDTP. After correction of all precipitating factors, absolute 
dispersions of QT and QTc were measured, as QTmax-QTmin, and QTc 
max-QTc min, respectively, before discharge. Long term clinical outcome 
was evaluated based on the occurrence of the following adverse events 
(AE): syncope (S), TDP recurrence (TDPR) and (SD). Pts were categorized 
according to presence or absence of AE (AE+, AE-). 
Results: No difference was found between AE+ and AE- regarding age 
(72.4 i 12 vs 75.4 f 9), gender (75% vs 79.1% female), heart rate (52 * 
12 vs 56 & 15). During a mean follow-up of 27 f 26 months (range 1-123 
months) 51 events occurred in 28 pts: 18 S, 15 TDPR and 18 SD. Univariate 
analysis and multivariate analysis were performed on 7 variables using Cox 
model with three end points defined as following: 
AE 
n=105 Uni. 
SD and/orTDPR SD 
Multi Uni. Multi Uni. Multi 
PDTdP-triggered VF 0.012 0.19 0.014 0.36 0.059 - 
History of MI 0.098 - 0.14 - 0.32 - 
Echo LVEF (%) 0.03 0.9 0.016 0.67 0.02 0.3 
Mean QT (ms) 0.017 0.2 0.013 0.16 0.06 - 
Mean OTC (ms) 0.3 - 0.14 - 0.17 - 
QT max-QT min 0.02 0.065 0.032 0.07 0.09 - 
OTC max-QTc min 0.008 0.02 0.015 0.028 0.043 0.043 
Conclusions: High rates of arrhythmic events are found in a population 
of PD TdP due to acquired long QT syndrome despite correction of initial 
precipating factors. QTc dispersion appears to be the only independent 
predictor of adverse arrhythmic events and sudden death at a long term 
follow-up. 
I 1187-96 Seasonal Variation in Implantable Cardioverter 
Defibrillator Therapy 
Robert W. Peters, Michael R. Gold, Mark D. Carlson, Douglas P. Zipes, 
Dean Follman, Robert S. Sheldon, Paul Mounsey, Scott Lancaster. The 
AVlD Investigators; University of Maryland, Baltimore, MD, USA 
Background: Examination of the chronology of acute cardiovascular events 
may provide important pathophysiologic information. Previous studies have 
suggested the presence of a seasonal variation in acute myocardial infarction 
and sudden cardiac death. To assess the seasonal variability of spontaneous 
life threatening arrhythmias, we evaluated patients (pts) in the antiarrhythmics 
versus Implantable Defibrillators (AVID) Trial. 
Methods: Pts with documented ventricular fibrillation (VF) or hemody- 
namically-destabilizing ventricular tachycardia (VT) were randomly assigned 
to treatment with an implantable defibrillator (ICD) or antiarrhythmic drugs. 
Analysis was performed on the 347/476 ICD pts who received appropri- 
ate therapy for VTNF (shocks or antitachycardia pacing) in 2491 separate 
episodes. ICD episodes were grouped by season. 
Results: The mean age of this group was 65 f 10 years, mean ejection 
fraction was 25 f 4%, and 79% were male. The distribution of therapies was 
nonuniform (p = O.OOS), with significantly more ICD therapies delivered in 
winter and spring (53.4% of total) compared with summer and autumn. This 
seasonal pattern was independent of treatment with or without beta blockers 
(54.6% vs 52.8%, p = ns) or geographic region (north vs south, 52.8% vs 
54.8%, p = ns). 
Conclusions: Malignant ventricular arrhythmias requiring ICD therapy 
have a preponderance in winter and spring. Sympathetic activation and 
geographic location do not appear to be responsible. 
I 1187 98 A Single Anatomic Linear Lesion Prevents Induction of Uniform Ventricular Tachycardia in a 
Porcine Model of Healed Infarction 
David J. Callans, Jian-Fang Ren, John Michele, Francis E. Marchlinski, 
Stephen M. Dillon. Universify of Pennsylvania, Philadelphia, PA, USA 
Background: Anatomic ablation of ventricular tachycardia (VT) may facilitate 
ablation during sinus rhythm of poorly tolerated VT. 
Methods: RV and LV programmed stimulation (PES, 3 extrastimuli) was 
performed in 6 pigs 6-10 weeks after LAD infarction (Ml). LV electroanatomic 
voltage mapping was performed to characterize the infarct using the CART0 
system. A single linear radiofrequency (RF) lesion, constructed of individual 
point lesions (50 W, 120 set), was delivered to the septal infarct border 
using a 3.5 mm irrigated tip catheter, guided by CART0 and intracardiac 
echocardiography. Mapping data during VT was not used to guide anatomic 
RF. Following RF, PES was repeated in pigs with inducible VT pre RF. 
Results: 10 morphologies of uniform sustained VT (cycle length 229 f 37 
ms) were induced in 4 of 6 pigs (67%). 4 VTs were right, and 6 left bundle in 
morphology. Linear ablation and follow-up PES was performed in the 4 pigs 
with inducible VT. Linear lesions were 34 f 10 mm in length, constructed of 
13 f 4 point RF lesions. Sustained VT could not be induced in any of the 4 
pigs after RF; nonsustained VT of a different morphology was induced in 2 
pigs. 
Conclusions: Anatomic linear lesions delivered in sinus rhythm without 
attempts at VT mapping eliminated right and left bundle VT morphologies 
in a realistic model of healed MI. These observations suggest: 1) anatomi- 
cally-guided VT ablation directed by sinus rhythm voltage mapping is feasible 
and 2) a single septal linear lesion ablated multiple morphologies of VT with 
spatially disparate circuit exit sites. 
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m 1187 99 Comparison Between Radionuclide Perfusion Imaging and Bipolar Left Ventricular Electrogram 
Amplitude Using Electroanatomic Magnetic 
Mapping for Quantifying Abnormal and Normal 
Myocardium 
Francis E. Marchlinski, Hemal M. Nayak, David J. Callans, William 
A. VanDecker, Alexis B. Sokil. University of Pennsylvania Health System, 
and Medical College of Pennsylvania Hospital, Philadelphia, PA, USA 
Background: Magnetic mapping (CARTO’“) can identify low voltage bipolar 
eiectrograms (BiEgm). However, the validity of this approach to locate and 
quantify abnormal endocardium has not been established. We sought to 
compare the defect size seen on radionuclide perfusion imaging (RPI) to the 
area of abnormal BiEgm with magnetic mapping in pts with coronary disease 
and ventricular tachycardia (VT). 
Methods: We performed detailed left ventricular (LV) sinus rhythm voltage 
maps (>I00 sites per LV) in 9 pts (6 men, age 65 i 5). BiEgm (inter-electrode 
distance of 1 mm), were recorded and filtered at IO-400 Hz (points/pt: 
155 f 67). A reference value of 1.62 mV, derived from LV voltage maps 
performed in IO pts with normal hearts, was used as the lower limit of normal 
BiEgm amplitude. The area of endocardial abnormality and percentage of 
abnormality in relation to total endocardial area was calculated and compared 
to fixed defect seen on quantitative RPI polar maps. 
Results: 1) The extent of abnormal endocardial BiEgm exceeded the size 
of the perfusion defect, (55% vs 33%, p < 0.02). 2) In 7 pts with anterior or 
inferior infarction and septal extension, the area defined by septal abnormal 
BiEgm uniformly exceeded the septal size of perfusion defect. 3) In the two 
pts with true posterior Ml, BiEgm abnormality was nearly identical in size to 
defects seen on RPI 27% vs 29% and 37% vs 36%. 
Conclusion: In pts with sustained VT and coronary artery disease, the 
area defined by abnormal BiEgms tends to exceed the extent of RPI defect. 
This overestimation appeared to primarily involve the septum and may rep- 
resent the subendocardial septal extent of scar that is commonly observed 
at VT surgery in these pts. 
1187-I 00 Vasopressor Therapy for Catheter Mapping and 
Ablation of Hemodvnamicallv Poorlv Tolerated 
Ventricular Tachycardia - - 
Etienne Delacretaz, William G. Stevenson, Kyoko Soejima, Makoto Suzuki, 
William H. Maisel, Corinna B. Brunckhorst, Kristin E. Ellison, Peter 
L. Friedman. Brigham and Women’s Hospital, Bosfon, MA, USA 
Background: Ablation of hemodynamically unstable ventricular tachycardia 
(VT) is limited by inability to map extensively during VT. We hypothesized 
that dopamine infusion may maintain arterial pressure (BP) and improve 
tolerance to sustained VT. 
Methods: Nine pts (age 67 f 12 y) with ischemic cardiomyopathy (EF 
25 f 8%), heart failure (NYHA class II-IV), and hemodynamically poorly 
tolerated VTs were included in this study. Stress induced ischemia was ruled 
out prior to the study. Right heart pressures were monitored in 5 pts. 
Results: Before therapy with dopamine invasive BP was 53 i 16/39 f IO 
mmHg during 15 VTs in 9 pts and prompted rapid termination of tachycardia. 
During intravenous dopamine at 2-7 (mean 3.4 f 1.5) wglkgimin 12 of 15 
VT morphologies were identical (id VTs) to those seen at baseline, and 25 
new VT morphologies (nw VTs) were seen in 8 pts (total 4.4 VTs/pt) 
Baseline Dopamine 
CL. ms BP. mmHa CL. ms BP. mmHa 
Sinus 938i-126 108ztl5/55i7 714+ 81' 126 * 16*/66 + 9# 
id VTs 372% 75 50116/36*10 384&89 67&20*/49f 12* 
nw vrs 332&63+ 67&26/49&15 
CL, cycle length;*p < 0.001 and#p < 0.05 vs baseline;+p < 0.01 vs id VTs 
Sustained VT was tolerated during several minutes and entrainment map- 
ping identified circuit sites in all patients. DC cardioversion was needed in 
7/9 pts during dopamine. VT substrate was modified in 4 pts and success- 
fully ablated in 5 pts. During a mean follow-up of 16 f 9 months 3 pts had 
recurrent VT. 
Conclusions: Dopamine infusion increased BP during VT without chang- 
ing its CL, improving the tolerance to sustained VT and allowing entrainment 
mapping. Mapping and ablation during infusion of dopamine is feasible in pts 
with hemodynamically poorly tolerated VT. 
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/ 1188 59 Defibrillation Efficacy for Spontaneous Atrial Fibrillation: Relationship of Shock Strength to 
Defibrillation Threshold 
Charles D. Swerdlow’ , Steven J. Bailir?, Eduardo N. Warmar?. For the 
Worldwide Model 7250 AF-Only Investigators; ‘Cedars-Sinai Medical 
Center, Los Angeles, CA; “lowa Heart Center, Des Moines, IA; 3Medtronic 
Inc., Minneapolis, MN, USA 
Background: The DFT+ (defibrillation threshold) is defined as the lowest 
shock energy that defibrillates on 2 consecutive trials. Ventricular (V) ICDs 
programmed to 2 x DFT+ terminate 2 95% of spontaneous ICD-detected V 
fibrillation (F). The relationship between the atrial DFT+ and shock efficacy 
for atrial fibrillation (AF) is unknown. 
Methods: We analyzed this relationship for pts implanted with the Medtronic 
Model 7250 Jewela AF, a dual-chamber ICD with A and V shocks. The ICD 
defines shock success as 5 consecutive beats of sinus rhythm prior to rede- 
tection of AF. Post-shook recurrence of AF prior to 5 consecutive sinus beats 
is classified as shock failure. DFT+ was measured using 90 WF biphasic 
pulses after 2 min of AF. Of 83 consecutive pts with AF, but no ventricular 
arrhythmias, 20 pts met 3 criteria: DFT+ was determined at implant, sponta- 
neous AF was shocked, shocks for DFT+ testing and spontaneous AF were 
given using the same pathway, tilt and polarity. 
Results: In follow-up of 5.1 months, 121 shocks were delivered for 95 
spontaneous AF episodes (1.3 shocks/episode). Overall efficacy was 91% 
per episode. The table shows efficacy per shock as a function of DFTc. 
DFT+ 1.5 DFTt 2 DFT+ >2 DFT+"* 
No. P&t/Shocks 6118 6123 8125 12155 
ShockSuccess 44%X 74% 80% 75% 
*p = 0.055 vs. other columns; 710 patients had shocks at more than one strength; 
**median = 4.8 x DFTt 
Corresponding first shock success rates for the 95 episodes were 40%, 
78%, 73%, and 68% respectively. 
Conclusions: ICD-classified atrial defibrillation efficacy increases markedly 
between shocks at DFT+ and 2 x DFT+, but does not increase further for 
stronger shocks. This may be due to Early Recurrence of AF after atrial 
defibrillation which is classified by the ICD as a shock failure. 
I 1188 60 Evaluation of the Type of Cardiac Rhythm Preceding the Onset of Atrial Fibrillation or 
Supraventricular Tachycardia in Atrial Fibrillation 
Patients 
Denitza P. Blagev, Mark L. Brown. Medtronic Inc., Minneapolis, Minnesota, 
USA 
Background: It has been hypothesized that optimal therapy for atrial fibrilla- 
tion (AF) patients may be stratified based on the cardiac rhythm immediately 
preceding the onset of AF. 
Objective: To estimate the relative frequency of different kinds of car- 
diac rhythm immediately preceding AF, and to estimate the prevalence of a 
dominant cardiac rhythm preceding AF. 
Methods: EKGs of onsets of symptomatic AF episodes were recorded 
with external loop recorders and were examined for 94 patients. For each 
recorded AF onset, the 4 ventricular beats immediately preceding AF were 
classified as a Short/Long sequence (S/L) if there was a difference of more 
than 200 msec between the beats, Tachycardia (T) if the average of the 4 
beats was less than 600 msec, Bradycardia (B) if the average of the beats 
was more than 1200 msec, or Normal Sinus Rhythm (NSR) if none of the 
above applied. The relative frequency of each type of onset was determined. 
In addition, for patients who had at least 6 AF onsets recorded, if a certain 
type of cardiac rhythm preceded AF at least 2/3 of the time, then that type of 
rhythm was defined to be the dominant AF onset rhythm for that patient. 
Results: Of the 442 AF onsets recorded, 83% (367) were preceded by 
NSR, 9% (39) by S/L, 5% (23) by T, and 3% (13) by B. 27 patients had at 
least 6 AF onsets recorded and 21 of them had a dominant AF onset rhythm; 
it was NSR in all cases. 
Conclusion: Most AF patients had a variety of cardiac rhythms preceding 
their onsets of AF. Among the few patients with consistent cardiac rhythm 
immediately preceding atrial fibrillation, the rhythm was always NSR. The 
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effectiveness of optimal pacing algorithm or pharmacologic therapy based 
on the ‘AF onset’ rhythm needs to be evaluated. Additionally classifying AF 
onsets preceded by PACs, PVCs, other episodes of AF, or a Short-Long-Long 
sequence may be useful in categorizing the cardiac rhythms. 
1188-61 P Wave Signal-Averaged Electrocardiography 
Predicts the Recurrence of Paroxysmal Atrial 
Fibrillation After Catheter Ablation of Accessorv 
Pathways. A Prospective Study 
Tatsuro Hiraki, Masanobu Ohga, Teruhisa Yoshida, lchiro Kubara, 
Takashi Hamada, Manabu Matsumoto, Hisao Ikeda, Tsutomu Imaizumi. 
Dept. of Int, Med. Ill, Kurume Univ., Kurume, Japan 
Successful catheter ablation of accessory pathways (AP) reduces paroxys- 
mal atrial fibrillation (Paf) attacks. However, Paf still occurs after successful 
ablation in some patients. To determine whether P wave signal-averaged 
ECG (PSAE) is useful for the prediction of the recurrence of Paf after suc- 
cessful ablation in patients with AP, we prospectively studied 23 patients with 
documented Paf and AP. PSAE was recorded on day 7 after successful ab- 
lation through a band-pass filter of 40-300 Hz. The filtered P wave duration 
(fPd) was measured by the vector magnitude method. We defined “fPd > 
130 ms” as prolonged fPd. Patients were followed up for 38 i 18 months. 
Results: Six patients (Group 1) had prolonged fPd, while the other 17 
patients (Group 2) did not. There were no significant differences in gender, 
age, left atrial dimension, atrial vulnerability and follow-up periods between 
the two groups. During follow-up, 8 patients (35%) had recurrent Paf. All 
patients of Group 1 (100%) had recurrent Paf, while the recurrence of Paf 
was only in 2 patients of Group 2 (12%). Kaplan-Meier analysis showed that 
the recurrence of Paf was significantly more frequent in Group 1 than Group 
2 (log-rank test, p < 0.0001). 
Conclusion: These results suggest that PSAE could be useful to identify 
patients who may develop Paf after successful ablation for AP with Paf 
(sensitivity; 75%, specificity; 100%). 
1188-62 Atrial Septal Pacing Decreases the Incidence of 
Atrial Late Potential in Patients With Paroxysmal 
Atrial Fibrillation 
Takahisa Yamada, Masatake Fukunami, Tsuyoshi Shimonagata, 
Kazuaki Kumagai, Hisakazu Ogita, Yoshihisa Asano, Akio Hirata, 
Mitsutoshi Asai, Noritake Hoki. Osaka Prefectural Genera/ Hospital, Osaka, 
Japan 
Background: The mechanism for prevention of atrial fibrillation (Af) recur- 
rence by atrial septal pacing remains unclear. The risk of Af recurrence could 
be assessed by atrial late potential (ALP) on the P wave signal-averaged 
EGG (SAE). We sought to clarify the mechanism from the viewpoint of ALP. 
Methods: We studied 17 patients (pts) (7 pts with (Paf) and 10 pts 
(non-Paf) without paroxysmal Af). SAEs were recorded during sinus rhythm 
(SR), high atrial septal (hAS) and right atrial appendage @AA) pacing. The 
duration (Ad) and root mean square voltage (LP20) for the last 20 ms of 
filtered P wave were measured in the vector magnitude. 
Results: Although Ad in hAS pacing was significantly shorter than that in 
SR or RAA pacing in both Paf and non-Paf pts, the degree of Ad shortening 
in hAS pacing was significantly greater in Paf than non-Paf pts (ANOVA, p = 
0.01). LP20 was significantly higher in hAS pacing than those in SR or RAA 
pacing in Paf but not in non-Paf pts. The incidence of ALP (Ad > 132 ms and 
LP < 2.3 @V) in Paf pts was significantly (p c: 0.05) lower in hAS (0%) than 
that in SR (71 [S/7]%) or RAA pacing ([S/7171 %). 
SR bAs RAA SR MS RAA 
*p<O.OS YS SRandRAA,**p40Svs SR. 
Conclusions: High atrial septal pacing decreases the incidence of ALP 
in Paf pts, which might result in the prevention of Af recurrence. 
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El 891 1 Effects of Azimilde, an IKr and IKs Potassium Channel Blocker in Patients With Implantable 
Cardioverter Defibrillator 
Jose M. Brum, Colin M. Hislop, Hussein R. Alkhalidi, Laurie P:Gunderson, 
Patrick Tchou, Tony Simmons Richard Henthorn, lmran Niazi, lgor Singer. 
P&G P Cincinnati, Ohio: University of Louisville, Louisville, Kentucky USA 
Background: Natural progression of the disease in patients with life threaten- 
ing ventricular tachycardia and Implantable Cardiovener Defibrillators (ICD) 
may require additional antiarrhythmic treatment to control excessive number 
of therapies (shocks or anti tachycardia pacing, ATP). The antiarrhythmic of 
choice should not affect the defibrillation threshold (DFT) in addition to being 
safe and efficacious. 
Methods: This was a double blind placebo controlled trial designed to 
assess the effects of azimilide in 172 (154 male, 18 female) patients with 
ICDs. Patients were randomized following a non invasive electrophysiologic 
study (NIPS) and DFT determination to receive once a day 35 mg (n = 44), 
75 mg (n = 45), 125 mg (n = 46) of oral azimilide or placebo (n = 37). The 
NIPS and DFT were repeated 30 days later and the patients were followed 
for 360 days plus one week. The time to first event (appropriate shock or 
ATP or death) or the frequency of events observed in patients on drug were 
compared to placebo. 
Results: There were no significant drug effects on the median time to 
first event although the number of patients who had an event in 125 mg 
(54%) was lower than in placebo (79%) at the end of one year. A significant 
decrease in the incidence of ATP or combined therapy (ATP plus Shock) 
was observed in patient receiving azimilide at all doses (table). Azimilide 
did not affect LVEF, the DFT or pacing threshold. The number of adverse 
events observed in patients receiving azimilide was similar to that in patients 
receiving placebo. 
Frequency of Events (number of events/years exposure) 
Placebo 35 mg 75 mg 125 mg 
Shock 3.1 3.1 2.8 3.8 
“S p = 0.01 
ATP 47.7 12.3 15.2 l 
p < 0.0001 p < 0.0001 p < 0.0001 
ATP + Shock 37.3 10.6 12.2 9.3 
p < 0.0001 p < 0.0001 p < 0.0001 
Conclusion: All doses of azimilide were effective in reducing significantly 
the number of VT episodes treated by pacing in these patients. 
4:15 km. 
891-2 Cost-Effectiveness of the Implantable Cardioverter 
Defibrillator: Results From the Canadian Implantable 
Defibrillator Study (CIDS) 
Bernie O’Brien, Stuart Connolly, Ron Goeree, Gordon Blackhouse, 
Andrew Willan, Raymond Yee, Robin Roberts, Michael Gent. For the C/D.5 
investigators: Departments of Clinical Epidemiology and Biostatistics and 
Medicine; McMaster University: and Centre for Evaluation of Medicines; St. 
Joseph’s Hospital, Hamilton, Ontario, Canada 
Background: In the Canadian Implantable Defibrillator Study (CIDS) patients 
were randomized to receive an implantable cardioverter defibrillator (ICD) or 
amiodarone. Given the high acquisition costs of ICDs we also conducted a 
prospective cost-effectiveness study to determine whether the (previously 
reported) gain in survival is achieved at an acceptable cost. 
Methods: Data on health care resource use to estimate costs were col- 
lected on 430 patients - 212 ICD, 218 non-ICD - 65% of the total sample (n = 
659). The perspective of the study was costs to a Provincial Ministry of Health 
over the 6-year within-trial time horizon. Resource use collected included: 
ICD devices, anti-arrhythmic therapy, other drug utilization, hospitalizations, 
ICD generator replacements, revascularization procedures and other tests 
and procedures. Costs were adjusted for patient censoring over time. Life 
expectancy over the six years of follow-up for each group was derived by 
Kaplan-Meier estimates. Costs and effects were discounted at rate of 3% per 
annum. Costs are 1998 Canadian dollars (lCA$ = 0.7US$). 
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Results: The cost for the ICD group was substantially higher than the cost 
for the non-ICD group (CA$87,715 vs. CA$38,600, respectively; difference 
of CA$49,115; pm< 0..05). However, life expectancy forthe ICD group was 
also higher (4.58 vs. 4.35 years; difference of 0.23 years). The incremental 
cost-effectiveness ratio (ICER) of the ICD group compared to the non-ICD 
group was CA$213,543 per life year gained. Although the results were 
not sensitive to alternative assumptions for device costs or the discount 
rate, extending the follow-up period for analysis using modelled projections 
beyond the trial suggests improved the cost-effectiveness of ICD therapy. 
increase in patient concerns (Table). More frequent shocks were associated 
with larger changes in these instruments. The development of shocks was 
not significantly associated with altered physical functioning. 
Conclusion: Sporadic defibrillator shocks are associated with a signifi- 
cant, independent reduction in self-perceived mental well being &an increase 
in patient concerns. Whether strategies aimed at reducing shock frequency 
will enhance QoL remains to be prospectively evaluated. 
Conclusions: ICD therapy is both more effective and more costly than 
non-ICD therapy. At over CA$200,000 per life year gained, the cost-effec- 
tiveness of this high-technology medical device is more costly than most 
accepted therapies. 
4:30 D.m. 
El 891 3 International Survey of Prophylactic Defibrillator 
Implantation 
David J. Wilber, Seah Nisam. University of Chicago, Chicago IL, USA 
Background: The Multicenter Automatic Defibrillator Implantation Trial (MA- 
DIT) established an indication for implantable defibrillators (ICD) as primary 
prevention in patients (pts) with previous infarction, ejection fraction (EF) 
~35%, nonsustained ventricular tachycardia (VT), and inducible VT not sup- 
pressed by Class I drugs. Few data exist regarding implementation of this 
indication in clinical practice. 
Methods: We surveyed 72 active ICD implanting centers (26 US, 46 
European) with respect to screening and implantation practices related to 
MADIT for the year 1998. 
Results: Prophylactic ICD implantation using MADIT indications com- 
prised 9% of all initial implants (15% US, 9% German, 5% other European), 
but ranged broadly from 0% (11 centers) to >20% (7 centers). Implant rate 
was related to total annual ICD volume: 13% at high volume (2100) and 7% 
at low volume (~40) centers. Only 4% of responders conducted systematic 
Holter screening of post infarction pts with low EF, and 41% screened for MA- 
DIT indications only in pts referred specifically for that purpose. With respect 
to specific elements of MADIT qualifications, responders 1) do not routinely 
perform drug testing following induction of qualifying VT (61%) 2) would 
implant an ICD in selected pts with NSVT and EF 235% if qualifying VT was 
induced (38%), 3) would implant an ICD in selected pts without NSVT, but 
with EF 535% if qualifying VT was induced (18%). 
Conclusions: If these results are applied to the total number of new im- 
plants in 1998, approximately 5000 ICDs were placed for MADIT indications. 
However, individual practices were highly variable, with some extrapolation 
from strict indications based on pt presentation and physician judgement. The 
impact of more recent clinical trials on prophylactic ICD use merits further 
evaluation. 
4:45 p.m. 
891-4 Defibrillator Shocks and Self-Perceived Quality of 
Life in the Antiarrhythmics Versus Implantable 
Defibrillators (AVID) Trial 
Derek V. Exner, Eleanor B. Schron, Qing Yao, Margot E. Vloka, Richard 
I-. Page, Judy Powell, Jonathan S. Steinberg. The AVlD Investigators; 
NHLBI, Bethesda, MD; The University of Washington, Seatt/e, WA, USA 
Background: While defibrillator shocks are potentially lifesaving, they may 
be painful & distressing to some patients, The impact of shocks on quality of 
life (QoL) is uncertain, but relevant to both patients & clinicians. 
Methods: Self-administered generic (Short Form-36) & disease specific 
(Patient Concerns) QoL instruments were completed at baseline & serially 
during follow-up. Data on defibrillator shocks were collected at similar in- 
tervals The relationship between shocks & change in QoL over time was 
assessed using generalized linear modeling, adjusting for duration of fol- 
low-up & important prognostic variables. To minimize the impact of missing 
data, only patients surviving ~1 year were included in the model. 
Results: Over the Is’ year of follow-up, shocks occurred in 212 (42%) 
of the 507 patients randomized to defibrillator therapy (median # shocks = 
0, 25rh, 75’” percentiles 0, 3). Of these 507 patients, 418 (82%) completed 
QoL assessments & survived ‘1 year. The occurrence of >I shock was in- 
dependently associated with a significant reduction in mental well being &an 
Table. Absolute change in QoL score over time (95% confidence interval) 
Number of Component Summary Score (Short Form-36) 
Shocks Physical Mental 
>l vs. 0 -0.92 (-2.12,0.28) -1.96 (-3.81, -0.12) 
>3 vs. <3 0.03 (-2.08, 2.14) -4.91 (-8.06, -1,76)*” 
*p c 0.05; **p < 0.001 
Patient 
Concerns 
1.47 (0.39,2.54)* 
2.16(0.15,4.17)* 
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/ 902-I 1 Reduction in Hospitalisation for CHF in DIAMOND is 
Due to the Effect of Dofetilide in PatientsWith Atrial 
Fibrillation 
A. John Camm. On behalf of the DIAMOND Study Group; St George’s 
Hospital Medical School, London, LIK 
Background: The Danish Investigations of Arrhythmia and Mortality ON 
Dofetilide CHF and Ml studies (DIAMOND CHF & MI) included 3028 pa- 
tients (pts) with a left ventricular ejection fraction (LVEF) _’ 35% and either 
severe congestive heart failure (CHF) or recent myocardial infarction (Ml), 
randomized to dofetilide (D) or placebo (P). 
Methods: The pre-defined endpoint of hospitalization for worsening of 
CHF was examined in patients with (506) and without (2522) atrial fibrillation 
or flutter (AF) at baseline. 
Results: Overall, there was a reduction in hospitalizations for D compared 
to P (1 year probability free of hospitalization: 0.71 (D) vs 0.66 (P), P = 0.051). 
This reduction in hospitalization can be attributed to the benefits of D on AF 
(Fig 1) as it was not seen in pts without AF at baseline (Fig 2). For patients 
with AF at baseline, the median duration to hospitalization with worsening 
CHF was >39 months on D, compared with 20 months on P. The benefit was 
greater in those patients who were maintained in SR versus those remaining 
in or reverting to AF. In 234 pts (148 D, 86 P) who converted to sinus rhythm 
(SR), the probability of remaining in SR at one year was 0.79 on D vs 0.42 
on P, P < 0.001, There was no excess mortality on D (541 deaths on D, 560 
deaths on P). 
Conclusion: A significant reduction in hospitalization for CHF can be 
achieved by the treatment of AF with dofetilide in patients with impaired 
LVEF. 
8:45 a.m. 
L-A 902 2 Cardioversion of Atrial Fibrillation or Flutter in Patients Receiving Combination lbutilide and 
Amiodarone Therapy 
Kathy Glatter, Kanu Chatterjee, Yanfei Yang, Jie Cheng, Steve Kayser, 
Melvin M. Scheinman. University of California, San Francisco, CA, USA 
Background: lbutilide (IB) is a new class Ill agent used to treat atrial fibril- 
lation (AF) or flutter (AFL) but can cause torsades. Amiodarone (AM) also 
prolongs QTc (corrected QT) intervals but rarely causes torsades. There 
is little data exploring the safety and efficacy of using IB in patients (pts) 
receiving chronic AM. 
Methods: Fifty-two pts (60% male, 68 i 12 yrs) receiving chronic oral 
AM therapy were referred for elective cardioversion of AF (44/52, 85%) or 
AFL (8/52, 15%). Pts were treated with chronic AM therapy (mean = 175 
days; mean dose = 354 mg/day) and given 2 mg IV IB. Pts were continuously 
monitored by ECG during and for 4 hours afler IB. Ten consecutive QTc 
intervals were measured before and after IB. Left atrial (LA) size and ejection 
fraction (EF) were measured by echo. 
Results: Four pts (4152, 8%) previously had cardiac arrest or VT, 4 pts 
had a myocardial infarction in the 2 weeks prior to enrollment, and 4 pts (83%) 
had structural heart disease. For the entire group, pts were in arrhythmia for a 
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mean of 237 days (range I-4015 days) prior to study, and the mean echo EF 
was 50% (range = 15-70%). Fifteen pts (29%) had class III or IV heart failure. 
Eighteen pts (18/44, 41%) with AF and 4/S (50%) with AFL converted to sinus 
rhythm after IB. Twenty-seven pts who did not convert after IB were treated 
by electrical cardioversion, and 25/27 (93%) successfully converted to sinus. 
For entire group, QTc intervals increased after I6 from 439 f 31 to 515 f 50 
ms (p c 0.001). One pt (l/52, 2%) had an episode of non-sustained torsades 
after IB. There was no difference between converters vs. non-converters after 
IB for QTc, LA size, EF, age, gender, days in arrhythmia, or days treated with 
AM prior to IB therapy (p > 0.05). 
Conclusions: In this pilot study, IB converted 41% of pts with AF and 
50% with AFL treated with chronic oral AM therapy. Despite increase of 
QTc intervals after IB, only 1 episode of self-terminating torsades occurred. 
Combination IB and AM therapy does not appear to either enhance efficacy 
or increase toxicity compared with prior studies using IB alone. 
9:00 a.m. 
1 902-S 1 Early Anti-Arrhythmic Therapy is No Better Than 
Rate Control Therapy Alone for Suppression of 
Atrial Fibrillation After Cardiac Surgery 
Richard Saucier, Melecio Abordo, Anis Hanna, Ellison Berns, David 
I. Silverman. St Francis Hospital, Hartford, CT; University of Connecficut 
Health Center; Farmington, 127; USA 
Background: Despite recent advances m therapy for atrial fibrillation/flutter 
(AF) following cardiac surgery (CVSURG), the potential superiority of antiar- 
rhythmics over rate control for suppression of AF has not been convincingly 
demonstrated. 
Methods: Out of 1100 consecutive patients (pts) undergoing CVSURG 
from 7/97-6/98, AF was identified in 425 (38.6%) prior to discharge. Pts with 
a history of chronic AF prior to CVSURG and pts who died within 48 hours 
of CVSURG were excluded from the analysis; 365 pts were studied. Group I 
pts received rate control alone; Group II received antiarrhythmic drugs within 
24 hours of 1 St onset of AF. 
Results: With the exception of frequency of pulmonary disease (4 vs 17, 
p = 0.009), CABG rate (35% vs 45%, p = 0.045), and rate of valve surgery 
(24% vs 15%, p = 0.028), there were no significant differences in clinical 
characteristics between the 2 groups. The table describes various in-hospital 
outcomes with regard to efficacy of rate control alone. (Group I) compared to 
antiarrhythmic therapy. (Group II). 
outcome 
SR within 24 hr of AF 
SR at Discharge, 
Total LOS (days) 
Post-op LOS, (days) 
Embolic Events, n (%) 
Before AF 
After AF 
Adverse Treatment; 
Events 
Death 
Group I (n = 163) Group II (n = 190) 
131 (80.4%) 155 (81.6%) 
146 (89.6%) 174 (91.6%) 
10.6 + 6.0 11.4+ 5.8 
8.4 + 15.0 9.4 5 5.3 
5 (3.1%) 3 (2.6%) 
2 (1.2%) 3 (1.6%) 
3 (1.6%) 2 (1.1%) 
2 (1.2%) 
3 (1.8%) 
5 (2.6%) 
6 (3.2%) 
P 
0.386 
0.259 
0.159 
0.061 
0.606 
0.292 
0.428 
0.113 
0.434 
Conclusion: Traditional antiarrhythmic therapy appears to provide no 
clear advantage over rate control post CVSURG in terms of length of stay, 
freedom from AF at discharge, and other common clinical outcomes. Routine 
use of antiarrhythmics for suppression of AF should be carefully reconsid- 
ered. 
9:15 a.m. 
EII 902 4 Amiodarone Reduces Procedures and Costs Related to Atrial Fibrillation in a Controlled Clinical Trial 
Gerald B. Lumer’ , Denis Roy’, Mario Talajic2, Nancy Frasure-Smith”, 
Marc Dubuc2, Bernard Thibault2, Jean Lambert2, Stanley Nattel’*‘. 
“Montreal Heart Institute; ‘McGill University: Montreal, Quebec, Canada 
Background: Atrial Fibrillation (AF) is the most common sustained cardiac 
arrhythmia. Health care costs for patients with a cardiovascular disease other 
than AF are significantly higher when AF is also present. The higher costs are 
driven by increased hospital costs. However, the impact of various treatment 
options for AF on hospital costs has not been evaluated in a randomized trial. 
Methods: We analyzed one year follow-up data on 392 patients random- 
ized to treatment with low dose amiodarone (200 mg/day) or conventional 
therapy (sotalol or propafenone) in a multicenter trial (Canadian Trial of Atrial 
Fibrillation, CTAF) of therapy for patients with AF in whom a decision had 
been made to prescribe drugs for sinus rhythm maintenance. 
Results: Amiodarone significantly reduced the number of AF-related 
procedures requiring hospitalization, concomitantly reducing the number of 
hospital days required for AF care and related inpatient expenses (table). 
Amiodarone Conventional P 
Theraov value ** 
Cardioversions (II) 65 111 0.003 
Pacemaker Insertions (n) 4 13 0.026 
Days in Hospital* 0.48 + 0.1 1.00zko.17 0.006 
Days in the ICU* 0.07 i 0.04 0.11 * 0.04 0.09 
Inpatient Expenses ($)* 512.03 * 112.36 1208.25 & 217.34 0.006 
“For hospitalizations with AF as the admitting diagnosis; **Wilcoxon 
Conclusion: For patients in whom antiarrhythmic drug therapy of AF 
is indicated, low dose amiodarone significantly reduces AF-related hospital 
costs by reducing the number of AF-related procedures. 
9:30 a.m. 
I 902 5 Dofetilide Use in Atrial Fibrillation: A Treatment Strategy to Minimize Proarrhythmic Risk 
Craig M. Pratt, Jeremy N. Ruskin, Tilman Friedrich. Baylor College of 
Medicine, Houston, Texas; Massachusetts General Hospital, Boston, 
Massachusetts: Pfizer, lnc, New York, New York, USA 
Background: Dofetilide (D) is an Ikr blocker demonstrated to be effective 
for both conversion and maintenance of sinus rhythm in patients (pts) with 
atrial fibrillation (AF). The major safety concern with any Ikr blocker is the risk 
of torsades de pointes (tdp). Two mortality trials in pts with left ventricular 
dysfunction (DIAMOND studies; N = 3028) have demonstrated a neutral 
effect of D on mortality. 
Methods: The oral D program consisted of 6883 pts. Of these, 2258 pts 
had supraventricular arrhythmias (SVA), primarily AF. Pts received placebo 
or D at one of three doses (125, 250 or 500 mcg bid). During the D clinical 
program, the following three safety steps were implemented to reduce the 
risk of tdp: 1) mandatory in-hospital initiation of D, 2) pre-dose adjustment for 
renal function (RF) and 3) ECG monitoring for post-dose adjustment based 
on QTc. The use of this strategy resulted in a reduction of D dose in nearly 
30% of SVA pts The major reason for dosage reduction of D was the RF 
algorithm. 
Dofetilide SJA Studies N = 2256 % of Patients with Dose Chanae 
Dose Adjustme@ (in-hospital) 
For CL cr 
For QTc prolongation 
Discontinuations (in-hospital) 
Due to Torsades 
Due to QTc txolonaation 
239 17.8 
105 7.8 
10 0.7 
37 2.7 
Results: In comparison to SVA pts treated with D before, implementation 
of the RF algorithm, the rate of tdp was reduced from 3.1% to 0.4% with no 
deaths attributable to D. A similar reduction of tdp rate was observed in the 
DIAMOND population (pre-3.9%; post-1.8%). 
Conclusion: D should be administered using the three safety steps 
validated by this large clinical trial experience. 
9:45 a.m. 
1 902-6 1 Mortality in Patients With Atrial Fibrillation - 1 Year 
Follow Up of EMERALD (European and Australian 
Multicenter Evaluative Research on Atrial Fibrillation 
Dofetilide) 
Terence J. Campbell, Robert A. Greenbaum, Kevin S. Channer, Harris 
W. Dalrymple, Jan H. Kingma, Massimo Santini, Karl Theisen, Lauri 
K. Toivonen. St Vincent’s Hospital, Darlinghurst, Australia 
Background: Atrial fibrillation (AF) has an annual mortality of i-3% in anti- 
coagulated patients (pts). Mortality may be increased in pts treated with class 
I antiarrhythmic drugs. The effect of a pure Class Ill antiarrhythmic agent, 
dofetilide (D), was evaluated in the EMERALD study. 
Methods: In the EMERALD Study 534 pts were randomized to D or P 
which was continued while pts remained in sinus rhythm (SR). 321 dofetilide 
treated pts [125,250, 500 mcg, all bid] and 106 placebo treated pts with AF 
of 1 week to 2 years in duration were converted to SR pharmacologically or 
by DC conversion and entered the maintenance phase of the study. Mean 
duration of treatment was 155 days on D and 83 days on P. All pts were 
followed for mortality to 1 year regardless of rhythm status or discontinuation 
of treatment. Mean age was 64 years, 69% were males, 47% had NYHA 
class ll/lll, 49% had structural heart disease and 46% hypertension. 
Results: At one year, the probability of remaining in SR was 39%, 51% 
and 66% for D-treated pts [125,250 and 500 mcg bid, respectively] (321) 
compared with 21% of pts on P (106). 
The 1 year all-cause mortality for placebo treated pts was 2.2% (31137) 
and 1.5% (6/397) for dofetilide. The hazard ratio (dofetilide/placebo) for 
mortality was 0.69 (95% Cl: 0.17-2.75). 
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Conclusion: The mortality risk for pts with chronic AF is low. Although 
this study was not powered to show a difference in mortality, in contrast to 
available data on Class I agents, treatment with dofetilide does not seem to 
increase mortality in pts with chronic AF. 
POSTER 
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1 1209-67 / Natural History of Wolff-Parkinson-White in 238 
Mrlitary Aviators: Long-Term Follow-Up of 
Twenty-Two Years 
Patrick J. Fitzsimmons, Paul D. McWhirter. David W. Peterson, William 
B. Kruyer. United States Air Force School of Aerospace Medicine, Brooks 
Air Force Base, TX; W/ford Ha// Medical Center, Lack/and Air Force Base, 
TX, USA 
Background: Individuals with Wolff-Parkinson-White (WPW) pre-excitation 
are at risk for tachyarrhythmias and sudden cardiac death. Most studies of 
WPW have a limited number of subjects and relatively short follow-up times. 
We sought to further clarify the natural history of WPW by determining the 
incidence of sudden cardiac death and supraventricular tachyarrhythmias 
@VT) in a long-term follow-up study of military aviators evaluated for WPW. 
Methods: We reviewed the records of initial and serial evaluations per- 
formed at a central facility on 238 consecutive military aviators with symp- 
tomatic or asymptomatic WPW from 1955 to 1997. Further follow-up was 
obtained via questionnaire surveys, telephone interviews and death certifi- 
cates Clinical events analyzed included sudden cardiac death, symptoms 
suggestive of a sustained tachyarrhythmia, and electrocardiographically doc- 
umented SVT. 
Results: initial Presentation: The study cohort included 232 men and 
6 women (military aviators). Average age at time of initial evaluation was 
34.3 years (range 17-56). At initial evaluation, 421238 (17.6%) had SVT by 
suggestive symptoms or electrocardiographic documentation and 196/238 
(82.4%) had WPW pattern only. Intermittent WPW occurred in 49% and con- 
tinuous WPW in 51%. Thirteen of the 238 (5.4%) had a family history of 
sudden cardiac death. Follow-up: We obtained follow-up on 2261238 (95%) 
for a mean of 21.8 years (range 2-41 years) and a total of 4,829 patient- 
years. Sudden cardiac death occurred in l/226 (0.4%) or O.O002/patient-year. 
During follow-up, SVT by suggestive symptoms or electrocardiographic doc- 
umentation was reported in 471226 (20.8%) or O.Ol/patient-year. 185/226 
presented initially with WPW pattern and 28/185 (15.1%) reported SVT dur- 
ing follow-up. 41/226 presented initially with WPW syndrome and 19/41 
(46.3%) reported SVT during follow-up. 
Conclusion: In this population of military aviators found to have WPW 
pattern or syndrome, the risk of SCD was very low (O.O2%/patient-year). The 
incidence of SVT was I .O%/patient year. Referral bias and some character- 
istics of the unique military aviator population may, at least in part, account 
for these low event rates. 
r’z 1209-68 Manifestation of Antidromic Reciprocating Tachycardia in Subjects With Paraseptal 
Accessory Pathways 
David M. Luria, Sumeet Chugh, Arshad Jahangir, Thomas M. Munger, Paul Background: Prior studies suggest that atrial fibrillation (AF) results in sub- 
A. Friedman, Robert F. Rea, Douglas L. Packer, Stephen C. Hammill, Win stantial impairment in health related quality of life (QoL). However, selection 
K. Shen. Mayo Clinic, Rochester, Minnesota, USA bias and brief follow-up duration limit these studies. 
It has been reported that proximity to the AV node (shorter macro-reentry 
wavelength) prevents participation of paraseptal accessory pathways (PS) 
in antidromic reciprocating tachycardia (ART). As conduction velocity and 
refractoriness are key components of macro-reentry, we hypothesized that 
slowed conduction (slower velocity) in PS or AV node may promote the 
occurrence of ART. 
Methods: To address these limitations, we measured QoL in 229 pa- 
tients from the FRACTAL registry, a multicenter, population-based registry 
of patients with new onset AF. QoL was measured at baseline (BL), 3 and 
Table: QoL measures for 229 patients with new onset AF 
Methods: Based on fluoroscopic and electrophysiologic criteria, acces- 
sory pathways were classified as PS, posterior (POS) or lateral (LAT). Con- 
duction time measurements were made during EP study for all components 
of the tachycardia circuit. 
Results: Of 24 patients with ART studied at our institution from 1992-98, 
PS were observed to mediate the tachycardia in 5 subjects. Conduction 
time through the accessory pathway was significantly longer in PS vs. LAT 
pathways. Retrograde AV-nodal conduction time was also greater in PS vs. 
Baseline 3 Months 6 Months p-value BL v. 6 mo 
SF-12 Physical 44*10 46zkiO 46ilO p < 0.0001 
SF-12 Mental 51+9 5219 525 9 p < 0.03 
St. Michael’s AF Severity Scale 
Limit-Physical s3+14 89i11 91 zk 11 p < 0.0001 
Limit-Psych 88+14 90*15 93i12 p < 0.0001 
Symptom Checklist 
Severity 1218 Qzk7 a*7 p < 0.0001 
FKXlWllCV 14*9 11 59 io*a 0 < 0.0001 
(Limit-Phys = Physical limitations, Limit-Psych = Psychological limitations) 
LAT or POS, but there were no significant differences in tachycardia cycle 
length (table) or ERPs. 
Tachvcardia CL (ms) 
PS POS LAT 
361 316 289 u=NS 
Retrograde AV-nodal conduction 123 67# 67* -p <‘0.05 vs PS 
(HA, ms) #p = 0.06 “S PS 
Anteroarade AP conduction (local AV. ms) 148 121 59* *II < 0.05"s PS 
Conclusions: In the subset of pa.tients with ART using paraseptal acces- 
sory pathways, anterograde pathway conduction time as well as retrograde 
AV node conduction time are prolonged. These differences in electrophysio- 
logic properties compensate for the close anatomic proximity of the limbs of 
the circuit, permitting the occurrence of antidromic reciprocating tachycardia. 
/ . 1209 69 The Value of Bundle Branch or Fascicle Block in 
Locatmg the Site of Septal Accessory Pathway 
Yanfei Yang, Jie Cheng, Kathy Glatter, Parvin Dorostkar, Melvin 
M. Scheinman. University of California, San Francisco, CA, USA 
A total of 34 patients with single septal accessory pathway (AP) developed 
bundle branch block (BBB) orfascicle block (FB) during orthodromic reentrant 
tachycardia (ORT). During ORT retrograde conduction was measured from 
the initial QRS to the earliest retrograde A (VA) and pathway locations were 
confirmed by successful catheter ablation. In our previous study, complete 
BBB associated with a free wall AP always showed a AVA > 40 ms (J Am 
Coil Cardiol 1999; 33: 157A). 
Results: A total of 13/23 patients with posteroseptal AP (PSAP) devel- 
oped left BBB (LBBB) and normal axis and was associated with a AVA of 
27 & 10 ms (range 12-45 ms) compared to ORT with normal QRS. In 3 
patients, LBBB was associated with right axis deviation (left posterior FB 
(LPFB) pattern) which was associated with AVA of 63, 91 and 97 ms respec- 
tively. Twenty patients with PSAP developed right BBB (RBBB) and had no 
change in AVA except for 2 with RBBB and LPFB who showed AVA of 15 
and 31 ms. The PSAP was successfully ablated from the right atrium in 18 
patients including the three with LPFB (1 of 3 from the orifice of the middle 
cardiac vein); in 5 patients the pathways were ablated from the left atrium. In 
7 patients with anteroseptal AP (ASAP), isolated RBBB was associated with 
a AVA of 24 & 9 ms (range 15-41 ms). One patient with RBBB consistent 
with a right mid-septal block pattern had a AVA of 41 ms. Neither LBBB nor 
RBBB resulted in change in the AVAfor 5 patients with mid-septal pathways 
and ORT except for one patient with a left mid-septal AP with LBBB who 
developed a AVA of 28 ms. 
Conclusions: (1) In patients with ORT, isolated BBB without FB asso- 
ciated with a AVA < 40 ms almost always predicted a septal pathway and 
the BBB pattern predicted the atrial AP insertion site; (2) This is the first 
demonstration that the posteroseptal space is activated from the left poste- 
rior fascicle and that the LBBB and LPFB pattern in patients with PSAP may 
show AVA similar to those with flee wall pathways; (3) Patients with true right 
mid-septal pathways appear to have no change in AVA with either RBBB or 
LBBB. 
Ll.- 1209 70 impact of New Onset Atrial Fibrillation on Quality of Life: Initial Findings of a Prospective, 
Multicenter Registry 
Peter J. Zimetbaum, Duane S. Pinto, Mark E. Josephson, Tomy Hadjis, Paul 
A. Friedman, David Schwartzman, Roberta Cosgrove, Nancy Jones, Mary 
Jane Mcdonald, David Cohen. Beth lsrael Deaconess Medical Center, 
Boston, MA, USA 
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6 months using the SF-12 a symptoms checklist, and the St. Michael’s AF 
Severity Scale, a disease specific measure of limitations due to AF (Range 
O-100, normall = 100). 
Results: At AF onset, substantial QoL impairment was noted on all 
scales except mental health (see Table). Over 6 month follow-up, most 
QoL measures improved significantly, but did not normalize in this diverse 
population. 
Conclusion: Most measures of QoL in patients with new AF are mildly 
impaired at baseline and improve over 3-6 months. Further studies are 
needed to identify the factors associated with sustained QoL improvement in 
this expanding population. 
r-1 1209 71 Spontaneous Atrial Fibrillation is Initiated by Premature Beats From Different Atrial Regions 
and Involves Atrial Regions Adjacent to the 
Trigger(s) at Initiation 
Sanjeev Saksena, Atul Prakash, Ryszard B. Krol, George Philip. Eastern 
Heart Instifufe-Atlantic Health System, Passaic, NJ, USA 
We performed simultaneous catheter endocardial mapping of RA & LA re- 
gions in 20 patients [pts] with recurrent atrial fibrillation [AF] at the onset 
of & during spontaneous AF episodes, RA & LA regions mapped included 
lateral RA [LatRA], interatrial septum [IAS], AV junction [AVJ], isthmus, su- 
perior LA including pulmonary veins [SLAIPV], & proximal [CSp], mid [CSm] 
& distal coronary sinus [CSd]. Regional atrial activation during the triggering 
atrial premature beat [APC] & onset period of AF was analyzed for earliest 
activation & activation sequence for the first 20 cycles. 
Results: The earliest region of atrial activation for the APC & AF onset in 
all pts is shown. 
A single stable atrial activation sequence from AF onset was observed in 
17 of 20 pts at AF initiation with 3 of 17 pts also having an unstable sequence 
during ~1 subsequent AF initiation. This was reproduced in all 11 pts with 
recurrent AF events. 
Conclusions: 1) AF is initiated by APCs arising in different RA & LA 
regions. 2) Initial maintenance of AF usually occurs in the same atrial region 
as the APC. 3) A single atrial activation wavefront exists at AF onset in most 
pts. 4) AF onset may be amenable to focal &/or regional ablation approaches 
in many pts demonstrating spontaneous APCs. 
L-L 1209 72 Clinical Significance of Focal Atrial Arrhythmias Following Cardioversion of Persistent Atrial 
Fibrillation 
Derick M. Todd, Simon P. Fynn, William J. Hobbs, Karen Armstrong, Clifford 
J. Garratt. Manchester Heart Centre, Manchester, UK 
Background: Previous reports have highlighted the importance of focal atrial 
arrhythmias as a mechanism for idiopathic atrial fibrillation (AF). We studied 
the clinical significance of immediate post-cardioversion focal arrhythmias in 
a group of patients undergoing internal DC cardioversion (ICV) for persistent 
AF. 
Methods: Fifty consecutive patients (mean age 60 years, mean duration 
of AF 26 months) were admitted for ICV of persistent AF. All cardioac- 
tive medication was stopped 5 half-lives before admission. A focal source 
was considered to be present if there was evidence of (1) self-terminating 
monomorphic atrial tachycardia, or (2) repeated reinitiation of AF with a repro- 
ducible atrial activation pattern, in the first 120 seconds following ICV. After 
discharge all patients submitted daily trans-telephonic rhythm recordings for 
1 month in order to determine time of AF recurrence. 
Results: A total of 20 patients were considered to have a focal source 
for their persistent AF. One patient had radiofrequency ablation of a focus in 
the left superior pulmonary vein and is excluded from further analysis. There 
was recurrence of AF within I month in 17 of 19 patients (89%) with a focal 
source and in 18 of 30 patients (60%) without a focal source (p = 0.026). The 
relative risk of recurrence of AF with a focal source was 1.5 (1.07 to 2.08, p 
= 0.038). Multivariate analysis of accepted predictors of AF recurrence (age, 
duration of AF, LA size and the presence of a focal source) found the only 
significant predictor of AF recurrence was the presence of a focal source 
(odds ratio 5.6, p = 0.04). 
Conclusions: Focal atrial arrhythmias following ICV of persistent AF 
are of clinical importance as their presence predicts a high likelihood of 
subsequent AF recurrence. 
I 1209 73 The Relative Impact of Atrial Fibrillation on Left and Right Atrial Size in Patients Following Mitral 
Valve Replacement 
Y. Adler, B. Strasberg, A. Feldman, N. Fink, A. Battler, A. Sagie. Dept. of 
Cardiology, Echocardiography Unit, Rabin Medical Center, Beilinson 
Campus, Petah Tikva; Sackler School of Medicine, Tel Aviv University Tel 
AviK Israel 
Background: It is widely recognized that mitral valve disease is associated 
with left atrial (LA) enlargement and atrial fibrillation (AF), but the relative 
impact of AF on LA and right atrial (RA) size after mitral valve replacement 
(MVR) remains unclear. The aim of the present study was to evaluate the 
relative impact of AF on the LA and RA areas in patients after MVR. 
Methods: Eighty-six patients underwent MVR were for evaluation of 
the presence of chronic AF: 56 had chronic AF (AF group) and 30 had 
sinus rhythm (sinus group). The LA and RA areas, during systole were 
traced with 2D TTE and the following echocardiographic variables were 
measured: peak and mean transprosthetic mitral valve gradient, mitral valve 
area, shortening fraction, left ventricular wall thickness, mitral and tricuspid 
valve regurgitation and pulmonary artery pressure. Multivariate analysis was 
performed to evaluate the best predictors of LA and RA size. 
Results: There were no significant differences between groups in age, 
sex and time following MVR (mean 8 yrs.). The LA and RA areas were 
significantly greater in the AF group compared to the sinus group (47.1 f 
25.5 cm* vs. 28.4 f 10.3 cm’, p = 0.0002; 29.7 f 12.5 cm2 vs. 17.8 * 6.2 
cm’, p = 0.0001, respectively). The LA area was significantly larger than the 
RA area in both groups (47.1 f 25.5 cm2 vs. 29.7 f 12.5 cm*, p = 0.0001; 
28.4 * 10.3 cm2 vs. 17.8 i 6.2 cm*, p = 0.001, respectively). However, the 
LAfRA ratio was not significantly different in patients with AF than in those with 
sinus rhythm (1.85 vs. 1.67, p = NS). On multivariate analysis, AF was found 
to be the only independent predictor of LA size (p = O.OOOS), whereas AF, 
tricuspid regurgitation severity and shortening fraction were all independent 
predictors for RA size (p = 0.0004, 0.005 and 0.014, respectively). 
Conclusion: AF is apparently the only independent predictor of LA size in 
patients after MVR; however, RA size is influenced by LV function, tricuspid 
regurgitation severity in addition to AF. 
1209-74 Temporal Changes of Human Sinus and 
Atrioventricular Node Function After Conversion 
of Long Standing Atrial Fibrillation: Is There 
Nodal Remodeling? 
Emmanuel M. Kanoupakis, Emmanuel G. Manios, Michail D. Kaleboubas, 
Magdalini K. Zeaki, Hercules E. Mavrakis, Panagiotis E. Vardas. Cardiology 
Dept., Heraklion University Hospital, Heraklion, Crete, Greece 
Background: Although electrical remodeling of atrial tissue has been ex- 
tensively studied, little are known about the effects of long standing atrial 
fibrillation (AF) on specific nodal tissues. In this study we searched for possi- 
ble changes in the function of sinus and atrioventricular node in chronic AF 
patients apter electrical conversion to sinus rhythm. 
Methods: Twenty five consecutive patients with long standing AF who 
were successfully converted to sinus rhythm underwent a series of three 
electrophysiological studies in the following sequence: immediately after 
conversion to sinus rhythm (A), the day apter (B) and one month after 
conversion (C). The following parameters were evaluated: basic intervals 
(AH and HV), PO interval (PQ), corrected sinus node recovery time (CSNRT), 
% reduction of sinus node cycle length after atropine administration (ATR%), 
atrioventricular node effective refractory period at a basic cycle length of 500 
ms (AV-ERP) and the Wenckebach point (Wp) 
Results: 
AH HV PQ CSNRT ATR AV-ERP WP 
IW (6 (W (ms) W (ms) (ms) 
A 1231k51 49f4 218f59 327f166 21zk8 387+85 442 A 96 
B 115154 44zk5 207zt66 352zk146 22zt5 352*95# 404+102# 
C 101 zk42’ 48zk6 194*52* 362 i- 129 25 h 7 331 f 73* 393 z!c 85* 
*p < 0.05 C “s A, ‘p < 0.005 B “s A 
Conclusions: Our results indicate that electrical remodeling resulting 
from long standing AF affects the atrioventricular node, while they do not 
confirm any changes in the function of the sinus node. 
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I .._ 1210 93 Is It Necessary to Prove Bidirectional Block After 
Umdtrectional Block at a Long Pacing Cycle 
Length? 
Kamran Toluie, David J. Callans, Dusan Kocovic, Behzad Pavri, Francis 
E. Marchlinski. Universify of Pennsylvania Health System,’ Philadelphia, PA, 
USA 
Background: Successful atrial flutter ablation has been defined as bidirec- 
tional isthmus block. Documentation of such block may require multipolar 
catheter recordings from both sides of isthmus. 
Methods: The frequency of bidirectional cycle length independent block 
in 46 consecutive patients who underwent RFA of IVCITA isthmus and de- 
veloped medial to lateral block at 600 ms was assessed. Recordings were 
obtained from multipolar “Halo” (standard positioning), Coronary sinus (CS) 
and His bundle catheters, Pacing was performed from the CS and distal 
“Halo” just lateral to the ablation line. Medial to lateral block was defined as 
reversal of “Halo” activation sequence with CS pacing at 600 ms. After doc- 
umenting medial to lateral block, CS pacing was performed at 400 and 300 
ms to assess the presence of rate dependent conduction delay with block 
at shorter cycle lengths. Lateral to medial block, defined by cycle length 
independent reversed Hi&S activation, was assessed during lateral pacing 
600,400, 300 ms. 
Results: When CS pacing at 600 ms demonstrated reversal of Halo 
activation sequence, the following were uniformly noted; 1) The interval 
between proximal CS and distal Halo electrode remained constant at all 
cycle lengths (mean 162 f 33, range 103-268 ms); 2) The interval between 
the distal “Halo” electrode to the proximal CS remained constant during 
lateral pacing at all cycle lengths (mean 141 f 37, range 70-222 ms); 3) 
Hi&S reversal was present during lateral pacing and remained constant at 
all pacing cycle lengths (mean 51 i 18, range 20-92 ms). 
Conclusion: Medial to lateral block at long paced cycle lengths after 
ablation uniformly predicts bidirectional block. These data have implications 
regarding catheter recording positions and monitoring techniques during and 
after ablation and optimal end points to assess isthmus block. 
I 1210 94 The Presence of a Left Atrial “Isthmus” - 
Implications for Radiofrequency Ablation of 
Lateral Accessory Pathways 
David M. Luria, Jan Nemec, Sumeet Chugh, Win K. Shen, Stephen 
C. Hammill, Paul A. Friedman. Mayo C/in& Rochester, MN, USA 
Background: We have observed a change in retrograde activation sequence 
along the mitral annulus during left lateral accessory pathway (LAP) ablation, 
at times with persistent orthodromic reciprocating tachycardia (ORT), not due 
to a second accessory pathway. We hypothesized that this stemmed from 
damage of the narrow isthmus of tissue between left inferior pulmonary vein 
and mitral annulus. 
Methods and Results: Between 1995-99, 75 patients underwent LAP 
ablation at our institution. Coincident with radiofrequency energy delivery 
(RF), a change in retrograde low left lateral atrial excitation was recorded 
by the CS or ablation catheter in 7 cases (9.3%). Appearance of double po- 
tentials (5 cases) indicated intra-atrial conduction block. ORT with increased 
cycle length was still inducible in three of these patients. Altered CS activa- 
tion sequence (6 cases) including complete reversal of the eccentric atrial 
activation (2 cases) falsely suggested the presence of a second accessory 
pathway. In all cases, AP conduction was subsequently eradicated by RF 
ablation in close proximity to the site of the first energy delivery, consistent 
with conduction block between the LAP connection site and CS electrodes, 
and not the presence of a second AP (figure). In 2 cases, the presence 
of conduction block was confirmed by distal CS pacing with a multipolar 
catheter positioned across the “isthmus” area. 
Conclusions: A narrow zone of conduction in the low lateral left atrium 
can be interrupted during LAP ablation attempts. Awareness of the “isthmus” 
concept can prevent misinterpretation of the atrial activation sequence, and 
facilitate ablation. 
121 O-95 Electrophysiological Effects of Toborinone on 
Rabbit Heart Pacemaker and Purkinje Cells 
N. Sato, J. Cordeiro, H. Tanaka, Y. Habuchi, W.R. Giles. Department of 
Physiology and Biophysics, The University of Calgary, Calgary, Alberta, 
Canada 
The electrophysiological effects of a novel positive inotropic agent, tobori- 
none have been evaluated on rabbit heart pacemaker tissue by making 
action potential, and voltage-clamp recordings from single cells from the 
sino-atrial node (SA-N), atrioventricular node (AV-N), and Purkinje fibers 
(P-f). Nystatin-perforated patch recordings from SA-N and AV-N myocytes, 
and conventional whole-cell recordings from P-f showed that in all three 
cell types toborinone, when added to the superfusate at concentrations ? 1 
pM, consistently lengthened the action potential and decreased the sponta- 
neous pacing rate of SA-N and AV-N myocytes. Voltage clamp experiments 
were done with SA-N and AV-N myocytes to define the toborinone-induced 
changes in Ca’+ current, IQ, delayed rectifier K+ current, IK, and hyperpo- 
larization-activated inward current, Ii. At 1 WM in myocytes from SA-N and 
AV-N toborinone produced only one consistent change in the membrane 
currents which are activated within physiological voltage ranges: namely, a 
decrease in 1~. In both SA-N and AV-N this decrease in IK appears to be 
a reduction in the rapidly activating component of the delayed rectifier, IK.R, 
since selective IK.R blockers mimic the effects of toborinine. The effects of 
toborinone on action potential duration in myocytes from ventricular tissue 
and Purkinje fibers also closely resemble those of the selective IK.R blockers, 
E-4031. In conclusion, effective doses of toborinone produce an increase in 
action potential duration (APD) in myocytes from rabbit SA-N and AV-N; as 
well as ventricular and Purkinje tissue. In SA-N and AV-N the spontaneous 
pacing rate is also decreased. These effects appear to be due to inhibition of 
IK.R, The increase in APD is likely to contribute to the negative chronotropic 
and positive inotropic effects of this agent. 
1_/ 1210 96 A Catheter-Based Modified Maze Procedure Using Conformal Catheters Terminates Sustained Atrial 
Fibrillation in Pigs: Initial Results 
Gregory K. Jones, Zhanbin Feng, R. Wayne Barbee, Freddy M. Abi-Samra. 
Ochsner Medical Institutions, New Orleans, Louisiana, USA 
Background: It has been shown that a catheter-based maze procedure can 
be accomplished using radiofrequency (RF) energy. Unfortunately, it requires 
many hours and prolonged fluoroscopy. The purpose of this study is to see if a 
modified catheter-based maze procedure using specially designed multipolar 
conformal catheters could terminate atrial fibrillation (AF) in a pig model. 
Methods: Pacemakers were implanted in four pigs (weighing 65-85 kg) 
to achieve sustained AF by pacing at 600-1200 beats/minutes for 12-16 
wks in the high right atrium (RA). Three different shaped 7Fr 8-16 multipolar 
conformal catheters (Elecath, rahway, NJ) with 2-5 mm ring electrodes and 
2-3 mm spacing were used. The material of the conformal catheters has 
malleable properties and their shape can be changed by applying direct 
current through a wire inside the shaft. Our previous studies have shown 
that continuous, transmural long linear lesions could be created by direct 
RF applications on myocardial tissue via these catheters. The catheters 
were advanced to different sites of the RA (SVC, IVC, lateral and septal 
wall) and pulmonary veins (PVs) area (via a transseptal puncture) under 
fluoroscopic guidance. Following fluoroscopic verification of the positions, 
bipolar RF energy was delivered sequentially to the electrodes for 30-120 
seconds at 20 - 45 Watts. The pigs were then euthanized immediately 
after the procedure or one week later, and the entire heart was removed for 
pathology. 
Results: One pig died during the procedure (perforation of lefl atrium): 
the other three finished the procedure, AF was terminated during ablation 
around the PVs in two pigs and during the RA ablation in the third. The 
average fluoroscopic time was 46.8 i 19.5 minutes. Post ablation, sustained 
AF was not inducible. 
Conclusions: 1) A modified catheter-based maze procedure could be 
performed using multipolar conformal catheters. 2) This procedure could 
terminate AF in a pig model and significantly reduce the procedure and 
fluoroscopic times. 
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/ 1210 97 8-Br-cGMP Reverses lsoproterenol Induced Changes of Cardiac Single L-Tvpe Calcium 
ChanGeI Gating - -. 
Frank Schroder, Gunnar Klein, Helmut Drexler. Department of Cardiology 
Medical School of Hannover, Hannover. Germany 
Background: Cyclic-GMP as the second messenger of the NO signaling 
pathway is increased in heart failure. In whole cell voltage clamp experi- 
ments 8-Br-cGMP diminishes the effect of B-adrenoceptor (B-AR) agonists 
on L-Type Calcium Current by Protein Kinase G (PKG) activation. Stimula- 
tion of ,&AR increases Protein Kinase A (PKA) dependent phosphorylation of 
L-Type Calcium Channels (LCC) via CAMP. At the single channel level, PKA 
dependent phosphorylation increases both availability and open probability. 
Hitherto, it is unknown how cGMP antagonizes PKA induced changes of 
single LCC gating. 
Methods: For registration of single LCC patch clamp technique in the cell 
attached configuration was used in mice ventricular myocytes. Depolarizing 
pulses of 150 ms were elicited by voltage steps from -100 mV to +20 mV. 
Results: The ,&AR agonist isoproterenol (ISO) enhanced single channel 
peak average current by increasing availability and open probability. Open 
probability was increased by a reduction of the time constant of long closed 
times. 8-Br-cGMP completely reversed these effects (table). Same exper- 
iments were performed in the presence of Phosphatase inhibitor Okadaic 
Acid. The effect of 8-Br-cGMP remained unchanged. 
Parameter Control IS0 8-Br-cGMP 
Peak Current [f] -131 * 32 -178 & 40* -79 rt 265 
Availability W] 67 l 6 77zIz5* 54*8§ 
Open Probability [“h] 21 l 5 27*6* 18&6§ 
Mean closed time [ms] 2.28 L!C 0.46 1.82 * 0.51 3.75i1.16 
Mean open time [ms] 0.61 i 0.07 0.58 zk 0.06 0.52 zk 0.11 
h.e, dti lmsl 0.61 i 0.13 0.58 rJz 0.14 0.59 27 0.21 
bbse, long Imsl 8.63 $I 2.0 5.31 f 1.1* 8.53 & 1.25 
Mean i SEM, n = 9 (paired), *p < 0.05 vs. control, §p < 0.05 vs. IS0 
Conclusion: cGMP reverses IS0 induced changes of single LCC gating. 
Since Okadaic Acid does not influence the effect of cGMP, PKG induced 
activation of Phosphatases is unlikely. Therefore it is rather suggested, that 
the reversal of the effect of IS0 by cGMP is either due to an inhibition of the 
B-AR signalling pathway or to a direct of phosphorylation of LCC by PKG. 
121 O-98 In Situ Hybridization Reveals Cardiac K+-Channel 
RERG-Expression in the Rat Embryo 
K.R.J. Chun’, J. Zehelein’, M. Koenena, H.A. Katus’. ‘Medizinische Klinik 
II, Medical Universty of Lubeck; ‘Max-Planck lnstitut f Medizinische 
Forschung, Heidelberg, Germany 
Introduction: Long QT-syndrome causes cardiac arryhthmias and is associ- 
ated with a specific form of ventricular tachycardia “Torsade-de-pointes-arrhyth- 
mia” which can degenerate into ventricular fibrillation and lead to sudden 
cardiac death. Recently mutations in a K+ channel, the human ether-a-go-go 
related gene (HERG) have been identified to cause the inherited long QT- 
syndrome. Little is known about the embryonic cardiac HERG expression. 
The aim of this study was to elucidate the HERG gene expression of the rat 
equivalent (RERG) in the rat embryo. 
Material and Methods: Rat embryos of the desired age E18.5 dpc (days 
post conceptionem) have been removed from the uterus and cut in 10 brn 
slices on a cryostat. Slices were fixed in 4% paraformaldehyde. In situ hy- 
bridization with a specific 50 mer [?‘sS-dATP] radiolabelled RERG-antisense 
oligo probe has been performed to detect RERG-mRNA-expression. Control 
experiments have been performed by adding unlabelled RERG oligo (100x 
excess) to the probe. Sildes were exposed to Kodak Biomaxa Film, scanned 
and processed in Adobe Photoshop@. 
Results: Here we describe the first visualization of specific RERG-mRNA- 
gene expression in the rat embryo, El 8.5 dpc. 
Very strong RERG-mRNA signal is obtained from the region of the heart. 
Additional RERG-mRNA expression is detected in the regions of central 
Fig. 1. El 8.5 dpc (sagittal section) 
RERG mRNA-expression 
Fig. 2. E18.5 dpc (sagittal section) 
control experiment 
nervous system, peripheral nervous system, striated muscle, thymus and 
small bowel system. (Fig. 1). Control experiments confirm specificity of RERG 
signals (Fig. 2). 
1 121 O-99 1 Heterogeneous Myocardial Sympathetic 
Innervation Influences on Myocardial 
Repolarization in German Shepherd Dogs With 
Inherited Ventricular Arrhythmia 
Akira Ido, Dong W. Gao, Carol A. Stillson, William O’Connell, Michael 
W. Dae, N. Sydney Moise. University of California at San Francisco, San 
Francisco, California; Cornell lJnivers& Ithaca, New York, USA 
Background: Previous studies have shown that German shepherd dogs with 
inherited spontaneous ventricular arrhythmia and associated sudden cardiac 
death have abnormal heterogeneous sympathetic innervation. We tested the 
effects of altered sympathetic innervation on myocardial repolarization in this 
colony. 
Methods: Activation recovery interval (ARI) was measured from 64 unipo- 
lar electrograms recorded on the surface of the heart in this colony (n = 5, 
age 7.0 f 0.7 weeks) and normal dogs (n = 3, age 7.3 + 0.6 weeks) during 
baseline and norepinephrine (NE) infusion, The distribution of myocardial 
sympathetic innervation and perfusion was imaged with autoradiography of 
l-125 metaiodobenzylguanidine and Tc-99m sestamibi in serial sections from 
the apex to the base. We compared the data from ARI in denervated regions 
(DR) to that in normal regions (NR) in the colony and the normal dog hearts 
0 
Results: 
involving 44 
All of the animals in the colony had sympathetic denervation 
.3% to 87.3% of the mvocardium (mean - 68.5 i 17.3%). The 
control dogs showed minimal denervation (11.1 i 1.6%, p < 0.01 vs the 
colony). Baseline ARI did not show a significant difference comparing DR and 
NR (132.3 rt 14.6 vs 130.6 + 13.2 msec). NE shortened ARI significantly in 
DR, NR and C (p < 0.01, respectively), however, the degree of ARI shortening 
in DR (-3.8 f 1.9%) was significantly larger than that in NR (-2.3 i: 1.2%, p 
< 0.01) and C (-0.9 f 2.2%, p < 0.01). ARI variability (difference between 
each ARI and mean ARI) in baseline was significantly greater in DR (-1.3 + 
2.5 msec) than in NR (-0.1 f 4.4 msec, p < 0.01) and C (-0.04 i 4.9 msec, 
p < O.Ol), and NE enhanced the ARI variability in DR (-2.3 i 2.9 msec) 
significantly greater than in NR (0.9 f 4.5 msec, p < 0.01) and C (-0.4 + 
3.7 msec, p < 0.01). 
Conclusion: The variability of myocardial repolarization and the response 
of repolarization to NE are related to the heterogeneity of sympathetic in- 
nervation in German shepherd dogs with inherited ventricular arrhythmia. 
Heterogenous innervation may play a role in increased arrhythmogenesis 
seen in this colony. 
I 1210 100 Diurnal Fluctuations in Atrial Fibrillatory 
Refractoriness in Humans 
Johan E.P. Waktare, Carl J. Meurling’, Fredrick Holmqvist’ , Antii Hedman, 
A. John Camm, S. Bertil Olsson’ , Marek Malik. St Georges Hospifal 
Medical School, London, UK; ‘Lund University Hospital, Lund, Sweden 
The nature of diurnal fluctuations of atrial cycle length during chronic atrial 
fibrillation (AF) has not been established. Dominating atrial cycle length 
(DACL) is a validated, non-invasive index of atrial cycle length during AF 
derived using the ‘FAF-ECG method’. 
Methods: Digital Holter (1 kHz sampling, 16 bit A to D, 17 hrs duration) 
was recorded in 21 pts (1.5 men, age 64 f 12 years) with AF. ECG from 
one lead was subjected to QRST subtraction and frequency domain analysis 
(windowed FFT) to derive the DACLof a 5 min segment each hour using the 
FAF-ECG method. 
Results: The mean DACL was 154 f 20 ms (range 133-186 ms), and 
was lower during the day (07:30-21:30) at 150 & 17 ms, than during the 
JACC February 2000 
night (23:30 to 06:30) at 157 i 22 ms (p = 0.0002). The difference between 
day and night-time values was greatest in those with a high mean DACL 
(Spearman R = 0.72, p = 0.001). Recorded patient characteristics (drug 
treatment, LV function, LA diameter, AF duration and age) exhibited no 
statistically significant relationship to the mean DACL or to the magnitude of 
night-day difference. 
Conclusion: Diurnal fluctuations in atrial electrophysiology occur during 
chronic AF. Although greatest variation is seen in those with a long DACL, 
suggesting a role for remodelling, clinical features such as AF duration do not 
predict the DACL. Diurnal changes seen would be consistent with an effect 
of fluctuations in sympathetic tone, but not with vagal tone, which lengthens 
the atrial refractory period. 
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121 I-59 lschemia Detection by Means of a Subcutaneous 
Electrode Array 
Shannon Nelson, Linda Nelson’, Lee Stylos, Kenneth Baran’, Rob Stadler. 
Medtronic, Inc., Minneapolis, Minnesota; ‘St. Paul Heart Clinic, St. Paul, 
Minnesota, USA 
Background: Electrograms recorded from a subcutaneous electrode array 
(SEA) mounted on a pacemaker have been shown to have signal character- 
istics comparable to the surface ECG. Continuous ischemia detection and 
diagnostics rom an implantable device may allow for warnings of severe 
ischemic episodes and possibly improved treatment for patients with coro- 
nary, artery disease. This two-part study was designed to test the ischemia 
detection performance of the SEA when the patient was at rest (PTCA) and 
engaged in exercise (stress thallium). 
Methods: In part one, twenty patients (13 male, age 60.5 & 13.4 years) 
underwent PTCA to alleviate cardiac ischemia. The signals recorded included 
ECG leads I, II, V6 and three signals from an SEA device. The SEA device 
was placed on the skin surface resulting in signals similar to a subcutaneous 
placement. Part two, consisted of nineteen patients (17 male, age 61.7 * 
10.7 years) with positive thallium exercise stress test. ECG leads II, aVF, V6 
and the three SEA signals were collected. All signals were processed off-line 
using an algorithm, which included beat-by-beat measurement of the ST 
segments and noise filtering steps to output ST changes normalized by the 
R-wave amplitude. The sensitivity curve for SEA and ECG to either balloon 
inflation or positive thallium was calculated by applying a varying threshold 
to the ST output. 
Results: There was no statistical difference between the two signal types 
over the range of thresholds in both studies. For example, at a threshold of 
5% of the R-wave amplitude the PTCA study showed the overall sensitivity of 
SEA and ECG to be 0.48 + 0.12 and 0.53 f 0.14 respectively. At the same 
threshold, the thallium study the sensitivity of SEA and ECG is 0.56 f 0.16 
and 0.53 i 0.11 respectively. Analysis by lesion location suggested the SEA 
was more sensitive to LAD and ECG was more sensitive to RCA. 
Conclusion: Through this study we have demonstrated that ischemia 
detection from the SEA shows the same level of performance as the sur- 
face ECG in resting and exercise environments. It is feasible with current 
implantable technology to implement the SEA and an ST-segment algorithm. 
Continuous monitoring of ischemia could aid the physician in the treatment 
of patients with acute coronary syndrome. 
121 l-60 Wavelet Decomposition of the Signal-Averaged 
Electrocardiogram in Evaluation of Prognosis in 
Idiopathic Dilated Cardiomyopathy 
Gang Yi, Katerina Hnatkova, Niall G. Mahon, Philip J. Keeling, William 
J. McKenna, Marek Malik. St. George’s Hospital Medical School, London, 
UK 
To evaluate the potential prognostic utility of signal averaged EGG (SAECG), 
wavelet decomposition (WD) and time domain analysis (TD) of the SAECG 
were performed in 82 patients (pts) with idiopathic dilated cardiomyopathy 
(IDC; age 43 f 14 yrs, 60 men) and 72 normal controls (CON; 44 rt 15 
yrs, 48 men). Conventional TD indices (QRSd, LAS40, RMS40) and WD 
parameters (QRS length, maximum count, surface area, relative length) 
were derived from each recording using Del Mar software and an m-house 
program respectively. 
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Results: 1) More IDC pts had late potentials (LP; 28% v 8%, p = 0.002) 
and abnormal WD analysis results (abWD; 50% v 3%; p < 0.0001) than 
CON. QRSd was significantly longer (p < 0.001) and all WD measurements 
significantly differed in pts than in CON (p < 0.01). 2) No difference in mean 
values of TD was observed either between pts who developed progressive 
heart failure (PHF) and those who remained clinically stable (S) or between 
pts with and without arrhythmic events (sudden death/sustained VT; N = 
11) during follow-up (23 i 18 months). Significant differences in 3 of 4 WD 
parameters were found between PHF (N = 23) and S (p < 0.001) but WD 
failed to identify pts with arrhythmic events. 3) Survival analyses showed that 
pts with LP tended to develop PHF more frequently than those without (p = 
0.06) and pts with abWD were more likely to develop PHF during follow-up (p 
= 0.027; Fig). 4) AbWD predicted PHF with sensitivity 74%, specificity 61%, 
positive and negative predictive accuracy of 45% and 85%, respectively (p 
= 0.005). A significant association between abWD and PHF was shown by 
univariate analysis (Cox model; p = 0.01). 
Conclusion: WD of SAECG is superior to TD for identifying pts at risk 
of clinical deterioration. Both WD and TD failed to differentiate pts at risk of 
arrhythmic events in IDC using present techniques. 
121 l-61 Improved Predictive Ability by Combination of 
Time Domain and Spectral Temporal Mapping 
Analysis in Chronic lschemic Cardiomyopathy 
Angelos G. Economou, George N. Kazianis, Spyros L. Feggos. 7th IKA 
Hospita/, Athens, Greece 
Background: Abnormal signal-averaged electrocardiogram (SAECG) has 
been identified as prognostic determinant after recent myocardial infarction. 
However, the prognostic significance in chronic coronary artery disease has 
not been studied systimatically. In this study we ingestigated the hypothesis 
that combined time domain analysis (TDA) and spectral temporal mapping 
(STM) of the signal-averaged electrocardiogram (SAECG) could improve the 
predictive ability for cardiac mortality in patients (pts) with chronic ischemic 
cardiomyopathy. 
Methods: We prospectively studied 310 pts in sinus rhythm, of whom 
68 (21.9%) with bundle branch block, aged 63 + IO years, with ischemic 
cardiomyopathy due to an old myocardial infarctrion and echocardiographi- 
tally estimated left ventricular ejection fraction (LVEF) < 35%. SAECG was 
recorded in all pts. TDA in pts with QRS duration in surface ECG < 120 ms 
was considered positive for late potentials (LP) when fQRSD > 114 ms and 
either LAS40 > 38 ms or RMS40 < 20 @V whereas in pts with QRS z 120 
ms was considered positive for LP when fQRSD P 155 ms and either LAS40 
P 55 ms or RMS40 < 17 @V. STM was performed using FFT-Plus software. 
The test was considered abnormal if the normality factor was ~30% in any 
of the three X, Y or Z leads. Eighty-two (26%) pts had prior CABG surgery. 
Results: During a follow-up period of 33 & 22 months there were 119 
(38.3%) cardiac deaths. In multivariate logistic regression analysis the inde- 
pendent predictors of mortality, in the following order of importance, were: 
age (x2 = 25.6, p = O.OOOOl), LVEF (x’ = 16.36, p = O.OOOi), combined LP in 
TDA and abnormal STM (x2 = 11.4, p = O.OOOS), prior CABG surgery nega- 
tively (x2 = 5.44, p = 0.020) LP in TDA (x2 = 4.88, p = 0.027) and abnormal 
STM (x2 = 4.85, p = 0.028). 
Conclusion: These results suggest that in pts with ischemic cardiomy- 
opathy the combination of LP in TDA and abnormal STM of SAECG is the 
next to age and EF most powerful independent predictor of mortality. The 
combined TDA and STM improves the prognostic ability of SAECG compared 
with TDA or STM analysed separately. 
/ Analyses 
1211 62 Heart Rate Turbulence: Frequency Domain 
Raphael Schneider, Georg Schmidt, Andreas Rock, Petra Barthel, 
Marek Malik’ , A. John Camm’ , Albert Schdmig. Deutsches Herzzentrum & 
1. Medizinische K/in/k, Technische Universitat Mtinchen, Munich, Germany: 
‘St. George’s Hospital Medical School, London, UK 
Background: Until present Heart RateTurbulence (HRT) has been quantified 
in the time domain as Turbulence Onset (TO) and Turbulence Slope (TS). 
Aim of this study was to investigate if frequency domain analyses reVed 
additive information. 
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Patients: A total of 571 patients of the placebo arm of the EMIAT study 
was enrolled. 
Methods: In second week after the index infarction a 24-hour Holter ECG 
was performed and the HRT tachogram was calculated. In the related power 
spectrum, the frequency (TF) and amplitude (TA) of the dominant peak were 
assessed. Their cut-off points were determined by the method of maximizing 
the log-rank test statistics. Primary endpoint was total mortality. Multivariate 
risk stratification was performed using TF and TA together with conventional 
risk factors. For the latter variables previously published cut-off points were 
used. Continuous variables were compared by means of the Mann-Whitney 
test. For dichotomized variables the Cox proportional hazards model with a 
stepwise forward procedure was used. 
Results: During a median follow-up of 21 months, 80 patients died. In 
the univariate analyses TA was significantly associated with mortality (p < 
0.0001) whereas TF was not. The optimal cut-off point for TA was 10.6 ms. 
The multivariate analyses revealed that TA, TO, mean heart rate and history 
of previous infarction were independent variables for mortality prediction 
(only significant factors are shown). 
Variable 
TA 
TO 
Mean heart rate 
Previous Ml 
Relative hazard 
2.2 
2.0 
1.9 
1.8 
P 
<O.OOl 
<O.Ol 
<O.Ol 
<0.05 
Conclusion: The amplitude of the HRT power spectrum is a strong and 
independent risk predictor in post-Ml patients. 
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El 910 1 Visible T-Wave Alternans in Carriers of LQTl, LQTZ, and LQT3 Gene Mutations 
Wojciech Zareba, Arthur J. Moss, Mark L. Andrews, Jennifer L. Robinson. 
The international LQTS Registry Research Group, University of Rochester, 
Rochester, NL: USA 
Visible T-wave alternans (TWA) detected in ECGs of LQTS patients always 
increases the awareness regarding potential risk of cardiac events (CEs) in 
these patients. The occurrence of visible TWA and its association with ECG 
characteristics and clinical course of LQTS were evaluated in 334 carriers of 
LQTS gene mutations: 146 LQTl, 134 LQT2 and 54 LQT3 carriers (mean 
3.2, 3.7 and 3.7 ECGs per patient, respectively, p = ns). Visible TWA was 
found in 34 (10%) of all LQTS carriers with the following breakdown by 
genotype: in 11 (8%) LQTI, 9 (7%) LQTP, and 14 (26%) LQT3 carriers (p < 
0.001). Table 1 shows ECG characteristics and CEs by TWA and genotype 
in studied patients: 
Table 1 
LQTI QTc (ms) 466 zk 46 536 + 70 0.04 
HR (bpm) 74 * 21 04 zk 23 0.14 
CEs 53% 73% 0.20 
LQTZ 
LQT3 
QTc (ms) 
HR @pm) 
CEs 
QTc (ms) 
HR @mm) 
466 * 53 507 i 43 0.30 
72518 68119 0.56 
36% 78% 0.02 
501 i 43 542 f 57 <O.Ol 
71*20 74f25 0.62 
CEs 15% 50% <O.Ol 
Prognostic significance of TWA in gene-specific Cox models for predicting 
CEs is shown as hazard ratios (p-values) in Table 2: 
Table 2 
LQT1 LQT2 LQT3 
OTC >500 ms 1.43 (0.122) 1.92 (0.021) 0.69 (0.576) 
TWA (+) 2.29 (0.030) 3.26 (0.005j 6.75 (0.004j 
Conclusion: TWA is more frequent in patients with LQT3 than LQT or 
LQT2 genotypes. ECG-recorded TWA is associated with an independent risk 
of CEs in all three genotypes, with the risk most marked in LQTB. 
lo:45 a.m. 
El 910 2 Swimming is a Gene-Specific Arrhythmogenic Trigger for Inherited Long QT Syndrome 
Michael J. Ackerman, David J. Tester, Co-burn J. Porter. Mayo Eugenio Litta 
Children’s Hospital, Mayo Clinic/Mayo Foundation, Rochester, Minnesota, 
USA 
Background: Detects in five genes encoding cardiac ion channel subunits 
provide the molecular basis for inherited long QT syndrome (LQTS). Muta- 
tions in KVLQTI are most common but only account for one-third of cases. 
Swimming appears to be a frequently cited arrhythmogenic trigger in LQTS. 
We speculated whether or not defects specific to KVLQTI would be found in 
a subset of patients with LQTS having either a personal or family history of a 
swimming-triggered cardiac event. 
Methods: A retrospective cohort, of 35 index cases diagnosed with LQTS 
from 1975 to 1999, was identified following review of the Mayo Clinic medical 
records. Exon-specific amplification by polymerase chain reaction and direct 
sequence analyses were performed on the KVLQTI gene. 
Results: Six of the 35 index cases had a personal or family history of 
a near-drowning or drowning. LQTS-causing mutations in KVLQTl were 
identified in all six cases. KVLQTl mutations were demonstrated in 3 of the 
remaining 29 index cases. The overall frequency of KVLQTI-mediated LQTS 
was 9 out of 35 (26%) in this cohort. 
Conclusions: Swimming appears to be a gene-specific (KVLQTI) ar- 
rhythmogenic trigger for LQTS. This study provides increasing evidence to 
consider a genetic basis for unexplained drownings. 
11 :OO,a.m. 
/_ 910 3 Familial Effort Polymorphic Ventricular Arrhythmias 
rn Apparently Normal Heart Map to Chromosome 
1 q42-q43 
Barbara Bauce, Andrea Nava, Alessandra Rampazzo, Luciano Daliento, 
Michela Muriago, Cristina Basso, Gaetano Thiene, GianAntonio Danieli. 
Dept. Cardiology Biology and Pathology University of Padua, /ta/y 
Objective: Polymorphic ventricular arrhythmias (VA) are described in coro- 
nary artery disease, congenital or acquired long QT syndrome and in a 
wide spectrum of “idiopathic” VA. In the present study we report another 
cause of this type of arrhythmia associated with familial arrhythmogenic right 
ventricular cardiomyopathy (ARVC) linked to chromosome lq42-43. 
Methods: Two families with 48 subjects were studied. The clinical study 
included 12-lead electrocardiogram, 24-hour ambulatory ECG monitoring, 
chest X-ray, M-mode and two-dimensional echocardiogram, signal-averag- 
ing ECG and exercise stress testing. Six subjects also underwent cardiac 
catheterization with right and left ventricular coronary arteriography and elec- 
trophysiologic study. The endomyocardial biopsy was performed in one sub- 
ject. The genetic study included pedigree reconstruction and linkage analysis 
with polymorphic DNA markers. 
Results: Five young subjects died suddenly during exercise. Autopsy 
was performed in three and showed segmental fibro-fatty replacement of the 
right ventricle, mostly at the apex. Two of them had had syncopal attacks 
during effort. Sixteen living subjects, without VA at rest, had polymorphic VA 
during effort. ARVC was diagnosed in 15 of these subjects whereas one 
did not have any demonstrable cardiac abnormality. The remaining family 
members were healthy and did not have VA. The linkage study assigned 
the disease locus to chromosome lq42-q43, in close proximity to the al- 
pha-actinin 2 locus (maximal lod score was 5.754 at Theta = 0) with a 95% 
penetrance. 
Conclusions: These data suggest that effort-induced polymorphic VA and 
juvenile sudden death can be due to adrenergic stimulation in a particular 
genetic group of ARVC patients, In our. cases the pathology was segmental, 
mostly localised to the right ventricular apex. VA which are present in these 
families differ from the monomorphic ones which are usually seen in patients 
with ARVC. 
11:15 a.m. 
I. 910 4 Antrarrhythmic Drug Therapy in the Multicenter 
Unsustained Tachycardia Trial (MUSTT): Penetrating 
the Matrix 
D. George Wyse, Mario Talajic, Gail E. Hafley, Denise Grimes, 
Kathleen Hickey, William H. Kou, Teresa K. Kus, Robert Lemery, 
Michael Proschan, James A. Reiffel, Peter Santucci, Steven N. Singh, 
Carolyn Stevens. For the MUSTY Investigators; Calgary, Alberta, 
Canada 
In MUSTT, antiarrhythmic drug therapy which prevented ventricular tachy- 
cardia (VT) induction or rendered induced VT hemodynamically stable (“ef- 
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fective”) did not confer any survival benefit. The present analysis explored 
the matrix (drug trial number, noninducible vs stable VT, specific drug) of 
drug testing in relation to death, censoring for defibrillator (ICD) implants. 
“Effective” drug therapy was found for a relatively constant proportion of 
patients during drug trials 1, 2 and 13 (32%, 29%, 39%). The proportion with 
noninducibility fell after drug trial 1 whereas that with stable VT increased 
(29%, 17%, 20% vs 4%, 12%, 18%, respectively for drug trials 1, 2 and ~3). 
A sodium channel blocking effect (Class I, amiodarone) produced stable VT 
(37/436 trials) but sotalol did not (l/82 trials). Stable VT was found most 
frequently with amiodarone (14/49 trials), used primarily after other drugs 
failed. Nonfatal VT recurrence was more frequent in patients with the stable 
VT endpoint. Survival (%) in subgroups discharged on “effective” therapy 
was: 
NO 
Therapy 
“Effective” Therapy 
All NOll- Stable CIXGS SOT PPF AM10 
inducible VT IA 
N 353 166 128 38 93 34 17 22 
lY 84 87 87 87 88 88 82 86 
2Y 73 75 76 73 78 76 65 73 
SOT = sotalol PPF = propafenone AM10 = amiodarone 
“Effective” drug therapy, other than PPF, was numerically better than no 
antiarrhythmic therapy in this 2 year on-treatment analysis. The numbers are 
small and differences nonsignificant so conclusions are tentative. 
Conclusions: PPF may be harmful in these patients. A single trial to 
achieve noninducibility with drugs other than PPF may have potential for a 
small benefit if tolerated, but without placebo control a drug effect cannot be 
attributed. Otherwise, ICD therapy is preferred. 
11:30a.m. 
!IIl 910 5 NYHA Class is More Predictive of Proarrhythmic Risk Than Ejection Fraction in DIAMOND 
A. John Camm. On behalf of the DIAMOND Study Group: St George’s 
Hospital Medical School, London, UK 
Background: The Danish Investigations of Arrhythmia and Mortality ON 
Dofetilide CHF and MI studies (DIAMOND CHF & Ml) included 3028 patients 
(pts) with a left ventricular ejection fraction (LVEF) ~35% and either severe 
(NYHA Class III/IV) congestive heart failure (CHF) or recent myocardial 
infarction (Ml). Patients were randomized to dofetilide (D) or placebo (P). 
Methods: Torsade de pointes occurred in 32 of 1511 pts randomized to 
D. The relationship between TdP and NYHAfleft ventricular ejection fraction 
(LVEF) is explored. 
Results: There was no excess mortality on D (541/1511) compared 
with P (560/1517). At baseline, 96 (6.4%) 651 (43.1%), 638 (42.2%) and 
83 (5.5%) dofetilide treated patients had NYHA functional class I, II, Ill or 
IV, respectively. LVEF as assessed by wall motion index was 2535% in 
1219 (80.7%) and ~25% in 292 (19.3%) pts. The overall incidence of TdP 
on dofetilide was 2.1% (32/1511). This incidence of TdP was related to NYHA 
class at baseline but not to LVEF (see table). There was no excess mortality 
on D (541 deaths on D, 560 deaths on P). 
Incidence 
of TdP 
NYHA NYHA LVEF 25- LVEF <25% Total 
i/11* Ill/IV” 35% 
71747 25/721 2511219 71292 32/1511 
(0.9%) (3.5%) (2.1%) (2.4%) (2.1%) 
* NYHA class missing in 43 patients 
Conclusion: The incidence of TdP is more closely related to functional 
capacity (NYHA class) than LVEF. There was no excess mortality observed 
in these two studies of patients with reduced LVEF. 
11:45 a.m. 
I 910 6 Impact Directly Over the Cardiac Silhouette is Necessary to Produce Ventricular Fibrillation in an 
Experimental Model of Commotio Cordis 
Mark S. Link, Barry J. Maron, Brian A. VanderBrink, Masaaki Takeuchi, 
Natesa G. Pandian, Paul J. Wang, N.A. Mark Estes Ill. Minneapolis Heart 
Institute Foundation, Minneapolis, MN; Tufk University School of Medicine, 
New England Medical Center, Boston, MA, USA 
Background: Sudden death can result from a relatively innocent blow to 
the chest by a baseball, hockey puck or other object (commotio cordis). 
Human data suggests that these lethal blows occur over the precordium. 
However, the precise location of impact relative to the risk of sudden death 
is unknown. Therefore, we sought to define the area of lethal chest impact in 
an experimental model of commotio cordis. 
Methods: Anesthetized animals with Millar@ pressure catheters in the 
left ventricle were placed prone in a sling. Up to 14 impacts were delivered 
under echocardiographic guidance at 3 sites over the cardiac silhouette (i.e., 
directly over the papillary muscle, base or apex of the left ventricle), 2 other 
non-cardiac sites on the left chest wall and 2 sites on the right side of the 
chest. Impacts were gated to the upslope of the T-wave, the vulnerable 
portion of the cardiac cycle. 
Results: Fifteen animals received a total of 179 chest impacts. Ventricular 
fibrillation (VF) was produced only by impacts directly over the heart (p x 
0.0001). Chest blows over the papillary muscles (7 of 23; 30%) were more 
likely to cause VF than impacts at the left ventricular base (4 of 30; 13%) 
or left ventricular apex (1 of 25; 4%). Greater peak left ventricular pressures 
induced by the chest blow correlated with the risk of VF (298 f 48 mmHg in 
those with induced VF vs. 170 & 74 mmHg in those without induced VF; p x 
0.006). 
Conclusions: For chest wall impact to cause sudden death (commotio 
cordis), impact must occur directly over the anatomic position of the heart. Ini- 
tiation of VF appears to be mediated by a substantial increase in intracardiac 
pressure induced by the blow. In order to prevent sudden death from chest 
wall impact in sports, chest wall protective equipment should be designed to 
cover all portions of the chest wall that overlie the head, even during body 
movement and changes in position occurring with athletic activities 
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